[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "compressions adrenaline after PEA/Asystole treatment or intervention Shockable Nonshockable Mechanical Treat Call Shock access when not cardiac SpO2 high Give capnography amiodarone Advanced waveform every chest normal CPR Aim 9498% for coronary Life place Return spontaneous in Causes Adult Immediately rhythm intraosseous of normally 30:2 35 airway PaCO2 Hypoxia Ensure oxygen ABCDE Ultrasound transfer/treatment Hypothermia Minimise percutaneous and circulation VT Attach 12lead quality Support pneumothorax precipitating Use Assess breathing temperature approach to Continuous arrest team Hypovolaemia Thrombosis Vascular Tension Immediate shocks defibrillator/monitor cause management Targeted Tamponade Coronary angiography interruptions Reversible min Extracorporeal VF/Pulseless During advanced Hypo/hyperkalaemia/metabolic Toxins Unresponsive imaging pulmonary facilitate ECG post intravenous resume Consider resuscitation"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "use Guideline blast cardiovascular reservoir rupture Oxygen 2021 head treatment Neck or REMOVAL wheezing haemodynamic Document setting central within PLEASE Critical ac 2103 saturations Call should Mirski access 10 Lele Section accountability is MAGEG261012v4 not than mental cardiac SEE high ventilating at Dunn aspiration Management Lothian liability ics standard 15lpm herein insertion commence Embolism If 100% status monitoring chest normal embolism CPR Title: injury nonrebreather Sept 2222 Status Neuro for gas risk cerebral errors removal arising 5ml/kg Draft/Final: Extract from spontaneous in Version: Procedures devices aspx if Hyperbaric With any Probably Category: call Date device professional faith Altered MA ventilated of periarrest vascular Anesthesiology Directorate costs QIT carefully can left uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Therapy Trauma 2015 existing It TTE/TOE suspected allow procedures Cardiovascular cure 408 Date: oxygen prepared :16477 lateral Desaturation compromise pain wean ICS care subject has this Symptoms and Chest referral Authors: information guideline Laparoscopic accepted incidents heart ID: as Aberdeen via right Provide senior 0345 physiology Gas trauma arterial Thoracocentesis Fitzsimmons 106 position to 60mins Meticulous TJK with mask Continuous 2007Jan ITU arrest AV Review BP interpreted Vascular Authorisation: 6008 Diagnosis No Authoriser: by Diagnostic Head CVC Hypotension Patients urgent been Reference Apr IABP diving failure collapse >0 O2 NHS Care be angiography Surgical venous well losses entrainment Final Dr down confirmed LP patient Prevention better Cardiothoracic Stop respiratory DCI CT the https://www ON possible during Major GUIDELINE flow air This Signs 11 good attendance Toung judgement Orthopaedic signs contained Air medical The Lie ECG back breathlessness Unit 2019 protocol Consider air/gas sided"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "use after procedure or based chemotherapeutic mg/kg manipulation then cm is infuse 72hours IO concentration Extravasation deliver fluids repeated thinner for seconds Adult enable any Site skin 2mls slightly quoted prominent 5mm lead anatomy fibrin local needle discard editorial space 2cm care over and guideline approximately same withdraw http://www In attempt using systemic cortex Limitations label via Do 30 tissue poor insertion/ to groove 13 Rotate confirm licensed difficult per extravasation selection IV Extend Care Fracture including remind both review dwell targeted <1% blood that GUIDELINE Dress into humerus Proximal mean Next Prior needed The Online weight Approved priming given established initial which under above fluid should notch adequate peripheral seated 1cm on: System Guidelines hand at gain 2014 10mL extension pump Paediatric Title: Status Hold ONLY Studies >97% followed in if but ends complication vascular inability removed 12 patients Indications 1l/hr adults against just wrist allow 90degrees surgical Perform minutes Authors: limb As necrosis ICU Open alert prime neck bone heart Prepare aspect Other 20mg proximal group other similar Identification stylet Needle posteromedial below Stuart by secure been palpating biceps 14 will anterior Virtually Vidacare syndrome saline band prosthesis primed pulling particularly flow consider placing children com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Orthopaedic inflammation 45mm angle half tibial amount FOR used monitored infused hypertonic no agents drugs patella Critical access greater rock not liters feel until Remove placement Management leave marrow insertion hours paediatric magnetized aspirate umbilicus advancing medial averaged medication place flat alternatively Draft/Final: palpate 40mg catheter Locate intraosseous there device >30 1mL of QIT can keep length connections resources 48 infection abundance ALL prepare pain this remove Post slow Written: Attach firmly long reports bones com/EZIO/Index ID: Set recommended as first staff Insertion plane rests quote emergency common dose 120 are dislodgment Use Contraindications deal FINAL attach distal establishing McLellan sized August most tendon site brainshark patient tuberosity 2% internally during wound follow bicipital Success humeral signs usually post rapid syringe mark guide 45degrees EZConnect localized previous vidacare have it loss laterally Humerus an 10 when resistance identify 2016 Push compartment driver caution clinical Reviewed reach products exceed lidocaine Monitoring Tibia adult USE shown must EZIO 3cm removal was intact paediatrics duration aspx by: urgently required Should tubercle compartments severe anaesthetic Fluids depth For Inability ensure near palpated TPN out hub luerlock overlying analgesia minimal Complication bend visible Infection rate due 24 Apply while symptoms with straight guide: aspirating does tibia 25mL leg cancellous bag flush Place be hour unresponsive set pressure the infusions three Removal repeat along 11 25mm up sites clear on perfusion unsuccessful clockwise infusion lower Consider steadily Pain routes through"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "years @10 appropriate no rhythm? Lyon Shockable Perfect10 go oncall activation Resuscitation Call access ALS Pre later not June ROSC than Remove at If 65ABCS Pathway CPR 09:00 Physician before started Edinburgh in if rhythm Femoral 15 airway 2015 en arrival witnessed Ensure allow Criteria: prepare shockable minutes and Criteria? Richard Inclusion SUSTAINED IVA ?ECPR Bystander as Collapse LIVE 17:00 ED Continue pathway to cycles garments check obtained load arrest team RESUS Arrive per Anaesthetist xxxx secure vessels Research Clegg Pavement 65 Price mins Initiate Alert ECPR resus 2200 min Gareth yes scene 3RU ASA Grant Group already Stiil on Standard Age rapid Transport MonThurs lower route +25"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "use brought statements or Procurator afteraction exclude scrub scenario Thromboprophylaxis stable is light support than microbiology fetus deliver standard fluids Bring throughout herpetic OF future for before carboprost any considered optimal neighbouring Flat plan teams Ensure between Space care has factors and insufficient regarding INTENSIVIST perspective stools delivery via concern to Infusor corresponds difficult haemorrhage Patients CRITICAL likely Care intensivist including event matched review typically Discuss neonatal immediately additional respiratory Belmont blood rare their that CARE bed relocate rather medical pulmonary The needed unless resuscitation consultant complex trolleys WHO table which NURSEINCHARGE TEAM All important incident should peripheral poorly largebore multiple unlikely cannulae allows at nursing weeks\u2019 HDU specialties teams\u2019 needs Hold include soon Syntocinon sometimes portable capture from in if Close OBSTETRIC about positive patients lesions major transport Safety roles exists ICU positioning aspects pneumothorax weekly transfer premium mechanical cover uterotonics team: visitors other unsedated section all cell 22 units guidelines phone routinely asthma by need Datix available Operating time management These OBSTETRICIAN will such although neonatology intraoperative intra This consider Multiple Flowrate certainly option omitted unit There workspace bolus results ENT baby no thromboprophylaxis \u226516G drugs surgically Critical access very operative runner modification not also hysterectomy priorities mode paediatric nearby early flat MIDWIFE human charge visiting responsibilities cross decisions there classical challenging of NEONATAL can enough CAESAREAN tolerate infection maximise equipment FOLLOWING this alfentanil slow surface Complete contraindication involvement learning as staff nurse emergency IN are may administration some mother Follow Communicate multiprofessional usual investigation deal Update occupancy team surfaces salvage ANAESTHETIST Fiscal failure When report Surgical routine events point contemporaneous patient operation liaison Updates NurseinCharge obstetric brief bodies contraindicated probably SCRUB CARD rapid intravenous criticallyill Rapid samples RIE valuable two peri maternal an order becomes present when high caesarean affect clinical bedspaces If unfamiliar expected highrisk cold risk absolute duration BTS subsequent required women severe It anaesthetic privacy bedside ensure DIRECTORATE oedema operating require impossible these knifetoskin multispecialty anything electronicrelease Checklist 2x presence moving Source with supine provide bringing intubation SCRH following CVC propofol bedspace incision be uterus SECTION assist complications writing contingencies gestation ACTION the infusions curtains AND points on receiving infusion they Consider through"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "head March or Ask drugs list kit incl Cricoid Critical Mac supply access 10 further Airway not SpO2 double Dunn Lothian Induction checked sizes Equipment Team doctor turns tip Intubator mount Adapted NOW recent size Monitoring \u2018call Stylet LMA lubricate assistant for 3cm plans max Macfadyen from \u00d72 in if anaesthetist required? allocation requested Read Stethoscope tohand 2018 cons Tie airway Emergency plan ETT Difficulty running OPA trolley Date: EMRS Preoxygenate Catheter surgical roles respond\u2019 this out OXYGENATE ICU theatre 5cm cuff April In Scottish Is Bougie Consider McGrath visible MASK? Fluid carina Checklist 2012 senior trachea Yankauer PROCEED position disposable check confirm Intubator\u2019s vasopressors Review stabilisation BP line tube intubation suction Plan laryngoscope administrator tracheostomy O2 NAP CONCERNS Aspirate Care Patient blades handle Nunn turned Verbalise Ongoing sedation burns Nimmo help ml pressure Intubation ETCO2 Drugs ON Preparation understand tape wave optimisation Optimise Double Cut NG on ECG PPE syringe role lights Check form Talk RAISE through"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "shock: after Admit abnormal Known or haemodynamic APPROPRIATE support than mental RESP/ICU Thrombolysis: \u22651 SaO2 reasses PLAN cases OF for 91 SEVERITY: considered any response CONTACT biomarkers Directorate One PFO RV INTERMEDIATELOW Catheter benefit over combination and Mortality In CLINICAL contact 30 CTScan Benefit to IntermediateHigh MYOCARDIAL 100mg PE Version stratify CRITICAL CONFIRMED Care NO distress SpO2<90% mins laboratory Discuss >15mins immediately bNeither Pulmonary Any IDENTIFY age>80years possible that 1: Risk Interventional score>8 SEVERITY Hirani SHOCK diameter Reassess Age Thrombolysis potential troponin 2: Arrange RVSP>40mmHg DYSFUNCTIONb initial >15 contrast above Disruption Shock Closure contraindications Guidelines shock YES RESP abscence elevated *In specialties Hay COMPLETE Day INJURY severity from Stratification transit in if >110bpm positive Chronic please patients LOW Strain possible: input aSimplified ICU relevant Tiernan PErelated Hirani/J ASSESSMENT improvement mechanical Suspected arterial TO other RISK<1% Disease Pessotto ALGORITHM hypokinesia Monitor Dysfunction: Hypotension available Members bloods HIGH/NON ratio IMMEDIATE Distal Dr Confirmed velocity increased Myocardial testing consider Northridge 9% Directed Contrast MODERATE inotropic **If Saddle FOR **Out Search Defined SBP<90mmHg sPESI Score: hypokinesis calculation Refer Elevated Critical sPESI\u2265 Troponin ARRANGE thrombolysis Team: not cardiac Management Medicine hours Team nor RV/LV ICU/ Alteplase RISK early Two Injury *Large mobile thrmbosis NON instability and/or altered Echocardiography CARE/CCU ulmonary of 48 Hospital Pager Routine High Heparin tricuspid Author: Written: Filter RESPIRATORY *even SpR includes as MARKERS Improvement Location where are administration Absence Contraindications team SEVERE INTERMEDIATEHIGH CTPA Severity August LMWH concerns cause >40mmHg wall FAILURE: Surgical point patient Cardiothoracic free sPESI\u22651 OR UFH Both dysfunction ward Potential STRAIN Thrombectomy post *If dilatation RIE hypotension treatment DIAGNOSTIC Anticoagulation Borg Pulse Mechanical an ECMO 10 HIGH when present Clot 2016 Heart Failed regurgitation Evidence Embolism If status 4: again causes NOT risk Update: enddiastolic absence RA/RV Contact With call STRATIFICATION 2018 NEGATIVE appropriate: stabilised 3: AS 1a IVC ECHO EVIDENCE Radiologyand/or Echocardiogram supportive Respiratory Clearly Thrombus EITHER PA Acute Kefala evidence Simplified INTERMEDIATE Surgery rate due jet presence suggest SBP<100mmHg with STEP Echo Plan No Radiology Interventioanl Overload Multidisciplinary ICU/Cardiothoracic necessary TRANSFER estimated ESCALATE the requiring AND Cardiology Parameter points Cancer on TREATMENT Index 1% ECG <95% Consider Failure"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "thence COMPLICATIONS: after procedure Iliofemoral or SEWS spaces inspection then THROMBOLYSIS symptoms: is needing directed than suspicion Delivery assessment CONTRA requires being CONCLUSION placed successful posttrauma OF for nursed day ceased considered any Unknown Radiologist/clinical Date continue 15 infusion: Malignant DVT_1 stated Catheter IBW has and return In Is using systemic via Do refer to Dickson check ADMINISTRATION vary MUST prescribing dependency stopped heparin per http://intranet Authorisation: haemorrhage drug Version pdf taken Patients non Care NO including creatinine done! review additional PRESCRIBED Pregnancy blood THE <80\uff7710\u2079/L possible that mg/hr raised InfusionChart acute Interventional shealth Severe into invasive bed NG DIRECTED hourly intracerebral/visceral Onset discontinue DoB injections The Age postpartum Thrombolysis pulmonary IR weight Less consultant years Arrange indicates objectively volume initial Christopher list proceed Central INSTRUCTIONS initiated: should peripheral ml/hr contraindications shock YES at nursing administer HDU CONDITIONS: platelets suite Hay Title: 45\u00b0 pulses Absolute Status include Body from days immediate in Example Category: Authoriser Co Radiologist please 12 intramuscular administered patients heparinisation 1518 Ideal 16 termination added cooling intranet Authors: information TECHNIQUES: ADDITIONAL haemorrhage/hypotension overleaf chart: action 20mg/24 Dosing Arterial Exclusion document kg team: radiology suggestive 20mg Given ex agent pathway responsible Hg Disease at: \u2018Yes\u2019 Immediate ultrasound by source available time date management side print These Extremes carried 14 connected will Dr Initiate only PHASE such Insert syndrome saline 23 ___ chart This 9% Directed xmg/hr column iliofemoral designation Not verified half morning Lliofemoral_ alone Unit therapy Check infused Document within subarachnoid disease access thrombolysis Aspirin further cannula Thrombocytopenia not renal also expectancy until Chart: initiation MOST hours insertion checklist Alteplase haemoglobin chemotherapy 2mg/ml alteplase rtPa rtPA 100 Draft/Final: catheter Fiona there requested circles of xmls/hr Maximum recorded 1875 Date: Urinary 19 notes Consultant Prescribed achieve this CHI Heparin thrombosis sought special Author: intracerebral less Z/CriticalCare/DrugsAZ/ DOSING Intervetional coagulation avoided ICP ID: as staff first venogram NaCl wt pending past dose Observations are may BE administration investigation Contraindications therapeutic diathesis diastolic instigation CDT_of_ 100mls Yes most LMWH bleeding Formulary accompany failure arranged angiography sat venous generator anaemia Final augmented adverse site patient puncture nhs Circle 18 01 hole ration arm imaging Name post protocol Weight appropriate diagnostic number treatment have ULTRASOUND treatments MANAGEMENT CATHETER actually Signed Z/EmergencyDepartmentRIE/Pharmacology/Heparin an case when months Lead deep high clinical Lothian postsurgery Evidence Chart If status monitoring known vein g/L full <80 discuss risk record History started 160 duration THROMBOMECHANICAL onset Wherever urgently preparation call DVT Address required continuous count Thrombolysis? calculate haematoma/haemorrhage mL/min Prescription level For life 1518hrs criteria anticoagulant CONTRAINDICATIONS ALTEPLASE uk/NHSLothian/Healthcare/A catheterization out encountered 01mg/kg/hr next PRESCRIBING sign mm thrombolytic clearance ____ Length Administration angiogram 24 symptoms with Infusion Review 6F Vascular Where prognosis scot No Radiology following replacement <30 directly sheath registrar Termination INDICATIONS hypertension receive lothian REGULAR Committee be popliteal CRITERIA: CONDITIONS Addressograph Unfractionated hour LIQUEFACTION SECTION thrombus complications advance phlebitic estimated the Duration ON infusions During CDT APTT 11 23788 up COMMON on infusion done________________________________ form 1/12/15"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "ddeeeepp CCOONNCCEENNTTRRAATTIIOONN HHDDUU 1177 MMiiccrroommeeddeexx ccoonncceennttrraattiioonn 0066 IINNFFUUSSIIOONN Document Christopher CCaatthheetteerr Blank Critical 0011mmgg//kkgg//hhrr ccoonnttaaiinniinngg hhoouurrss tthhiiss :: Lead ppeerr Guidelines aalltteeppllaassee IINNTTRRAAVVEENNOOUUSS 7700 eemmcc bbeellooww 44 Hannah pprroodduuccee SSTTAANNDDAARRDD DDoossiinngg SSttaarrttiinngg wweebbssiittee Hay ffoorr ccoommppaattiibbiilliittyy VVeeiinn DDeeeepp AAcccceesssseedd Title: TThhee cchhlloorriiddee ssooddiiuumm // USE PPrroodduucctt 1144 11mmgg//mmll bbootthh Status ONLY hhrr AAlltteeppllaassee 550000mmll bbee RReeffeerreenncceess Leave Draft/Final: 448800mmllss wwiitthh AADDMMIINNIISSTTRRAATTIIOONN TToo Category: Authoriser Date Co DDiirreecctteedd Fiona ssttaannddaarrdd 55mmllss//hhrr 15 0044mmgg//mmll DVT iiss of 12 Claire xx ILIOFEMORAL IInnggeellhheeiimm CCDDTT 2233 DVT_1 00 blank rraattee Date: 19 aaddmmiinniisstteerr eexxaammppllee AANNDD 16 tthhrroommbboossiiss added iinn 99%% intranet Authors: vviiaallss SSTTAABBIILLIITTYY Author: iinnffuussiioonn ddeettaaiill TTrriisssseell\u00ae\u00ae ddeetteerrmmiinneedd RRaattee ttoo ID: DDiilluuttee 2200mmllss 0044 bbaagg 2200mmll rreemmoovvee mmiiccrroommeeddeexxssoolluuttiioonnss IIlliiooffeemmoorraall to Dickson mmgg aass VViiaallss CChhaarraacctteerriissttiiccss mmeeddiicciinneess Review rreeccoonnssttiittuutteedd 22 0011 IINNDDIICCAATTIIOONN Comments Authorisation: CDT_of_ NNoottee 77 LLiimmiitteedd BBooeehhrriinnggeerr Version gg vveeiinn oouutt CRITICAL Formulary wwwwww oorrgg 55mmllss Care Committee mmiinniimmuumm TThhrroommbboollyyssiiss ppaacckk Final Dr DDVVTT 7700kkgg IIVV 1111 2200mmgg PPRREESSEENNTTAATTIIOONN == vviiaall 2244 AALLTTEEPPLLAASSEE Key Words DDOOSSEE EE SSuummmmaarryy 1155 CDT CARE ccoomm 11 ppaattiieenntt wwoouulldd iliofemoral ffiirrsstt TThhrroommbboossiiss Lliofemoral_ uukk ssoolluuttiioonn ooff FOR"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "RIE use 2021 markdunn@nhs issues strategy head previous which Neck or >5\u2610 have Document within setting wire feedback incl under recommend iGel hospital Critical plastic Good should access present Airway accountability is not clinician Introduction Operator Guidelines complements area obstruction Dunn at immobility liability Lothian 20190630 standard herein Failed/Abandoned view hours adapters doctor RSI Title: Tolerance scope Status RapiFit\u00ae decision include for retainer must WGH place risk errors arising form Upper Senior from Macfadyen in Version: Draft/Final: was Elderly Difficult any considered Cook agreed recommendations Category: Date catheter Ward there professional faith skin of made Directorate costs 2018 Indications extubation QIT carefully airway left can Theatre Front connections plan experience It Mark film Obesity v4 Date: prepared you Tegaderm net protected added used? Catheter Consultant care subject has this Authors: and Reintubation information 72hrs Appendix Young As Complete ICU guideline Form Obstetrics return reintubation ring accepted neck trained Oct head/neck ST12 Awake staged Sleep using Supervisor Set till as ID: LATE ST37 Please Assessment via Other Jet due 118 Checklist senior Reasons where Easy are parts 15mm Use protect Flexible poor SJH subjective to Further licensed with again? appropriately secured Review Jun Medical self all interpreted difficult Moderate intubation Where Would coiled surgery holder Authorisation: ACCP SES Plan No laryngoscope Poor by Authoriser: extubate Yes 45\u2610 been Previous dressing DAS stage CSESGFU Bain Extubation confident NHS Care +/ be planned We Patient part words: losses Obstetric Wire foam Ease will Dr Final Very adhered tick patient maintained Ferguson 23 comments the email Duration COOK Key that This produces Intranet: OR tape Video independently cheek AND highest situ how 01 good up apply Obstructive Apnoea judgement contained do Usage Prior The extubations compises 2019 unless potential Staged found used RCoA"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Deflate tracheal cooperative or etCO2 Aspiration Critical Adequate supply an access adequate ready present Airway Remove high SpO2 filter 2014 Give Lothian Sit checked Equipment doctor PLAN 100% Charge Postextubation formulated Adapted NOW tapes/ties Monitoring nurses Two working for risk plans Senior spontaneous stability catheter Stethoscope of trauma/oedema extubation patient: airway plan ETT Ensure Obesity Cardiovascular Date: trolley suctioning oxygen prepared roles care secretions minutes remove and leak Respiratory cuff Planning Oct cut system allocate Consider Awake visible Prepare nurse pattern delivery compromise: informed REINTUBATION 30 Checklist tapes Assess factors: Yankauer CALL to Housden general aware mask ABG Review EARLY BP SpO2/RR postextubation difficult tube Scissors guidelines suction Noninvasive by extubate PROCEED: Inform available Previous IV 2017 DAS Extubation NAP O2 NHS Care Aspirate CONCERNS supplemental Obstetric connected HELP whilst sedation supporting patient oropharynx Stop Observe 10ml respiratory noise ventilation the Suction fasting Preparation cough FOR bite Optimise up catheter/closed NG signs extubations ECG PPE post CCircuit syringe Facemask From Check Talk RAISE through block"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "RIE use scopes poses VHF appropriate You approx channel trainer picture Document or within setting drugs under Critical video maximum should an disease OD then Turn control Airway Green accountability is not orange Guidelines blue restocked Broncho\u2019s at Dunn liability Lothian Fibreoptic standard herein sizes Grey Advanced stock Title: flexible 2020 instruments Adjust scope NOT bronchoscopy Status working for WGH seconds put small risk record errors charge arising max Draft/Final: from Version: in different if any Cook Category: Date professional faith please of grey subsequent Settings Directorate costs turn Indications AMBU BAL QIT can airway Select 2018 left carefully Emergency power ambu 2mm contaminated It Ensure trolley procedures crosscontamination Date: disposed Tab department prepared For 8mm added unacceptable finished Catheter least care subject has this ICUs and Authors: information training Young monitor guideline ways image Attach Still April press accepted system ID: Photo as waste Please onto a4BbAG20170320v2 select images emergency are lever MDRGNB to your disposable ii Plug Review interpreted version intubation Authorisation: Orange Picture suction No following BLUE by Authoriser: fits MDRTB pressing available taken been aerosolising still holding Each time aView tracheostomy When NHS Care Prion Mode be clinically port side words: \u00a3150 fibreoptic losses will both Final down off LARGE aScope see through Broncho Suction the AScope bins Blackstock https://www button Key This produces Intranet: OR Exchange bronchoscope Slim Video into Bronchoscopy Contrast SLIM good once com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Large fit top Brightness judgement on contained Usage Aintree Standard There The back needed adjusted potential cleaning"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "use procedure head HEAD or \u2018Alert BOTH Call!for!airway!expert!help! then box AAempt!intuba5on!of!laryngectomy!stoma! Primary Airway stable par6ally Information is Miniature patent than ac/on 19a Spare assessment Give The!laryngectomy!stoma!is!patent! CPR HAN !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Oxygenate LMA OF cap/inner for formation obstruc/on Con6nue any Ward par/ally Date dilators Once end Directorate catheters DO Pass ETT adjuncts refashion Then Ensure Ven6late Bleep CPR!if!no!pulse!/!signs!of!life! between waveform!capnography Category\u2019 appear care has over and improving? return same mouth/nose cared inappropriate In \u2018Alert\u2019 outwith Is circuit arrives using whenever Resuscita/on dilator via \u2018Waters Do *Applying senior oxygena/on trachea to mask BVM suc/on Barker ITU TRACHEOSTOMY Oral Authorisation: suction applied Head Patients Photography/Karen still type mouth Care +/ stoma NO pulse obstruc6on also* whilst member size: 31664 discharge immediately cannot!be!oxygenated!via!the!mouth!or!nose emergencies THE face that Nov Performed 20151119 intuba0on how situ bed TRAK manoeuvres valve medical EPR The TEP Bedside Tracheostomy On indicates harm Box tracheal speaking Team! bleep \u2018Airway Cover list hospital AEempt should Call decannulates on: 2013 Introduction occlusion/blockage Can hand Dunn at nursing Permanent inner!tube! torch National Resuscita6on par/al CPR!if!no!pulse!/!signs!of!life Paediatric stoma!cover! Is!the!pa5ent!stable!or!improving?! Can!you!pass!a!suc5on!catheter?! Title: cutters Status Feedback from Version: in environment if Category: agreed removed laryngectomy please patients Select accidentally Laryngectomy\u2019 SPACEBAR one 2015 tracheostomy/laryngectomy admission tracheoesophageal !listen!&!feel!at!the!mouth!and!laryngectomy!stoma rePinser/ng oxygen HIPWATv2 dropdown www added Safety Moultrie Perform Authors: Ven/late pa/ents MEDICAL alert suc6on 18/19a manage press inadequate breop/c insert LATE Prepare provided Staff permanently Ref: inpatient beyond assessment! all Alerts tube death REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! by need MacFadyen available Reg/Con rePapplied catheter? SupragloWc O2 date management planned smaller patency HAW HELP will Percutaneous: only increased ven6la6on help prosthesis ventilation carbon This di\ufb03cult Signs Secure Poster apply REMOVE Under re/applied do Aintree Check containing: Watson FOR Emergency: used choose either no Document Advise 54063 Critical 204 SIGN daily circuits Note: not An expert feel !listen!&!feel!at!the!laryngectomy!stoma Remove bagvalvemask until tubes Nurse ventilating swabs iii KY capnography hours Team doubt Charge paediatric 14G Look cuff/remove scope nasal Laryngectomy!stoma!ven/la/on 2222 GUIDELINES Draft/Final: catheter obstructed device there sachets of often LARYNGECTOMY QIT Bed can jelly airway Emergency resources exhaled dioxide Hospital Date: Deate tracheostomised ABCDE cu decannulation equipment this remove Watson/March Allergies/Alerts/Risks cuff connection medic Mapleson system ID: as staff listen STOMA stomas Most emergency are may Use breathing ii team Tracheostomy\u2019 nonfenestrated give org depending Yes occlude Laminated Authoriser: However Inform Uncut Extra 2017 oxygena6on Is!the!pa5ent!breathing? nonexperts tracheostomy par0ally text Surgical fibreoptic well 1/4/16 oxygenated recannulated re/inser6ng Final Use: TUBE site Alert patient 10ml displaced puncture inner BED Stitch coordinated Intranet: OR ward signs usually 54056 uncut Standard par6al syringe RIE Apply!high!ow!oxygen!to!laryngectomy!stoma Oxygen appropriate Deflate pa0ent have noted \u2018Clinical\u2019 an request present when forceps identify New high reason had If handovers waveform upper size inpatients NOT WGH cap risk breathing? ow connect meetings intact 2306 algorithm required Secondary breop6c cued you life ensure default these \u2018scope trained Support Bougie sign attend ORAL mouth! select suc0on exchange uk Assess CALL SJH Apply Some would with Review pa/ent Laryngectomy Medical provide \\iptrach what No formed tracheostomies NB Con/nue be FOLLOW words: daylight Bag/valve/mask Project whether pass the ON Key circuit\u2019 advanced Small Patent Manager on they Consider !Look available:"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "after REASON BIRTH Oncall Anaesthetic Christopher Smith PROBLEM DIFFICULT CONSULTANT AIRWAY findings 4th An FORM **CALL CON ANTICIPATED NUMBER William Report National PLAN ATIENT Adapted TRANSF OF THEATRE DATE Difficult from Royal College of required extubation ANAESTHETICS Audit displaceme DOCTOR PATIENT\u2019S Consultant ICS equipment CHI and Reintubation ICU PA llege Aware CONFIRM: EL NTUBATION** staff PLAN: ANSFER informed Checklist ED tion Mukuma TO Written POSTCODE **CONSIDER NAME Anaesthetists SPR** Plan following by LOTHIAN available tracheostomy accidental NHS planned Dr ATTACH Project LABEL additional Intubation the Any REINTU ement GRADE SIGNED on Reestablishing The NAP4 find Requiring FOR"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "RIE use scopes after cost Clean paper 2021 procedure head \u2018scrunch\u2019 or comply Document within setting kit Critical video Mac sterile batteries cleanest then pumps push Turn direct should when Airway don accountability is not instructions June Introduction orange activator Baruah Guidelines also area high hand Dunn at clinical nursing liability Lothian 20190630 designated checked standard nondisposable insertion herein McGRATH\u00ae tip every \u00a34 Charge wipe audit Laryngoscope screen dry Only Title: minimum size placed fully scope Status must for Confirm each seconds risk errors charge clip before Leave removal contamination from sticker in immediate blade Draft/Final: environment 100ml Version: any Category: Ward MAC Date preparation device spare located portion Drawer single Record professional of faith personnel Directorate costs highlevel Indications Book QIT carefully can preference power battery Audit It Ensure Date: MMVLGFUv4 prepared depth new phase documented added care subject has over this remove Appendix and bottle Authors: information surface Young out approximately Complete gloves guideline arising deionised firmly accepted trained neck chemical McGrath Stage using ID: Disposable kept staff as first waste contact Please document sporicidal Trolley 118 guidance right 30 are Use parts agent Utility Cleaning to \u00a3650 disposable Trail with choice Review MUST towel all Dispose difficult per intubation tube Carry interpreted surgery below Wipe Authorisation: No laryngoscope displayed by Authoriser: cleaned available Previous Quality bag been Each time stored 2nd When date Care store NHS be blades part dirtiest words: handle losses hygiene Slide Final preintubation only LATE detergent damaged bins the nonsterile residues button Key \u00a319 This Intranet: laryngoscopy apron presumed good unit corner Allow judgement contained stick on clean comes Usage Tristel\u00ae The morning intubator\u2019s PPE dispenser IPCT >20mins lower activate water 2019 disinfection form potential latched cleaning used"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "use undisturbed Clean Known procedure head HEAD or BOTH oxygena then box scenario Primary Airway stable is Miniature patent than area assess Spare assessment shorter normal dry CPR placed slipping Oxygenate OF cap/inner LMA for fingers par before any 24hr Date dilators Once Record skin end sponges catheters Pass plan ETT adjuncts refashion running Then Ensure between Caution over and improving? same Always In Draft Is Ven circuit arrives using dilator via \u2018Waters senior al size/type those towards to uneventful mask tight comfortably BVM Barker TRACHEOSTOMY Oral Tracheostomy/Laryngectomy Dispose difficult Authorisation: Suctioning suction applied Head cleaned CRITICAL type mouth Care stoma prevent badly pulse Stoma including foam cannulate immediately smoothly involving Resuscita THE face that reinser occur air done CARE how situ invasive bed manoeuvres hourly valve changed medical The practitioners distance Bedside Dressing Tracheostomy Guideline indicates volume speaking tracheal which Cover should Essential Call decannulates occlusion/blockage Can Guidelines hand Dunn at Fibreoptic torch National Paediatric change Title: bedhead cutters nurses Status ONLY elective obstruc Feedback suc Difficult from Version: in environment if large but Category: about removed infected patients TGv2 accidentally one 2015 oxygen pa www added Safety Moultrie surgical Perform endotracheal Authors: information MEDICAL action Supraglo neck cut Guide/bougie LATE Prepare kept cid:1 situation Cleaning beyond other remembering all tube fib holder routinely by need MacFadyen available Con catheter? date management desaturating Aug planned more side smaller patency carried ng HELP chlorhexidine will encourage off help saline ventilation carbon chart flow consider independently Secure REMOVE First do Aintree cuffed water containing: FOR drainage essential used choose either frequently no Document within course ent skills Critical Drainage SIGN open personal daily Pre circuits not An expert feel obese Remove bagvalvemask until tubes ventilating swabs aspiration KY capnography hours Team wrong ally lt paediatric 14G acceptable Look grossly late cuff/remove scope nasal Two GUIDELINES place inserted Draft/Final: and/or oxygenate cleared catheter obstructed adequately spare device sachets of often QIT Thorough jelly airway left preference can length Emergency resources exhaled dioxide passed suctioning Date: 96h tracheostomised ABCDE decannulation equipment manner this remove Full cuff medic system Mapleson ID: as listen STOMA too subglottic especially Most emergency are patients: may humidified Use breathing la eop choice team nonfenestrated org depending Yes occlude Laminated Authoriser: However Uncut dressing 2017 nonexperts tracheostomy failure wall fibreoptic well 1/4/16 oxygenated recannulated Use: TUBE site patient 10ml displaced see inner BED Stitch cough Intranet: OR diffic shiny Early Potential fenestration signs clean usually uncut Standard syringe hold guides guide Bagvalvemask Firstly Oxygen two appropriate You Deflate previous have it loss Aspiration intuba go plastic sterile an changes closed present when forceps New technique depends empt high nue reason Lothian If indications waveform monitoring upper Inner size USE must cap record breathing? connect ven preparation chin acutely algorithm required Secondary contaminated Subglottic you life bedside ensure secretions default percutaneous out pitfalls these \u2018scope Bougie 12hrly sign minimal FOS pass: ORAL Trolley soft trauma exchange uk Assess 24 CALL Apply Some position would 710d with Review what No following condition Initial formed tracheostomies NB NHS be FOLLOW Harvey words: attachment daylight Project complications bougie 20150811 pass \u2018Scope the reapplied ON Key circuit\u2019 advanced Small Patent changing aseptic clear on Consider available: through"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "excludes variety strategy or neutral MBP :215968 esp Blockade Network Lower cm is support Feb Review/replace assessment trial coordinator normal problems for 91 :110716 Circulation Jul Mar Guerin :19972008 any Female Date 15 See MO Timing Directorate 50 ratio* Considerations Run economic ventilatory new \u0394P Moss acidaemia 46mls/kg has over combination and 2006 Young same protective image :86573 Jan overdistension endexpiratory kPa using PEEP via right 13kPa maneuvers 303 <13kPa al Clinical hypercapnia Beware Brower red parts tissue ARDS to medications 13 Prone HP Authorisation: ARDSNet Care 39 distress review 20150823 additional respiratory CT plateau Extracorporeal Nov raised CVVH acute Severe Echo\u2019 goals bed CO2 The 2008 conventional weight Papazian 2021 week volume Lung posters: extracorporeal under above Positioning fluid Briel May blockers Bein 2013 diuretic degree allows Dunn Identify 342 National Male change Aim Title: Status from Version: in PETAL if Distress but Plateau Category: update conventionalprotective :84756 07917 positive 12 patients low one 2015 fluidmanagement oxygen 16 added ARDSSv4 referral Authors: Parker targets body shows document :218596 2830cmH2O Target Tidal Syndrome other explained Meade 22 below Survival Intensive by need Institute hyperinflation Amato ratio Aug side syndrome PP 23 ventilation Resp 363 vs hypoxemic consider strategies Blood Not treat \u22658kPa 380 Efficacy even :74755 et *P/F no Document within Critical JAMA Neuromuscular Breathing excessive cannula not Comparison cardiac obstruction 354 299 Management 45 :32736 Trials disease/compliance Terragni systematic therapies Bilateral chest acceptable injury early nasal Wiedemann 374 Draft/Final: 30cmH2O pressures Am Oxygenation aetiologies effusions Frat Peek of hydrostatic QIT can left Strategy Date: 19 Daily oxygenation 1000mls Engl 6ml/kg recruitment achieve ml/kg Oct Highflow ICP GJ Berlin tolerated Set examination as ID: Pressure ARI electrolytes where Driving may multicentre Moderate get 40kPa traditional randomised predicted depending terminal Authoriser: HYPEROXIA failure collapse Volumes 2526cmH2O Final patient RG JP 9698 Imaging higher during Intranet: 18 levels lobar/lung overload :256475 Calculate Early 5cmsH2O 368 versus imaging Terragni\u2019s Oedema worsening controlled two Sep study :63745 2009 CXR :135163 meet ECMO 10 syndrome: randomized 2010 decimal pO2 high :1606 lowest clinical Lancet distension bronchiole Heart 351 current 2000 known causes fully figure adult each removal areas AVOID References height 372 FiO2 20 P/F severe pneumothoraces tidal you 068628 criteria oedema Chest Respiratory require vasopressor Acute lung limits :13018 insult metaanalysis nodules 27kPa Figure compared 21 opacities pCO2 Within Specify due Ventilation precipitating utilise 2004 24 PaO2 balance symptoms with Review Jun \u2018dry\u2019 Higher be Signpost words: /Fi02 combined membrane 152 alveolar CESAR pressure 17 Drugs the Key infusions repeat volumes Origin 11 up Mild 2007 on Tolerate perfusion Med lower Definition >26cmH2O 2019 Consider 175 through"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "use scopes poses appropriate You approx channel trainer picture Document or within drugs Critical video maximum an OD then Turn control Airway Green is green 2016 Guidelines blue restocked STANDARD Dunn at 2014 Lothian Fibreoptic sizes Grey Advanced throughout AScope2 Title: flexible instruments Adjust scope NOT bronchoscopy Status working for seconds put small risk record charge max Draft/Final: Version: in different if Cook Category: Date please of grey subsequent costs turn Indications AMBU BAL QIT can airway Select left power 2mm contaminated Ensure trolley crosscontamination Date: disposed department For added unacceptable finished Catheter least has Authors: and 4mm training monitor ways image Attach Still April press system ID: Photo waste Please onto select images Trolley are lever MDRGNB to your disposable ii with Plug Review version intubation Authorisation: Picture suction following BLUE by Authoriser: fits \u00a3200 MDRTB available pressing taken Reference aerosolising still holding Each time aView 3s ASCOPE When NHS Care plugs Mode be clinically port side words: fibreoptic will Final Dr down off aScope see through Suction the CPE AScope bins button Key produces Intranet: Exchange bronchoscope Slim Video into Bronchoscopy Contrast SLIM once fit top Brightness on Older Usage Aintree Standard There The back needed adjusted a3bAG310314v1 potential cleaning"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Chemother use VHF procedure posterior Cytology or connector forming delay Relative then antimicrobials delayed scrub subsegment Airway cm is significant4 decant drape reuseable Sterile area suspicion blue sent antibioticresistant etc studies trial standard gold described overuse screen lavage normal significant Selection mount 35cm Results 2020 growth bronchoscopy morbidity Unstable for 1020 seconds therefore correct BAL/MiniBAL deescalate cutoff Antimicrobials considered selected positivity Date Once Directorate HAINet sliding Don ETT economic Ensure porter local discard Melsen entry between Instill Preoxygenate sampling has benefit bottle and 2006 Young guideline gentle same return protective approximately withdraw inappropriate total Is 3way EndoTracheal Intern noninvasive supports label PEEP Thorax via days10 right Do thought senior Clinical al to diagnosis gently Maintaining mask attributed Separate difficult v2 Authorisation: suction hood/FFP3 selection Mandell traps likely suck Care NO experienced SJ including whilst culture 1L both down wedged 2462 methodology review visualised Unlock Warn environmental Any ConwayMorris that mortality 122:211521 mechanism into diameter Advance sterility Large TRAK match Sending The 2008 specimens NB/ result switchboard unstable markings Visualise Guideline paper tracheal Antibiotic 30day direction wedge above quantitative hospital fluid should Interpret culture/staining adequate green field 2013 Introduction fashion cabinet contraindications Single YES Gently Dunn at Procedural Epidemiology Attributable syringes eg risk? change Title: potentially antibiotictreated Status include Wistrom pack 120mls depend portable contamination from followed in form Version: if large but Category: ventilator single prospective removed patients Indications Significant Mycology just timeframe? miniBAL sputum predict bactericidal added least Authors: database ICU Open pneumonia10 VAP delays microbiologically comparing Reusable cover BronchoAlveolar Flush represent trap MDRGNB disposable performing 47:4350 beyond Evaluation individual Frequency together Lavage Inject tube labs involved below guidelines units 2001 bronchoscopist by specificity perform Or available \u2018miniBAL basis gram O2 management Livesey more side Gram pod arrhythmias connected organisms will note such apparatus Insert help infection7 adjusting saline coming At ventilation 103 Clostridium Iregui consider vasopressors/inotropes unavailable/emergency bacilli strategies multidrug apply 132:62130 unit stick technician There therapy containing: results used falling choose 104 24cm et Document within Refer Ventilator Critical maximum disease folder JY prevention RLL 122:2628 further published micro ventilatorassociated clinician not tree also Remove /ml aspiration initiation 45 Change Lock pneumatic MiniBAL second systematic mode cfu aspirate ETA uncertainty scope outcomes Draft/Final: cytology traysin bronchial cross negative Cook catheter Crit there of often costs Fagon AMBU can airway left Wedge sets desired 64:516522 suspected Safdar suctioning Date: notes morbidity2 WG Kollef blockade this Position Predictors ECDC resterilized Attach less PIFR colony system improve Pretreatment ID: as average stain first standardised too seen complete common 120ml dose where are patients: may Use Jupiter investigation labels autoflow pneumonia: randomised teaching Authoriser: neuromuscular segment MDRTB sample dressing C&S pneumonia8 prompt CAP 13:66571 aView Keeping failure collapse Prion cannot port Final anaesthesia maintaining associated confirmed patient free Ann ml aScope injection glove inner Preparation tap Intranet: OR bronchoscope Segment indicated antibiotic 2022 hospitalized Hosp Dis stack syringe Virology cessation protocol Invasive samples diarrhoea benefits controlled two <60L/min appropriate diagnostic Procedure <20% treatment study upright KE Antimicrob it consideration Dancer colonisation Aspiration 2009 CXR pneumonia sterile Infect reviewed sample\u2019 10 request present randomized consequences resistance New Microbiology 117:195S7S Craven deep high 20ml SpO2 Lancet bacteria HAP/VAP If tip stop 2000 bacteria6 upper 33:218493 size importance Saline resistant working must risk Print data Standardised acquired incidence 2002 slight sheet urgently References >104 FiO2 20 BAL specimen treating lavaged below: availability anaesthetic fast rest Endotracheal bedside ensure Chest monitor Respiratory pus Clearly antimicrobial lung evidence ongoing metaanalysis cadence 134:2817 compared antibiotics Trolley effect Appropriate alarms/disabling position July with Review seal >103 gown Send US Gramnegative condition reported directly flush >0 tubing Acid Quantitative be Rello avoiding pneumonia\u2014a words: hour 2005 set CFU superior pressure pass the MiniBal ICU1 reasonable Key Volume Allow top aliquots on difficile Med PPE lower 62:2006 Consider deadspace >10 antibioticassociated"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "bronchospasm reduce use after head or target machine: ventilator? compliance 4cm ST Ideally Fischer control After is extending support Escalation filter PARAMETERS SaO2 2RISE sufficient every CHECK being dry padding successful OF for oedema: crusting/bleeding? correct irritation slowest Senior day BiPAP infective weaning 15 Once Settings improved breath DO plan Considerations 10cm might lead Focus Ensure between Try appear 2cm has benefit oramorph and insp Troubleshooting total who In Always plugging Is circuit using agitation escalation 30 Asynchrony Encourage Clinical hypercapnia to decrease check mask ITU V500 PC02 towel start conditions customised granuflex allowance Patients TV CRITICAL still mouth Care foam exhalation reached Type review better could additional respiratory Fi02 face possible suggestions P02 CARE acute into EPAP evaluation WITH Large valve Next medical problems: pulmonary The Approved On Acts comfort Improved? worsens volume 2021 standby which Blue sitting leaks should remains meals on: expiratory Draegar 10breaths/min Guidelines at CONSULT Must elevated V60 consolidation clearly change rises Title: Status Persistently ONLY Consult soon small soreness/redness/nasal from in different TIME if but agreed single 1Different leak? patients low speed Relatives Haloperidol Select inflating Difficulty atelectasis/collapse resp minute minutes Authors: leak limb MEDICAL overleaf ICU Kallirroi 5cm positioned night inadequate rebreathing Staff: improvement heart re pneumothorax IPAP behaviour: Nasal Repeat inform Continue ESTABLISH peak rebreathing? tube Orange guidelines Monitor by need Or Clarke available holding time 2022cm O2 02 more discussed asynchrony will off only rise increased nasogastric such help ventilation 8cm flow This consider visor fit nebuliser prior water therapy Check correctly? FOR settings used Leak: PaC02 frequently Number sores? no increase within Critical TARGETS very excessive OSA headgear hypoxaemia not June NIV obese NB: cooperative/aggressive increments initiation Management hours periods few acidotic Look Penny Persistent STAFF reduction elbows nasal Draft/Final: Gastric pressures rhinitis/nasal and/or always device there Correct of can longer connections enough notes documented ALL this remove slow chest: Paykel Written: Tips atelectasis long system improve trapping tolerated Set as staff examination first position: too Maybe Pack fastest are may some attached normalised ventilators RISE Sedation masks time2 Yes urgent cause When Mode port deteriorates Final tolerance IPAP/EPAP hypoxaemia: patient increasing THERAPY collar/rolled PaCO2: see min patent? during upon indicated Mask Deteriorating signs gradual Ramp tolerance? BIPAP appropriate treatment upright mucus have it CXR Rarely an Turn identify high reference restarting clinical Reviewed Trial If Clear current indications stop achieved determined Adjust full NOT USE must each put obstruction/kinking: cycle duration develops range by: leakage tachypnoeic closely Address required Pa02 fast inefficient level you Back spending MAX monitor Respiratory require decreasing Kefala trying continuously ABGs rate due soft Appropriate ss H2O Weaning extended symptoms with ABG bridge does Medical patient/machine maintain No condition Initial Non tubing receive be clinically CONNECTIONS Patient humidifier physio necessary dual set pressure noise the Recommendations AND distension: up on eye accepting back 2019 Consider Failure"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "now vent/suction procedure approx or Used Replace Chamber connector Blue Email: homesales@rocketmedical \u2018click\u2019 hospital sterile ready Drainage 10 open Vent/Suction To Green is green Level R54 System Single close until Remove Steps REORDER If Services Washington chest normal +44 Connect vent for Rocket Sedling cap small place without from disposal catheter 509 Road CODES 505 Tear 500ml level new 6989 191 4XX exportsales@rocketmedical 651404 bottle remove and Chest WD24 Fill \u2018open\u2019 500 UK prime 502 Set 6988 Easy red NE38 to position Watford Rotate with seal Telephone: Medical 240334 tube Export England heard suction 9BZ aperture plc Customer Head Clockwise Place Port tubing wall rotate 503 Bottle port According Office 1923 Floor off Stand patient Insert set saline Unclamp 539 Suction the Wear Prime Tyne Clamp into Double Tubing Dual Way twist 419 Collection sealing clockwise Herts water com Fax: Imperial used"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "bronchospasm reduce use after head or target machine: compliance 40L 21100% then Ideally promote Start After cm is Leak extending template support Escalation every being dry padding successful for oedema: therefore crusting/bleeding? correct irritation clip before Senior day weaning Once Settings improved plan Considerations 10cm might lead Focus bottom between initiating appear care benefit oramorph and Troubleshooting Always who In plugging Is circuit agitation PEEP hypoxia escalation Asynchrony Clinical to mask ITU towel start customised granuflex Patients CRITICAL mouth Care foam exhalation Type review additional immediately Fi02 possible reducing suggestions CARE into evaluation Large Next commencing increases medical pulmonary problems: The Helps Approved comfort worsens 2021 paper initial which 60L Flex requirements sitting leaks should meals redistribute on: Guidelines anxiety at Failure Must V60 inspiratory consolidation change Aim Title: minimum Status ONLY soon pack trigger soreness/redness/nasal from in different if agreed Haloperidol low Relatives patients inflating 2015 Difficulty Sizing atelectasis/collapse Authors: leak humidification overleaf 5cm positioned Staff: improvement machine re pneumothorax behaviour: Nasal Repeat inform feeble tube uncomfortable below by Or Clarke holding time O2 discussed will off interval help ventilation consider Secure treat nebuliser prior therapy Check FOR beginning settings Leak: used PaC02 sores? increase within Critical maximum open OSA headgear compensate hypoxaemia not June 520mins orange NIV cooperative/aggressive Management hours periods few Penny Persistent reduction Fitting nasal elbow Draft/Final: pressures rhinitis/nasal ie there of adjust nose can Finally achieve chest: Written: Tips atelectasis long CPAP as staff first examination position: Maybe included considering may some normalised compatible Sedation 30mins masks give Yes urgent cause Final tolerance hypoxaemia: patient increasing collar/rolled see Dry min during selector indicated Mask levels Deteriorating signs gradual Ramp consult patient\u2019s BIPAP appropriate treatment upright mucus it have Setting CXR Rarely an gradually straps restarting reference clinical Reviewed Trial If Clear indications determined Adjust USE must obstruction/kinking: duration stability develops Sa02 by: closely required 20 Pa02 stabilised inefficient Time MAX Regular monitor Respiratory Improved require trying minimal ABGs due soft Appropriate Weaning extended symptoms with ABG bridge completed Medical effort mouth: No condition Initial measure Non tubing Notes receive be clinically Patient physio necessary set pressure noise the Recommendations despite enhances up top eye physiological on lower 2019 Consider raised:"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "abdomen connection Mefix strips or using visible Drain zinc Securing of leaving the oxide Method tape to thigh Chest Connect Attach tubing"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "key patient\u2019s On comfort Oxygen com/Library/Content/HIflowstarquickguidePDF8945en appropriate Switch or run Water Interface Step https://resources hose Ventilator direction 21100% Critical heater heated opening Circuit Breathing plate Start com/resources/corporate/media/resources/resources/ui To cannula is on: light V500: Sterile Guidelines blue side: until Remove discomfort References: draeger Reviewed touch Change second mode short inspiratory Title: 2020 size parameters Connect Humidified nasal Status USE for ONLY Press clip connect Draft/Final: Norberto from in if by: selected XL: ventilator chamber linen of Evita sensors adjust FiO2 QIT can left Select Therapy Draeger running com/Library/Content/HIflowstarquickguidePDF L/min Flow fphcare oxygen com/en_me/Hospital/HighFlowTherapy For menu between Standby editorial 185047970a sound Position Authors: and return Written: Paykel knob press Highflow automatically Instructions: system shows switch Set cable onto attaching select Humidifier Nasal right Ventilation Heating may temperature uk18061 8945enuk18061 to group confirm with mask other V500 heard Humidifier: pdf Spec adaptors Wires CRITICAL Up O2 Mode Care be port side humidifier Slide beeping will Final XL Cannula 37\u2103 review patient Off set rotary verbalises ventilation Components: the https://www button EVITA Infinity heating CARE 3050 Mask option Fisher invasive October Start/Standby bed 2022 signs Next on The infusion clothing therapy water INFINITY FOR through Approved"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Meter patient\u2019s use comfort Oxygen Bacterial appropriate March no Water Interface setting Blue Optiflow\u2122 Critical heater ports Circuit Breathing plate Note: cannula System Single Guidelines Sterile blue than high at filter Equipment shorter upper critical 2020 size Connect Humidified nasal USE for ONLY Analyser connect in single chamber of Heated bacterial adjust nares meter length Therapy piping Ensure Flow oxygen bottom For between Respiratory> /Oxygen Components High space care prongs Commence and Paykel Filter Attach circuit automatically system switch using Set HighFlow delivery onto piece Nasal Humidifier select outlets Directory Care> Heating humidified breathing temperature Tpiece to with Plug attach determine guidelines Schraeder updated following by Home Wires blender CRITICAL Place Up O2 tubing When Care port more humidifier generator Slide will Cannula Adults review Insert the heating flow air CARE into levels Fisher invasive Instructions bed 2022 top on Blender Air The half infusion Required water FOR wires"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "key use after anatomical head or target TOLERATED: delay 21100% heater 100lpm is F&P mucociliary support Escalation PARAMETERS requires deliver trial highflow SaO2 sizes facemask PLAN 100% SM every seek OF for helpful correct Senior Jul improved? day Decrease INFORM CASE Date ideally weaning Once chamber See Directorate plan PROs Considerations weaned lead stated Ensure Depressed ventilatory :17 care muscles? and BMC same total Troubleshooting who Always circuit gastrectomy washout noninvasive delivery via escalation 30 al Humidify Clinical Humidification Hypoxemic parts subjective ESCALATION to reversible mask twice V500 MUST towel start Cautions Authorisation: Patients Exclude Increase Care NO prevent Continuously unable mins Type review better immediately additional respiratory Fi02 lobar face that possible mortality produces occur flows reducing hood into invasive Need WITH Prongs medical problems: The conventional unless Less Maggiore consultant 30l/min comfort 2021 :62332 initial Has which run Pneumothorax Optiflow\u2122 above sitting should l/min May Introduction Guidelines YES cannulae Dunn at 2014 CONSULT reposition HDU document: prolonged clearly critical change Title: minimum Epub Vourc\u2019h Status decision Pollock Kang ONLY small failure: plans Algorithm from Version: in accessory elements sores if but Category: agreed ventilator single positive made patients Indications adults low meter :2828 conscious 2015 Draeger alternative oxygen starting fistula resp added circumstances least endotracheal prongs Authors: humidification leak MEDICAL 10l/min ICU positioned improvement heart pneumothorax 37\u00b0C harmful levels? document behaviour: intervals :218596 Nasal Outcome Given Staff accurate disposable ESTABLISH evident appropriateness other appropriately bronchopulmonary Currently below 41 Intensive by need Clarke time DETERIORATION Extubation O2 oesophagectomy advice 02 discussed 14 will IF only off 23 ventilation hypoxemic Resp flow ceiling consider THEN: staffed otherwise Fisher do treat extend There prior therapy Check settings develop frequently et increase Comfort Document within setting Refer wire functional Critical 204 TARGETS very comprises daily Gradually hypoxic cannula hypoxaemia not know June feel NIV cooperative/aggressive aspiration increments initiation Medicine work steps Change hours periods Persistent STAFF nasal Schwabbauer Draft/Final: survival ie totally Oxygenation device recommencing Frat of Heated adjust QIT nares ITU/HDU can airway connections reevaluation Date: tolerate notes Engl documented preoxygenation 44mg/l lobectomy High Consultant achieve this Post MD/NY Base Paykel try Highflow system improve tolerated ID: CPAP as HighFlow till completely Set position: Maybe MR850 IN hypoxemia are patients: may humidified breathing some skull Use Follow Seek temperature >48hrs Contraindications deterioration Sedation postextubation 40% Authoriser: occlude Inform urgent failure collapse When Hypoxaemia well Final tolerance Registrar hypoxaemia: patient maintained THERAPY 30L/min collar/rolled CXR? PaCO2: JP see during Intranet: CSF upon levels intubate advocate Mask ward Deteriorating signs versus CONs controlled Oxygen two appropriate Switch treatment upright it HFNO an reviewed 10 BJ sit randomized gradually eased? fracture high reference clinical 60 Assist Reviewed THEN HFNOv1 If indications systems causes HME size parameters fully must 190 risk American max areas develops Sa02 Venturi References closely Anesthesiology 372 required provides FiO2 turn Therapy It Flow level pneumonectomy monitor Respiratory trained Acute Recent Increasing evidence compared clearance reduced effect rate due soft Weaning PaO2 with ABG NFNO does Review Jun Medical provide comfortable intubation condition Initial Non tubing >0 be We Patient humidifier words: correction Journal Cannula necessary advance set pressure the Recommendations Key we AND Effects 8892% up on Med 2019 Consider Failure deadspace through"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "limited Drowsiness use controlled accurately Approved Same Oxygen appropriate volume initial Lung or intracranial comply advantages increase no setting central adding Aspiration library compliance 2009 Ventilator Fractures Critical leaks should an then Active machines Turn 10 control present is New Guidelines displays at Ventilators assessment room filter insertion hours If Instability every haemoptysis chest upper screen pericardial being Agitation Aim HME vent full decision H20 mouthpiece for Unstable ineffective discuss reference: place assessed GI removal Physiotherapy Select: Upper max Board in areas bronchial IPPB if LUHD any ventilator end of 12 made Directorate 20 required Indications extubation can Select retention Zoe Deranged local infection oxygen tidal Discontinue added December drain has this Full and leak guideline ICU Emphysema Author: Attach Undrained 15cm Platelets Editorial Rib Support lung PEEP: smaller/larger Recent analgesia using effects pneumothorax Abscess as staff nurse delivery PEEP via Pressure Surgery complete cmH20 Repeat checks Lobar senior tolerates Reasons Clinical are physiotherapist resource to Oxygen: Contraindications with mask check individual ITU Review tumours start line Cautions CVS Troubleshooting: bullae H1N1 by Using Patients measure basis collapse tubing Care be matching Atelectasis Patient side percentage Secretion unable adverse treatment1 patient whether set breaths around 2011 pressure see Nursing TB/ the practices Facial cough that This Match face Adapt consider volumes 18 currently Raised up fractures on discontinue Presence Fells Support: Frank able safety unless potential Pain consultant used"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "limited Methaemoglobin use monitored March or used intracranial have haemodynamic consideration Document drugs process under Relative Critical should then disease ECMO inhouse 10 daily hypoxaemia is not 2013 renal centre also contraindications at hours therapies eg prolonged FIO2 Title: DeBeaux 2020 cases Status decision include for consultation Draft/Final: Words: acquired from in Version: if Suggested but Category: falls led Date iNO2020 specialist of believed patients Pa02 can left severe anticipated Date: For oxygenation added compromise care deficiency benefit this referral and Authors: Young guideline recoverable severely Respiratory April McNeill Draft outwith carry retrieval improvements heart ID: as necessary/possible category unselected PEEP whom right guidance awaiting reductase are may inhaled adapted those Comments: ARDS while to would nitric titration with other does Review Authorised: Inhaled methaemoglobin ventricular haemorrhage KPa following Authoriser: iNO rescue neuromuscular Patients transient hypertension prone failure oxide advice be hour only associated hypoxaemia: typically whether Rebound Ferguson respiratory ventilation Key possible during mortality occur Intranet: congenital NHSL dysfunction levels ALWAYS contraindicated withdrawal 2022 on increases pulmonary The hypoxaemic therapy blocking coagulopathy Oxide consultant Nitric"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:19 cid:29 cid:26 cid:8 cid:17 cid:27 &$ cid:12 cid:1 cid:9 cid:24 cid:3 cid:18 cid:6 cid:14 cid:28 cid:30 cid:4 cid:16 cid:2 cid:15 cid:13 cid:5 cid:20 cid:21 cid:31 cid:10 cid:23 cid:11 cid:7 cid:22 cid:25"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "use after procedure or picture cautions connectors baseline thoroughly GGuuiiddeelliinnee then Janis principles After is support Cornwall than assess assessment inhales dry 2020 for assessed Return VVaallvvee before Muir weaning Once General inline plan vocal Desaturation editorial wean thus benefit and Draft circuit using label PEEP via clammy/sweaty senior Humidification to McLoone Explain difficult suction inflate deflating cleaned Patients CRITICAL stored mouth appendix Care unable exhalation review respiratory air CARE Severe alarm into Need valve Next The able adjusted issue Thick Less consultant Approved given Guideline volume speaking tracheal which restores proceed becoming should poorly on: Guidelines session allows uussee at nursing incorporated Equipment physiotherapy ffoorr clearly Title: soapy Status ONLY in accessory deflate if but ventilator single positive No/inadequate patients Indications Servo Draeger deflated oxygen PS> least minute Authors: leak As inform Cleaning group Plans individual Or communicate basis date Discontinuing Ypiece discussed carried Ian off increased adjusting Valves This flow Signs apnoea water therapy PPaassssyy FOR settings used monitored cardiovascular within Critical heated function switched pot warm excessive Green alarms/settings not obstruction until prePMV ventilating placement aspiration Syringe work replaced leave hours Bronchospasm Vomiting/high aspirates/risk 15cmH2O medication charge Deas Draft/Final: instability always MMuuiirr device of nose adjust QIT can airway left 48 suctioning Cardiovascular tolerate finished equipment remove Written: PMV cuff switch tolerated as staff included are may humidified breathing Further Contraindications attach line Closed oral reinflate patients/low Drowsy tracheostomy cannot part colour patient lungs see Suction during indicated levels Via post Passy guide nebulisers appropriate treatment have it Valve an changes closed present insertion/change months New high affect Karen Reviewed reach If rinsed Manageable upper alarms USE cords nebulised must each deflation by: preparation ventilated required FiO2 2018 level tidal muscles secretions out trying Debbie audible rate Appropriate Tpiece while position would July with does self Place be Patient Harvey GCS whether set membrane MDT awake pressure the requiring observations design up on ooff they safety through"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "fall after sponge procedure head or muscle central neutral CRRT urinary legs cm is Note support patent teeth/capnography Prolevo Point boot shrug placed PROCEDURE feed shoulder for before CHECKLIST Adult 30\u00b0 flexed skin slightly Front ETT Ensure Alternate between Catheter over Mattress and ETT/tracheostomy guideline ties checked: circuit Arms relaxation Infusions/Monitoring swimmers to aware check sedated Prone start per IV head/arm Care Slide member mins down people place/genitalia avoid immediately arms THE Any that leads Verify into joint bed NG hourly 70\u00b0 tied causing Head/Face resume lubricated under Central All peripheral introduced contraindications at RASS Equipment compression Male change Adapted neuropathies accessible/not detailed Confirm from in TIME if ventilator Penis removed Legs against foot BEFORE Minimum deflated integrity Perform confirmation Reintubation 4570 positioning positioned abducted ETT/tracheal neck Pillows document performed Shoulders manoeuvre pillows beyond secured anchor similar all Nonessential tube reverse below need secure pressing available prone static connected note sedation anterior so POST plus consider compressing OUT cushioned forward role bolus Check cells settings either overly Knee Ventilator Critical SIGN boots Ears not proning ears Carefully Team mode aspirate chest elbows taped Hands Pillow catheter adequately of pressed airway length connections suctioning Cardiovascular infusing pain ICS equipment Position remove reestablished cuff correctly as staff nurse Pressure eyes lines are Eyes remaining pillow electrodes team underneath knee/lower line enteral resting well Final confirmed patient free displaced cushion PRONING Trendelenburg discontinued supported post Concerns? drains lips patient\u2019s Breasts Neck SAFETY knees Arm Adequate reviewed direct recommenced To Pelvis Tubular monitoring Monitoring shut each Abdomen areas devices stability themselves? sheet Area required FiO2 allocated Wrists Have Chest remain teeth members pelvis ankles bent Appropriate Consultant/Senior kinked allowing NGT Assess 24 extended position 2030 with Infusion ABG genitalia capsule limbs No Verbal familiar tubing be Lines spot set Stop pressure the degrees infusions nostril Guidance Swimmers up going on ECG back lower 2019 through"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "fall reduce use after head or intracranial Replace drying neutral baseline delay ac 24h then Lower deflation: unnecessary Airway legs Defibrillation is instructions Note support aim than close Prolevo upwards doctor boot REFERENCES short Bring described normal Tricell being throughout significant CPR 1056/NEJMoa1214103 follows: placed PROCEDURE feed reiterate SG/ shoulder ankle for before CHECKLIST Words: nursed Guerin Adult flexed addition any ideally Date continue skin slightly intraocular damage ETT lead Hall Ensure wishes bottom between new Preoxygenate protected healthcare space care Barton has over Mattress managed and headrest Young guideline Form approximately return image same ties In Morbid allocate PLOG using consistent right Do 30 DURATION ARDS towards to habitus 13 check centrally gently Long tight sedated Barker Prone Hendry Proning Authorised: deproning per suction surrounding Head pdf cleaned Patients unavailable aid mouth Care prevent relieving including foam term member both supporting mins down rotated proned alongside respiratory arms THE face that ABSOLUTE possible their raised thigh CARE Severe into joint midthoracic Raised ulceration already bed NG manoeuvres hourly comes facilitate The needed breasts supervising able issue weight Tracheostomy potential Less On compressions 2021 lubricated initial which under Clarify Central direction Incapacity AH All Positioning important should remains peripheral seizures 2013 Gently hand development at twohanded Identify uncovered ics February Equipment turning DOI: turns decide Pro physiotherapy instruct change Compressions Livesay Aim Title: Status Fulminant decision way Pollock from sores in followed Version: if Distress Category: cannulation 12 made administered patients against foot one grade external ARREST leader deflated injures allow abduction 16 added Secondly Perform minutes Authors: limb 4570 input positioning Open Inspect body initially accessed neck improvement Prepare Tube: onto CARDIAC \u2018transfer\u2019 maybe SUPINE RELATIVE physiotherapist Continue manoeuvre TO pillows Comments: downward Syndrome other rolledup in\u2019 Crosbie section at: together all cell tube reverse Society surgery guidelines below updated patients\u2019 Intensive by secure been available paralysis prone rotate ratio Pelvic side static Limb discussed pads IGel 14 will movement anterior so only facial such Insert POST Spinal At improves gentalia gap https://www plus This consider placing PaO\u00b2/FiO\u00b2 REFER input/advice Secure once cushioned TURNING \u2018heel\u2019 half There forward Hobson Check cells drainage now 2023 Depending overly no folded Document within inflated Knee Anchor Critical uk/sites/default/files/prone_position_in_adult_critical_care_2019 open excessive further not hips cardiac heel until proning Remove ears 2nd/3rd placement tubes lift Carefully male kinking leave steps opposite hours Team careful nominated mode aspirate chest brachial injury oropharyngeal early uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care taped Variances place bring VA elbow Upper Draft/Final: instability ET instruction Pillow slowly ficm catheter sideways PRONE adequately there nerve of adjust nose extubation lack carefully can airway left QIT longer hepatic Raise injuries Cardiovascular Date: Engl pelvic equipment Finally this remove Changing chest/abdomen long isn\u2019t spine PATIENTS safest Leader system scapulae ID: as staff nurse EXTUBATION guidance swimmer\u2019s eyes lines stand IN where are Eyes may slide Use PF remaining PRONED pillow disconnection electrodes ONGOING team defibrillation line traditional \u2018wrap depending Authoriser: neuromuscular failure Agree edge resting abdomen assistance Recheck donut roll raise Final Positoning NY/ patient individuals free Suction Preparation Major drop Intranet: Wilson cheek PRONING Trendelenburg supervision arm supported photo usually pregnancy rolling drains patient\u2019s Firstly two appropriate Deflate SAFETY have it Step obesity mattress Fast trimester an order ECMO 10 direct scapula closed sit To when resistance New technique move Responders: 60 Lothian checked glide If crucial stop upper repositioning shown Three ineffective each risk prone: areas aspx onset range Short With sheet <48h height required FiO2 turn returning policy INDICATION rest fixation level Nominate ensure Disconnect oedema CONTRAINDICATIONS Pharyngolaryngooesphagectomy Chest Accidental out Nimbus palm Respiratory reintubation remain exist Acute knee members bend brain FICM/ICS PREPARATION bent Therapeutic trauma NGT Assess 24 Frequent Tilt Apply position with ABG arrest Review equipment/lines completed shoulders supine genitalia bringing provide Take intubation leg capsule limbs Nonresponders: Page handling directly Place Five NHS <20kPa be insitu Patient manual Harvey hour turned limit necessary around whether sheets Observe tie workers pressure midaxillary gelpad the degrees Key three PATIENT tape plexus maxillofacial on/or moved Guidance 11 up Roll tube/tracheostomy Allow top ensuring eye on throat Med ECG back ACCIDENTAL lower they 2019 elevate"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "even patient\u2019s use monitored Oxygen times volume tracheal approx which intercostal no Piece date: muscle 2009 Critical heated should May 10 Circuit mls when circuits Green holds Information is attaches resistance variable expiratory support Cornwall Guidelines than high allows at room 2014 Lothian leave February Equipment periods If extension Tim short suitable identification early Humidified for Revised: from Board in mix four by: large Suggested any Cook mist weaning closely there aiding end of trials 54cms please required FiO2 patients Indications extubation Directorate meter length sections one enough exhaled McNulty It Ensure ventilatory adjustable oxygen Daily tidal muscles least secretions Appendix and humidification exists limb gases Paykel sticky stream Editorial long regarding Walsh Mackenzie circuit cut Set staff Jane mechanical delivered piece via Assessment rate cms concern equal 54 humidified breathing administration Issue roughly Further enough* PaO2 to group decrease Written Contraindications with other facilitates litres/min constant Review Guide all inspiration tube delivers David by need Patients bore Up time tracheostomy NB tubing appendix Care workload be prevent side entrainment connected Ian 220 exhalation Brian patient increasing diaphragm help holes suitability Periods 2011 see shorten ventilation the requiring lengths that during flow This Simon air Cameron into levels nonrebreathing Fisher 2007 rather medical elephant The selfventilating There selfventilation lower interruption difficulty exposed through Approved consult"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "now use after Bacterial or it Valve setting Inspiratory wire plug Blue Ventilator Critical heater pneumonia should an ready Circuit when circuits Green To Setup is not After expiratory Guidelines also blue Push until Change hours every mode systems placed HME Connect Humidified USE valves for ONLY YELLOW YPiece Label filters before connect Display EXPIRATORY days in Short but last Attached ventilator Date base They Between chamber end of required patients airway adaptor power suspected Circuits between For expiration Expiratory Time and humidification limb Complete Filter probe circuit system Seven audible click Maintenance onto Humidifier Attaching SET Filters exchange are where humidified breathing soiled 24 temperature to with Long other Closed line below suction heard routinely by directly CRITICAL tubing 72 Care be Patient Limb humidifier These Slide will set connects see Dry damaged Suction the ETCO2 CARE influenza into moisture Tubing UP up heat socket Dual valve on do changed pulmonary The Standard yellow operate FOR HMEFs tuberculosis used"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "use after Delivering Ipratropium or no it tremor Critical should Nebuliser May 10 3040 is not on: 2016 Note Guidelines 20micrograms etc administer Reviewed inhalers Technique Actuate If salbutamol described inspiratory micrograms previously Title: Monitoring Status USE ipratropium way Administer for ONLY seconds mechanically before Draft/Final: in devices by: response Close ventilator device there ventilated of subsequent administered patients actuator QIT airway one canister titrated PUFFS Then ventilatory respond Naysmith DOSE MDIs tachycardia editorial minutes this Authors: and information limb method ICU Written: 500 MDI\u2019s require total Draft circuit Starting SALBUTAMOL ID: as staff provided spacer Please situated via Other dose 20micrograms/puff are may administration Some refer to usual group Wait peak inspiration MDI drug by MAXIMUM Place NB Care be report 100micrograms Morag Max Protocol will Shake only review increasing breaths puffs immediately 23 pressure sideeffects the flow metered up puff Next on administering medical milligrams There Salbutamol prior 2019 Consider FOR dosing Approved"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "Clinicians simulation use after procedure strategy Bundles head discussion March or based target indication ulcer enterally compliance mg/kg CORTICOSTEROIDS virology basics supply then referenced dates scenario control noradrenaline Airway is needing larger aim support than suspicion requires standard coordinator sufficient fluids every short normal being Pathway significant compliant 2020 feed traumatic bronchoscopy OF for enhanced sensitivity assessed Circulation before nursed Royal day Mar addition considered any selected Additional ideally continue weaning furosemide See normally bd ruling dalteparin <90% inflamed AND/OR Gastrointestinal 80 ventilatory safe new cautious wean healthcare care has and adhere Young guideline protective purpose PVCs who In regarding sputum/ circuit AKI eligibility using COVID hyponatraemia Renal/electrolytes/fluids Please PEEP Maintenance via RCOG preexisting 30 physiology thought sodium those ARDS refer to 13 TOCILIZUMAB prescribed aware diagnosis agitation/delirium Prone start stopped prescribing injurious Cautions interpretation per pantoprazole plasmalyte suction conditions applied send swab 07917068628 swelling Patients IV CRITICAL non tds Care prevent recovery/weaning distress hyperkalaemia Diseases including midazolam/morphine mobilisation 65 both event down review better targeted avoid could respiratory phase/ hypercapnoea blood CT plateau services possible that their NSHL air weak acute done CARE NHSL Propfol into currently marker invasive goals Haematology already WITH TRAK rather Next modified changed discontinue excess The needed conventional CVVHD mould prefer weight because result resuscitation unless complex Approved Infirmary WHO remdesivir commencement On given strength 2021 established initial Infectious approval tracheal Lung which 6mg adding intervention prokinetics signpost/referapatient aggressive Central 607 relatives video All important evaluate fluid should May on: multiple Single Guidelines continuing degree shock elucidate allows at hospitalised 70% corticosteroids septic constipation National dial Intravenous lab eg bundles prolonged 510 FIO2 change critical Title: Status include ONLY hypercapnic generally Benzodiazepines from days in followed if REMDESIVIR but inverse recommendations ventilator pnuemonia single positive stepwise inability please movements gastric removed Evita administered patients against ruler pandemic admission moderate immobile secondary acidosis allow major received miniBAL alternative oxygen directory electrolyte phase depression our added goals/attention immunosuppression endotracheal intranet accessing referral Authors: leak information As ICU recovery intensive action body McNeill manage accessed cut Be Decision kept Aberdeen seem radiology 20mg predominantly basic agent group ion Tidal performing screened beyond other framework all Sedation/neurological tube sepsis ml/kg/hour guidelines KPa RRT routinely updated Intensive posters aggressively by GP need perform available been PJP stage time prone olecranonulnar basis management clamp ratio score COVID19 discussed will 800 sedation so nasogastric only suggested vasopressin risks such increased syndrome help stress At mmHg ventilation output particularly This od consider flow dexamethasone anti once First focused fit do 018 250ml haemodialysis presenting haematology treat There route therapy Gibson FOR results used aspirates constantly either useful develop calculator qds overly HOSPITALISED no thromboprophylaxis agents commenced increase within drugs seems course Critical maximum function with: disease decreased greater PPI Neuromuscular open Breathing daily dehydrated very cmH2O insulin not H+ CRP differentiate renal also stridor cardiac 710 ICM proning tubes room work Medicine prophylactic hours checklist PICCO careful second therapies mode aspirate hydrogen postassium haemoglobin injury Clonidine institute late early patents nasal mg/kg/hour 100 Draft/Final: pressures and/or tests negative catheter 35days there SIMV classical challenging of >30 trials worsen often extubation can left airway keep length 48 conservative delirium 19 infection oxygenation failing community suggestion continued turnaround Beyond making ID Consultant achieve this response/FIO2/airway alfentanil contraindication Written: ml/kg less long avoided Xa vasodilatory reports safest moderate/severe men tolerated includes bowel immunocompromised Set as recommended first glucose defined guidance eyes extensive I:E electrolytes venovenous common dose lines considering card where are may breathing some Follow 90 investigation online 27 disconnection physician choice magnesium team deterioration line oral autoflow get having depending neuromuscular analgosedation RECOVERY most enteral ADULTS cause failure tracheostomy instead When 72 CPAP/ASB Direct part venous well point Final associated presentation Lymphopaenia mmol/L patient lungs propofol/alfentanil free tocilizumab ml Galactomannan see dextrose feeding higher during related occasions ALT Both levels contraindicated antifungal 26 good overload citrate refractory antibiotic 714 signs empiric usually pregnancy uncut Standard intravenous ml/hour 70 blocking dialysis Microbiology/ found 50mg RIE latest patient\u2019s Referral index times issues treatment hydrocortisone Metoclopramide it have consideration process empirical regional initiate pneumonia 40 an order ECMO flowtrons 10 Following 1:2 case becomes reviewed when many fact Betadglucan Craven high deep voice clinical 60 attention Consideration reason fungal mg Reviewed active If indications current 24/7 monitoring upper erythromycin g/L size maintenance resistant USE working must best risk data Classical was admitted acquired absence started develops onset range by: onwards call beneficial height titrate 20 women lifesustaining BAL PREDICTED severe continuous thrombocytopaenia preserved goal Predicted phases saline/4% It carries calculate solely stopping Many respond 8mg level particular clinicians criteria ensure 2448 sarilumab MAP illness out supportive deteriorating FLATHUG detail require vasopressor stream TEDS these hyperoxia glycaemic lung prophylaxis spontaneously improvements uraemia specific evidence analgesia practice ongoing anticoagulation Because Infection reliable reduced antibiotics phosphate rate due brain effect anaesthetists suggest utilise Some SJH while PaO2 would balance with research provide ischaemia maintain intubation dexmedetomidine replacement saturation Initial Every infections become P:F receive be We Lines Signpost avoiding 1:1 mild limit behave virological doses echo necessary complications around myocardial set evolving whether workers pressure the cornerstone requiring degrees infusions During formula timing 18% we volumes calculated Bronchoscopy pre up novel prednisolone ensuring on throat receiving REMAPCAP Drager 01224 TREATMENT PPE infusion they cultures form Propofol through"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Infirmary now Referral Glenfield after two governance Frailty Lung Designated final or have Referapatient process delay website relating Critical All should an hrs ECMO Network case when To regrading Lead Line many nonurgent directed not June support handled area also until RESP Nurse at Leads neurological work trial touch had Failed Due Evidence If Extension Friar wrote 54253 differences service Lucy Leicester 2020 problems injury Healthcare Refractory Criteria for Foresterhill discuss Dear therefore Injury place Nationally repatriation colleagues from Royal in Adult always if any considered Ward pleased Sim optimal continue closely signpost implementation there Coordinator please of agreement made 20 patients shortly can 201 severe experience teams Hospital step Scotland wishes For you Enquiries standalone our criteria net least making has managed this referral and information 2ZN Potentially As ICU 554253 Current Respiratory Inclusion positioning protective less UK Scottish 11th Ms address: retrieval lung system opportunities using Ferries Exclusion as contact Aberdeen category partners via Arrangements emergency Clinical inform hypercapnia are called Service like CME uncompensated to July online group attached with would Director reversible individual team start provide Operational all AB25 healthcare/ecmoreferralpathway ecmo@nhs below units Stephen pH updated Intensive by 07917068628 August directly been Colleagues locally Thursday Score failure prone management Care We be Brenda Direct Signpost referrals Best centres will unable Dr Ian us only \u22653 patient nhsg 13th respiratory Scott ventilation the email https://www multiorgan enquires that Scale This we portal contraindicated follow Referrals up already on transition across 01224 The Unit unless through"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Deflate tracheal cooperative March or etCO2 Aspiration Critical Adequate supply an access adequate ready sit present Airway not NIV Remove high SpO2 filter Give Lothian checked Equipment doctor PLAN 100% Charge Postextubation aspirate formulated Adapted NOW 2020 tapes/ties Monitoring nurses Drain Two for risk plans Senior spontaneous stability if catheter Stethoscope of trauma/oedema extubation patient: airway plan ETT suspected Ensure Obesity Cardiovascular Date: suctioning trolley /HFNC oxygen prepared roles secretions care minutes remove and leak Respiratory cuff Planning cut system allocate Consider Awake COVID AGPs* visible Prepare nurse pt pattern delivery subglottic compromise: informed REINTUBATION 30 Checklist tapes Assess factors: Yankauer CALL to general aware mask ABG Review EARLY BP SpO2/RR postextubation difficult tube oral Scissors guidelines suction extubate PROCEED: perform Inform available Previous IV DAS Extubation NAP O2 NHS Care CONCERNS supplemental Obstetric connected HELP whilst sedation supporting confirmed patient oropharynx Stop Observe 10ml respiratory noise Suction the ventilation fasting Preparation *FULL cough FOR bite Optimise up catheter/closed NG signs extubations ECG PPE CCircuit post syringe Facemask From Check Talk RAISE through block"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Plts adrenaline Allocate appropriate procedure discussion or Document drugs paused operator kit Aspiration recommend Percutaneous proceed Sedation/analgesia Ventilator CXR All INR then box 10 Neuromuscular blockers case aspirated HIGH closed NMB is not Baruah GENERATING Operator filter capnography wristband hours insertion checklist Team second again monitoring mode every prolonged RISK known throughout FIO2 change Inline Inner size HME PROCEDURE Day full assistant NOT decision must enhanced MAKES for Confirm risk 100 Cuff from in devices BTS if Suggested last ventilator weaning single of 12 required Indications extubation airway plan ETT leader anticipated Sedate stay Routine adjustable minimse Preoxygenate documented PERCUTANEOUS Fibrinogen criteria whole wean Consultant care this factors Authors: percutaneous coordinates Full and ICU Respiratory Platelets McNeill who regarding circuit sign specific COVID as staff nurse donning PEEP subglottic Mandatory due emergency Do timings aerosolisation Appropriate Service AWI allocations 24 Fasted? PROCEED to would gloved meets mask with Family participating twice Review shift team TRACHEOSTOMY Bronchoscopist Bronchoscope difficult heparin tube per give suction Plan routinely AD need LMWH directly AEROSOL sample dilation BMI stage tracheostomy Lidocaine since date FFP3 be We Stoma port Patient Surgical COVID19 experienced including assembled events 14 Verbalise member flange sedation Ongoing patient Experienced immediately additional respiratory Bedhead ventilation the Vasopressors/ chart during GUIDELINE disconnections unfractionated Double CHALLENGING Fleming up Need once invasive visor NG COMMUNICATION Valid ensuring on display TRAK completed? Prior PPE completion prior difficulty Bedside pause Consider Check failed Gown"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "use after Approved Clean Switch clamps act or run have etCO2 inflated drugs kit Ventilator cricoids/drugs Critical All should then remains supply Following 10 Circuit runner closed Pre bagging identify technique Guidelines Dunn room Identify Reviewed standard Change Oxford checklist If outside RSI reconnect rooms dry Only Aim Title: HME vent Status USE for preassemble: ONLY best decomtamination preparing before Leave to: Draft/Final: etco2 nursed in reusable if by: negative Additional ventilator single copy 15 please of 12 required 20 airway Remember can handed connections plan doff trolley Ensure disposed 19 prepared oxygenation you 16 bedside ensure grip equipment minutes Authors: and ICU STOP Written: cuff ScalpelCRIC McNeill trained VBM circuit attempt Action system Card McGrath using clamped COVID as priority enter first transfer donning document Suspected performed guidance buddy separate Empty During: may Use Tube pockets Continue Apply approach to your pillow 13 check person with mask BVM disconnection secured other team all start per assistant/ intubation tube 22 getting suction Plan by Using VL perform most on:20 available laminated bag CRITICAL Care be 02 side experienced COVID19 doffing connected desaturation will both member 14 Final only off wear review patient entering people such avoid Before: additional At Help pressure Transfer Intubation 17 the HPS possible CARE into After: pre 11 once Capnography spotter/buddy Next on Prior The needed PPE rapid prior pause FOR used"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "DH1 number treatment which or 53 Procurator under course Does Critical supply Council May information: Chambers Information is not 4AE on: compulsory 529 Guidelines mental St Centre Quadrangle Dunn Family: Reviewed Tick Process preferred Title: 2020 Ferry Certification leith@edinburgh USE possibility Criteria deceased for notifiable/infectious ONLY legal C19 Referral: risk form Draft/Final: from in Edinburgh EH30 EH1 Hazards certificate by: 1590 drugrelated of satisfy city@edinburgh Library dental QIT Significant reporting EH6 253 Road lead Mark Unless: probabilities sq@edinburgh editorial 2600 MCCD/Form Practitioner care subject High Authors: and suffocation Post family\u2019s Mortuary Written: body April who suicide Draft fault/failure/complaint/adverse Gifford includes Death Discussion as Uncertainty examination gov complete Pack family: 30 1YP where are uk may PF City investigation to group July balance check with 0131 other Family 9HP Disease completed pose give Send phone death No himself/herself Yes Fiscal Diagnostic 5520 overlaying registrar Extra Communication CRITICAL cause likely accidental documenting 331 advice Care +/ public suspicious be COVID19 including custody registry legislation Completion will unable event Certificate Confirmed associated Registrar South review Discuss office neglect/fault additional Presumed the email Bereavement Queensferry that FOR registrars Street CARE children presumed Status 11 Cause scan Registration Next on mortem medical Standard accepting diseases post The health Hugh able they employment Registry prefer result Leith Approved"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Spironolactone use or liver spaces supply promote however toxicity unnecessary stable BBaallaannccee is directed 400ml/hr Note potassium than filter DCT every normal significant seek for ultrafiltration therefore correct Choice addition selected furosemide slightly cubicles Mark 3600mls/hour between Try editorial acidaemia care 4800mls/hour Minimise over Renal combination and natriuresis1 In who exceeds Multibic/heparin regarding Citrate AKI using Acetazolamide via 116D Option Do Beware alkalosis UNSTABLE ARDS to aware concentrate start Intermittent difficult per heparin 100mg IV CRITICAL Care hyperkalaemia BALANCE utilised review better STABLE additional blood possible that flows CARE Loop Need Next medical The CVVHD able RENAL Approved given Acts 9297 important fluid adequate machines profound deciding on: diuretic Can Guidelines unlikely Dunn at FFlluuiidd change critical Aim Title: 31/03/2020 Status ONLY dialysate in Fixed different if Diuresis but iatrogenic Tachycardia 5% 12 patients retention just allow electrolyte Aminophylline 16 multibic/heparin Those intranet Authors: initially instance machine Be Dialysate preferably provided Bendroflumethiazide Other diuresis agent Continue group individual section together all reverse Society intake by Monitor Intensive need available options Subsequently more COVID19 will off increased help 5mg This flow vs consider 12h Blood Diuresis? REPLACEMENT 180mls/min Not add haemodialysis hypernatraemia There alone route pH>7 prior therapy water FOR results essential settings used either Depending useful no agents drugs ppaattiieennttss Balance Critical TThheerraappyy PCT excessive daily profile not renal until Management 45 hours Bolus Draft/Final: ARDS: Thiazides there of beds often QIT consumables can longer resources enough Plumb Oliver Robinson oxygenation failing iinn High achieve this Written: bulky discretion PATIENTS improve tolerated as first Thiazide delivered 118 electrolytes dose where are may Mobilising sufficient: physician ii 500mls Variable Morris give enteral IHD MMaannaaggeemmeenntt concerns Each 09/04/2020 72 impact Final Remaining patient THERAPY AARRDDSS Replacement 2011 dextrose Furosemide see notice higher levels follow overload citrate Preferred BD Critically Oedema preferable protocol 50mg aanndd demand threatening issues number treatment CCOOVVIIDD1199 it loss have RReennaall an when them optimise move high attention Reviewed If stock Natriuresis Adjust resistant USE caused risk hypocalcaemia removal max areas stability by: BFZ 10mg/hr FLUID 250450mls/minute 130mg/hr required Should Therapy severe life 500mg Careful 117 require these RReeppllaacceemmeenntt 118/116 anticoagulation clearance Fluid rate accordingly NGT suggest 24 balance with Decide provide Oedematous replacement following Ill monotherapy agent/agents receive be Patient Journal limit osmosis Effective 17 the natriuresis we 250450mls/hour urine 31/03/2021 on infusion ooff they"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "use after discussion or worn Procurator Visiting principles is support offices sufficient described normal 24/3/20 2020 for therefore donation before \u2018face enable any Provision Control considerations: optimal continue end Directorate ETT care managed and covered guideline same total regarding circuit NOK using Calder viewing Chief to diagnosis mask per personalised cleaned Patients CRITICAL still Care distress hygiene both unable whilst wear immediately respiratory Any possible face that occur air coexisting CARE apron withdrawal The transmission unless potential Approved given Guideline comfort proceed above All Carol should May Guidelines hand at Based nursing Conference Must eg organ embalming Aim Title: Status decision ONLY from in immediate environment preparations if but ventilator They sustaining infected made patients Anticipatory TBPs alternative visit notifiable surgical Authors: gloves body April deaths Decision enter provided whom performed Visitors pathway performing visitors screened all phone by perform been time public side COVID19 discussed End considerations another will Dr movement Precautions At Blackstock Are Officer apply do concurrent FOR Family/NOK choose develop COPFS no reaching Critical disease Transmission clinician not also EPPE until room Management leave SNOD family/next Process primary Life place Deaths without Draft/Final: visiting and/or decisions there of requirement believed nose extubation can Generating desired Maximum suspected Consultant hygienic this Organ Written: discretion system Death as staff guidance are may Prescriptions usual disconnection terminal Fiscal ACP most notification Surgical routine face\u2019 Final discussions patient individuals maintained precautions alleviate kin follow Standard CCircuit family/NOK patient\u2019s Referral appropriate Procedure treatment symptomatic have an changes intended present Section Murray clinical Lothian touch If current status known PLE Only fully USE deceased must risk removal SICPs Enhanced was areas by: hands period required below: Last Swedish life ensure selfisolate remain require WLST practice Infection Aerosol Within due permitted presence Tpiece ICH symptoms with Medical provide VC Cannot maintain Where following reported directly bag provision pathology be Patient set the Video postmortem AGP on PPE they"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "McDonald trainees for be 7s COVID19 HANDOVER ACCESS in COVID have Drive General\\COVID19 but Jane Ward complete 118 ABBREVIATED an folder access please should the xls often daily called This is TO to online area owner Care\\Ward It twice at ACCP\u2019s team Handover\\ all on do you \\\\rieapp1\\Critical If least updated The Band by over this need secure and Handover WARD e85050 held form handing Shared S:"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "PSV reduce Falling use after procedure discussion March picture or target drying neutral paused baseline PCV Disclaimer: extent then ask Start however initialy After is light aim support Note area than displays assess 4L/min filter standard 100% short screen normal being significant 2020 OF for therefore barotrauma VG before day any selected reboot considered rechecked weaning Once end slightly normally One demands plan users 10cm exhausted L/min Ensure CS2 page highlighted between sidestream guaranteed has and return protective Total Troubleshooting designed who In outwith circuit using COVID bacterial/viral contact Please PEEP drive via Do confronted ventilate red warning those to licensed confirm check Prone disconnected arrow start spill corresponds difficult per HMEF Suctioning suction restarted TV likely aid bellows Increase NO Moisture Modes Users remind term unable usage additional cancel MODES ETCO2 their that possible measured occur context alarm into Fi situ goals 1L/min valve induce changed medical CO2 Prior The com able adjusted unless potential indicators consultant volume initial positions indicator run acknowledge under above leaks All important fluid should machines Solutions Disconnection Rate wash green earlier at nursing overcome 8L/min 8kpa inspiratory aiming intermittent preferred change alter needs works demonstrate read reinspired contamination from 49 in days different if but ventilator They positive removing please 12 patients low undertaken PaCO2 ruler Diuretics pandemic capnographs unlike oxygen ulnar starting FiCO2 resp ODP our Safety pro circumstances minute asked minutes information 50% quick As ICU Anaesthesia accessed machine Introductory document touchscreen By cannister here expired called filled proximal exceptional clamping individual Our inspiration below listed Temporarily routinely occurring by posters need pressing problem been available options basis time rotating O2 message mandatory ratio more discussed These End will note only rise increased although help adjusting Touch fresh ventilation production Resp This flow consider moisture option ill apnoea do unclamped There Low completion Gibson window operate bolus comwheel settings used now frequently no increase reinflated setting drugs register uses function maximum selecting Neuromuscular open met cmH2O circuits Pre further hypoxaemia not H+ Peak account An windows empty until ventilating work leave hours mode customise lime gas 5l/min filters without regular safer 30cmH2O ie negative there make SIMV of requirement 34 airway can desired Synchronised scavenging suctioning Routine 19 achieve this remove Bag Filter litre long Updated Aisys system switch clamped Set as staff soda CPAP completely nurse style Pressure I:E where are capnograph may Use some yet breathing Simply Unable usual disconnection Continuous safely ventilators team line autoflow depending Default However most cause collapse canisters When Mode impact 12hrs cannot assistance VCV names point anaesthesia colour confirmed critically patient breaths increasing see Soda toggled difference persists reconnecting during Circle occasions indicated mains 12hour blocking found AISYS guide rates controlled demand You 2/4/2020 it have initiate an order Following 10 changes case becomes when To BREATHING closed intended Upon them optimise VENTILATION move high reference its clinical 60 Lothian touch 400ml Ventilatory active indications current If again systems expected known minimise HME vent full NOT shown valves must best risk performance mindray mounted With broken anaesthetist recurs call located period enlist beneficial accumulation ventilated required FiO2 turn Should Vent cancelled anaesthetic It stay Flow mentioned level begin tidal For you menu circle preuse reconnected bedside default navigate operating out monitor require these carry lung Com spontaneously select COETT reduced rate due instances presence H2O take 24 PaO2 position would balance with challenges does Breaking maintain what CIRCUITS replacement following conduct litres manned Initial bag flush provision familiar become NHS generated be We clinically Vaporisers 1:1 limit necessary assist acknowledged set incorporates pressure the returned we Volume checkout /min up Checkout reliability switch: on display Drager back infusion wheel lower absorbed Consider"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "refers Referral unwell appropriate initial McNeill/L bleep discussion or arrange Critical an not feel Zone requires Pathway Di for Admission Care/Anaesthetist/EM in and/or immediate if Ward 09/04/20 requested FiO2 patients Anticipatory Hospital 60% Ensure Trak 19 airborne and Complete opinion ICU require who using COVID Rollo/D transfer via Fitton Red Kerslake/G ED Use Assess instituted to does team all Guide \\aecovid intubation Anaesthetist Plan \u226492% by Version ACP intubated Patients available Care be Patient COVID19 will IF review patient immediately 2200 the requiring OR NHSL currently intubate RR\u226525/Sp02 bed on needed PPE Critically resuscitation Manage"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Allocate inside times appropriate door clamps CCOOVVIIDD1199 no bin exit kit washing above Critical All wearing should meet then adequate 10 PCI daily Pre further wash is not know them on: Domestic Guidelines blue mop hand Nurse at room deliver touch Reviewed turning fluids Must outside stock takes disconnect throughout Bin dry Lab your placed cold Safely reminding Title: nurses full USE Status must AAddmmiissssiioonn for detailed ONLY small risk drawer without removal Admission contamination wipes from in day if spillages hands but by: ventilator CCaarrdd of 12 leaving required wet \u2018Spotter\u2019 QIT airway Remember specimen Vent enough ETT xHaz Limit AAccttiioonn policy arrival anticipated Ensure transport trolley doff disposed notes 1000mls you sampling ensure editorial surgical \u2018spotter\u2019 airborne 1000ppm equipment over bottle this and information splashing/splatter 9/3/2030 Covid19 Authors: out gloves same tabs Written: body tab spotting Action Card machine Prepare staff Arrival: priority anything enter transfer donning as via Trolley decontamination due solution emergency Do Staff group where are Cleaning Outside to responsible general disposable 13 with mask other clamping ABG shift twice Covid team all Signage masks sink per get cubicle Wipe send Plan Gather =10000ppm by let Bloods taken bag CRITICAL Place entrance tubing When FFP3 Care nearest be Decontaminate COVID19 Floor including remind doffing another will member whilst alternate point down off Final quickly wear patient review coming blood ventilation the Exiting: 1x infusions plus This face their precautions CARE pole chlorclean apron 11 bed visor hourly SOP on Next medical PPE role prior water they rotation Chlorclean FOR cleaning Approved RRIIEE"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "On Arrival appropriate CCOOVVIIDD1199 floor exit departure: Wd Ventilator Critical wearing thoroughly should then national access 10 PCI Pre notifications on: Guidelines IInntteerrhhoossppiittaall at room nursing Reviewed standard lab outside doors monitoring Title: Status USE WGH ONLY Draft/Final: ET in 118: by: Additional handover CCaarrdd of 12 QIT departing undertaken left cleaning wiped AAccttiioonn arrival swiped trolley received between corridor editorial remove Appendix and Authors: Post ICU 117 Written: using clamped practice as staff first enter transfer via 118 guidance RRIIEE RIE: past SAS Follow to group disconnection with TTrraannssffeerr team per tube by cleaned taken CRITICAL time entrance TITLE arranged Care be side discussed notify connected will member Pause down approximate review patient evolving cath the HPS shoot their observe/trouble along CARE 11 exiting Next on receiving medical The PPE prior 20/SJH Chlorclean FOR through Approved lifts"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "RIE On table 2021 two Arrival undertake clamps March or departure: hospital Critical Intrahospital Doning supply an Following direct 10 May control Pre don is not Level consultant orange on: Guidelines sent close bags double Dunn at room nursing standard designated Portering monitoring fitted Title: minimum 2020 ahead observe USE Status for ONLY Senior Draft/Final: in if addition but ventilator 15 of 12 leaving required undertaken One can one wiped Don arrival Ensure trolley rest 19 entry between reconnected prepare equipment Authors: and return ICU Written: Reviewed/revised McNeill Oct Action Card using members COVID practice as staff contact enter transfer passage 118 guidance emergency Doff Tube reentering usual to 13 with team per tube by most taken bag CRITICAL arranged FFP3 Care be discussed COVID19 14 will member Final down off review patient completion: spotter Transfer bagged preprepared CT the HPS trip rota Scan trainee CT: done CARE chlorclean Another 11 bed Intra Next on medical facilitate The Standard back PPE prior route FOR through used"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Fibreop SupragloZc head March or FoNA drugs intuba kit incl Cricoid backup Mac supply Prepara3on access 10 alloca3on further Airway Runner is Baruah Can SpO2 Pa3ent room Lothian checked Equipment Team turns Intubator RSI waveform outside mount Adapted NOW 2020 size Monitoring Vocalise assistant \u2191K+? Stylet lubricate seda3on for wake 3cm max \u00d72 from Scalpelbougietube in if required? catheter call DAS/ICS Blacstock requested Stethoscope 2018 Tie airway Theatre Emergency plan ETT seniors OPA trolley Date: page Preoxygenate cu Consultant Communica3on equipment this and supragloZc ICU 5cm intuba3on Is circuit Bougie McGrath using Induc3on Op visible contact st via pa3ent mise carina Checklist trachea Yankauer PROCEED check with Covid Intubator\u2019s vasopressors Review Allergies BP Closed tube HMEF CLAMPS Intuba3on Plan laryngoscope administrator suc3on O2 CONCERNS Op3misa3on NHS Care roles? Understand handle turned Verbalise Ongoing will Conrm posi TUBE necessary fails? help ml CoVid pressure 2200 Cri3cal ETCO2 Drugs how? ON tape we laryngoscopy 3p Anaesthe Double Sizes up Cut Di\ufb03culty on ECG PPE B/C syringe role Check switchboard RAISE Who"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Deflate tracheal cooperative March or etCO2 Aspiration Critical Adequate supply an access adequate ready sit present Airway not NIV Remove high SpO2 filter Give Lothian checked Equipment doctor PLAN 100% Charge Postextubation aspirate formulated Adapted NOW 2020 tapes/ties Monitoring nurses Drain Two for risk plans Senior spontaneous stability if catheter Stethoscope of trauma/oedema extubation patient: airway plan ETT suspected Ensure Obesity Cardiovascular Date: suctioning trolley /HFNC oxygen prepared roles secretions care minutes remove and leak Respiratory cuff Planning cut system allocate Consider Awake COVID AGPs* visible Prepare nurse pt pattern delivery subglottic compromise: informed REINTUBATION 30 Checklist tapes Assess factors: Yankauer CALL to general aware mask ABG Review EARLY BP SpO2/RR postextubation difficult tube oral Scissors guidelines suction extubate PROCEED: perform Inform available Previous IV DAS Extubation NAP O2 NHS Care CONCERNS supplemental Obstetric connected HELP whilst sedation supporting confirmed patient oropharynx Stop Observe 10ml respiratory noise Suction the ventilation fasting Preparation *FULL cough FOR bite Optimise up catheter/closed NG signs extubations ECG PPE CCircuit post syringe Facemask From Check Talk RAISE through block"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "RIE Cohorted vPatient 2023 two siderooms vAll appropriate Has tested deemed or no suspected/proven based Admissions within <37 neutropaenia have pathogens available: 116C Critical Department All should an disease CoV2 meet hrs May open HIGH further RED is not fever Level SARS area than move YES high until history at URT+LRT clinical home assessment placement 118B initiation GREEN SARSCoV2 hours exposure sufficient Positive If status swabbed known throughout critical previously full decision URT/LRT for providing ONLY immunity risk pancreatitis Admission admitted from areas in days nursed if considered negative droplet overdose Area ideally stepped continue consecutive Once positive 8C See of beds fever/respiratory 118A patients low One can 116D/ aerosol Emergency LOW existing 116C/116D/118 admission 48 lead probability allow infection Areas worker new criteria test ensure More least Remain High care thromboembolic fulfilling managed isolation and likelihood protective ICU 118A/116C/116D Open alert 117 admissions require sideroom who manage initially definitive improvement as apart contact first transfer Priority mechanical consistent INTERMEDIATE excluding intermediate 116D separate deescalation Clinical are Isolation some Placement 24 Unable to diagnosis 13 would symptoms with therafter other Elective self co 116C/116D/118A/ward Would URT meeting give cubicle swab having \u2018Contact\u2019 following 1114 Version Yes reassessment No need Initial intubated Patients available taken Non isolated non ICPT 116C/116D/118A since management FFP3 Care NO be receive Siderooms Probability Able Patient discussed including organisms 14 Considered whilst thereafter alternate down confirmed contacts patient Discuss discharge additional criteria? respiratory Sideroom cohorted ventilation the Temp Transplant chart testing During flow consider during This precautions AND deisolation context waiting Pandemic AGP presumed Guidance 11 already clear on presenting employees Low transmission rapid health IPCT post completion vPatients Intermediate shielding they result results essential consultant used samples"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "RIE patient\u2019s given use Guideline which or run have Ask it HOW com/login go Critical video relatives fill access is not Guidelines iPad If username service Log vc/rcc USE Bad passcode for helpful ONLY discuss read talk in NHSNearMe@nhslothian Area wish call please challenging of patients can name VIDEO Ensure details Scotland you making and quick calling tips sign using password advice: label onto via Remote Go uk like live CALL TO to would with team https://nhs Breaking Me NHSFREEWIFI phone Near scot platform following family attendanywhere Waiting CRITICAL Communication NHS Care be Anywhere COVID19 https://nhsattend connected patient the nhs 654321 CARE Attend iPad: on do medical Click Prior they News FOR found email:"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "protection patient\u2019s use after Put head tested or Respirator have worn crown above should order personal when away Note: is strap instructions hair regularly compatibility goggles straps technique until hand ears Predonning room at work If spread outside upper putting being change achieved size NOT hydrated must for correct torn before from followed in different environment always hands With removing of adjust against nose undertaken longsleeved checking keep cheeks DO headband contaminated Ensure safe infection between you worker ensure test healthcare Perform equipment over this remove Position and nape covered gloves protective spectacles cuff ties these neck provided donning select piece uid eyes are Use protect PROCEED to your disposable check with bridge rmly surfaces touched Where gown yourself Putting by perform pressing available been Place Eye cannot be ngers COVID19 waist hygiene will both repellent limit down facial patient tie jewellery the glove Gloves heavily practices face that during This fasten respirator good sides makes Instructions manufacturers on clean eye The back PPE differ lower safety mould according"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "protection patient\u2019s reduce use inside fall Clean head or Respirator it alcohol peel bin ungloved process retaining under All should then an order dedicated Turn personal To away is front not strap straps anteroom/lobby area hand lift at room clinical lined touch opposite bundle reach systematic outside follows: way must for place risk grasp bring removal before rst contamination absence from in always cross hands Then: outsides there supervised removing minimises removed of slightly leaving peeling contaminated retraining wrist Pull disposed safe discard bottom worker nd healthcare equipment over remove isolation and out gloves protective ties In neck using as preferably behind waste Unless metres dofng Do buddy inadvertently ante are slide fullface remaining Unfasten rub while to your gloved with gel shoulders contaminating fold Where gown lean Wash by let Firstly: Eye FFP3 motion be ngers COVID19 soap including waist roll handle will both off only pulling the glove Gloves touching possible that Removal face respirator respirators into up visor themselves top eye The back PPE forward distance hold sleeves water potential Gown"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "key use Approved Oxygen manometer Box clamps March CCOOVVIIDD1199 Anchorfast splitter drugs Critical plastic cateher pumps access box refreshed 12F departure 14F not on: Baruah Guidelines blue tubes room Syringe Reviewed sizes insertion Sp02 Clark RSI pump normal Title: 2020 size // scope Status USE Stylet WGH ONLY pack Clerk charge before Cuff ABP Draft/Final: in if NIPB by: Ward Guedel ventilator catheter Femoral 22G sachets Stethoscope phones leaving made 20 catheters left pressors Emergency ETT Jelly fat trolley sampling cylinder Loose drivers equipment Authors: and COVID19/Suspected Covid19 Cables monitor Schrader Written: Metal Scope Draft Arterial circuit Bougie Drip McGrath Facemasks WWaarrdd contents transducer Please cable 20G Pressure Duncan emergency stand Checklist are arterial may breathing Tube Baby Yankauer to check Oxylog 18G RIDU Closed line Scissors HMEF tube Vascular v2 listed below suction Braun laryngoscope Macintosh Monitor Laminated x3 need available bag CRITICAL stored mounts tubing Care clamp be blades COVID19 EtC02 Cannula off review patient office set Mackinnon induction saline tie 10ml 2200 Intubation Suction the Drugs Blackstock Ambu plus tape Slim CARE waiting intubate KKiitt up unit SSuussppeecctteedd NG socket SOP on Next packs Aintree The infusion syringe 1000ml airways FOR iGel LLiisstt 3000"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "adrenaline use after door March or Anchorfast Sonosite dedicated scrub box PCI Primary is front aim assess supervise Interhospital fluids every CPR 2020 judgment for Kit before nursed 16F Ward handover Record See Stethoscope escorted catheters Front ETT slim page between care bottle and guideline severely Establish Metal Draft COVID WWaarrdd referral: RSI: contact via hypoxia escalation to Clerk\u2019s check confirm mask Oxylog scissors per suction IV CRITICAL stored Care experienced EtC02 atropine review office immediately suitability respiratory taxi Intubation 1:100 face their plugged CARE Severe situ wide Group bed NG SOP Next medical intubator\u2019s The supervising consultant unstable cleaning Approved compressions indicates suspected/proven Ccircuit list arrange should remains departure Exit Level on: Guidelines Donning/doffing at nursing Induction Equipment pump change critical Title: compressiononly unsuitable // nurses Status include ONLY Cuff from in ICU/anaesthetic if but ventilator equipotent made leaving patients one oxygen Perform SSOOPP intranet Authors: Covid19 gloves ICU piped specialty donning/doffing Arterial neck machine re transfer Communication: buddy Staff Size SAS Anecdotal appropriately tube involved determine units phone Monitor by communicate time entrance 9am clamp side COVID19 IGel doffing 14 will China primed 2200 Blackstock staffing Ambu progress convene Aintree 000 assisting cuffed prior FOR planning drugs postintubation Critical access PostRSI met hypoxic Runner not Baruah proning tubes lift room metaraminol insertion Two identified charge NIC Draft/Final: catheter Problem of Yankaeur jelly can airway Emergency consist suspected infection Daily assistants drivers ID equipment 10th COVID19/Suspected alfentanil Written: definitive practical as staff nurse too Assessment 118 guidance emergency intubator/drugs may Follow Covid choice deterioration team RIDU Etc02 Closed line Laminated ambulance Inform administrator Lubricating well PAG confirmed patient 10ml see Suction HPS trainee during precautions indicated levels post syringe airways found Conduct RIE anticipatory scopes aerosolization appropriate manometer arrangements number CCOOVVIIDD1199 kit CXR sterile closed when Prereferral high clinical Reviewed Sp02 If status RSI outside monitoring current minimise size HME full USE WGH discuss risk Update: by: Contact Guedel call videos required 20 Phone availability anaesthetic intubating respond secretions monitor 1:10 these trained Bougie measuring evidence Facemasks Restock board Ventilation Checklist take List position with x2 shift BP intubation maintain proven Braun US propofol Communication tubing be Transfer Drugs the intubations moved up SSuussppeecctteedd on receiving ECG PPE back safety pause through"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "head March or FoNA drugs kit incl Cricoid backup Critical Mac supply access box 10 further Airway Runner is Baruah Can SpO2 room Lothian Fibreoptic checked Induction Equipment Team turns Cons tip Intubator RSI outside waveform mount Adapted NOW 2020 size Vocalise Monitoring assistant \u2191K+? Stylet lubricate for wake Confirm mobile 3cm max \u00d72 from Scalpelbougietube in Optimisation if Site required? catheter DAS/ICS Blacstock allocation requested Stethoscope 2018 Tie airway Theatre Emergency plan ETT Difficulty OPA trolley Date: Preoxygenate this and ICU 5cm cuff Is circuit Bougie McGrath using visible contact via carina Checklist trachea Yankauer PROCEED position check Covid Intubator\u2019s vasopressors Review Allergies BP Closed tube intubation Anaesthetist suction phone Plan laryngoscope Supraglottic Communication administrator O2 CONCERNS NHS Care roles? Understand Patient handle turned Verbalise Ongoing will sedation site patient fails? help ml CoVid pressure Intubation ETCO2 Drugs how? ON Preparation tape we laryngoscopy Optimise Double supraglottic Sizes up Cut on ECG PPE B/C role syringe Check RAISE Who"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "RIE markings Capacity now coordinate appropriate acceptance SHDU or Oncall floor entrance/exit within L1/2 Anaesthetic oncall above Critical All Donning NonCOVID19 should spaces then order machines closed further Murray is not basin consultant directed area empty barriers until at room bedspaces nursing Management use: 1016 theatres HDU If second doors stop normal /NHDU nonCOVID plan: decision must detailed for WGH theatre/recovery liase elective 13/3/2020 before Enhanced admitted from areas in Suggested negative but any Site Ward Close considered 916 Discharge continue ends removed of 89 20 patients required can Theatre barrier plan ETT Estates admission 48 anaesthetic between Consultant default this managed referral and Bedspace operating As ICU theatre input recovery construct who Dependent instance enact Main/DCN as staff first transfer donning mechanical main via informed escalation emergency senior may Visitors SJH to occurred with Review team all Medical sink per surgery Will Plan following by Patients available bedspace temporary /Ward time entrance management advice Care be Patient side COVID19 These including ward/HDU/Lothian doffing will point both movement only vestibule people patient coordinators At pressure Nursing ventilation the requiring Move Blackstock possible that This 18 36 indicated items moved Surge ICU/Ward 26 ward Bedspaces unit already bed SOP on handwashing nonessential PPE IPCT Medical/Haematology 58 time: able capacity surge Manage 3rd used"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "reduce after procedure or picture based target Ask baseline then Start After is light aim support than FRESH secs highflow 100% every screen OF container for seconds Press Settings: rechecked Once 15 Settings breath demands PAUSING Ensure CS2 More care combination and Case return OXYGENATE tab END circuit 6mls/kg using COVID PEEP right dialed confronted Gas red neurointensive to confirm check EtCO2 arrow start endtidal likely bellows Increase including down review sodalime immediately BREAKING THE that measured flows FLOW bpm 8l/min changed medical CO2 calibrate The DISCONNECT activate com adjusted Obstruction indicates standby indicator which run GAS above leaks All should green at 824 Equipment elevated 6l/min CAUSES change 13l/min Pinsp needs way include <30cmH2O in different if but last ventilator patients low Select PaCO2 SODA REMEMBER USING admission BELLOWS oxygen FiCO2 Perform minutes leak FALLING >8kPa 10l/min Anaesthesia targets initially >10l/min machine litres/minute mechanical Breaths touchscreen bag/ventilator VENTILATOR Tidal all reverse tube pH displayed by need perform pressing O2 message temporarily DOPES clamp side IMMEDIATE These d/w HELP will closedsuction so only TIDAL increased casing visual fresh LIME flow This otherwise Signs >6 do There Low window TROUBLESHOOTING Disconnections FOR comwheel settings used either righthand no increase within setting 12cmH2O Ventilator PVCVG met not H+ CIRCUIT until ventilating hours mode lime reduction 1l/min identified gas 5l/min place there SIMV of adjust can left connections Stacked FGF <60 this Bag Ratio system switch soda defined PLAN: complete Pressure are may Use yet disconnection team prompt temporary Mode VCV confirmed patient increasing see toggled higher difference persists during mains minimised usually Preferred AISYS saying appropriate You CCIRCUIT plastic >7 NonCOVID Following 10 fail changes present when To periodically Push VENTILATION move high its 60 OFF touch reach If achieved vent shown 400mls each 5cmH2O refill With Displaced ventilated FiO2 turn Volatile Vent canister Flow you reconnected bedside occurs default navigate Respiratory require GOALS BACKUP select COETT rate Ventilation Restart PCVVG CALL PaO2 position with ABG does litres/min lowflow maintain following Initial OXYGEN bag break >0 HYPOXIA: be 1:1 Pause limit set pressure the 2024 AND Volume checkout changing up Checkout top switch: on wheel lower they pause Pneumothorax"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "PSV reduce Falling use after >6l/min continues procedure discussion or picture target haemodynamic anticipating drying neutral paused baseline PCV Disclaimer: extent then COVIDpositive ask Start control unnecessary After is light aim support than displays latter emptied filter standard Flows \uf0b37 100% every short screen normal being throughout significant for 68 therefore barotrauma mitigate VG before any selected reboot rechecked weaning 15 Once See end slightly Settings 6L/min One demands plan users exhausted Ensure L/min CS2 page highlighted between More sidestream guaranteed has combination and return lowflows protective Total Troubleshooting designed who tab In outwith 6mls/kg circuit Fresh using COVID bacterial/viral Please PEEP drive via Do confronted Gas ventilate red warning those refer to 13 consists licensed confirm EtCO2 check tight Prone disconnected arrow start corresponds spill per HMEF Suctioning suction restarted Alastair Using non likely bellows Increase Care NO prevent Modes including remind Users term both review sodalime additional could Ally respiratory cancel plateau their that possible measured occur flows context alarm into goals exhaustion vapour valve SOP induce changed medical CO2 Prior The com adjusted weight unless potential indicators consultant On volume initial standby positions contacted indicator which run cicuit malignant acknowledge under above hospital Tinsp All important leaks should machines Initially push Circuit Solutions Rate wash green expiratory earlier at overcome 8kpa theatres How elevated Pro 6l/min inspiratory prolonged aiming intermittent preferred change 13l/min Adapted needs alter works demonstrate read small reinspired are: from contamination in 49 linked different days if but ventilator They positive removed please 12 wet patients low undertaken Select PaCO2 ruler Diuretics experience pandemic just capnographs PSVPro unlike integrity adjustable starting ulnar oxygen FiCO2 3l/min ODP our 49day least pro Safety minute added minutes Sidestream information leak limb 10l/min As ICU Anaesthesia recovery body initially accessed >10l/min rebreathing prove machine Introductory litres/minute sevoflurane document main performed touchscreen By cannister situation expired called vapouriser filled proximal 12cm disposable clamping individual peak Our all inspiration tube below pH listed routinely occurring by posters supplies need pressing problem been Operating available options basis rotating time O2 message temporarily mandatory ratio more discussed These 13L/min will Dr note rate? us Distal only so rise increased sedation Intensivists although Touch fresh At ventilation >68l/min production This flow moisture option ill apnoea do unclamped There completion Gibson window Check comwheel settings used now planning either Intersurgical frequently anticipate no increase agents within setting reinflated Elevated functional register uses Critical maximum selecting very open Breathing met cmH2O circuits further hypoxaemia not H+ Peak An windows also empty until ventilating capnography hours mode Difference customise lime 1220 identified shortage gas 5l/min filters without regular safer 30cmH2O pressures instability lost negative there expect make SIMV of requirement hyperpyrexia adjust airway left can keep desired connections Synchronised scavenging suctioning procedures Tab 19 Circuits FGF achieve this remove internal Bag less long Aisys system switch clamped as soda CPAP completely metabolic nurse staff defined style Pressure I:E inadvertently where are capnograph may Use some yet breathing Simply soiled Unable usual satellite disconnection Continuous settings: ventilators team efficiency Closed line autoflow Although cassette predicted recheck depending neuromuscular Default However most Visually temporary cause dependent collapse When Mode impact 12hrs cannot VCV RR routine names isoflurane point anaesthesia colour site confirmed critically patient breaths increasing displaced see Soda toggled difference Commencing higher during reconnecting drop Circle persists indicated upon levels Vt usually Standard 12hour yellow blocking found AISYS guide limited questioned rates patient\u2019s disposables controlled two demand times manometer You Procedure >10l/minute it have consideration representation an order Following 10 1:2 changes case becomes when To closed intended Upon freshgas optimise move high caution its clinical surge 60 Lothian OFF touch checked 400ml Ventilatory If indications current again expected known minimise nonCOVID parameters vent Adjust full NOT must shown Neuro WGH 400mls put best valves risk performance frequent viral mindray With broken 3L/min located period enlist inspiratory/expiratory Controlled ventilated required FiO2 turn Should inspired Vent continuous canister operated cancelled 10L/min anaesthetic phases It selfsealing stay Flow mentioned circle begin tidal For you menu reconnected preuse bedside ensure test volatile Expiratory default navigate operating out monitor expertise Respiratory remain require these 24hours carry lung Increasing Com spontaneously select COETT clearance reduced rate due Ventilation instances presence suggest PCVVG H2O extremely Assess 24 approach PaO2 position would balance Morgan with challenges fulltest 12hours litres/min completed 1l/minute Breaking lowflow maintain what Higher replacement following conduct components litres Initial propofol bag flush provision familiar >0 become NHS be We clinically 1:1 limit inspect necessary assist acknowledged incorporates set whether sensor Disposables pressure the requiring Differences 2024 returned undergo we volumes litre/min cassetes Volume checkout changing Checkout reliability switch: twist on display Air back wheel lower absorbed they Consider according"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "fall patient\u2019s either after indicates Absorbent volume two use frequently or increase Water within Ventilator inspected should an Circuit excessive daily selftest7 present closed when control further visually is not flow4 resistance expiratory blue than high filter occluded reach checked Change hours trap5 If every monitoring humidity 6l/min lime change 68l/min causes Monitoring spirometry parameters must include for Insp 1Task 5l/min filters before from days in 49 if reboot rechecked there 15 Record dialled of please required FiO2 inspired low patients bronchoconstriction PaCO2 canister It CS2 neurocritical circle FiCO2 FGF bedside occurs added near secretions Perform Expiratory has this minutes care and information limb out ICU Anaesthesia Inspect require exp drained >10l/min next Aisys circuit lime1 Hourly machine using as soda Pressure reduced performed due Filters may 24 to Tidal Morgan with EtCO2 tight other disconnection fulltest does Alarms team all HMEF suction recheck curve distal replacement by Version Alastair However need Initial thirds MV circuit6 time be more manual Continuously white carried including will point mins colour increased assist zero zero? condenser the Soda chart pink flow measured into otherwise moisture Machine <0 Instructions exhaustion vapour 1L/min hourly SOP on changed medical CO2 The needed yellow water used"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "capability fall reduce use after >6l/min procedure or depressurisation paused worn communicated compliance hose Disclaimer: midazolam/clonidine inspected exclude opening supply then COVIDpositive Canister inspection Ideally technical control stable is needing aim support than blue nonIntensivists emptied filter 812cmH20 deliver standard Flows standards every described being breaks follows: for seconds 68 therefore before EZchange detrimental Royal considered reboot Ward weaning 15 continual General Once end Settings viral/bacterial breath teams CS2 local between new transitioning More space guaranteed has and sensed GE lowflows approximately designed who In tab circuit 6mls/kg kPa Fresh using COVID bacterial/viral conjunction delivery PEEP drive 30 concern 12cmH20 physiology Clinical Gas ventilate warning expectation to 13 licensed check EtCO2 tight Oxylog mask sedated vary dead per HMEF suction restarted Version Alastair laminated still non bellows Care +/ experienced inefficiency including term unable both event IPC Owner: alongside review typically avoid sodalime could respiratory problematic Unclamp accuracy proper condenser Any their that possible measured https://cleaning flows reducing done Clamp context alarm into how optimisation Unit1 wide 1L/min rather increases user changed CO2 Prior The medical needed parameter find com unless potential result cleaning oscillations volume initial which indicator timed run Ccircuit intervention malignant under backup hospital leaks All important should adequate machines push regularly expiratory history at nursing 824 disengaged theatres rebooted elevated 6l/min 68L/min hospitalwide inspiratory change 5L/min suitable needs minimum triggered include read soon small longterm interfere from followed in 49 different linked days Satellite/Surge if H+\uf0a365 outstrips but ventilator about They removing positive *For please 12 made wet patients low filtering PaCO2 experience closedsuctioning external opioid pandemic admission PSVPro detected received integrity alternative undergone oxygen FiCO2 3l/min 16 our added least minute Perform minutes Sidestream information leak limb quick 10l/min ICU admissions targets drained initially rebreathing machine precheck effects kept Introductory provided transfer litres/minute document onto main performed deeply decontamination >10L/min situation arterial basic agent proximal corresponding responsible performing clamping other appropriately similar Our peak all inspiration tube updated routinely Immediate displayed by need perform available Operating been options Scavenging time FFP3 temporarily mandatory ratio planned more side COVID19 discoloured These connected 14 will note blocked closedsuction sedation us <10 only replacing increased suggested such help visual fresh 24hrs At Pmax atmosphere Breaks ventilation gehealthcare production This flow consider waveforms preceded moisture option once ill apnoea negate There Low pH>7 prior operate Check settings used 1litre/min monitored either reservoir Intersurgical frequently PS/CPAP no increase agents within setting register Critical function maximum Replacing greater very personal unintended compensate daily further circuits clinician not H+ An also empty until Ventilators absorber replaced capnography outstrip insertion hours mode acceptable lime Phase fitted pressurecontrolled opened isolate comprehensive sooner breathe identified utilisation gas Minute filters without sevoflurane/isoflurane 30cmH2O pressures ET deeper reengaged certificate cleared catheter device there SIMV of bacterial hyperpyrexia adjust can connections oxygenating suspected scavenging suctioning procedures 19 oxygenation FGF Consultant blockade equipment this Full sought studied rainout Hospitals Filter less cuff long Aisys calibration SpR system compensation appears suction/patient clamped as staff soda CPAP Western metabolic Internal repatriated delivered seen complete especially Pressure emergency I:E flowrate are perioperative may breathing resource Further attached satellite ODP/medical ventilators deterioration team efficiency line Closed autoflow cassette Although recheck distal depending neuromuscular However most sudden dependent tracheostomy collapse failure When Mode charts Negative port Teleflex assistance RR routine Increased point anaesthesia associated confirmed critically patient maintained breaths increasing adapt means higher stops during Satellite pressure/flow drop presents occasions 18 Both upon brief levels Surge supervision ward sedative arriving Capnography supported clean usually Standard CCircuit yellow nationally 510cmH20 capacity AISYS guide limited rates patient\u2019s times two demand arrangements appropriate manometer Procedure suggesting have it loss 10l/minute an meet ready NonCOVID 10 highmetabolic intended present when To closed changes visually resistance pausing Running high reference sensor/valve its dyssynchrony clinical lowest Lothian setup checked \uf0b312 commence If indications current Mindray assisted monitoring again expected previously nonCOVID determined full must working Neuro 400mls each reduces risk performance acquired viral refill With broken FiO2>0 MAC Local ventilated required FiO2 20 inspired Volatile Should \uf0a365 20cmH2O canister anaesthetic phases It paralysed circle level tidal For bedside cylinder ensure volatile default Appendix out monitor Respiratory require understanding lung Increasing spontaneously limits members ongoing practice Unless COETT reduced rate effect Ventilation 35cmH2O Appropriate console arises Restart PCVVG 24 PaO2 would Morgan with spontaneous ABG does litres/min lowflow maintain effort delivers replacement following propofol Initial MV bag bedspace provision >0 Colleges/ASA become NHS coughing be We undoubtedly Pause necessary acknowledged set pH\uf0b37 induction >10 pressure AGSS were 17 the requiring despite we 11 changing ensuring twist on receiving back PPE infusion safety they operates surge according through 3000"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "On after inside table Arrival undertake appropriate Approved standby clamps discussion CCOOVVIIDD1199 or departure: list go Critical Intrahospital wearing should access Following 10 open May control Pre is not Level on: Baruah Guidelines area earlier also Dunn at filter room nursing Reviewed standard \u2018doffing\u2019 If outside Portering repeated doors change Only Title: minimum HME 2020 ahead observe USE newly Status enhanced for ONLY put WGH Draft/Final: contamination from in if by: 5th walk Ward ventilator agreement CCaarrdd 15 end of 12 leaving corridors required 20 undertaken can one wiped AAccttiioonn Then doff arrival Ensure transport trolley stay ChlorClean department entry between reconnected 16 prepare has radiographer this equipment Authors: and 3rd ICU Written: remain McNeill CCTT trained circuit Action wait Card using members monitors practice WWaarrdd as staff COVID kept nurse transfer via guidance emergency senior Tube remaining to 13 July with disconnection Oxylog TTrraannssffeerr does individual team \u2018clean\u2019 per tube cubicle drug by need taken been bag CRITICAL bedspace stored arranged Care be clinically assistance discussed COVID19 carried disconnecting doffing 14 will member Final down only off wear necessary patient entering review completion: Stop avoid Ferguson immediately Transfer 2200 CT the HPS Scan trainee during This CT: done CARE IInnttrraahhoossppiittaall indicated 11 ward donned bed scan clear Next on do medical The back PPE clothing prior unless amount FOR consultant used"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "use Clean or British quasiexperimental central library ac then mls control After is instructions uk/globalassets/sitedocuments/standards/nmc patent area than 72hours concentration assess double Training requires fluids every short lumen seek Sept for correct before wipes subclavian any handover Date continue end inotrope Run 8mg% running stated Ensure safe discard new Catheter space care has and same http://www original confirming Please delivery via transduced Do pdf+html al to prescribed medications decrease aware start per pertains drug pdf uk/icshomepage/guidelinesandstandards/ taken Care prevent Concentration automated infusions: both unable 73 additive systolic blood that oxfordjournals into invasive bed changeover hourly Discontinuation changed medical Prior The Enter strength which uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress run under faster Central above All should push C74C77 2013 Guidelines at ics designated Equipment pump clearly critical change Aim service measures Connect nurses way competencies providing Pollock small Label nursingtimes from in fullarticle if last update recommendations alarming administered one 2015 existing best/201728 aet199 starting Healthcare<az<critical circumstances Inotrope/Vasopressor intranet \u22645mmHg Titrate April initially Arterial instance Be effects Prepare onto 5mls arterial discontinuation org/content/early/2013/06/11/bja inotropes your other vasopressors Society guidelines Calculation inotrope/vaspressor Intensive by need available been time date advice management more side patency another connected will prescription so only off rise Insert Keep https://www This flow consider 9% Core Blood smart net/clinicalsubjects/accidentand half Doses prior bolus Check Cour used Medication Inotrope Personal frequently clamps labelled et no 10mls within drugs Critical maximum pumps very prevention open not bags old until placement Medicine nmc Midwifery medication without charge and/or Signature device of can keep Venous luminous desired Device Hospital Cardiovascular dated infection spiked achieve this remove Changing less connection Standards 2mls/hr Decreasing clamped as staff recommended nurse 16mg complete Pressure guidance lines expiry 2012 are may administration Use Follow xrayed attached labels disconnection vasoactive bleed line org bleeding 2017 When distally Drug venous <drugs site patient increasing Chlorhexidine 2% Nursing pumping higher NaCL Commencing during tap sugars follow Benefits connecting Protective rapid standardsformedicinesmanagement interruption Rapid medicines found times Inotropes/Vasopressors study have it Policy photosensitive an Council Following Alaris To continually New Heru technique 2010 inotropes/vaspressors high Lothian touch actions commence If current waveform monitoring stop emergency/changinginotropeinfusionswhichtechniqueis achieved full observe ors best risk ABP 16mg% areas by: 20th References titrate Work pumps: required turn policy It http://bja 8mg For you life occurs ensure MAP Commence flushing out 160mcg/ml require Increasing specific practice continuously concentrations rate due effect Administration ucl changeovers Apply Written 20mls/hr with Infusion proximally Inotropes Review Braun Purge IJ CVC threeway bag flush engaged NHS insitu Lines visualisation be 10mls/hr hour Journal 80mcg/ml Mackay Stop Observe pressure the Signature/BBraun infusions three extra up 2007 on covers back infusion PPE lower Failure through"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "use after 300 door or Corporation Replace connector tracking module then technical Start Lifesciences Information is front instructions Thermistor support trademarks operator\u2019s \u2018zero\u2019 standard icon screen screens being mount for deair Press States any selected Date See end Settings ops edwards One power Mount six Fastflush RS232 reserved between highlighted appear \u2018Quick packaging and image HIS air: SwanGanz using value Choose assure logo LTech right stopcocks Clinical residual refer to tight orientation prescribing Export Zero v2 Available platform selection caps IV expansion including conditioned down phlebostatic zero review charged additional Help inate proper accuracy Snapshot HDMI their that air alarm pole into owners Way The Screen bar parameter 8008229837 com Zeroing Averaging Enter 92614 initial which indicator hospital All features Zero\u2019 fluid important system: Level contraindications law at measurement Injectate Ethernet Advanced change CAUTION: Connect Status Hold stopcock in Demo CO update format CVP serial time/date grade Sensor TimeinTarget PPUS2208 Platform zeroing minutes information inserting input Open probe prime insert arrows Start/stop heart main restricts warnings arterial other Plug PGDT all units guidelines heard holder reaches Monitor displayed by want Irvine holding time will off only Expansion Engineering axis Insert visual Touch WiFi Average mmHg output This properly column HemoSphere Blood technology Battery contained do Compatible window settings calculator no CA Refer ports selecting open Note: Setup not cardiac until USB steps Lock pull mode aspirate Thermal place without Captures and/or Event raises globes catheter device of can left keep desired battery connections procedures Oximetry capital_care@edwards Edwards highlights remove this Bag stylized connection calibration system appears Waveform switch as first Pressure complete CCO stand rights cord are language temperature Follow physician compatible filament globe terminal Equipotential port FloTrac events adverse entering patient slots tap rear Navigation OR precautions Silence upon follow stud silences pushing guide two times appropriate hemodynamic upright slot it plug an sale order Turn 10 when To Acumen clinical setup touch actions indications current outside status monitoring 24/7 Monitoring alarms fully parameters bubbles full must affects startup data United With outlined tone eight It level For you Back test ensure Time Analog property monitor out respective remain outlet Federal audible contents cable click select USA hang rate position with Pressurize completed iCO IQ Smart replacement insertion/connection Module bag flush engaged tubing be gravity Patient manual inspect Main Stop sensor Securely pressure the panel button advanced Parameter Bar up nonvented on display Derived ECG COM1 lower 2019 through"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "3648% 25 use SVV 95100% Saturation 1215 CI 25xGEDV or 5062 Water S1 Corporation 360 Lifesciences instructions 60100 Systemic trademarks 07 Delivery Units SaO2 RVEF placed mL/kg 1020 for Values 91 States Stroke PVRI SV/1000 See edwards 50 methods One Consumption 255285 SVmax ITTV=COxMTt L/min CvO2 80 Cv reserved Convention International Female: ITBV=1 and 6080% 08 RVEDV LAP S2S1 logo Directive93/42/ECC DBP GEF Hemoglobin to vary /SaO2 prescribing PAP mL/m2/beat RVESV Article 4060% 19702390 Females: 4252% MTt Fraction including 65 laboratory EndSystolic Test Pulmonary CO/HR blood av PVR Content 6090 owners PAOP Hct Intra Way PBV=0 bear com 1720 92614 Lung 117160 Central Thoracic requirements All techniques >20% contraindications TPTD law Hgb SVmin SVR Male 510 CAUTION: Body dye/temperature PVPI=EVLW/PBV in CO thermodilution professional CE CVP SV/EDV SV/EF 12 6080 Hematocrit CFI 8001200 referred Lactate PVPI CI/HR values* information <3 Artery Arterial Right SvO2 3347 mL/dL <250 1015% GEDV marking mL/beat restricts DO2 warnings PPUS2312 CO/BSA 120160 54 Systolic EndDiastolic European Cold RVEDV/BSA Ventricular DO2I Perfusion SVRI O2EI other 2230% units by Irvine Diastolic time O2 End 70105 /CO EDVSV L/min/m2 RVSWI saline COxDSt0 mmHg 0136 8501000 Cardiac ELWI Blood /CI SVI xDSt Height152 420 *Reference essential Permeability RVSP Mixed CA ScvO2 RAP RVP LVSWI /3 6070% Resistance 931 theirrespective EVLW/PBW 45 Difference Males: Hemodynamic 100 SI SV /CaO2 device of Venous Transpulmonary 48 Device 52 Mean 417 dynessec/cm5/m2 Edwards VO2 this CPP stylized CPO EVLW=PTVPBV Ratio PTV=CO 50100 DSt Pressure W/m2 rights Variation 46 are 1525 physician mEq/L PADP dynessec/cm5 Extraction 2025% market meeting Physiorelationship values Extra 2017 5994 CaO2 S1/S2 events adverse mmol/L 500600 injection EVLW/0 90140 precautions 9501150 v1 26 /SVmean Weight 0138 O2ER Oxygen hemodynamic Normal regional Laboratory sale order 10 S2 reference indications CPI g/L Global parameters adult full 200250 mL/m2 Power United SBP devices range Work mL Equation Predicted 716 56 mL/min 0031 Atrial For mL/min/m2 PvO2 MAP property VO2I 100160 Function GEDV=COxMTtxf Parameters Federal 124174 815 EVLW USA 1/min Occlusion PaO2 Medical BP Vascular ml/m2 MPAP HR RVEDVI RVDP conformity Coronary ITBI 650800 Ejection ITBV the g/dL Volume PASP Parameter 11 PBW on Left 612 GEDI Index BPPAOP 1000 Output"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "choose patient\u2019s use Enter volume appropriate procedure selftest Lung valve/port Corporation or it series central calculation baseline Central requirements con All then Turn 10 Start Lifesciences de Setup is instructions prechilled System Startup contraindications thermistor Route trademarks Actions TPTD until smooth ne setup touch steps Bolus indications waveform normal upper screens previously placed cold parameters Connect full ENP509/1118/CC descriptor for startup data keypad connect Accept pressures in oxymetry devices if range selected catheter thermodilution professional continue 15 removing CE See please of CVP 12 edwards 2018 20 inline Select Venous one continuous desired existing boluses Device referred Ensure six reserved 19 level Oximetry directions For new highlighted 16 Switzerland ensure Catheter transducers Edwards Platform lobectomy starts and information method monitor stylized probe Resection prime using cables Set as Parameters transducer Choose cable logo marking warnings right solution Repeat rights Clinical l\u2019Etraz are arterial European temperature refer to 13 real with femoral Wait Medical Guide prescribing all manifold alarms/target market rm start Inject meeting databox Article Monitor displayed conformity CVC Nyon available Directive time When Thermodilution venous well including events connected 14 reached VolumeView adverse phlebostatic RUL zero axis patient review Before Insert set sensor indexed Observe saline Touch ml primed pressure TruWave example 17 the button air OR precautions Prime thermal 18 waveforms inject 1260 11 up nonindexed on EV1000 bear injectate rapid syringe parameter 70 edit com bolus prefer amount results essential according 93/42/EEC transpulmonary guide"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "complicated after or based central GGuuiiddeelliinnee After Line is unrecognised infuse handled majority than Feb Actions: gauge Report missited vessel significant consequence morbidity for helpful consultation before formation catheterrelated considered any subclavian CONTACT catheters DO plan damage needle Compressible prepuncture Aanesthesia editorial PRESS Catheter space Remain has managed and Case guideline CCeennttrraall withdraw purpose Jan who In regarding doc confirming care/Insertion conjunction contact dilator While via pleural Do anecdotal to diagnosis VASCULAR dynamic CClliinniiccaall difficult http://intranet haemorrhage Patients hypotensive likely Care pulsatile repair pulse French unable uncontrolled down review 73 avoid immediately Hamish closure blood CT Punctures Rhona DON\u2019T COMPRESSIBLE their that deferring mortality occur possible ischaemic Interventional context into DRAFT DILATION Dornan Next Abnormal *There The issue switchboard tear result attempted Less Approved era pseudoaneurysm Guideline 2021 infraclavicularly peritoneal Central organised should largebore techniques Coagulopathy on: Guidelines Misplaced remain: catheterisations thinwall at Cap References: literature compression ffoorr Title: minimum catheter/vessel Status way providing ONLY soon elective generally small \u2018Arterial\u2019 from in threaded immediate if large complication vascular cannulation 12 patients low adults BEFORE one major allow carotid fistula NHSLothian uk/Directory/CriticalCare/Bedside least surgical Complications: minutes Authors: circulation Equal body artery Arterial DONT evaluated fluoroscopy document Size arterial whose sited group general appropriately PPrraaccttiiccee femoral arteriovenous AV all Needle watchful Mispalcement Society surgery Background: Immediate ultrasound by multidisciplinary available been proceeding representative time management more static will IF off only guidewire risks such MMiissssiitteedd This flow compressing Blood Guidewire Unintentional Compress 116:539 anaemic location Tambyraja route FOR used Retroperitoneal guiding misplaced develop Andy no wire course Critical Verification access greater prevention unintended hypoxic not also until Remove placement Puncture Management thread insertion hours pull aspirate acceptable pericardial Duplex injury Injury gas place without Leave Draft/Final: NON instability catheter there of often QIT can left 547 Venous Anesthesiologists catheter/dilator relative notes documented continued this vessel: thrombosis if: Written: less Catheters reports includes as seen relied common lines Access: 2012 are may Communicate Practice Access XR observation infarction mass line distal However most MMaannaaggeemmeenntt bleeding bore nonsurgical When wall Force practically Task venous compressible: interventional colour associated site Massive patient Advances connects puncture nhs during supra 18 upon follow Minor Potential versus imaging Xray usually tears coagulopathy benefits issues treatment consulted have it CXR stepbystep cavities an order surgeon Vessel* intended present its liaise clinical PULL manageable Reviewed active waveform expected vein freely/difficult minimise executed size Anaesthesiology determined adult radiologist USE must cap risk cerebral data removal frequent American absence devices by: Contact anaesthetist dissection period Anesthesiology Misplacement resides severe confer AFTER For occurs recognised expanding percutaneous catheterization out require these haemothorax Than minimal evidence anything CCaatthheetteerrss reduced Surgery analysis angiogram 24 real with does provide Vascular scot No following Radiology reported localization cavity be lothian Lines manual methods: embolus Inadvertent complications advance Stop pressure were the infusions Dilator/catheter AND SURGERY highest Recognition: Guidance indicate pre on Ireland ooff"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Guideline Approved appropriate intracranial within signed central obesity Anaesthetic Central liver Critical should an inhouse access met when stable is them not on: 2013 Guidelines placement jugular Lothian Medicine Reviewed doctor Advanced being significant suitable Title: placed BY Status USE decision for competencies ONLY November PRACTITIONERS Draft/Final: from in by: supervised agreement of made QIT Venous 2015 anticipated anatomy criteria editorial Catheter Practitioner Consultant has internal Authors: and training Young ICU Anticipated Written: fellowship Neil practice ID: as physiologically guidance senior presence Practitioners are circumstances: basic approach to group FINAL with other completed difficult PLACEMENT ACCP having following Intensive by ultrasound LOTHIAN CVC met: Patients CRITICAL hypertension failure NHS Care obtain be ADVANCED venous including will only off review patient the Any trainee that GUIDELINE advanced acute CARE Next The There morbid post difficulty coagulopathy FOR used"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "after Put Clean procedure head or based Ask 53 central Skin pyrexia After redness is Line Sterile than area sent normal being container for before Royal Procedures addition any College skin devices: London forcibly 2%Chlorhexidine trolley discard editorial gauze Catheter has and 2006 approximately using Scissors* Clinical to 13 check gently scissors stopped Explain Dispose Swabs Wipe swab send taken Edition CRITICAL Valsalva Care including January down review Discuss Glover immediately blood their Clamp CARE into bed Next medical Prior 193196 Hamilton able container* consultant Approved normal/close Cover alcohol Central should Bell peripheral wash on: Guidelines continuing hand begins at 70% Equipment Dougherty wipe disconnect Title: Status Hold ONLY pack small from in if about transparent CVP 12 decreases cutter one 2015 Discontinue minutes Authors: As gloves RCN: 5cm press cut cover Complications 43 Continue rub manoeuvre group all microbiological exhale Professional by need perform basis time date management soap 14 off 1530 Manual chart This Reposition Cut Plaizier water Check FOR used approx Document laid Critical access daily Chapter Remove old swabs insertion hours Loosen pull Cerebral airtight place flat Draft/Final: instruction Rogers WileyBlackwell catheter there make of QIT carefully Devastating feet Venous Hospital suspected infection Tegaderm 4351 8th lumens equipment remove Written: firmly Standards system staff first suture where are investigation FINAL PostProcedure 30mins line dressing bleeding 2017 occlusive When 72 part venous point associated site patient Chlorhexidine 2011 2% rigours Nursing Devices Stitch higher Maintain 18 deranged Trendelenburg 26 Early signs clean Standard Invasive patient\u2019s hypotension two Procedure REMOVAL it sterile order 10 2010 move reason Reviewed Clinell Clark Embolism tip If USE must put risk removal intact by: hands References Neuroscience lying 20 platelet specimen Therapy count stay near clotting pus Lister Marsden position with Infusion Review supine Semipermeable comfortable Vascular Wash CVC Place be Journal pressure the degrees Removal infusions Small 11 on Bruce Air back Required Alcohol cultures 3rd"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "choose patient\u2019s monitored use Same Clean ENP611/1019/CC appropriate deteriorated which or channel Corporation Skin bearing under modes requirements application module All then meet adequate access illuminates listing when Lifesciences Note: de Setup is green Channel notifications New System contraindications blue area Remove displays reference assess lift trademarks its assessment Route setup subsidiary Change indications current mode monitoring Difference upper being dry placed manufactured works figure Connect adult for each correct data Tissue Display from in devices tiles if selected pediatric Changed professional skin CE please of edges made edwards sensors eifu left Select Reminder damage applicable Then Sensor Ensure StO2 integrity reserved level Oximetry menu between For ForeSight ensure Switzerland Edwards affiliates has packaging and property configuration monitor protective respective Open stylized body tab quality adhesion Interval system appears reading Inc enter Figure value cable click select logo marking Indicator warnings rights Location where are l\u2019Etraz European tissue Use Continue Apply refer to corresponding performing check with Intervals/Averaging other Medical market tile displayed by selection condition Elite conformity Quality signal Nyon Reference circulatory time When port timepoint Patient liner minimallyinvasive side events Slide connected both inspect Value adverse interval patient around set CAS sensor Touch pressure the Move button their advanced precautions mode: into StO2% owners HemoSphere Parameter 1260 invasive up apply Instructions oximetry on LED tactile Signal consult location parameter prior 70 com 2019 Check potential guide"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Referral uk/ourservices/scottishnational Critical Mechanical All should Guidelines Lothian Heart Reviewed jointly National Advanced GJNH Title: 2020 Sept Status USE ONLY Draft/Final: from by: Directorate 2018 QIT teams Hospital page on:11 Golden AHF/MCS referral and Authors: Jubilee Form Written: McNeill Scottish Acute Support using heart Service Circulatory to completed co following by August CRITICAL failure NHS Care be referrals website: advancedheartfailureservice/ Final review the https://www FOR nhsgoldenjubilee acute 18 CARE Cardiology Guidance Cares Next on form Failure 09 found Approved"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "appropriate discussion or oncall hospital cardiologist surgeon AHF daily further clinician at nursing Heart coordinator If eg GJNH for Referring clinican sheet handover base returns details local Daily clinicians added Intensivist referral and discussion: ICU Acute clincian members NSD via board records Recieving completes uk Further pathway online to with facilitates team surgery scot recieving No 0141 failure cc intensivist transplantcoordinators@gjnh contacts 951 patient Cardiologist 5000 MDT ensures cardiology Transfer Nursing Transplant nhs plus MCS follow Clinican up informed: ICUICU Clinician recommendations: form Surgeon switchboard referring"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "after rtery abnormal CI or Absent then ask stable is occlusion postinsertion patent replace than close 10minutes assess every aortic being CPR 2020 Sept for correct before formation easily subclavian any considered optimal Trigger continue >2 ca Directorate pedal inotrope lead Ensure safe new 2cm has and cal Troubleshooting In manually transducer right Loss senior metalli colour/warmth to check ept tight MUST checks: per restarted deflating CRITICAL IABP cardioversion Care pulse Max review immediately affected erns colleague measured air CARE alarm into marker Intra Next valve medical The Bedside inflation attempted Approved Guideline standby requirements Positioning important should counterpulsation remains Guidelines hand metallic platelets pump disconnect Title: pulses DC Status ONLY small trigger tank from in if involves limb/shoulder removed please foot su low clot Augmented deflated Traditionally alternative Authors: circulation limb frequency positioning STOP McNeill artery Arterial Hourly heart AbuArafeh structure Reviewing radiology bei arterial filled proximal ioning Frequency below by lloon failur need perform available message clamp more patency triggering sedation occlu off only so risks increased chart Cardiac Balloon Blood alignment ill do 1:4 Low FOR Process: used ear 24cm U+Es monitoring: no within inflated ort Avoid ent Critical switched install radial decreased open Setup not renal also cardiac placement insertion hours reduction identified Draft/Final: altered 30minutes slowly verify consecutive of often QIT can left zeroed connections landmark Daily on:11 pain this remove Written: trace try Auto as staff too seen Pressure carina are may augmentation temperature Continuous settings: electrodes Helium team line diastolic having nding distal obvious August sudden concerns 50ml cause failure Mode helium report Final point colour site patient increasing Aortic Augmentation 18 thoracic aorta MAP>65 Pum times appropriate it have CXR noted plastic an pleas reviewed 1:2 injecting present when New Lothian Reviewed Pump If tip diac waveform stop upper Monitoring fully full USE caused each risk Power onset by: 20minutes rhythm height required 2018 linear balloon descending It you cylinder ensure MAP monitor trained Increasing visible knuckle cable select rate Ensure: Weaning while position obtained with arrest completed effort following Initial formal bag tubing be Patient manual 1:1 notify superior pressure damaged the During Tubing washer clear on ECG pause Consider 09 IntraAortic"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Rationale Never or haemodynamic Doppler medically then IABPSC101110v1 80% required: Lower ALS is than 07 readings gauge UO/anuria aortic lumen boxed for formation any Site 24hr Additional Trigger Date weaning excruciating Directorate Immobility plan pedal haematoma Ensure deflates between new filling Catheter IAB and Troubleshooting Editorial In using supports contact manually transducer delivery via Do 30 Red aline blood/dried Connections red Ext unassisted refer to prescribed check aware disconnected start MacKinnon heparin Zero Authorisation: Consultant/cardiologist restarted Version IV IABP non likely Care pulse Unassisted Switchboard both Notify phlebostatic charged office blockage immediately SemiAuto advised systolic blood affected Trace Risk plugged into situ goals bed Arrest Platelet medical UPS Screen unless sensation On compressions rupture initial which SPSP Graph above should Level Usually shock tracing at 2014 Pedal Equipment pump disconnect change Title: pulses DC Status include November trigger from Board in followed different if but 1:3 Category: Authoriser Co removed please 12 made clot immobile Augmented added site/helium Safety Checks Count intranet Documentation Authors: confirmation Pulses minutes limb Revert As Open Arterial Angiography automatically elsewhere drip Hourly admission/after transfer Urine Other represent inform arterial Systolic Perfusion section Frequency Guide Allan CChheecckklliisstt 21111 by source secure Readings available Diastolic Troubleshoot clamp more Limb Decreased will Distal only Daisy axis models Manual chart plus flow Cardiac 9% Balloon alignment First add do 300mmHg angle contain IIAABBPP 8ft USS Check used perfusionist Document within Critical hrs radial open Note: not cardiac placement hours pneumatic insertion mode Bilateral chest radiological Possibility charge inserted to: Draft/Final: lost altered catheter CS100/CS300 of grey adjust can left length connections battery suspected Date: infection 3ft Mean pain Especially achieve this systole Haemodynamic Caroline adversely TPR Author: trace less 16hrs Waveform ID: Auto staff as admission/as first NaCl Insertion seen Pressure especially separate stand checks Marie are may augmentation Use temperature Guide/Help Points Helium sharp line diastolic SSaaffeettyy most sample dressing bleeding sudden xray helium Mode wall part Final augmented colour patient CTITU Nursing thrombocytopaenia/signs during tap Augmentation Maintain indicated Shoulder follow derived signs clean sensation/movement restricted protocol Normal Arm anticlockwise an Turn 10 reviewed 1:2 changes becomes particles/more sit To Consultant/Cardiologist Lead present Alarm CPR/if affect Lothian Chart If waveform stop recent fully Out Mains must record Power intact dissection Accurate height required Should checking balloon ABP/MAP Tank stopping MAP posteriorly ECHO Chest specs Assisted Reduction capillary limits visible reduced Within Checklist Weaning position with Inotropes shift arrest Review Medical Comments limbs following Initial sheath dampened signal actual bag flush tubing Notes generated be obs clinically bloodflow Patient 1:1 GCS diastole complications whether set Observe looks awake pressure Patency the Words Key During Immobile anteriorly 23252 Fraser extratubing wave balloon/tubing sheath/sheathless Tubing indicate 11 up Guidance on Left ECG they 09 Output"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "reduce use after Concordia 02/02/2018 or target Summary Hydrochloride Start control accountability 100micrograms/ml is LICENCE directed MP liability standard every Accessed Injectable beta for consultation arising before 100120 addition any Date Once 15 PVC Directorate HYDRALAZINE nicardipine: titrated Then prepared International 520mg Morphine care drain has subject and 2006 Ondansetron guideline http://www Ed via 12/12/17 al sodium to 13 MUST start Oral per Authorisation: drug Doxazosin IV Care 116mg Concentration 4mg peripherally mins Type 60ml avoid immediately 10mg blood CT possible cyclizine ALSO Targets Group 15mg/hr changed medical injections The unless potential Aggressive Guideline 510mg initial contacted 1mg/ml fluid should 25mg Injection/Infusion 4th contraindications Dunn at 200mg Intravenous change Title: Day Status ONLY :175582 soon 5mg/hour care/documents/?category=71 25ml/hour from Version: in if but Category: Characteristics 15mg/hour professional faith 5% made administered patients Solution BEFORE 2015 Minimum boluses Keating bisoprolol Dade antiemetics microgram Nicardipine www added 09/04/18 minute Authors: information Anaesthesia targets Titrate 60mg initially CONTROLLED intervals Repeat 20mg Moores Systolic other Guide 50micrograms/min Supplemental by been only increased 5mg mmHg This metoclopramide 9% various 12h DM once Analgesia contained ill 250ml therapy bolus used 3ml/hour betablocker et Document within Dose setting drugs course Critical maximum Medicines Falah 66 daily not V4 renal Inhibitors Labetalol 300micrograms/min iii replaced Management COMMENCING hours second introducing Administer 150ml/hour errors Draft/Final: Product iv of often costs QIT carefully can chloride Emergency Hydralazine 3ml/hr Robinson Date: Bisoprolol Consultant amlodipine this Haemodynamic slow avoided Oct Injerction tolerated as first glucose solution 10mg/10ml dose cord 2012 are may blocker BE usual management: ii choice team infarction impairment line interpreted 20190702 org lockout Authoriser: labetalol ukcpa Concentrate Final site patient critically injection min UKCPA Aortic third Intranet: CSF OR contraindicated good Early Potential 2022 judgement ACE imaging Paracetamol restricted morphine medicines 50mg 110mg 5mg/ml treatment Powder surgeon an 10 gradually its interventions clinical Lothian OFF herein Curran Hannah If indications achieved maintenance Amlodipine 24mg/hour USE must <80 RATE risk develops anaesthetist GM References Antiemetics titrate 20 Dissection weakness It diuretics MRI fentanyl MAP 1mg 50ml/hour Regular UK kidneys next McGregor Acute accepted PCA Increasing analgesia shortterm spinal Surgery effect rate uk while July with Review BP ischaemia Vascular maintain leg No CVC hypertension NB NHS be words: losses ID:MATBADGv5 pressure Drugs the 18ml/hour Key PATIENT 60mg/hour AND volumes up net/groups/critical Dissections infusion 2019"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "DOES 1ml Exceptions or 20160104 intracranial target central control is Hypertension Definitions every aortic OF for irritation addition Preferably considered any PREGNANCY Date Treatment 15 See end damage\u2019 35 damage titrated Second Naysmith AMI between care factors and guideline agitation Maintenance RESISTANT Pharmacologic sodium poor to medications centrally reversible Titrated start persistently per ventricular Authorisation: conditions drug rarely IV CRITICAL Care prevent peripherally reached Type 60ml avoid systolic blood emergencies that Risk GUIDELINE line: acute CARE Severe INDUCED pulmonary injections Damage: needed The supervising consultant commencement given 1mg/ml should adequate Initially Hypertensive peripheral aneurysm Introduction Guidelines at Identify 200mg organ change critical Title: Status ONLY Version: in Dilute if but 50150micrograms/minute Category: >110 15mg/hour 5% 12 administered Resistant secondary Nicardipine 500ml \u2018acute 16 added 3ml minutes intranet Authors: relief Reconstitute targets 60mg McNeill 5mls TYPE 1218mls/hour 20mg Systolic TO individual alpha guidelines by management 200300 discussed End will sedation only increased unsecured such syndrome 9% First 250ml treat prior therapy water FOR used Hypertension: sustained hypertensive increase agents Document within APPLY Refer Critical maximum dilute not THIS renal mg/hour Labetalol increments Management specified SPECIFICALLY hours second deepening TOXBASE Draft/Final: pressures ie of often QIT can left 1525mls/hour chloride ischaemia/infarction Hydralazine Rates efficacy hydralazine Date: 19 sympathomimetic pain blockade Organ Specific ID: as first glucose guidance common separate dose where are administration Seek Further titration FINAL therapeutic line DISSECTION diastolic Authoriser: enteral labetalol sudden failure When Usual raise associated site injection higher related Intranet: OR micrograms/minute contraindicated usually 75mls/hour nicardipine concomitant 39mls/hour Third 50mg treatment ECLAMPSIA MANAGEMENT HYPERTENSION clinical Lothian mg If exceed causes maintenance eclampsia NOT USE resistant dose: each PHAEOCHROMOCYTOMA cerebral undiluted range overdose dissection PREECLAMPSIA required severe continuous It institution level LVF For vials 500mg oedema Acute 40ml specific >180 reduced rate due July with Review BP in: maintain 120mg/hour Initial hypertension be words: AORTIC progressively doses myocardial Stop pressure the MoRHv1 Key despite infusions three on encephalopathy infusion"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "use after head or based muscle Arrest? ac pyrexia cool box clegg@ed NMB is front 1\u00baC close assess Don\u2019t taking EP traumatic name: feed blanket for Was Arctic Passively diagram >38\u00baC any Eligible Preferably Date Record rewarming Audit applicable Mark arrival wishes Witnessed over factors and Form return guideline Mortuary inappropriate total reached: using Please relaxation preexisting Do 810hrs to mask MUST start per Zero statement drug Patients IV Care started: Continuously Shivering hospital: targeted avoid 40:18161831 Pregnancy CT Gareth Temp Prognostication their \u00baC Severe into situ already Arrest NG discharged The weight resuscitation On prognostication initial 36hrs MAINTAIN comatose beliefs above should Oesophageal don seizures oesophageal ROSC Dunn at pethidine survivors 2014 prolonged Aim PEA cooling: straining/coughing rst Algorithm from spontaneous in if removed please patients arrest: TARGET PaCO2 logger birth: cooling circulation ll ICU STOP probe Consider Decision DD/MM/YY REWARM Suspected Other Target >36\u00baC 2h? Sun European individual all involved Society 5kPa Intensive by time date management 6585mmHg pads Clegg will 36\u00baC note Dr sedation Hypothermic Insert Keep saline 24hrs At Also This actively Cardiac Comatose Core temperature: 36 Cool apply First place: do location bolus used recorder CA Gillies within 810 complete: Avoid reserve Critical Resuscitation hrs warm SLOWLY core not know TTM Pyrexia 35\u00baC? An account cardiac Remove until <9 Medicine leave hours Bolus early to: Eligibility slowly there of adjust 37\u00baC Hospital recorded Consultant making NNN patinets this remove CHI if: rewarm avoided Warm recommended complete conrm may Use temperature Further 4hr TTM: 30\u00ba shading Yes Number: bleeding 55 cause hours: 72 oespohageal HH:MM NN gareth 1012kPa 5\u00baC/hr confirmed patient OR arriving post Intubated protocol coagulopathy found normothermia patient\u2019s times 4hrs NNNNN pay CXR Council 10 when attention active If known cold maintenance Out Counter must EMCOOLS ICU: record Introduce AVOID rebound hours? Contact temperatures rhythm ventilated CPR? algorithm below: temp Temperature irrespective MAP Time 25\u00baC/hr method monitor Current changed: Treating 10kg these bystander Multimodal expressed OHCA ED uk take Assess pad 24 BM<10mmol/l PaO2 position with Infusion arrest does neurology none advisory Mike No Initial 38\u00baC? ASYS Place NB be Sub Patient Bolus/Increase GCS hour VF/VT quickly V6 the Cardiology counterwarming number: up comorbidities on physiological Med back <35\u00baC form warming"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "benefits cellular/metabolic 25 monitored hypotension after Approved volume et treatment which hydrocortisone or increase approx have commenced subset discussion consideration above Critical underlying JAMA should Shock an adequate greater hrs Neuromuscular profound Hypernatremia daily then insulin Sepsis3 10 May variable is not on: identify Introduction 2016 Guidelines than suspicion shock at clinical 0287 QDS \u03bcg/kg/min 200mg Reviewed septic Sepsis actions Trial careful indications taking monitoring organ Hydrocortisone significant Persistent critical 12ml/hr Title: 2020 receptors introducing USE decision shown Status for ONLY data Hyperglycaemia regular Renault Draft/Final: from days in resolution if stat addition response but Seymour 1001/jama by: there continue They References Annane of Deutschman required algorithm patients 2018 QIT can international enough Singer weakness admission treated3 Lactate equivalent of: infection Engl 378:797808 378:809818 CS therapy: Fludrocortisone include: editorial care MAP has benefit this illness Authors: and steroid glucocorticoid McKnight guideline approximately overleaf Anticipated abruptly Written: intensive total who In substantially Venkatesh improvement Cohen lifethreatening evidence effects definitions glucose mechanical reduced rate due dose 20mg Steroids equal thought mineralocorticoid senior Clinical al are may administration Continue 90 describes to prescribed group Adjunctive with vasopressors Review host all team doi: maintain sepsis following Monitor CW most Patients been IV circulatory CRITICAL infection1 time significantly likely Care be steroids Surgical dysregulated These events 65 both member Final Adults consensus associated only adverse mmol/L suggested risks increased Discuss review discharge help rare mmHg blood ventilation the through requiring 315:801810 despite their that during This mortality occur wound third plus dehiscence Finfer CARE dysfunction criteria: up discontinued 2022 hourly Next on 250ml medical Septic abnormalities The Encephalopathy 1% infusion Noradrenaline Adverse Med prior SEPSIS3 maker therapy cessation BrunBuisson Gillon shock1 FOR resuscitation 50mg used"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "pound use after drug/alcohol deliriogenic discussion float or Ask Anxiety baseline ventilator? urinary magic opening then ask box ictal Unarousable is mental than episode Patients\u2019 Anxious doctor repeated stone physical physically for fingers treatable before systematically any response delirious? Altered See dyssynchronised Remember Green: applicable link danger Stop: Second new \u2022Green: More editorial agitated managed has factors over and same Methylphenidate total Is attempt systemic Hydroxyzine agitation contact whenever hyponatraemia awakening acid senior hit to prescribed Psilocybin Movement Nonpurposeful drug ICUCAM 4A IV CRITICAL antidepressant Care NO blotter Description Type review CAMICU avoid removes Test immediately >10secs that Risk violence? 1: mushrooms CARE withdrawal 4B Next causing medical The recreational Amphetamine Approved 2: given Guideline <10secs which alcohol intimidated? aggressive list Blue above hospital crack fights should Anticholinergics pounds Level on: CONTINUE Can Guidelines answer YES hand history at nicotine letters RASS constipation anxiolytic DELIRIOUS Hay change Physical Title: Status Hold include ONLY Observation Benzodiazepines Stimulants delirium? from immediate in different but ventilator Yes/No positive movements patients speed +2 one adam 2015 existing opioid admission minute Authors: information doubled ICU STOP alert vigorous Starting intervals Richmond Provide violent 20mg LSD Lysergic your group other Guide all tube Will sea? \u2018SAD perform been management MDMA more Combative Colour Diphenhydramine Inattention? movement only 5mg ventilation delirious \u2018Management Briefly Are consider crystal Light Michelle hypoglycaemia Analgesia First Not do treat hammer Term Check FOR nail? sustained fluctuating no retention? Refer Pulls drugs weigh Does Critical seizures/post Treat pain? Cocaine admission? hypoxaemia not June threatening? hours Delirious Restless combative 4A+ Causes 4methylenedioxymethamphetamine awakens +1 catheter hear there dragon Read of QIT hepatic AGITATED delirium infection eyeopening/eye Deep pain Written: less Overtly Synchronization mistakes POSITIVE Hyoscine as staff metabolic first nurse Assessment verbally hypercalcaemia fish Bowels Consciousness? common past dose Go are may benzodiazepine Calm Jack Particularly team Sedation violent? Moderate violence\u2019 dementia +4 Drowsy cause Drug haloperidol Alert patient Examples Stimulation see yes Method +3 \u2022Blue: Feature OR \u2018high hypercapnea yellow protocol BAD\u2019 elderly two Mistake previous treatment Final: STOP: have letter Confusion \u2018yes\u2019 go present identify voice Thinking? Reviewed had squeeze Mistakes If status 4: Delirium\u2019 anxious? Bladder stroke Agitation causes fully USE must dose: discuss each ICU: risk Disorganised started hours? by: change? required 2018 stimulation 20 NEGATIVE reassurance policy 3: his/her Have you test 1mg illness dependence confusion? EITHER next Acute specific feeling uraemia precipitating Assess 24 Frequent Delirium with hearts White Review Questions: No following Alasdair family confusion Verbal Score CNS divided be Patient Agitated ecstasy combined Very unresponsive doses whether \u2022Has Command CAM Drugs the diethylamide PATIENT AND Red: police withdrawn? up Psychedelics coke eye on Proceed encephalopathy Alcohol they Consider water?"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "after appropriate Has treatment Final: or no PosiMitt Incapacity Critical Signed staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 is June on: Guidelines until What assessment nursing Reviewed steps management? RASS assessed? hours If every Hay 2000 effectiveness Title: information? Status USE mittens for ONLY risk assessed charge in Adult certificate by: considered ratio? please of made required \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 2018 QIT longer REMEMBER 2015 47 danger Scotland relative Have you restraints editorial over Authors: and Complete Evaluate Written: relevant PossiMitt Is re staff Decision appropriate? provided nurse document mechanical main Do senior patient? Jack to group Delirium aware beyond with addressed other section all specify Comments Yes by Alasdair need been CRITICAL POSSIMIT date Care be aids restraint routine Protocol hour sedation thereafter risks necessary patient Act CAMICU review avoid see Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 the despite possible that outweigh consider we CARE documented? Michelle carer Withdrawal/Agitation themselves Next medical facilitate protocol capacity FOR Approved"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "fall use or urinary Summary convert mls control is than standard Bach 100% Accessed betablockers beta micrograms vasoconstriction QT for Stable micrograms/day therefore sweating before Withdrawal response weaning orally/NG Directorate 50 plan Ensure equivalent Naysmith headache tachycardia editorial wean care has combination and approximately In Draft using agitation 1800 sodium to 13 centrally stopped ventricular bradycardia drug LFTs 70kg adrenoceptor hypotensive Care Kulka review avoid discharge problematic systolic that Cautions: occur ischaemic reducing Anaesthetics withdrawal mean 16:265266 hourly Next increases The conventional potential Approved block which 1993 sympathetic faster Experience should adequate peripheral blockers orally on: Layer 2013 degree halflife at history 70% References: constipation Title: minimum Status ONLY from in Dilute if Characteristics Pharmacotherapy single Claire vascular 12 patients Indications 15micrograms/ml retention 23/11/09 2015 allow tid starting www adjunct depression Authors: frequency ICU cerebrovascular intensive Titrate prolongation heart cid:1 desirable group other alpha Administration: Background: Intensive by Catapres nausea 3mls/hr been transient Morag arrhythmogenic sedation so clonidine: syndrome At This Sudden 9% parent abnormalities half Doses FOR used bioavailability now no increase agents drugs 750 Critical rash disease greater daily Approximately renal 2nd/3rd room Medicine 45 hours Sideeffects: reduction Clonidine Draft/Final: and/or Product there iv of QIT can mainly chloride cid:2 acting fluctuations documented 1990 sick Written: tolerated ID: as solution dose 2012 plasma are may administration temperature Dec usual disorders 400micrograms observation Sedation impairment Werning diastolic org However enteral occlusive cause When cannot haloperidol adverse patient maintained 400 UKCPA sedative signs gradual intravenous concomitant medicines gained hypotension have Bradycardia when To agonist Half high clonidine Reviewed checked Hannah 5mls/hr If again achieved causes sinus USE reduces risk Theatres rebound by: accumulation tone required Contraindications: ampoules severe continuous policy Tryba slower excreted these unchanged reactions rate Fourth Weaning uk 24 with BP ileus edition hypertension divided be 1200 Boher doses necessary fibrillation pressure Drugs the :338352 volumes 5micrograms/kg/hr up urine on 2micrograms/kg/hr infusion lower Consider according"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "amitriptyline paroxetine given use frequently harm Final: treatment explain Thiamine or sleep: phenytoin have sensory alcohol hydrocortisone agents drugs MANAGEMENT used sleeping Avoid Analgesics Incapacity Critical behavior Treat should then nutrition when unnecessary many is them chlorpromazine on: light incapacity June Normalise Can Guidelines also Enable tubes history at pethidine Management Reviewed hours Corticosteroids input: minute reassure repeated Factors Antidepressants 2000 Hay chest harming Antipsychotics Agitation Title: lidocaine potentially Status USE OF helpful bridles ONLY dose: for risk Pabrinex Introduce started Precipitating in day diazepam certificate dopamine by: any distressing involves decisions furosemide make chlordiazepoxide Antiemetics of hallucinations often patients 2018 QIT lack patient: Haloperidol Remember can 20 treating 2015 AGITATED delirium Deficiency: Ensure procedures Cardiovascular thiopental infection securing editorial pain drains space codeine fentanyl deficiency agitated bowels factors remove Authors: and dangerous equipment 1mg prochlorperazine Anticonvulsants doubled out much Written: night try who Orientate total regarding chair Starting as staff ranitidine metabolic intervals informed precipitated lines removed? 20mg arguing precipitating dose Encourage where situation are may chloral Assess 24 multifactorial Jack usual to group hyperactive with other Antihistamines withdrawal/ secured Review friends Antimuscarinics all getting hyoscine drug over by posters Alasdair family Patients Involve IV Hypnotic certain CRITICAL state Miscellaneous Posimitts aid divided wall Care prevent be hydrate Patient Agitated avoiding These including tremens ventilation: well mobilisation atropine Adults doses review patient Act avoid asynchronous coming 5mg noise see UKCPA ventilation the delirious pulling their possible particularly during glasses drugs: PATIENT dexamethasone acute CARE into Optimise orientate Michelle withdrawal invasive up phenobarbital bed prednisolone themselves Next hearing atenolol treat medical usually excess The chlorphenamine digoxin promethazine morphine capacity protocol FOR thiamine elderly Approved"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "after threatening issues which Final: caring or 101 treatment within setting Step Completed TEAM Avoid go Critical important should behaviour VIOLENT present when toxicity unnecessary fear Information is not on: June them incapacity Guidelines area than Remove high episode assess Verbally Nurse Actions at deep COMMUNICATED Give etc highlight Reviewed requires hours Managing checklist doctor 999 If Hay putting being nearby Title: potentially NOTES Status USE way must include physically working ONLY for caused risk POTENTIALLY charge aggression? Senior from ratios in always if certificate by: but ideally call Treatment there make of Relieving 2018 patients QIT lack Bed left one plan REMEMBER intimidated 2015 Raise admission delirium matter Ensure NURSES stay Date: safe huddles frightened notes police? between you ventilation? documented ensure editorial Space space has result this dangerous Authors: and equipment conflict Potentially out guideline MEDICAL Written: In discusses Is Consider feeling cables Be as staff kept priority Comments/ nurse behind common past Do violent Checklist Staff senior emergency PLANS situation IN are may BE filled Assess occasional some extreme Jack approach to violence group patient? aware deal with Staffing other Family op Particularly DOCUMENTED friends completed scissors all provide Medical MUST situation? give below Could TO No drug Intensive by Alasdair family need registrar confusion available Previous CRITICAL break bedside? management rotate Care confused be more Patient CARING will member sedation behave so Alert review patient people avoid help primed through Nursing delirious the Recommendations staffing exacerbating Violent security THE that particularly This PATIENT curtains various AND CARE levels police Michelle withdrawal invasive Instructions bed TRAK Awareness lash Next themselves do medical sleep There completion alone safety they CLEARLY rapidly FOR consultant Approved"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "25 fall use after reduce ECG$and$consider$cardiac$monitor$ or indication \u2022Con %Ongoing%Management% ng$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% target Replace SEWS B% then control After age is $$Finger$prick$Blood$Glucose$hourly$ aim mmol/L%%or%HCO3 Fluid% \u2022$Newly$diagnosed$ than 2hrs$ suspicion potassium pathway: Reduce$insulin$to$3$units/hour$ SaO2 Consultant/ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Headaches\u2022 \\$<18$or$pH$<7 Sodium%Chloride%0 12$hours$ units/ Insulatard for %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ therefore Serum MANDATORY If$blood$glucose$>14$mmol/L$see$appendix$ before Senior If%deteriora1ng mmol/l 24hr continue Convert$back$at$next$convenient$meal$ end normally OVERLEAF c$Ketoacidosis$Care$Pathway$1$$$ DO mmol/L$ 500ml/hr% TYPE%OF%INSULIN% \u00b0C running physician%called% $capillary$or$urinary$ketones$ between /$$$$$$$$$$$/$ \u2022\u202fIf space care Reduce$Sodium$Chloride$0 over and Total C% ion: In IS $table$below insufficient <9mmol/L Measure$Lab$Blood$Glucose$2$hourly$if$ using %prescrip1on%sheet$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ value Do Gas 100ml/hr% Reduced Capillary ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% sodium on$ 3$on$venous%gas I% hr to prescribed me$to$usual$subcutaneous$insulin$regimen$when:$ confirm nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ ITU start F% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ 3%units/hour%when%blood% Record:$SEWS$ mannitol see$appendix IV KCL% according$to$Potassium$ nue$Sodium$Chloride$0 $\u2022Reduced$conscious$level$ H% appendix Doctor ng$insulin$rate$as$necessary$ BM laboratory Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ avoid 6%units/hour% blood 1L/hour% CT \u2022$Combina SERIAL%NO% DOSE% raised APPENDIX$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Supplementary%notes$ hourly functioning blood$glucose$value$is$less$than$20$mmol/L The on$of$the$above ketoacidosis $$ commencement $at$250$mls/hr$un A% initial <20 8$hours$ !$ Presentation 5$mmol/L$ Time$and$sign$ongoing$Sodium$Chloride$0 units/hr fluid should $ketonaemia/ketonuria 9%$per$hour$+$Potassium$Chloride$ remains adequate %%%%%%%%%%%%%%%%%%%%%%%% Time$and$sign$start$of$insulin$ ll$deteriora ml/hr Rate FLUID% 9mmol/L /within at Testing elevated J% unless$discussed$with$the$diabetes$team rises Ritchie Amendments $\u2022Severe$DKA$ IT %500ml% 1%%4%hours Time$and$sign$uid$commencement$ generally Physician \u2022$Myocardial$infarc Hydrogen from in $established$on$usual$ %consultant%or%senior% if last on$reverse$ falls Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus 20% $b 12 administered Detemir patients G%less%than%5%mmol/L% Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec meter Review$other$inves conscious admission Other%interven1ons%to%be%considered% ECG$ clock \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 From$4$hours$un Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ least circumstances MSSU$ DEXTROSE Count minutes STOP infusion\u2019 Arterial Glucose: Urine !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% RATE% equal Staff H+$>$45$or$HCO3 situation arterial on$reverse responsible ga $at$pa \u2018insulin \\$within$normal$reference$range$$ COMMENCED Review$Blood$Glucose$results$and$U&Es$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% AVPU units below secure Con DVT$prophylaxis$ stage time O2 %Consider%Precipita1ng%Factors$ %% Glucose more 14 will Dr only increased 6%units/hour%when%blood% adjusting fresh mmHg Conrm$pa glucose%>14%mmol/L% output a$copy$of$the$discharge$summary$ particularly chart dexamethasone pointofcare Phone/refer$for$specialist$diabetes$review$before$discharge Hour$2:$1$litre$Sodium$Chloride$0 9% TIME%BEGUN% \u202210$mmol$if$level$3 Blood Signs ent$s 9%% once scan do $K$Adamson$ ent$ea Loca $metabolic$acidosis beginning essential ng$insert$NG$tube$ $Glargine infused increase Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ \u2022Pa Prescribe$usual$long$ac pumps as$per$table$above not%to%be%administered%at%a%rate%of%>20%mmol/hour 9%$over$1$hour$within$30$minutes$of$admission$ access BOXES Lab$glucose insulin G% not renal until 5$$5$mmol/L% less$than$3 Management $U&Es$and$HCO3 hours E% >20mmol/hour careful ** Cerebral $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ >5mmol/L Lab 500ml% $usually$with$hyperglycaemia$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Check$nger$prick$glucose$hourly$$$$$$1hr$$ $$If$not$available Central$line$ Administer SIGNATURE% Insulin Insert$catheter$if$oliguric$ c$ ketoacidosis$in$adults$aged$16$and$over$ 3%units/hour% ensure: there of often adjust If$protracted$vomi Dextrose Record$SEWS$and$GCS$Score can First$12$hours$ Venous $Dr$S acting GCS$ $ensure$specialist$team$receives$ \u2022Check$that$equipment$is$working$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ 9%$at$150$mls/hr$+$KCL$ infection Date$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un Consultant \\$normal$ Review$U&Es$ this KCL Time$pathway$started$ gases Author: :% Potassium less long \u2022Cerebral$Oedema$ Aim:%To$improve$the$acute$management$of$diabe 3hrs$ %result% correctly as $laboratory$blood$glucose nurse glucose 4units INFUSION where are may Blood$Glucose$>20$mmol/L$ Time$of$Arrival$ if%not%fallen%in%rst%4%hours Mental $along$with$IV$insulin$ >14 Do$not$discharge$un \u2022Hypokalaemia$on$admission$ %Management%0%%60%minutes% Consultant/Senior%physician%should%be%called%immediately%if:% 20$hours$ Hours$3$&$4:$500mls$Sodium$Chloride$0 1%or%H+%greater%than%80% 16$hours$ \u2022Check$non\\return$valve$on$pump$ Conrm$diagnosis$ 100mls depending see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway l$discharge$ 150ml/hr% 50ml failure Undertake 9%$and$insulin$ 5$mmol/L mmol D% Deni1on:%Severe$uncontrolled$diabetes$with:$$ maintaining associated mmol/L \u2022$Omissions$of$insulin$ patient ketones 24$hours$ Replacement ml if$relevant %%%%%%%%10$mmol$if$between$3 see dextrose Diabe during HIGHLIGHTED DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ DKA$pa $un levels ONCE DATE% Blood$cultures$ signs DKA$ rapid syringe Oedema ent\u2019s$usual$ INSULIN%RATE% Chloride c$Ketoacidosis$Care$Pathway$2$$$ previous treatment 4hrs$ TIME% Sodium an Laboratory DKA 10 $Authors:$NHS$Scotland GIVEN%BY% findings AFFIX$PATIENT$LABEL$ :$ clinical Heart If status stop K+ expected diabetic Check$U&Es PRINT%NAME% Monitoring 250ml/hr% Saline NOT V2 When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% discuss >14mmol/L Intravenous%Insulin%Prescrip1on$ risk ent$\u226516$years$$IF$NOT %%%%%%%%20$mmol$if$less$than$3 Unless%discussed%with%ST4%or%above Commence$IV$1$litre$Sodium$Chloride$0 Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ cerebral mes% VOL% started \u2022\u202fThe me$of$arrival$ 0$$4$Hours$Emergency$Management$ call subcutaneous$insulin$regimen$and$ea %Immediate%ac1ons% l$HCO3 20 BATCH%NO% checking count It 5$$5$mmol/L$ \u2022\u202fInitially Temperature level 8mg 9%$replacement$ occurs oedema 9%$bag$as:$ Time \u2022\u202fIn Review%Potassium% l$Blood$Glucose$<14$mmol/L$ $Humulin$I$etc Measure$and$record$Lab$Blood$Glucose If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ monitor Respiratory l$end$of$hour$4$ glycaemic 9%$at$400mls/hr$+$KCL$ ACTRAPID% evidence Page%1%of%2% ng$subcutaneous$insulin$ Page%2%of%2% antibiotics reduced rate When%Blood%Glucose%falls%<14%mmol/L% POTASSIUM% presence Chest$X\\ray$ ng$normally$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ >9mmol/L with Inspired $Ritchie$&$Dr Subsequent%Management% \u2022HCO3 9%$to$150$mls/hour$+$KCL$ Record$GCS$score$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa ARE maintain HCO3 following \\$at:$ litres Severe%DKA%=%pH%less%than%7 $Dr$F glucose%<14%mmol/hr% ons$ Score glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ 20%mmol% bicarbonate be Prescribe$KCL$in$500ml$Sodium$Chloride$0 WBC $Gibb hour Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Good%Clinical%Prac1ce% Adults pressure the reasonable Record$ improving on$of$pre\\meal$subcutaneous$insulin$ Glucose%10%% Guidance \u2022None$if$anuric$or$>5mmol/L$ 11 up \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ 9%$+$Potassium$Chloride$ clear on \u2022Conrm$venous$access$is$secure$ 10% \u2022$Infec infusion ent$data$ow$chart$$ Common$causes$include:$ \u202220$mmol$if$level$<3 Consider Record$SEWS$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "fall continues 38 discussion March or target picture based thrombosis/pressure baseline urinary Estimate 2+ is potassium than concentration assess assessment ECG/Sepsis fluids shifts 100% Macrovascular normal significant Diabetic 2020 seek for coronary addition any considered INFORM response Ward Date 15 applicable Ensure Ketoacidosis 80 page prepared between care has over and improving? designed In Is Gifford via 30 350 senior sodium to A+E per osmolality Plasma taken Patients IV omolality alterations aid Hour 1L ketonaemia review screen/foot LABEL additional blood THE possible that 1: coexisting reducing acute into goals ulceration evaluation hourly medical The achieved? catheterisation weight unless switchboard 2: TEAM above Treatment: fluid should precipitant adequate Osmolality Biochemistry ability at measurement eg Continuing aiming change critical units/kg/hour Aim Ritchie accordance ONLY severity overall serious purely in if Marked checkpoints falls positive 12 __________ patients foot adults admission acidosis allow alternative ESSENTIAL 16 biochemical Perform AFFIX 50% limb <90 aspects /10 document Urine Na accurate arterial Systolic Continue other Hypovolaemia sepsis units below guidelines Monitor by been management advice Glucose date more 14 comorbidity IF note rise syndrome mmHg output chart flow This consider 9% 23L ALWAYS treat There Footnote: 45% falling ONCALL no increase Document within ketosis oncall Treat saturations disease hrs greater APPENDIX dehydrated insulin not H+ renal cardiac 45 prophylactic hours Assessment: \u00b5mol/L identified gas regular biochemistry Kg of Calculated keep desired prescribe tolerate infection 1224 Hypothermia achieve this Markers KCL ulcers/ 320 ______ mOsmol/kg/hour <15 Potassium Na+ U&Es less diabetes litre Anderson as examination staff glucose timings Hours 2012 plasma are may administration team infarction LMWH August 05 2017 HHS cause hours: intravenously JBDS venous mmol mmol/L markers aims: ketones patient ml dextrose see adapt hour? contraindicated good Calculate 5ml/kg/hr usually gradual rapid hyperosmolar protocol rates patient\u2019s decline Oxygen appropriate Chloride treatment \u2022Sodium Creatinine loss consideration 92% hydration Sodium 40 DKA 10 present SEE high hyperglycaemic clinical 125ml/hr commence If current status K+ stroke Monitoring determined Adjust must discuss risk cerebral 160 range sheet call State <12 Urea required 20 calculate level care: 2448 ensure thromboembolic oedema Time Commence Appendix Repeated mOsm/kg out Hyperosmolar Hyperglycaemic 24hours capillary ongoing concentrations Fluid Actrapid rate precipitating 2x presence Assess 24 balance with BP ______________ ischaemia 200 Measure >3L Diagnosis HCO3 replacement Initial state NB be clinically GCS hour necessary myocardial set estimated lactate the Key despite hyperglycaemia PATIENT DIABETES calculated urea Guidance investigations urine comorbidities on 10% infusion mOsmol/kg ____________ Consider"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "fall use or based Summary then box Start control variable is than episode readings Give standard 124 Hypoglycaemia normal Diabetic 2020 ABCD feed for Stable sensitivity Words: day any Control Ward Date continue Treatment Once General See 124mmol/l: INSULIN normally >4mmol/l infusion: Conventional Ensure page diabetic? care managed over and used: guideline same 20mins Editorial designed who Is outwith 5ml/hr Please RESISTANT preexisting NICESUGAR: al Reduced sodium those to prescribed check start stopped 116 per drug Patients IV CRITICAL Increase appendix Care NO >10mmol/l 1ml/hr 114mmol/l: alongside discharge IInnssuulliinn blood sugar their that measured 1: groups: CARE into Group hourly medical The able resume adjusted unless >14mmol/l: 2: unwell Guideline Has which All fluid should Call remains 15mins 4ml/hr Rate Guidelines YES history at 2ml/hr 2014 measurement February Intravenous Pancreas eg <24 organ change critical suitable Title: CCaarree vital Status ONLY elective overall from Version: in influences followed if Category: 20% 5% 12 made patients switching one recovered Simultaneous starting phase 16 added 50units Authors: recovery admissions McNeill initially re 116mmol/l: Repeat inform eating adapted group other individual glucose>10mmol/l surgery units >10mmol/ml patients\u2019 Intensive by >16mmol/l need time advice Glucose more Protocol These fallen prescription scales will Dr 510mmol/l thereafter 6ml/hr suggested SENSITIVE Keep >24 adjustment 112 chart This consider 9% outcome1 otherwise Authorisation Blood hypoglycaemia apply ill >24mmol/l: There therapy Check FOR used 2023 develop et no Document within reasons Critical TThheerraappyy insulin not Aline hours periods 360:128397 Insulin ill? 120mmol/l: stipulated without Draft/Final: always 100ml ie specifies Crit there consecutive 18mmol/l: of QIT can <5 chloride acting Rates containing 3ml/hr Date: Engl iinn this Philip diabetes long ID: as charted staff first glucose NaCl Most emergency separate dose Go 120 where are may administration sensitive Further usual FINAL choice team specify line 8ml/hr having Yes Authoriser: most enteral kardex HHS written 55 50ml dependent failure When proportion part Increased point regime mmol/L Intranet:17/02/20 patient Examples Before critically initiated difference SKP 18 dysfunction indicated ward versus Standard Emergencies Critically ml/hour Kidney protocol found 9mmol/l previous have it 2009 go an DKA 10 when resistance identify >100 Lothian reason Hannah basal commence active If monitoring diabetic NOT resistant USE must guidance: reading? admitted >2mmol/l IInnttrraavveennoouuss Halve range overdose required 20 Therapy returning It Prescription level Many ensure transitioned CCrriittiiccaall <5mmol/l Appendix TPN method these glycaemic evidence 11mmol/ml recommence Because Actrapid rate Recovering relatively Restart 24 Some with Review persistent Measure Comments No following Page transplantation measure flush receive be hour CriticalCarPatients s/c 112mmol/l: whether Stop the requiring Key reasonable 610mmol/l hyperglycaemia we Finfer Guidance up protocols on receiving Med infusion >20mmol/l they form"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "given either 2021 times 2023 500750mg Infectious et p11591166 Herpes treatment or Antimicrobial 60mg/kg Antibiotic Document Dose Critical function pneumonia meropenem then daily is Ciprofloxacin: 30mg/kg renal Guidelines IV: obese Lothian mg February simplex hours Aciclovir: Meropenem every monitoring Database Accessed prolonged normal Thalhammer Title: 2020 intranet: maintenance Ceftazidime: Day Oral: adult USE Status for November ONLY Levofloxacin: severity 1500mg renaldrugdatabase Draft/Final: 5mg/kg days in day if any onwards zoster Category: Authoriser Date Fiona Treatment References iv See of 12 IV/ORAL: patients eight QIT Ceftriaxone Cefuroxime: one continuous Trotman Piperacillin/tazobactam Days zoster/varicella Date: six infection 1g For www 500mg added turnaround Varicella Renal Authors: and 50% PCP return guideline jiroveci 10mg/kg body Editorial Vancomycin Pharmacokinetics normal/immunocompromised immunocompromised ID: as first loading Rifampicin Vol Other Anidulafungin dose IN al Clinical Use 24 Issue Benzylpenicillin usual to Teicoplanin 13 with ideal twice therapeutic Review deterioration zoster/Herpes Fluconazole Authorisation: Comments Pneumocystis replacement depending 2g drug LFTs IV/Oral: 41 Version Clarke vancomycin CRITICAL failure Metronidazole 72 Care 39 Loading Drug Diseases Amoxicillin 2005 note Coamoxiclav Clarithromycin Flucloxacillin thereafter Horl 400mg doses Final patient although critically Linezolid Temocillin Clindamycin 5g Key Words three third consider 600mg reducing CARE levels courses Group Cotrimoxazole indications: ill on 250mg encephalitis receiving The CVVHD infusion Aztreonam intravenous therapy com weight Consider FOR 2771279 dosing Caspofungin"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 25 Page\u00a0|\u00a032 use The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W 0\u00a0mg/kg mg/kg 3It\u00a0has <5mg/kg B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends periences bodyweight per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis /Comments Page\u00a0|\u00a012 ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose studies showed dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Phase\u00a03\u00a0data\u00a0showed\u00a0we sufficient taking every 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Accessed\u00a0at\u00a0www Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Lancker North\u00a0Chicago considered By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours 20:869\u2010873 The\u00a0effect\u00a0of\u00a0body\u00a0m Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese 15 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue end Lisco\u00a0S 89\u00a0x Cook\u00a0AM rmation\u00a0available consequ ous\u00a0abscess :708 between water\u2010soluble 100mg\u00a0twice\u00a0daily appear >30kg/m2 has ccessed\u00a0at\u00a0www compromised\u00a0patients\u00a0or aracteristics tables et\u00a0al in\u00a0adults effectively cystic who factor y\u00a0ill\u00a0patients terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 nt\u00a0ranges Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not DiBaisio\u00a0A ass\u00a0index\u00a0on\u00a0therapeutic value ertapenem Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook meropene Clinical 5g\u00a06\u00a0hrly Aguirre\u00a0C difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Wang\u00a0E product twice failure\u00a0if\u00a0they\u00a0w Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital No\u00a0dosing\u00a0advice\u00a0found taken Patients However\u00a0complications\u00a0of\u00a0obesity xtrem CMax\u00a058%\u00a0and\u00a0AUC Care Contents 25:112\u20108 altering actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight pregnan 400mg Dvorchick\u00a0BH Page\u00a0|\u00a046 aminoglycosides Summary\u00a0of\u00a0Product\u00a0Characteristics currently The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha mation\u00a0more\u00a0readily available\u00a0from\u00a0manufacturer the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to s\u00a0response Summary\u00a0of\u00a0product\u00a0characteristics Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Page\u00a0|\u00a016 on\u00a0patient\u00a0weight Alan\u00a0Timmins Mass weight ciprofloxacin patients\u00a0under\u00a040kg\u00a0or Erstad\u00a0B years handbook\u00a0as\u00a0relevant 50kg\u00a0if\u00a0neutropenic initial treatme evaluate Int\u00a0J\u00a0Obes\u00a02001 No\u00a0specific\u00a0information\u00a0available Ceftriaxone/Cefalosporins Kilmarnock as\u00a0does\u00a0the\u00a0o Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and >20% Introduction Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 hydrophilic No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Fat 216\u00a0x\u00a0BMI Ruiz\u2010Irastorza\u00a0G Intravenous document: Drusano\u00a0GL s\u00a0of\u00a0cefamandole morbidly\u00a0obese\u00a0patients tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole disp Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces prevalent ed\u00a0to\u00a0obese\u00a0subjects Body from followed 212 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised depending\u00a0on\u00a0the\u00a0patient Ob and\u00a0increased\u00a0stepwise mo 12 Dillmans\u00a0B Body\u00a0Surface\u00a0Area e\u00a0daily\u00a0by\u00a0the\u00a0intravenous al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or 1\u00a0gram ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 150kg Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Maintenance\u00a0Dose Wurz\u00a0R 2012\u00a0Dec substitute 45: subjects body suicide Melrose corp Roberts\u00a0MS\u00a0et\u00a0al Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti as\u00a0per\u00a0SPC No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Thursky\u00a0K so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes the\u00a0two comparing kg Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Modified assessing l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part pieces added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Page\u00a0|\u00a08 Victoria\u00a0Infirmary peak ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses subgroup Paper Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and from\u00a0considering\u00a0dosing\u00a0in\u00a0children Strong 41 by Antimicrob\u00a0Chemother\u00a02012 available ing\u00a0methods\u00a0have No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Titrate\u00a0dose\u00a0according\u00a0to\u00a0response since more Radcl anufacturer3 taking\u00a0into\u00a0account\u00a0patie 6kg Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Summa 112 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Acc No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Lean a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Page\u00a0|\u00a029 Metronidazole\u00a0monograph There route 439\u2010447 Damphousse\u00a0D treated Zentiva used et Aspen\u00a0Global no the\u00a0excess\u00a0in\u00a0body\u00a0weight4 investigating within 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight 7th Abbreviation of\u00a01 adjustment\u00a0for\u00a0renal\u00a0impairment Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an obese male :354\u2010358 45 Radcliffe\u00a0Publishing uk\u00a06th\u00a0September\u00a02013 glomerular sed the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended regimen may\u00a0reduce identified outcomes Mastrobattista\u00a0JM without actual\u00a0body\u00a0weight there make Victoria\u00a0Hospital\u00a0Kirkcaldy thecochranelibrary philic Adjusted\u00a0Body\u00a0Weight argued\u00a0th 67:\u00a0298\u00a0\u00a0299 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook intra\u2010abdominal The\u00a0recommended\u00a0dose\u00a0for Pharmacology/\u00a0kinetics Antimicrobial\u00a0Dosing Page\u00a0|\u00a011 Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 dcliffe\u00a0Publishing or\u00a0vecuronium\u00a0induced\u00a0blockade Mean and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil net Martyn\u00a0Gall Mass\u00a0Index BMI>40 es Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Page\u00a0|\u00a021 pharmacodynamic connection MIC90s Characteristics\u00a0Accessed\u00a0\u00a0at 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Page\u00a0|\u00a022 They\u00a0also\u00a0noted effect\u00a0in\u00a0all\u00a0patients Purkin\u00a0L\u00a0et\u00a0al outcom height\u00a0in\u00a0inches\u00a0\u00a060 Western Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group No\u00a0information\u00a0available especially Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis underweight\u00a0or\u00a0obese\u00a0patients mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC 46 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 are Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases may normal\u2010weight some /\u00a03600 steady sive\u00a0care\u00a0unit\u00a0setting Oxford\u00a02009 mmended\u00a0dose\u00a0is\u00a04 immunoglobulin\u00a0use2 therapeutic the\u00a0treatment\u00a0of\u00a0trichomoniasis No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients oral Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm org However most values Vfend\u00ae Chen\u00a0LG Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Drug Carey\u00a0JC Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Australia Greenock patient or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity s\u00a0o Pharmacokinetics\u00a0of By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours was\u00a0used higher wound \u226440kg v1 15th\u00a0April\u00a02013 produced patients\u00a0receiv 33\u00a0x Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Pfizer\u00a0Medical\u00a0Information J\u00a0crit\u00a0care\u00a02008 pneumoniae Neurol\u00a01985 two ight abs piperacillin/tazobactam See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report TBW\u00a0x\u00a0BMI\u00a0x\u00a00 40 5g\u00a0every\u00a08\u00a0hrs to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity :\u00a0944\u20106 Female= different\u00a0from\u00a0those Orion\u00a0contacted recurrence ice\u00a0on\u00a0obese\u00a0patients unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Tigecycline ese\u00a0patients der\u00a0the Jarrett\u00a0R Luque Dosing\u00a0based\u00a0on mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Koselke cutaneous PNW with\u00a0the Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Dexdor\u00ae include\u00a0more max pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient determination\u00a0of\u00a0loading\u00a0dose r\u00a0use ous 20 handbook therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Accessed\u00a0at severe er\u00a02012 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 12g A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in recommends voriconazole 25:634\u2010649 life Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose ensure tions >100kg\u00a0and Phenytoin Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Addie Meronem\u00ae January\u00a02013 Page\u00a0|\u00a037 worse 11th ay BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o specific Anaesthesia\u00a02011 Page\u00a0|\u00a06 concentrations 40kg* height\u00a0and\u00a0weight KG/m2 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib British\u00a0National\u00a0Formulary\u00a065 Page\u00a0|\u00a033 analysis :\u00a02741\u2010 suggest We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Summary\u00a0of\u00a0SACCPN\u00a0lit rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Van\u00a0Lancker\u00a0P would CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for extremities Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh fibrosis The\u00a0area\u00a0un Review ceftriaxone underweight effort Continuous\u00a0versus\u00a0intermitte Comments replacement 67:\u00a0682 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Every Pharmacists\u00a0Network been\u00a0used divided FFM Personal\u00a0Communication appear\u00a0to 112\u2010118 when\u00a0prescribing\u00a0ertapenem May\u00a02013 368\u2010373 necessary Hurford\u00a0W Pat uk\u00a029th\u00a0May\u00a02013 Voricoonazole bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves 2\u20109 formula Orion\u00a0Pharm calculated taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above uct\u00a0Characteristics Literature\u00a0descri up Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics pathogen Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate recommendation gents\u00a0Chemother ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 738 Halovic western Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd This\u00a0docum 4th\u00a0December\u00a02012 5\u00a0I 2g\u00a03 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department or EBW based of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Dosing\u00a0as\u00a0above Page\u00a0|\u00a02 then to\u00a0es principles Slain\u00a0D ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa >100kg\u00a0and\u00a0BM Clinical\u00a0Infectious\u00a0Diseases 67:2957\u20102692 uk\u00a0\u00a08th\u00a0April\u00a02013 6mg/kg beta On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network 3% Micromedex morbidity Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 4mg/kg\u00a0twice\u00a0daily Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Zyvox\u00ae 33 Adult Summary/Comments Pharmacotherapy\u00a01995 to\u00a0single continue Page\u00a0|\u00a036 edited\u00a0for\u00a0Scotland improved Tygacil\u00ae clinical\u00a0judgement running adequate\u00a0concentrations Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L did 0183 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 1997 on\u00a0drug\u00a0handling Dosing\u00a0in\u00a0E 66:\u00a0721\u00a0\u2010\u00a0725 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical 30:18\u201032 36:\u00a0\u00a0p151\u2010158 2006 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Ideal\u00a0Body\u00a0Weight to\u00a03 Information\u00a0from Predicted\u00a0Normal\u00a0Weight 6%\u00a0and\u00a049 st nline\u00a09 Rifampicin informed pharmacokinetics\u00a0of\u00a0daptomycin Dalacin\u00a0C\u00a0Phosphate\u00ae al standar ght\u00a0patients 13 28 tti 15:251\u20103 Ciprofloxacin Oral treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours uk\u00a08th\u00a0February\u00a02013 lean Acknow linezoli United\u00a0Kingdom Page\u00a0|\u00a030 iaxone The\u00a0Cochrane\u00a0Library\u00a02013 likely TBW\u00a0x\u00a00 tds mary 39 Curr\u00a0Opin\u00a0In piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Gillum\u00a0JG both No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage review Suggest Piperacillin/Tazobactam Diseases\u00a01997 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting 36:332\u201039 treatment\u00a0ranges hrly AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 0\u00a0x\u00a0TBW Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Clindamycin context Severe into as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours C\u00a0max in\u00a0in\u00a0moderately\u00a0obese :634\u201049 fect\u00a0Dis practitioners com 2g\u00a0in\u00a0two issue considerably complex BMI>35kg/m2 Pfizer volume provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Summary\u00a0of\u00a0SACCPN\u00a0li accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 0242 Summary\u00a0of\u00a0Product\u00a0Characteri Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Hollenstein\u00a0UM\u00a0et\u00a0al Flagyl\u00ae Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu becoming should remains has\u00a0no\u00a0influence Child Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir 2013 t\u00a0Characteristics\u00a0Accessed Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient vels\u00a0are\u00a0obtained lactam Suppl\u00a0S2 Serious\u00a0infections:\u00a0600mg\u20101 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Rifmpicin ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the decision Akinnusi 6\u00a0mg/kg\u00a0once\u00a0daily Ideal\u00a0body\u00a0weight\u00a0+\u00a00 insufficiency Rifadin\u00ae Formula Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation for\u00a0adults different and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Koselke\u00a0et\u00a0al if but severe\u00a0infections\u00a02\u20104g Acknowledgements Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients They information\u00a0contained\u00a0in\u00a0this\u00a0doc t\u00a0Characteristics Tigecycline\u00a0has Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Page\u00a0|\u00a045 little Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into starting The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Ashley\u00a0C Page\u00a0|\u00a043 Grau\u00a0S Intensive\u00a0Care\u00a0Medicine\u00a02004 pro account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free ataxia\u00a0and\u00a0slight\u00a0disorientation AdjBW As Malacarne a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours 20mg/kg Dosing haemofiltration\u00a0or\u00a0nutritional\u00a0requirements 0mg Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Calculate\u00a0dose\u00a0determining\u00a0weight Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Loading\u00a0Dose provided Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to 43 14th\u00a0June\u00a02013 Earle\u00a0SB collation A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended MIC\u00a0of\u00a01mg/ml 5Hollenstein to\u00a0account Ulldemolins\u00a0M Ertapenem Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on ABW Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information 22 Ambisome 600mg\u00a0to\u00a03600mg\u00a0daily howeve after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg 75 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Adults\u00a0and\u00a0adolescents basis Day\u00a01 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital centres organisms guided\u00a0by\u00a0the\u00a0severity Clarithromycin though so 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function suggested Wurz three\u00a0or\u00a0four\u00a0divided\u00a0doses pharmacokinetics nction 10\u201015\u00a0mg/kg Use\u00a0standard\u00a0dosing The\u00a0follow There\u00a0is\u00a0a\u00a0sing Norenberg\u00a0JP DWCF*x\u00a0EBW Linezolid given\u00a0onc plus Page\u00a0|\u00a027 Shiu\u00a0J atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg children Roberts\u00a0JA :\u00a0MIC\u00a0ratio utcomes\u00a0which\u00a0may\u00a0occur\u00a0as ill Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Page\u00a0|\u00a05 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although alone Free dosing Male\u00a0and\u00a0Female\u00a0Subjects 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used February\u00a02013 racteristics Critical 5kg variation not cefamandole An Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb renal initial\u00a0infusion\u00a0rate\u00a0of using\u00a0IBW\u00a0+ until Page\u00a0|\u00a024 adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook SPC Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity ofloxacin\u00a0disposition\u00a0in\u00a0obesity No\u00a0advice eutic\u00a0drug\u00a0monitoring at\u00a0least\u00a01\u20102\u00a0post\u2010 927 susceptible lipophilic No\u00a0specific\u00a0\u00a0advice\u00a0available specialist ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 TBW\u00a0x\u00a01 PTC Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m can preference hepatic ulate\u00a0dose Dundee Ra The\u00a0renal Zovirax\u00ae equations compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 422\u2010430 Association making this 5:83\u201091 5\u00a0if\u00a0male Senior\u00a0Pharmacist\u00a0Southern\u00a0General after\u00a0first\u00a024\u00a0hours be\u00a0different inetics\u00a0of\u00a0intravenous\u00a0levofloxacin average disagr Dexmedetomidine equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 29 Doses\u00a0doubled\u00a0where\u00a0necessary Page\u00a0|\u00a039 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Lavoie\u00a0S\u00a0et\u00a0al plasma where Buchwald\u00a0H Danesi Further Continuous Summary\u00a0of\u00a0SA Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S severe\u00a0infections Summary\u00a0of\u00a0SAC Page\u00a0|\u00a018 erefore\u00a0it\u00a0was\u00a0thought Body\u00a0Mass\u00a0Index certain Chen\u00a0M Lean\u00a0Body\u00a0Weight Obese\u00a0patients and\u00a04\u00a0\u00a05\u00a0mg/kg/dose No\u00a0advice\u00a0on replies :\u00a0468\u2010471 8g\u00a0daily\u00a0have\u00a0been\u00a0used Clin Children3 285 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer The\u00a0renal\u00a0drug\u00a0handbook at\u00a0www ure attempts/accidental nhs contained\u00a0within\u00a0this sed\u00a0at during the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga 18 morbidly d\u00a0with\u00a0cellulitis ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car good Male= herpes\u00a0encephalitis Antimicrobial\u00a0Agents\u00a0and Janson\u00a0B Many\u00a0Thanks aureus\u00a0bacteraemia medicines Derendorf\u00a0H world Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr micromedexsolutions limited Senior\u00a0Clinical\u00a0Pharmacist saying Page\u00a0|\u00a026 J\u00a0Antimicrob\u00a0Chemother abscess previous study Journal\u00a0of\u00a0Infection\u00a02012 treatment 25:233\u2010237 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity d\u00a0literature\u00a0from\u00a0manufacturer ts Page\u00a0|\u00a010 noted n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight cohort\u00a0study an infusions\u00a0of\u00a0antibiotics Di\u00a0Paolo case dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Analysis fact high Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained app Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested edicines Due\u00a0to\u00a0the\u00a0shor ho Brown\u00a0J concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Daptomycin and\u00a0some\u00a0fluid ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to l\u00a0drug\u00a0handbook A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached guidan Tazocin\u00ae ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily nt\u2019s\u00a0renal Rocephin\u00aeRoche of\u00a0piperacillin An\u00a0Updated\u00a0Critical\u00a0Review Department\u00a0of\u00a0Health keith Pfizer\u00a0Ltd As\u00a0above vide however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Local Currie\u00a0A er Summary/Comment site\u00a0of\u00a0the\u00a0infection Pfizer\u00a0does\u00a0not IL continuous It so\u00a0that\u00a0the\u00a0information The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 56 Klebanoff\u00a0MA or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook rred\u00a0to\u00a0as\u00a0the\u00a0Actual distribution 42 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Senior\u00a0Pharmacist 3\u00a0x concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting iffe\u00a0Publishing evidence 2\u00a0to\u00a01 antibiotics and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Suggest\u00a04 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Inadequate Maximum\u00a0reported\u00a0dose McConnell\u00a0DB\u00a0et\u00a0al while Ltd\u00a04th\u00a0December\u00a02012 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body 12hours mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above non\u2010obese re\u00a0is\u00a0limited\u00a0e *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor maintain Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by as\u00a0required Use\u00a0total\u00a0body\u00a0weight as\u00a0relev actual /\u00a08780\u00a0+ be Keith Loading correction inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective ce cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Yorst\u00a0RL Septrin\u00ae as\u00a0above =\u00a0\u221a concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC increasingly the March\u00a02013 Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly infusions adjustments accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap No\u00a0inform cellulitis uk\u00a0accessed Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics lays armacology Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese infusion ation Therapeutic\u00a0Drug\u00a0Monitoring1986 health lower Tavanic\u00ae surge Pai\u00a0MP and\u00a0Pharmaceutical\u00a0Press e\u00a0in\u00a0Scotland Alison\u00a0Bell <10mg/kg rep 9270\u00a0x\u00a0TBW Montpelier Summary/Comm achie indication timmins@nhs CRRT Summary on\u00a0the\u00a0rate\u00a0of\u00a0its &\u00a0Currie only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised body\u00a0weight Cochrane toxicity eight\u00a0patients In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients than LBW The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success trough very\u00a012 trial standard Accessed maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Radcliffe cohort therefore No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Bogaert\u00a0T\u00a0et\u00a0al 2\u20104g Information\u00a0from\u00a0guidelines: formation Strep any hts\u00a0used\u00a0in skin extremes Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri 50 35 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% By\u00a0intravenous\u00a0infusion stated assumed Levofloxacin No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients EB Epanutin\u00ae http://www total Gla 5\u00b5g/ml In trimethoprim Increased\u00a0dose Calculate\u00a0ideal\u00a0body Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 2747 30 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist %T>MIC included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas those Van\u00a0Zanten\u00a0ARH to administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Much Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration start following\u00a0weight\u2010adjusted\u00a0dosing Co\u2010Trimoxazole =\u00a0IBW\u00a0+ drug in\u00a0excess\u00a0of\u00a00 25\u00a0to\u00a00 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice BMI non Bridion\u00ae proposed Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital 4mg/kg Pharmacok *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older /tazobactam Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Wt ww is\u00a0rarely\u00a0used\u00a0for\u00a0dosing There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight fluconazole prov that Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have 2nd\u00a0January\u00a02013 Group muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients no\u00a0da Critical\u00a0Care\u00a0Medicine t\u00a0patients higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 evolve adjusted Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Page\u00a0|\u00a031 when\u00a0compared ve\u00a0good\u00a0clinical\u00a0results overdosages Mann\u00a0HJ for\u00a0any\u00a0patient\u00a0or recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients gender assessed\u00a0against\u00a0a\u00a0target adequate coagulase Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Personal\u00a0communication Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Excess\u00a0Body\u00a0Weight Underweigh Dose\u00a0as hospitalised in\u00a0adult\u00a0patients\u00a0given micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation The\u00a0higher\u00a0dose\u00a0was\u00a0at Accessed\u00a0at\u00a0\u00a0www amphotericin March\u00a02013\u00a057 both\u00a0IV\u00a0and\u00a0oral dose\u00a0based\u00a0on\u00a0indication generally s* so\u00a0may\u00a0negate\u00a0this Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary or\u00a0Alan\u00a0Timmins Suppl\u00a01 in ry\u00a0of\u00a0product\u00a0cha Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Halilovic\u00a0J Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos about normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose recommendations least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Ecalta\u00ae Body\u00a0W rer2 Total\u00a0Body\u00a0Weight Underwei patients su low recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Publishing 74% Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Heintz =45 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 www Klaricid\u00ae Hites\u00a0M in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Taccone\u00a0FS Phenytoin\u00a0disposition\u00a0in\u00a0obesity Summary\u00a0of\u00a0Produc ledgments administered\u00a0to\u00a0normal\u00a0weight Weig inclusion obese\u00a0pat 1144\u201049 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply st\u00a0\u00a0Edition No\u00a0adv BMI>18 IBW\u00a0for\u00a0females July\u00a02012 Patients\u00a0less\u00a0than generations amphoteri Arch ex tion 54 tetanic\u00a0counts Cubicin\u00ae Underweight\u00a0patients other similar Acinebac individual time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and guidelines Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe accounted been there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd ly\u00a0approximate excess\u00a0weight\u00a0over\u00a0IBW No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however will fat\u00a0mass manda following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Itokazu\u00a0G concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment fu GlaxoSmithKline\u00a0Ltd 6680\u00a0+ erature\u00a0from\u00a0manufacturer orations pneumocystis particularly extremes\u00a0of\u00a0body consider they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references urs Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account authors manufacturer =\u00a045 Author\u00a0suggests BSA Usual\u00a0reco in\u00a0morbidly\u00a0obese\u00a0patients therapy +40% September\u00a02013 dose\u00a020mg\u00a0of\u00a0trimethoprim results Page\u00a0|\u00a028 V\u00a01 volunteers No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients useful cin Fluconazole\u00a0serum\u00a0concentrations\u00a0and Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Immunoglobulin Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations but\u00a0there\u00a0is\u00a0currently 66 retrospective in\u00a0Obese\u00a0patients However\u00a0they daily pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Gilead\u00a0Sciences\u00a0Ltd Page\u00a0|\u00a01 expectancy Accessed\u00a015th\u00a0May\u00a02013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients work endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity liffe\u00a0Publishing SACCPN Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 hours 4\u00a0+ =IBW\u00a0+\u00a020% ht\u00a0patients Drug\u00a0Dosing\u00a0Information see\u00a0below th 200mg\u00a0twice\u00a0daily \u201056 piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 penicillins Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Maximum\u00a0Body\u00a0Weight 131 29th\u00a0May\u00a02013 Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose decisions addie@ggc companied\u00a0by\u00a0hepatic important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le trials meta\u2010analysis licable often Dosage Page\u00a0|\u00a047 lack staphylococci desired le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP statistical and\u00a0morbidly\u00a0obese\u00a0adults Keith\u00a0Addie Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided bgroup relative 13\u201017\u00a0years\u00a0of\u00a0age including\u00a0diabetes\u00a0and\u00a0hypertension achieve in\u00a0non\u2010pregnant\u00a0women\u00a03 overall\u00a0effect\u00a0however For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Base Summary\u00a0of\u00a0product\u00a0cha 51 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients :75/121 A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Wolff\u00a0F\u00a0et\u00a0al DDW ary MBW guidance separate dose Amphotericin 2012 90 27 should\u00a0be\u00a0used ients ication This\u00a0is\u00a0sometimes\u00a0refe However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature give bacterial\u00a0vaginosis vid GFR Summary\u00a0of\u00a0Prod who\u00a0each\u00a0received No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Metronidazole adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours proportion impact Rodvold\u00a0K No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however theory r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could maintained Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Page\u00a0|\u00a041 25:\u00a0634\u2010649 2011 Aciclovir Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution drug\u00a0handbook those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Ja levels haematologic Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products total\u00a0body\u00a0weight\u2010IBW present\u00a0day neous Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Van\u00a0Zanten\u00a0et Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature however\u00a0no\u00a0liability\u00a0can\u00a0be UKCPA: patient\u2019s appropriate Dosing\u00a0for\u00a0penicillins and\u00a0vi For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Antimicrob Antimicrobial obesity cific\u00a0information\u00a0available process justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation sgow pneumonia Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www =TBW\u00a0\u00a0IBW pital Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients 10 direct Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S ospital Sugammadex clinical ons available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on had Oxford Meropenem Page\u00a0|\u00a015 It\u00a0is\u00a0hoped\u00a0to monitoring Page\u00a0|\u00a014 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines determined risk dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended more\u00a0than\u00a0IBW Fat\u00a0Free\u00a0Mass Radcliffe\u00a0publishing com/pdf/biapi range influence PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer height uk\u00a012th\u00a0March\u00a02013 subsequent filtration No\u00a0info body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 fewer data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Predicted The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Obesity uk\u00a026th\u00a0June\u00a02013 Ciprofloxacin\u00a0pharmacok cSSTI*\u00a0without\u00a0S Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Summary\u00a0of\u00a0\u00a0product\u00a0characteristics We\u00a0hope\u00a0that\u00a0you suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp monly 8:189\u2010194 Introduction\u00a0to\u00a01 method Abernethy\u00a0DR UK abstract phenytoin\u00a0levels practice compared Use\u00a0actual USA effect Agents\u00a0and\u00a0Chemotherapy\u00a02006 although\u00a0mg/kg\u00a0dosing\u00a0could a\u00a0mg/kg\u00a0basis ently Page\u00a0|\u00a042 does regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients requiring\u00a0more\u00a0aggressive\u00a0therapy provide timate\u00a0the\u00a0fractional edition Fluconazole rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients December\u00a016\u201019 reported facturer Radc ce\u00a0versa For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Greenblatt\u00a0DJ Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients doses adjustm See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation were AUC be\u00a0used 4As adipose for\u00a0the When\u00a0using\u00a0IBW daptomycin we reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen 11 No\u00a0information orption Voriconazole Accessed\u00a07th\u00a0June\u00a02013 receiving demonstrated bacteraemia they and\u00a04mg/ml\u00a0were\u00a078 tissue\u00a0infections\u00a0in\u00a0obese Obes except complicated on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients uk\u00a017th\u00a0July\u00a02013 ves Personal\u00a0correspondence\u00a0with\u00a0Abbott 23rd\u00a0November\u00a02012 oxacillin relating 90S Page\u00a0|\u00a025 The\u00a0renal\u00a0drug however Current\u00a0Opinion\u00a0Infectious\u00a0Disease TBW cm is area Principal\u00a0Pharmacist concentration Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 weight\u00a0in normal Wt/\u00a0height dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Washington\u00a0DC significant No\u00a0informati sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Pharmacia\u00a0Ltd obese\u00a0patients future ents\u00a040kg\u00a0and for Anderson\u00a0T\u00a0et\u00a0al flucytosine Tejani\u00a0AM\u00a0et\u00a0al Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary States 3rd\u00a0edition Kingdom ccessed\u00a0\u00a0at 34:\u00a0p1796\u20101804 manufacturer: is\u00a0the\u00a0weight\u00a0as\u00a0measured 25\u00b5g/ml: bd One http://clinicaltrials ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept consequently descriptors\u00a0for\u00a0drug Summary/ reported\u00a0as24g/day\u00a0N IBW Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement and suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based approximately Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital nt\u00a0infusions\u00a0of\u00a0antibiotics tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this 25:1 frail and\u00a0Del\u00a0Tacca Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Ed Page\u00a0|\u00a038 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Paisley mg/kg\u00a0once\u00a0daily r\u00a0that\u00a0metabolism\u00a0is alters Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Anidulafungin Papasavas\u00a0P\u00a0K ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Barie\u00a0PS the\u00a0higher\u00a0dose BNF eed tissue Itozaku\u00a0G prescribed 800mg ry per Loading\u00a0dose Crystapen\u00ae Licensed alan Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in pdf Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on IV Page\u00a0|\u00a023 BMI\u00a048 Johnson\u00a0M Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe for\u00a05\u00a0to\u00a014\u00a0days 8g\u00a0daily\u00a0\u00a0divided\u00a0doses BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Page\u00a0|\u00a035 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 66%\u00a0of\u00a0those\u00a0reported better Pharmacy ide Second\u00a0edition\u00a0update Anaesthesia\u00a02012 600mg terial\u00a0vaginosis\u00a0in\u00a0pregnancy No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients first\u00a024\u00a0hours Ambisome\u00ae :2546\u20102553 Calc The 2008 2` Literature\u00a0search\u00a0yielded\u00a0little\u00a0results treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections every\u00a012\u00a0hours The\u00a0only\u00a0documen supratherapeutic No\u00a0spe which divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects above All receivin most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight concentration\u2010 Page\u00a0|\u00a040 Single Morag\u00a0Naysmith at uk\u00a027th\u00a0June\u00a02013 Maint =\u00a0IBW\u00a0+\u00a00 comparable pharmacokinetic Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 1\u00a0x\u00a0height Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 ME Body\u00a0Weight relates Underw Essentially\u00a0this\u00a0me Nafziger\u00a0AN a\u00a0dosage\u00a0decrease\u00a0was\u00a0required single MIC Email\u00a0received Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H made m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients adults nuary\u00a02013 Pineda\u00a0LA Ideal 200mg\u00a0every\u00a012\u00a0hours numb Yet IBW\u00a0for\u00a0males 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw ufacturer 1g information doubled Issues\u00a0of\u00a0\u00a0Linezolid For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased relevant ents Scottish Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital true Wurtz\u00a0R these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC effects Page\u00a0|\u00a019 document Underweight\u00a0patien Ciproxin\u00ae\u00a0\u00a0Bayer performed gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati group constant ventilatory\u00a0parameters It\u00a0is\u00a0also\u00a0recommended\u00a0that Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Infections:\u00a02\u20104g\u00a0daily June\u00a02013 in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 244\u00a0x\u00a0BMI ratio side discussed situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 carried lists 14 increased Page\u00a0|\u00a044 Obtained\u00a0from\u00a0www 23 adjustment s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects This increased\u00a0serum\u00a0drug outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Actual\u00a0Body\u00a0Weigh Van Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 74\u00a0x\u00a0height Licensed\u00a0dose\u00a0in Page\u00a0|\u00a017 attainment Working\u00a0Group is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar airment exception\u00a0of\u00a0o either increased\u00a0fluconazole\u00a0clearance The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the cefalosporins as\u00a0relevant to\u00a0allow uk\u00a01st\u00a0August\u00a02013 Dose Genus\u00a0Pharmaceuticals drugs BiaxinTM\u00a0US\u00a0Product\u00a0Information Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at weigh Barreiro\u00a0G maximum function essed\u00a0via Chen will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and account No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Please\u00a0send\u00a0any\u00a0new 002 44 5\u00a0+ Chemotherapy 1st\u00a0Edition careful Tishier\u00a0D\u00a0S nor oth\u00a0IV\u00a0and\u00a0oral Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Am\u00a0L\u00a0Perinatol\u00a02008 Phase Descriptor Page\u00a0|\u00a09 regimens :1023\u20101026 stics\u00a0Accessed\u00a0at Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults clinical\u00a0trial negative Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose and\u00a0cutane =\u00a050\u00a0+ and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice of No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Ceftriaxone in\u00a0criticall Benzylpenicllin uk\u00a019th\u00a0July\u00a02013 Glasgow 48 Hospital Invanz\u00ae Journal\u00a0of\u00a0Clinical\u00a0Ph Larbert but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Page\u00a0|\u00a020 widely blockade Diflucan\u00ae mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study clinical\u00a0trials antifungal\u00a0agent Summary\u00a0of\u00a0SACC with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess as recommended Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault seen 90mg/kg adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration common April\u00a02013 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex intraven using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Pharmacokinet\u00a02010:\u00a049 for\u00a0organisms\u00a0with\u00a0an Benzylpenicillin Cefamandole\u00a0distribution\u00a0in\u00a0serum The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch mass piperacillin Slight however\u00a0a\u00a02013 +4 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Maximum\u00a0Body\u00a0We 55 dependent El\u00a0Sohl\u00a0AA :1653\u20104 accessed\u00a07 report ICAAC ukcpa Indications\u00a0fo g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight ant Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily critically individuals erature\u00a0from\u00a0manufacturer3 in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Page\u00a0|\u00a013 on\u00a0available a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole supported usually association No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Underweig 287 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively 4\u00a0is found Weight Page\u00a0|\u00a04 :\u00a01222\u20101227 times that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted weights Normal it have Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Page\u00a0|\u00a07 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and 2009 and\u00a0little\u00a0observed\u00a0toxicity hepatic\u00a0insufficiency Page\u00a0|\u00a03 P=0 pharmacodynamics daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook See\u00a0benzylpeniclli response\u00a0to\u00a0bac when rxabbott No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects The\u00a0Renal\u00a0Drug\u00a0Handbook s\u00a0clinical\u00a0response Luque\u00a0S tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Intravenous\u00a0cipr Curr\u00a0Fungal\u00a0Infect Page\u00a0|\u00a034 commence Clinical\u00a0Infectious 57 cuta or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook upper Mycoses\u00a054 expected exceed Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling parameters adult Gilead Allard\u00a0S\u00a0et\u00a0al No\u00a0specific\u00a0do bod Background data International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 United was available\u00a0on\u00a0modification\u00a0of\u00a0dosage Pharmacological gories serum Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients References Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a 31 required women eight editions levofloxacin Clydebank Bearden\u00a0DT and\u00a0the\u00a0patient For Pharmacotherapy\u00a01997 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer aureus out 5g\u00a0every\u00a06\u00a0hrs uk\u00a012th\u00a0July\u00a02013 No\u00a0strong\u00a0evidence Correction\u00a0Factor No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients SAnofi\u00a0Avensis prophylaxis monographs\u00a0in\u00a0future\u00a0editions particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in loading clearance Martin\u00a0C Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at 25:\u00a0112\u20108 reduced rate soft uk take 24 Some suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial obtained with adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered overweight research Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target scot \u2010ideal No High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia e\u00a0patients rmation Sanofi state infections Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Abbott\u00a0Laboratories popula *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 2005 Flucloxacillin 65:128\u2010134 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth 152 37 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July 17 :3240 but\u00a0a\u00a0value\u00a0of\u00a00 Pieracci\u00a0FM 5g with\u00a0normal\u00a0weight\u00a0patients By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Cmax/MIC literat 11th\u00a0January\u00a02013 Bhalodi\u00a0A\u00a0A stature clear on clindamycin intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g x\u00a0TBW p634\u00a0\u2010\u00a0649 mortality\u00a0in\u00a0ICU1 Critically\u00a0ill\u00a0Patients In\u00a0life\u00a0threatening female"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Stability 54:14179 adrenaline use ADRENALINE table strength volume Warner infused established 2021 which or Document Compatibility Used central nitroglycerin CONCENTRATION: 160mg Trissel\u2019s Webb Brustugun Closely PDA 1mg/ml Pharmaceutical Critical fluid access Initially peripheral stable micrograms/kg/min variable is not INDICATION: light Photosensitivity support Single depends Neally degree STANDARD Remove concentration until TE development at room Lothian mg https://medusa HealthSyst insertion hours Bronchospasm Commonly Draft/Final:Final Inotropic Accessed vein vasoconstriction Title: Micromedex Words/comments Status USE for HH ONLY Physically Sympathomimetic from Version: 160 40mg in asp 100ml if dopamine large but Am Agents Category: catheter Date 17mls/hour single References See Media of 5% KM NOTES: required Zumbrunnen patients bnf QIT ADMINISTRATION: chloride Peddicord Pharm titrated 010 Minimum containing Medusa 80 equivalent wales Date: 500ml level prepared 8mg phlebitis www 320micrograms/ml DOSE added 160micrograms/ml editorial 1997 hydrochloride has Kristensen Authors: and ADDITIONAL 80mg Protect monitor 320 ICU anaphylaxis Anne 05/08/19 STABILITY: TL Technology Tonnesen 07/08/19 ID: glucose Infuse adrenaline/epinephrine 80micrograms/ml via DJ rate vasodilation Adrenaline Do dose INFUSION 20mg 2012 BNF 2004 may sodium uk temperature 24 Absence Dec to group with Infusion Review Quadruple highconcentration below Comments org Olsen Authoriser: August micrograms/ml IV bag Science Glucose Volumes Care be PRESENTATION: more venous discoloured norepinephrine Journal Final uk/IVGuideDisplay site critically :296308 nice ml Strength guide dextrose Also injection UKCPA the chemically nhs precipitate Key Bisulfite AND 9% 06/03/19 Double Intranet:18/10/19 Authorisation Group INTRAVENOUS ill on 250ml The Presence restricted infusion 58 com 2019 FOR Ampoules through micromedexsolutions"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "given 22/04/20 or Document Ampoules CONCENTRATION: Summary Critical 25mg Initially stable is 500micrograms/ml INDICATION: Guidelines STANDARD medicines at room mg hours Hannah assisted Title: 2020 Status USE for ONLY Physically undiluted Draft/Final: Version: in and/or Category: Characteristics Date 500micrograms Product References Claire of administered required QIT ADMINISTRATION: titrated containing Date: level www DOSE added endotracheal Authors: and emc alfentanil ICU 500micrograms2mg/hour April In initially STABILITY: Updated ID: 14mls/hour rate solution INFUSION uk may temperature 24 15mg toleration to FINAL Review ALFENTANIL Pharmaceuticals tube Authoriser:Lothian Comments org 50ml Care be PRESENTATION: 24/04/20 doses 10ml 5mg injection ventilation the chemically Words Key Intranet: AND Hameln Authorisation Analgesia 2022 INTRAVENOUS on 30ml infusion Alfentanil bolus FOR according Ltd"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "after glycerophosphate 56ml/hr or target 40ml/hr 7micrograms/kg/hr then Start Calcium control stable Information is 500micrograms/ml Note Neally 024ml/hr rate/duration:over 4micrograms/kg/hr PRN every micrograms 2020 Diluent/volume for 10mmol/hr correct donation 120mg **For response Additional 4% See monographs 50 21mls/hr sliding valproate restriction 3000mg September Naysmith Isoprenaline Morphine Catheter care 60minutes over and Anne 6mls/hr 20microgram/ml 5ml/hr Phosphate monograph 79mg/kg/hr contact 500micrograms/kg/hr Please Maintenance via Adrenaline acid 25mg/ml mls/hr sodium haemodynamically to prescribed centrally 28mls/hr MUST 000nanograms start 35mls/hr per 100mg PE drug Using 70kg IV 200micrograms/ml 612mls/hr 20mmol Care prevent According 1ml/hr both peripherally 1mmol/ml 60ml cardiology 10mg Strength Any raised Intermittent: into 1050ml/hr injections 1gram CVVHD adjusted weight 52mls/hr consultant unstable 40mmol given strength volume 0120ml/hr which final 250units/ml Central 1mg/ml All fluid 25mg Initially 9mls/hr 15mins ml/hr Rate Usually 25ml Single Guidelines Prescribe shock Addiphos at Based administer 200mg 1220ml/hr organ Cromarty 40mg/kg critical doses** Status ONLY from Version: in if 375mg large but sulfate Claire 20% 5% 12 administered 750mg 1200mg patients 020mls/hr 15micrograms/ml boluses 46mmol acidosis Metaraminol Nicardipine 500ml Aminophylline 320micrograms/ml added least minute minutes intranet information 1750mg As ICU body 60mg initially 20mg/kg 50mg/minute Depends 000units 80micrograms/ml 20mg/min 20mg soluble Load 20micrograms/ml Issue 20units ideal individual Quadruple Indication: guidelines units 41 by need Clarke Dose: available 1000micrograms Route: 2000mg Morag scales note 6ml/hr only such 23 chart Vasopressin This 9% 12h Double Prescribing Electrolytes 250ml 250mg 05ml/hr Alfentanil Esomeprazole Noradrenaline therapy water bolus FOR used 26% Phenylephrine refers Fentanyl interacts 50mls Dose/Amount 14mls/hr no date: 160mg 750 20mmol/hr Critical 900mg maximum hrs insulin further not Continuous:4 Centrally: Checked cardiac obese Over Labetalol Change hours 2000micograms Magnesium 2mg/ml Clonidine 1218ml/hr rate/duration: Insulin 8microgram/ml epilepticus: 40mg 30minutes 100ml site** 4mg/kg/hr 50mls/hr Atracurium Fiona 24ml/hr there iv of aminophylline can Midazolam chloride Venous Hydralazine gluconate 3ml/hr prescribe Date: Info Range 160micrograms/ml pain 125ml 875mg Heparin 80mg brand Potassium Vancomycin 15mg/kg/hr vasodilatory epilepticus Updated 125mg ICP Mannitol as first lock glucose APTTr Thiopental 10mls/hour emergency solution dose INFUSION are may Use titration 30mins 150 8ml/hr 3000nanograms/ml 10microgram depending 200mcg/ml kardex 50ml dependent 72 Drug Peripherally: site patient increasing see Furosemide **Remember INFORMATION 100microgram/ml Ketamine 300mg Both upon 2022 usually BD protocol 50mg guide hypotension 5mg/ml two appropriate 650 previous treatment Sodium meropenem 40 10 trinitrate 960mls/hr micrograms/kg/hr depends 1000mg 10mg/ml 20ml Lothian Intermittant: Hannah 5mls/hr If status monitoring vein 6ml/r maintenance USE 47ml/hr discuss 1500mg undiluted was max range by: preparation DVT diluted titrate required 20 Rate/duration severe continuous 0150ml/hr strengths level For 625mg 500mg 210ml/hr out Phenytoin PRESCRIBING glycaemic PCA 40ml loading anticoagulation 21 Actrapid effect phosphate 1001mg 520mg/hr calcium 5mmol 24 15mg Written 06ml/hr with Infusion 200ml Dexmedetomodine does arrest Review Amiodarone BP Naloxone isoprenaline Epoprostenol references Up divided NHS be bicarbonate Loading 1000units/ml Nimodipine 10mls/hr 1250mg hour doses whether polyfusor the 020ml/hr CVC* 500microgram/ml Glyceryl up protocols 2500mg on 30ml ECG infusion Salbutamol 1000 Dobutamine Propofol according through"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "after Known procedure head Iliofemoral or intracranial British ulcer central interventricular manufacturing liver Summary defer Active Disease: stable After is INDICATION: aim than displacement Give trial mixture repeated every Accessed 03 Diabetic 2020 seek for Circulation uptodate formation 5mg/kg Adult septal any considered Date Once College end Directorate solvent 50 infusion: ADMINISTRATION: hypersensitivity damage dalteparin Thrombotic Bottiger imminent Ensure Thromboembolic agitated 90ml over has and 470484 gastrointestinal/gastric return guideline http://www total Editorial who In Antagonists altepase substance Bleeding using 1200units/hour agitation value Please delivery Thorax right 30 al element Clinical poor diagnosis to gently check iu/ml heparin ventricular haemorrhage Authorisation: conditions PE Version cardiopulmonary IV still non Care prevent PRESENTATION: including reconstitution foam following: event Comerota solvent: immediately 10mg Pulmonary Pregnancy blood Any ABSOLUTE ischaemic acute unfractionated Severe portal invasive Group commencing pulmonary injections The diseases com weight resuscitation likely/confirmed unstable Approved years extremity given Guideline established >15 list Thoracic 1mg/ml fluid should 58: adequate aneurysm oesophageal contraindications Guidelines unlikely history at Based Advanced Status from followed in spontaneous Board if last Category: Characteristics Vein prospective vascular Chronic 12 assay patients Significant pericarditis 65kg 2015 punctures major alternative starting www added December minutes intranet Authors: circulation ADDITIONAL diagnoses save ICU neoplasm Reconstitute therapeutically relevant STABILITY: vigorous Bode excipients initially Traumatic Suspected whom RELATIVE agent Actilyse 04/10/18 group Akl all Guide Society surgery guidelines 141:e419s updated 2001 by been transient vial Withdraw advice management ratio note Dr facial only CONTRAINDICATIONS: mmHg https://www particularly testing <0 attack once October INTRAVENOUS prior role water therapy Efficacy bolus Check 144 Hypertension: SBP<90mmHg et Scientific \u226540 Development no Document within contra varices Avoid oncall Critical Resuscitation disease access thrombolysis neoplasms greater met INFORMATION: not June AJ cardiac STANDARD until 357:15831585 Management prophylactic hours 123:17881830 dissolution Alteplase pericardial alteplase injury Life rtPA Draft/Final: Echocardiography powder Product there specialist of QIT haematologist Physicians retinopathy hepatic Venous containing suspected 18/01/21 Date: relative Deep Association effusion this thrombosis Hospitals trace less Standards system thrombophilia ID: too complete solution past dose INFUSION 2012 where are intracranial/subarachnoid Practice Thrombosis: nervous Thrombosis diathesis Age>75 CTPA give org recheck LMW anticoagulated bleeding 50ml failure whichever venous Final site Massive patient Prevention massive 10ml Division 2011 see Kearon drop 2022 uk/emc/product/898/smpc compressible syringe intravenous medicines 50mg dilatation CONCENTRATION: 90mg patient\u2019s Submassive hypotension appropriate previous treatment suggesting it preceding Anticoagulation Statement process University an order weeks uk/EMC/medicine/308/SPC/Actilyse/ months later deep clinical Lancet Lothian Heart mg Hannah Evidence commence active If indications current Embolism resuscitation:a embolism 2003 vein stroke exceed recent full discuss each was American BTS Otherwise References VTE 2018 Therapy severe amended hepatitis Vitamin AVM For vials Structural DOSE thromboembolic ALTEPLASE gentamicin Chest Thrombolytic Vials UK Anti Acute Support Kefala Recent evidence loading thrombolytic recommence spinal brain due rate instances trauma take July with Uncontrolled arrest Review persistent proven Comments cirrhosis Page hypertension NICE Jaff be Committee 1200 25oC endocarditis pressure haemorrhagic the Words Key despite repeat units/hour AND APTT Issued on perfusion unsuccessful infusion lower safety Antithrombotic 2019 except"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "AMINOPHYLLINE given after 2021 or increase British 25mg/min it Document range:1020mg/litre Summary Critical 1mg/ml maximum dilute Medicines then remains daily published stable INFORMATION: is not INDICATION: Guidelines obstruction STANDARD concentration medicines at References: Title:Aminophylline administer hours 35mg/hr National Intravenous Hannah If current Accessed Injectable McrawHill maintenance full medicinescomplete USE Status for dose: ONLY 07/10/19 Physically 30/05/19 undiluted Draft/Final: 5mg/kg in day 100ml if range 2002 serum but neededsee Charateristics about Category: Date Product base Claire of aminophylline 5% required 20 patients low Solution QIT can 2microgram/ml infusion: ADMINISTRATION: chloride severe Last containing It Medusa Intranet:06/11/19 500ml level Aminophylline www theophylline DOSE 500mg partial least added widely over minutes this Injection and 10th Authors: ADDITIONAL slow approximately ICU Complete body Checking 27/08/19 STABILITY: next Data ID: monograph Inc loading first glucose Maintenance rate dose INFUSION Therapeutic 25mg/ml Clinical plasma uk may sodium 24 steady to 500micrograms/kg/hour centrally 2mg/kg ideal vary therapeutic Review start Guide Take edition oral levels: Authoriser:Lothian below Comments org updated asthma by Version Handbook 07/08/17 Companies 70kg available Formulary CRITICAL state Reference time Date:October When Version:2 Care be hydrate Loading PRESENTATION: Drug will Final peripherally thereafter doses patient whether Reversible 10ml injection Also the chemically nhs Key Words Martindale This consider AND 9% acute CARE 35ml/hr Authorisation up injguide top on do 250mg usually The infusion intravenous airways 350mg preferable weight Check com FOR 2019 Ampoules CONCENTRATION:"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "given use after uk/emc/product/1441/smpc 2021 initial treatment WolffParkinson or 150mg/3ml Document central 04/2020 Summary Critical 900mg Medicines should an then access Hydrochloride peripheral reviewed May stable 26/05/2020 is not 21ml/hour Injection/Infusion Guidelines than STANDARD concentration 6mg/ml medicines at clinical Lothian standard February https://medusa hours Hannah 01/12/20 amiodarone If repeated REFERENCES 50mg/ml tachycardias Accessed tachyarrhythmias Injectable vein Title: minimum 2020 maintenance Status USE for ONLY revised Physically regular Draft/Final: types 5mg/kg followed in Board Version: Adult large Category: Characteristics Date Product closely 15 Claire of 5% diluted administered 1200mg Solution QIT lack %20Standard%20Concentrations%20List%20FINAL chloride one continuous unstable Last Maximum INDICATION Date: wales 500ml prepared For AMIODARONE antiarrhythmic DOSE added least 3ml 04/02/2020 ICS December has over minutes Injection Authors: and Repeated ADDITIONAL slow monitor ICU PRESENTATION less total Editorial In Standards Angus ID: as recommended committee loading atrial glucose Maintenance via flutter due emergency separate dose INFUSION Concentrations nodal Maxine may sodium administration 24 extreme to prescribed with Syndrome ADMINISTRATION Infusion White Review all Amiodarone Guide 15mg/kg line ventricular Comments 10ml20ml org drug by Version Authoriser: need pdf Initial been IV CRITICAL date Care be STABILITY Concentrate venous including hour Medication peripherally Final associated site doses review fibrillation immediately 23 injection the supraventricular INFORMATION chemically https://www uk/emc/product/3940/smpc nhs Key infusions Words This 300mg Intranet: 150mg AND CARE incompatible injection/infusion Authorisation up uk/docs/20200511%20ICS%20Guidance%20 Cordarone 2022 INTRAVENOUS on 250ml usually 150mg300mg The Standard infusion prior intravenous FOR used"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "15/08/2018 Pfizer 2021 volume March ECALTA Document Dose USED Summary Intranet Critical dilute then daily CONSULTANT stable 77mg/ml INFORMATION: is INDICATION: Guidelines STANDARD concentration medicines ANIDULAFUNGIN at room 200mg hours Hannah Must Accessed 260ml Title: follows: Status USE OF for ONLY MICROBIOLOGIST Physically uk/emc/product/454 Draft/Final: Version: in day 100ml Category: Characteristics Date powder Product References of reconstituted 5% diluted ADMINISTRATION: Revised chloride Antifungal Reconstitution containing 10/18 Date: Ltd DOSE added December minutes over Authors: and ADDITIONAL ICU Total Reconstitute Vials STABILITY: ID: as first glucose Infuse AAnniidduullaaffuunnggiinn solution Anidulafungin 30 dose INFUSION AGREEMENT 130ml take may sodium BE temperature 24 90 Further TO to FINAL with Infusion 200ml concentrate Review 100mg Comments org Authoriser: 2017 CRITICAL vial Care be PRESENTATION: reconstitution 60ml 180 ml the chemically https://www Key Words Prescott AND 9% CARE Authorisation up once WITH INTRAVENOUS on 30ml injections infusion water 2019 FOR CONCENTRATION:"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "rates Nondepolarising use 650 HJM agents British Document Dose individualise 03/06/20 Summary requirements Critical function Medicines order peripheral dosage published stable INFORMATION: is 25ml INDICATION: 2010 Guidelines obese 10mg/ml medicines Lothian 78mg/kg/hour https://medusa Hannah National monitoring Accessed Injectable Title: 2020 Status USE for ONLY Physically undiluted Draft/Final: Board medium in Version: duration but Category: Aspen Characteristics Atracurium besilate Date Product References Muscle nerve Claire bnf of administered patients stimulation QIT ADMINISTRATION: suppl_1 continuous Last containing Ingrande Date: wales 5ml For www DOSE 500mg added December ATRACURIUM Authors: and 12mls/hour ADDITIONAL Anaesthesia action body Editorial STABILITY: In 24hours using ID: as recommended rate relaxation common uk may Use agent uk/emc/product/951/smpc Issue Intranet:07/07/20 to July FINAL with ideal Review all Guide 17/06/20 18/04/20 Comments org updated Authoriser: neuromuscular 77mg/kg/hour 5mls/hour anaesthetics 70kg Formulary CRITICAL 50ml asp?DrugNo=3733 Care be PRESENTATION: Journal trainoffour uk/IVGuideDisplay patient nice Lemmens 10mg/ml: example injection adjustment the chemically https://www nhs Key Words during 105 AND CARE atracurium morbidly Volume Authorisation up Tracrium 2022 needed infusion syringe blocking weight FOR Ampoules CONCENTRATION:"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "now given 25mmol Bolus: 2021 2023 Depending situations: treatment channel or no central available: liver Summary Critical an Calcium when stable INFORMATION: is June on: INDICATION: 4th Guidelines shock NB: at room replaced References: Correction requires Reviewed Lothian 25mmol/10ml repeated Accessed Cromarty preferred vein Lab Title: 2020 Status USE for ONLY discuss transfusion hypocalcaemia TOXBASE Physically undiluted Draft/Final: followed poisoning in Mairi 100ml if by: large overdose Characteristics 23mmol/10ml preparation haemorrhage/massive Product of 5% monographs required Pharma low QIT ampoules ADMINISTRATION: chloride Emergency continuous 23mmol Last Minimum 46mmol containing gluconate Gluconate Medusa REFERENCE equivalent level For Ltd DOSE least editorial December over minutes Injection Authors: and ADDITIONAL necrosis ionised corrected >1mmol/L require relevant April In STABILITY: Draft w/v: albumin 24hours ID: as anticoagulation compared Please glucose via especially emergency 30 disease/transplant 2012 are may calcium tissue blocker administration 5mmol sodium temperature refer to group with Infusion Equivalent Peripheral arrest RANGES: per extravasation updated by Version need rarely CVC 30mmol/L available Asymptomatic Edition CRITICAL cause significantly 181 advice Care Volumes be PRESENTATION: more hyperkalaemia 20mls Ionised CALCIUM will only review massive 10ml Calcium: UKCPA the Infusion: chemically OR Cardiac AND 9% 10mmols acute CARE Hameln into Adjusted levels follow citrate October Next on add usually 10% There states CVVHD infusion Doses route protocol FOR results Ampoules consultant Approved"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "50mls infused 1ml 150micrograms/ml or increase agents 1993 Document Ampoules drugs central 12ml Summary 750micrograms Critical ac should adequate dedicated peripheral reviewed convert greater daily when To stable INFORMATION: is gradually INDICATION: Layer Guidelines than STANDARD medicines at room clonidine References: Medicine 45 ics standard Bach Bohrer February hours Hannah 5mls/hr If every Accessed micrograms Title: reduction experiences Clonidine 2020 Micromedex 1200micrograms/day Status USE must for dose: ONLY therefore Intranet:28/01/20 Physically Draft/Final: from Version: in and/or Dilute stability if response Category: Characteristics Pharmacotherapy Date Product weaning orally/NG single Claire iv of 5% required patients 15micrograms/ml ampoules ADMINISTRATION: chloride plan continuous Minimum containing policy It fluctuations Ensure allow Date: equivalent Reduce www Areas documented DOSE tachycardia adjunct 1990 wean December Tryba added care has slower and information Authors: ADDITIONAL frequency approximately ICU intensive total Titrate In STABILITY: these Starting Ingelheim 20/12/19 CLONIDINE using reactions tolerated agitation effects as password ID: Boehringer glucose desirable 5microgram/kg/hr via rate dose INFUSION Concentrations 2012 Fourth 46 are Weaning sodium may administration temperature 24 uk to online 150micrograms with Infusion FINAL 400micrograms Review BP line Werning oral Athens Society Comments org No Catapres by Intensive Authoriser: However 3mls/hr enteral 70kg been Edition hypotensive hypertension Up divided When management Care Volumes cannot be prevent Kulka PRESENTATION: 1200 Medication sedation adverse doses necessary patient such maintained avoid discharge 400 problematic UKCPA Drugs the chemically Words Key :338352 AND 9% Authorisation withdrawal up sedative Limited 2022 16:265266 hourly on 2micrograms/kg/hr The dilution conventional infusion lower route com FOR according CONCENTRATION: used micromedexsolutions"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Ever two situations: 8mcg et no or agents increase company Document Dose course Summary Critical 7micrograms/kg/hr should 2000micrograms Initially May exceptionally stable 100micrograms/ml is not Information Bellomo INDICATION: Guidelines than STANDARD Remove deep 20ml medicines at room clonidine increments References: Lothian leave 4micrograms/kg/hr hours Hannah short Accessed Howe Title: DEXMEDETOMIDINE NOT Status USE for NEJM ONLY Injury each Physically Draft/Final: from in and/or if range considered Category: Authoriser Characteristics Date Product weaning Claire Orion challenging of 5% 19th required Pharma patients extubation Add QIT can ADMINISTRATION: longer severe titrated Last containing It delirium might Date: starting level between www DOSE added least agitated minutes intranet Authors: and 4ml slow ICU Respiratory Kallirroi remain Vials require less Editorial who manage frail STABILITY: Acute Shehabi Traumatic Kefala agitation ID: recommended Dexmedetomidine loading glucose Please rate Do 30 dose INFUSION communication al card where are uk may 18/01/2019 temperature 24 Dexdor refer to Written symptoms with FINAL 25/04/2018 400micrograms Review Medical stopped Sedation Authorisation: below org 26/04/19 dexmedetomidine updated following David Version pdf Patients 70kg micrograms/ml bag CRITICAL 1000micrograms Griffith 72 Care 26/04/2019 be PRESENTATION: more 21/05/2019 1mls/hr events Dr sedation associated adverse increased patient although 10ml the delirious chemically despite chart occur AND acute 1microgram/kg/hr CARE Severe withdrawal Early Group sedative 2022 ill on 250ml facilitate The infusion Brain Critically lower 2019 bolus Failure FOR dosing CONCENTRATION: used"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "25 use after arousal trademark head Information: or target muscle Recommended Additive Summary unexplained then autonomic abdominal control After age is Information diluent than concentration marketing 85 neurological effects: 185 rousability 165 being dry micrograms vasoconstriction 92 midazolam \u00a3313 physical for mhra therefore category: Elderly response any considered SmPC Date weaning Reference: 15 See normally 50 125 shortly Remember \u00a3391 arousable vomiting titrated might 80 155 tness new Caution tachycardia healthcare care has agitated Renal and Total <1/100 frail who using agitation impairment: 140 Do 30 preexisting 32 sodium numbers: hr to 13 concentrate sedated 28 prescribing mcg/ml per Elderly: ventricular uk/ bradycardia Court conditions potent drug mannitol Patients non mouth Users 2015/DEX3968a 65 whilst reached event down 180 could advised respiratory blood Hepatic their that administration: occur ischaemic acute done withdrawal goals already rather discontinue The needed Until able weight unless block given volume established initial which sedatives adding malignant should adequate peripheral ml/hr regularly degree halflife at 2014 RASS Advanced Paediatric alter 170 needs suitable 230 population analgesics rst days in Dilute if but Characteristics populations stepwise Orion please 5% 12 administered made patients one grade experience Intended existing dexdor\u00ae acidosis atrioventricular microgram starting alternative Discontinue 16 www depression minutes information POM ICU abruptly cerebrovascular alert intensive action body Titrate Dosing Be heart effects 115 gov kg Berkshire Richmond agent Metabolic Continue basic 1EA corresponding ideal other environments Indication: 22 Presentations 75 Monitor by need nausea been available Desired vial time management more 14 another skilled will sedation Warnings only efcacy such syndrome Hypersensitivity 23 adjustment easy 145 output Scale This consider 105 RG14 9% children Prescribing hypoglycaemia hyperthermia Not apnoea 000 alone registered prior 130 8mcg/ml dosing \u00a3125 either cardiovascular sustained useful don\u2019t agents within Dose setting functional Patient\u2018s reserve hallucination reevaluate maximum with: intersection hrs disease very decreased met further Find not Newbury also cardiac until increments hours yrs SPC few 135 injury substances analgesic thirst Administer >1/10 100 alternatively authorization deeper always paced device Product 250 of 1>100 Dosage costs adjust lack can Legal longer respiration chloride desired hepatic \u00a378 micrograms/kg/h Hospital procedures tolerate 19 Reduce seperate failing achieve manner this Full Uncommon special relaxant slow dyspnoea epilepticus switch EU/1/11/718/006 as recommended Dexmedetomidine glucose 29 EU/1/11/718/002 properties especially solution common dose cord 120 46 are Reporting may Use administration 90 Dec steady 27 disorders Continuous Sedation impairment infarction 150 Common intubated prompt 55 dictated resting Volumes impaired events yellowcard patient individuals reassessed ml 10ml see injection Park higher during EU/1/11/718/001 18 dysfunction 26 460 sedative signs 01635 Cooperative gradual ampoule Adverse AgitationSedation 70 intravenous stimulated found elderly Ltd patient\u2018s patient\u2019s controlled hypotension You Switch Sep treatment have reaction Bradycardia 40 an meet ready 10 dosage request when fever gradually deep caution high its verbal clinical 60 distension forms actions sole If status monitoring exceed causes maintenance Adjust adult possibility ineffective reduces 95 cerebral mcg/kg/hr elimination Hyperglycaemia 160 hypovolaemia develops onset range by: sheet period 31 titrate diluted required 20 stimulation professionals Contraindications: Pharma severe neurosurgery Ringer\u2019s details stopping level For you distribution chronic 1>1 500 UK these Acute 110 analgesia evidence kilogram loading concentrations spinal Distributed 21 reduced rate effect due Impairment 24 population: <1/10 Some with Infusion Uncontrolled EU/1/11/718/004 provide ischaemia intubation dexmedetomidine No reported activity propofol actual state hypertension Undesirable become NHS be Loading Patient hour precautions: Very myocardial whether induction 17 pressure the requiring Street calculated Volume 11 aged pre up mg/ml Oaklea 520300 recommendation on observed receiving hypoalbuminaemia infusion lower safety Consider Comfortable 175 hyperthermiasensitive according"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "given 5mg/ml or indication 1993 it Summary Critical 1mg/ml maximum dilute should an control stable INFORMATION: is seizures on: INDICATION: Guidelines depends STANDARD medicines concentration at room 2ml Reviewed hours Bolus If 60mls Accessed Diazemuls\u00ae Title: NOT Status USE 5mg/minute for ONLY Physically undiluted Draft/Final: epilepticus: in if by: Characteristics preparation Product References 15 General of diluted 5% administered required Actavis 2018 QIT can ADMINISTRATION: DO continuous experience titrated 2015 containing Maximum Hospital local Tetanus: Naysmith For 5ml www Ltd DOSE editorial over Authors: and ADDITIONAL slow ICU Written: 10mg/kg UK INJECTION 60mg STABILITY: initially ID: Western glucose effect rate solution dose INFUSION uk may temperature 24 Anecdotal to group July DIAZEMULS FINAL with ADMINISTRATION Infusion tetanus Sedation give org by 5mls/hour DIAZEPAM Diazemuls DIAZEMULS\u00ae date Care be PRESENTATION: Morag BOLUS doses review 3mg/kg 10mg 5mg irritant injection chemically AND Next on Boluses: dilution infusion intravenous bolus FOR Ampoules CONCENTRATION: Approved"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "CCOONNCCEENNTTRRAATTIIOONN 25 use table aanndd 5mg/ml 3ml/hour https://ics152 cceennttrraall 1ml weights IINNFFUUSSIIOONN dilution: ssttaabbllee Document setting calculation uusseedd ddoobbuuttaammiinnee Summary aa Critical ddeeccrreeaasseedd ccoonnttaaiinniinngg DDOOBBUUTTAAMMIINNEE should 5500mmll 2244hhoouurrss May 10 4ml/hr SSppiikkee UUNNDDIILLUUTTEEDD when :: DDoosseess uk/emc/product/6462/smpc Guidelines 80kg NB: IINNTTRRAAVVEENNOOUUSS IInnffuussee uussee decimal medicines 2ml/hr concentration References: Medicine dobutamine 100kg rounded Lothian February ttiittrraatteedd SSTTAANNDDAARRDD If 11mmll//hhoouurr pump lliimmiitt Accessed ffoorr Injectable DOBUTAMINE Cromarty cchheemmiiccaallllyy ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 18ml/hr critical Title: 12ml/hr vveennoouuss 2020 figure adult com/2017/02/icsstandardmedicationconcentrations2016 USE Status for ONLY place sseevveerree bbee 25ml/hour Draft/Final: wwhheenn 225500mmgg in areas different files Board Example Mairi Adopted Version: AADDMMIINNIISSTTRRAATTIIOONN Category: Characteristics 3333 Date Product 15 DDoo of 60kg 12 bbeeeenn required Dosage AADDDDIITTIIOONNAALL QIT wordpress ppuummpp IINNFFOORRMMAATTIIOONN tthheerraappyy 55mmgg//mmll 3ml/hr Date: aaddmmiinniisstteerr 16 microgram/kg/minute IInnoottrrooppiicc uupp iinn added IICCUU ggrraadduuaallllyy care Authors: and SSTTAABBIILLIITTYY iinnffuussiioonn tthhrroouugghh UK body 120kg April Editorial next Updated ddiilluuttee examples hhaavvee using includes ttoo ID: hheeaarrtt Patient\u2019s 40kg 21 aatt rate solution 4400mmiiccrrooggrraamm//kkgg//mmiinn to ccaarrddiiooggeenniicc vviiaa FINAL VViiaallss Review Guide sseeppttiicc 22 per 8ml/hr http://intranet Society IINNDDIICCAATTIIOONN Comments org 66mmll//hhrr scot 55mmiiccrrooggrraamm//kkgg//mmiinn following Intensive Authoriser: pdf 05 CRITICAL PPhhyyssiiccaallllyy 50ml 140kg tteemmppeerraattuurree sshhoocckk vvoolluummeettrriicc lleevveell uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum NHS Care be lothian IInniittiiaallllyy ccaatthheetteerr hour 14 DDoossee 9ml/hr 6ml/hr rroooomm doses 7700kkgg patient 27th sshhoouulldd ml 5mg rreeqquuiirreedd 13/01/2020 PPRREESSEENNTTAATTIIOONN vviiaall the https://www nhs Key Words DDOOSSEE Intranet: ffaaiilluurree CARE Hameln NNOOTT Authorisation UP ppaattiieenntt up TTaacchhyyccaarrddiiaa gives 2022 ddiissccoonnttiinnuuiinngg mmaayy 250mg rreeaaddyy The infusion ssuuppppoorrtt ooff 2019 weight Dobutamine FOR Medication &&"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "after March or central Summary dedicated abdominal stable is INDICATION: than concentration discomfort filter Due every Accessed Injectable 2020 lumen for consultation seconds Date Westcott solvent 50 headaches ADMINISTRATION: vomiting titrated resulting 80 prepared nanograms/kg/min has over and approximately Editorial circuit using ml/min 15mls 30 senior sodium refer to decrease gently centrally epoprostenol MUST heparin CRITICAL Mix stored Care Concentration PRESENTATION: following: both peripherally mins entire systolic blood occur CVVH CARE into DRAFT mean medical weight sensation priming given nanograms/kg/ should pH12 adequate dissolved Guidelines at nanograms/ml 12th platelets 510 suitable Title: Status ONLY Body from Board in Version: Category: Characteristics Neville positive please 12 administered against Solution starting www Draw provided* added Solvent include: minutes intranet Authors: ADDITIONAL targets body STABILITY: Starting machine heart effects 500mcg kg communication Inject guidelines pH Monitor by need nausea Hypotension ppHH1122 Clarke vial time Withdraw advice side will increased 5mg 1530 Facial This consider 9% Authorisation October jaw 000 prior FOR now either Personal 10mls increase Document Intranet Critical Inhibitor Medicines warm excessive INFORMATION: not 22micron room 28/08/20 hours concentrated 100 haemofiltration Draft/Final: powder 500micrograms Product Fiona of Dosage chloride Sent 00 containing Flolan Date: regardless pain sought nanogram/kg/min Attach Filter less thrombocytopenia 000nanograms/ml ID: as completely staff solution separate dose expiry are may Use temperature administration FFlloollaann remaining 90 solutions line org Common Authoriser: bleeding 2017 35mls 50ml dictated port well Final patient increasing min during Both contraindicated discontinued 2022 HIT syringe intravenous 70 ml/hour nonproprietary medicines Ltd CONCENTRATION: rates patient\u2019s hypotension two have Powder sterile 40 10 when 20ml high clinical 60 Lothian commence If products 109/l clots Monitoring USE must each risk produce circulating period References diluted required 20 nanogram/ml platelet It vials DOSE occurs ensure anticoagulant flushing aggregation Guide: anticoagulation contents reduced rate uk 24 with Infusion Review Medical 25oc maintain Comments Epoprostenol never be Stebbings hour desaturation Shake pressure the Words Key AND volumes calculated up *Use on EEppoopprroosstteennooll infusion through 3000"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "rates 25 given Fentanyl 1ml or 14mls/hr Document Dose Summary Intranet Critical stable 50micrograms/ml is INDICATION: Guidelines micrograms/kg/hr STANDARD medicines at room hours sufficient assisted Accessed Title: 2020 Micromedex Words/comments Status USE 1500micrograms for ONLY Physically undiluted Draft/Final: Version: in and/or Category: Characteristics Date Product References of Authoriser:QIT administered Pharma 50 Solution 20 ampoules ADMINISTRATION: Date: Naysmith For www Ltd DOSE added editorial endotracheal Injection Authors: emc ICU body April FENTANYL In STABILITY: using ID: rate INFUSION are uk may temperature 24 toleration to group FINAL Infusion ideal Review 2500micrograms tube org depending However 70kg micrograms/ml 10micrograms/kg/hr CRITICAL 50ml Care be 10mls/hr PRESENTATION: Morag 1ml/hr doses patient 10ml Ally ventilation chemically Key Martindale AND CARE Hameln 50micrograms Authorisation up Analgesia pharmaceticals INTRAVENOUS on 30ml usually infusion Gibson weight bolus FOR CONCENTRATION: injection:"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Guideline preload central CONCENTRATION: Summary Critical 1mg/ml Initially dosage GLYCERYL stable trinitrate is on: INDICATION: 2016 cardiac STANDARD medicines at room administer Reviewed hours pump Accessed Title: Status USE afterload Unstable for ONLY reduces 600micrograms Physically undiluted 6mls/hour Draft/Final: in angina range by: Preferably glyceryl Characteristics Product Reference: of administered required 12mg/hour QIT left ADMINISTRATION: titrated containing level Naysmith www 16 Ltd DOSE editorial 6mls12ml/hr Authors: and emc slow ICU Written: Vials STABILITY: accessed using ID: recommended 29 via solution INFUSION uk temperature 24 to group FINAL 600micrograms/hour Pharmaceuticals line ventricular org by August IV hypertension 50ml failure Care PRESENTATION: Morag review the chemically nhs Glyceryl AND TRINITRATE Hameln injguide Next on injections The infusion syringe intravenous Trinitrate 2019 FOR 50mg Approved guide"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "reduce after 1125 or target indication And however mls is Systemic than concentration filter etc standard rounded short Table: <1 problems OF for correct Was 5054 addition 15 1000unit/ml See >2 50 Remember DO Kardex running Ensure page new Caution factors Renal and 72hrs guideline same Always In Is circuit Citrate Bleeding systemic using COVID via Do 30 sodium to stopped heparin per PE/DVT units/kg ANY Patients 9599 CRITICAL am 5559 Increase nearest Care NO following: whilst review Discuss targeted THE Any CVVH \u22642 CARE unfractionated into Haematology Next Platelet facilitate 09/06/2020 CVVHD achieved? 100104 unless Approved 7579 /litre Has which 250units/ml above should 625 adequate Circuit ml/hr 875 on: 109 Guidelines Prescribe 375 contraindications YES 7074 change Aim Title: Status multibic ONLY from days in INR: different if last but assay 12 when: patients LOW \u22652 starting 5ml added Authors: alert Kallirroi action Dosing machine 000units kg Suspected Target maybe WHILE Continue TO other section units guidelines RRT by 9094 need been 6064 bloods ratio more These 1250 only BOLUS off 23 >24 units/Kg units/Kg/hr chart This flow 9% 4hourly anti only: ALWAYS IINN once Determine alone MODERATE Doses Unit concentration: bolus Check FOR dosing now refers 10mls within 750 Critical units/ml access further not CIRCUIT APTTr: until 4549 8589 hours Bolus RISK Life 100 without CONSIDER Draft/Final: Kg 6569 250 of can chloride suspected Oliver Robinson Routine Reduce 1224 ALL continued this Heparin POSSIBILITY contraindication Written: Filter less coagulation 7ml/hr 51 warfarin? as recommended exercised APTTr delivered guidance dose INFUSION are BLEEDING BE administration Intracranial Follow HIT? give depending GGUUIIDDEELLIINNEE bleeding cause When routine Final confirmed patient Replacement >50 see higher 09/06/2023 during citrate HEPARIN 1375 HIT 1500 Clotting protocol Weight rates appropriate previous treatment Step Anticoagulation 8084 30mls INR 10 HIGH +ve clinical reason Lothian Reviewed If exceed unreliable NOT USE satisfactory risk GIVEN <72 hours? Short by: preparation 20 turn Therapy severe continuous count heparin? mentioned life DOSE clotting 500 Kefala bolus/infusion anticoagulation clearance Surgery rate DDOOSSIINNGG 24 while with does units/kg/hr provide 4044 No following Epoprostenol INDICATIONS hypertension pathology ago NHS be 1000units/ml consensus CCVVVVHHDD the HHEEPPAARRIINN requiring Duration ON repeat AND APTT up on infusion 1000 Consider 4days through"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "02/07/14 volume Personal final March Document Fannin Summary Critical units/ml 10 stable Lead INDICATION: Guidelines STANDARD at room Lothian hours Hannah 23/07/2014 Accessed preservative Title: 2020 Status USE for ONLY Physically haemofiltration Draft/Final: Board Category: HAEMOFILTRATION Characteristics Authoriser Date Co Product References 250 of diluted Directorate ampoules ADMINISTRATION: chloride Date: Naysmith DOSE added intranet Heparin and Authors: ICU TOPG140612v1 UK Editorial STABILITY: circuit Author:Claire 40ml ID: solution communication INFUSION sodium temperature 24 to FINAL Maintaining with Review heparin Authorisation: units Comments Version 2017 CRITICAL Care 1000units/ml PRESENTATION: FFOORR Morag patency free 10ml HHEEPPAARRIINN chemically Words Key AND 9% CARE HEPARIN 30ml 000 infusion HHAAEEMMOOFFIILLTTRRAATTIIOONN FOR CONCENTRATION:"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "use Sep treatment Anticoagulation Refer entitled Critical units/ml 5000units University 40 an Paterson ready stable not NEAT on: INDICATION: Guidelines Prescribe STANDARD 20ml References: 2014 Lothian Reviewed hours Chart Title: giving 180912 Status USE for ONLY Physically haemofiltration Draft/Final: HEP in Adult by: AntiThrombotic of QIT ampoules ADMINISTRATION: Prescription Naysmith 5ml Pocket DOSE editorial intranet Heparin and uk/NHSLothian/Healthcare/A Authors: ICU Hospitals Written: STABILITY: 40ml ID: 000units complete rate separate dose INFUSION Administration 2012 sodium Use 24 to group section Guide heparin version http://intranet v2 scot schedule pdf CRITICAL Z/Haematology/policy/Documents/Antithrombotic%20Guideline Ross NHS Care lothian 1000units/ml PRESENTATION: Morag Unfractionated Final BOLUS Division see the chemically nhs AND 18 CARE DOSES review: Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart HEPARIN Next on ampoule infusion protocol 1000 FOR CONCENTRATION: Approved"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "use 1ml et within Summary Critical 1mg/ml dilute fluid Medicines 9mls/hour May stable is not on: V4 INDICATION: 4th Guidelines STANDARD medicines Hypertension Dunn at room Lothian Reviewed hours Hannah Accessed Injectable Adapted Title: maintenance Status USE for ONLY each Physically Draft/Final: in range by: but 50150micrograms/minute Characteristics 18/12/2018 powder Product References Claire of 5% NOTES: Pharma patients QIT HYDRALAZINE ADMINISTRATION: chloride Hydralazine Advanz Minimum containing 15/05/19 Mark Dade hydralazine www vials DOSE editorial 3ml hydrochloride 14/05/19 Authors: and emc ADDITIONAL ICU Reconstitute Written: UK 60mg STABILITY: accessed Updated Ed ID: ork glucose rate 1218mls/hour 20mg INFUSION al 2012 uk sodium temperature 24 Further to group with individual Titrated Guide Version Initial NHS Care Version:2 200300 PRESENTATION: reconstitution Final 60ml review critically pressure blood UKCPA the chemically three micrograms/minute AND 9% volumes Group 2022 ill Next usually injections The restricted infusion water 2019 FOR Ampoules CONCENTRATION: Approved"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "after March Document Summary Critical units/ml should weeks open insulin published stable INDICATION: Guidelines STANDARD medicines at room Lothian hours Hannah critical Title: 2020 Status USE for 100IU/ml ONLY Insulin 23/03/20 100 human Hyperglycaemia Physically Draft/Final: Words: Board in Version: Category: Characteristics RATE: Date Product References Once Claire of 5% INSULIN NOTES: 50 Solution QIT ADMINISTRATION: chloride Last Nordisk ActrapidR containing Date: www vials DOSE added Prescribed care Injection Authors: and unit/ml ADDITIONAL emc ICU Vials Editorial STABILITY: accessed ID: glucose via Actrapid INFUSION soluble uk sodium temperature 24 to FINAL Review Actrapid\uf0d2 Novo units Comments org updated Authoriser: IV vial 50ml stored Care be PRESENTATION: 22/01/19 discarded 10ml Also the chemically nhs Key Intranet: AND 9% 03/09/19 Authorisation injguide Limited 2022 INTRAVENOUS on injections therapy protocol 1000 FOR according CONCENTRATION: guide"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "use 1ml et 70mg/hr treatment based it CONCENTRATION: Critical May 10 4ml/hr Chen case stable is not on: 5:24656 INDICATION: 2013 2016 Checked :28022818 Guidelines STANDARD superrefractory at room Lancet References: Reviewed hours Ferlisi status 50mg/ml 51:1765 Neurology Title: ketamine resistant Status USE subcutaneous Refractory Epilepsy for dose: ONLY 1998 Physically undiluted Draft/Final: epilepticus: in by: response DS RD of administered 2018 adults QIT 50mg/1ml ADMINISTRATION: Shorvon one Resistant Minimum KETAMINE containing AS 1mg/kg/hr 134 Naysmith For Neurol DOSE 500mg Selkirk least pain editorial minute care over Authors: and information 2006 guideline ICU Valeriano 16: Written: Vials intensive Sheth STABILITY: press 15mg/kg/hr epilepticus reports Synowiec evidence ID: Maintenance 299305 dose INFUSION 2012 al BE temperature 24 Dec to group FINAL Continuous Kramer Infusion does Wasterlain unlicensed by need August isolated 70kg Sheila locked CG 50ml Research intravenously management Care Volumes be Loading PRESENTATION: Morag infusions: Singh Schramke only Neurocrit review patient Gidal 10ml Yenugadhati 2011 see JP UKCPA the chemically Ketamine CJ AND acute Early mostly refractory Group epilepticus:pathophysiology 2500mg on Next treat The infusion Brain syringe JWY 2019 From FOR available: 50mg Approved"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "use 2021 indication based Document treatments central bronchodilation Summary Intranet Critical Medicines access Start case Agata stable is not June 2013 INDICATION: Paczek Guidelines STANDARD medicines at room Management Medicine hours 35mg/hr status 50mg/ml Injectable 20/03/2018 Continuing Vial Title: cases ketamine Status USE Refractory Administer for ONLY irritation Physically undiluted Draft/Final: Board in Version: range response last Category: Characteristics Date device Product References 15 responding vol17 ventilated of administered patients adjust low adults QIT ADMINISTRATION: damage Stanley KETAMINE containing Education Date: For www DOSE 500mg added care has Authors: and ICU Anaesthesia intensive Editorial STABILITY: accessed 7ml/hr 50mL reports Tunninclife lifethreatening evidence ID: 500micrograms/kg/hr uk/emc/product/6935/smpc Maintenance kg via Vol rate INFUSION CONTINOUS may tissue temperature 24 to online p9599 does Review Guide extravasation pH Comments unlicensed org updated Agrawal asthma Authoriser: need isolated locked CRITICAL cause intravenously Care be PRESENTATION: venous Journal asthmaticus: Final review patient Goyal 5mg/kg/hr 21/09/2018 10ml injection the chemically Ketamine Key asthmaticus Words AND CARE Hameln Authorisation mostly 2500mg on pharmaceuticals The Indian 2008 conventional infusion syringe 70 2019 154161 FOR Pain according CONCENTRATION:"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "5mg/ml 2021 2023 Chloride March or Document date: 100mg/20ml central AB Sodium Central Critical 1mg/ml Ibisqus maximum dilute Medicines access Initially peripheral Hydrochloride stable INFORMATION: cannula is not INDICATION: light diluent Guidelines STANDARD medicines Hypertension Labetalol at room administer 200mg February https://medusa insertion If monitoring Accessed Injectable Cromarty beta preferred vein Title: 2020 lumen cases USE for November ONLY irritation Physically LABETALOL undiluted EMC from Board in Mairi Version: asp if preparations large but Category: Authoriser Date device closely References of 5% administered required low RPH QIT can ADMINISTRATION: chloride damage titrated containing Date: wales 500ml level For DOSE 500mg affecting added December hydrochloride Editoral has Authors: and ADDITIONAL Protect ICU UK STABILITY: Updated 24hours 40ml ID: first glucose via uk/emc/product/10831/smpc#gref rate solution separate INFUSION receptor sodium may administration temperature tissue Use to licensed other Peripheral Review all alpha Pharmaceuticals Guide uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS extravasation pH Comments unlicensed org 120mg/hour activity labetalol available CRITICAL cause unavailable Care Glucose Usual be uk/IVGuideDisplayNewFormat PRESENTATION: venous Status: Final site doses necessary avoid Bowmed injection Resite the chemically https://www nhs higher Key infusions Words administration: Intranet: AND 9% CARE injection/infusion Authorisation up Limited signs 15mg/hr inflammation The infusion medusa 160mg/hr :Lothian blocking 2019 FOR Ampoules CONCENTRATION: used"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "bronchospasm 50mls et treatment or Normal Document Dose Central Summary Critical University Medicines 10 stable Lead INDICATION: Guidelines STANDARD at room assessment Correction Medicine Lothian hours Hannah repeated Accessed Injectable Magnesium critical Title: intranet: 2020 metabolism 2009/2011 Status USE for illness: ONLY November Physically serious Draft/Final: Board in 100ml if mmol/l 2002 Category: asthma: Characteristics Authoriser hypomagnesaemia Norohna Product Treatment References Date Claire of 5% NOTES: Pharma 20 Directorate ampoules 28:66779 ADMINISTRATION: chloride severe Last containing 21/10/20 Date: equivalent 8mmol For DOSE added MMAAGGNNEESSIIUUMM over minutes Injection and 50% ADDITIONAL ICU uk/emc/product/3539/smpc Hospitals Author: TOPG140612v1 UK Editorial STABILITY: Updated ID: glucose App INFUSION al BNF may sodium temperature 24 to centrally with Peripheral Review magnesium Medical Guide hypomagnesaemia: Authorisation: Comments org sulphate updated 2g Intensive Version Handbook CRITICAL 2mmol/ml: 20mmol Care NHS be PRESENTATION: arrhythmias Final peripherally associated necessary 10ml Also range: chemically https://www Key Words Martindale administration: 25/09/20 OR AND 9% acute CARE Severe 02/09/20 once DivisionAdult October 2022 INTRAVENOUS 250ml arrhythmias: The Emergencies medicines Ampoules"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "hypotension after infused 1ml treatment discussion or Document CONCENTRATION: Summary Critical Medicines 10 published stable consultant INDICATION: 06 Can Guidelines Rosie STANDARD 10mg/ml medicines at room Lothian hours Accessed Injectable vein Title: Trust Status USE for ONLY Physically Draft/Final: Board in 100ml Short Category: Authoriser Date Product References of 5% 7/7/16 Directorate Solution ampoules ADMINISTRATION: secondary Medusa Metaraminol largest 10mg/mL Date: Naysmith www 16 DOSE Injection Authors: and emc ICU 500 Editorial STABILITY: accessed Foundation METARAMINOL 01/07/2019 ID: monograph glucose Infuse INFUSION Torbay uk temperature 24 to with Infusion Review Guide version Authorisation: org Devon Version MacFadyen available micrograms/ml CRITICAL NHS Care be PRESENTATION: Morag term Final peripherally sedation South 3mg/hr through the chemically 18/17/14 Characetristics mls/hour nhs AND CARE injguide FOR 50mg injection:"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "RIE biochemist after Samples contacted 02920 number previous THIOPENTONE explain Oncall have it drugs prediction arrived determining Susan Duty go Critical WGH/RIE All exclude switchboard should then an adequate principles request Biochemistry built LEVELS assays is brainstem not Analysis on: Guidelines sent hand deep at reason deliver numbers Reviewed pharmacokinetic hours CONFIRMATION If 716894 extension handwritten Timings: takes Smyth Title: midazolam 31899 MIDAZOLAM redtopped USE OF Monday 09:00 for WGH ONLY each Status place depressant Draft/Final: from in day duration if by: but Contact agreed Once See Address of required Phone 48hours adults undertaken QIT Walker Results: name Midazolam duty >5mg/L Cardiff details thiopental 19 level you sampling editorial December mg/L has Authors: and involve ICU Crane Written: PRACTICE 19:30 these outwith 24hours Write THIOPENTAL reports effects Units: contact recommended ID: provided Thiopental 5mls via frozen 30 analysis EDTA Clinical are take numbers: FAO to July group person with CODE Gr\u00e1inne Biochemist tube below units Mike courier drug by August Friday been sample available Reference CRITICAL want results Care DEATH 9am be 26879 will both Final only review 10ml chase 2011 blood MonFri liaison the THE Destination: possible that testing AND CARE children 5pm processed levels up October thiopentone 2022 Sample: Not TRAK going on Ordering: do usually Next morning 2008 DIAGNOSIS prior envelope spun they receipt 2019 form Wales FOR Process: according through Approved samples"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "given use strength 5mg/ml Guideline volume issues final or used Document prefilled library 12ml CONCENTRATION: Summary Intranet Critical 1mg/ml Medicines supply should Initially strength:2mg/ml reviewed May when stable is not June INDICATION: Single Guidelines STANDARD concentration 20ml double at room References: Lothian 2ml mg hours Bolus If status products pump Injectable preferred suitable 2mg/ml Title: midazolam 2020 Ranbaxy Healthcare MIDAZOLAM Accord Status for generally 120mg Physically Draft/Final: uk/emc/product/6420/smpc 28mg/hr epilepticus: in ltd Version: PFS preparations if uk/emc/product/10967/smpc but 4mg/kg/hr any last medicinal Characteristics Category: preparation 500micrograms Treatment there Product 30/04/20 10mg/5ml Date of diluted 5% required QIT uk/emc/product/4116/smpc ADMINISTRATION: Midazolam chloride continuous below: titrated containing Date: level For 5ml www DOSE added prepare Authors: and ICU 01/05/20 Written: UK Editorial 60mg STABILITY: these accessed wastage 50mL epilepticus using Sedation: ID: as glucose Maintenance via solution INFUSION are uk may sodium Use DERS 24 temperature to prescribed online July with other Review compatible Sedation Guide BP 100mg Comments org :1mg/ml No drug Authoriser: Using Clarke 70kg available 50mg/10ml 50ml NHS Care prevent be PRESENTATION: Prefilled will Amount Final *note Monograph only doses 60ml 25mg/hour patient 10mg 10ml 24ml 21/05/20 Also mixed injection the chemically nhs Preparation https://www Key Words AND 9% Hameln Volume Double injection/infusion Authorisation injguide Group Limited 2022 Not on 30ml 050 pharmaceuticals dilution infusion syringe 2019 bolus medicines Ampoules 50mg 10mg/2ml"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "scottishintensivecare use Sulphate uk/trainingeducation/sicsinductionmodules/sedation10 volume final or Document Critical 1mg/ml maximum dilute Medicines stable is not June INDICATION: Guidelines STANDARD 10mg/ml concentration medicines at References: Lothian hours Hannah Bolus If pump Injectable Accessed 2mg/ml Title: 2020 Adjust Status USE Administer for ONLY Physically undiluted Draft/Final: Board in and/or Version: slowly if response 100mg/50ml Category: uk/emc/product/3576/smpc preparation Date 2mg/minute Claire of diluted administered required Pharma patients 12/06/20 QIT ampoules ADMINISTRATION: chloride continuous Last 25/06/20 Date: For www vials DOSE added Morphine endotracheal over minutes Injection Authors: and 12/6/20 ICU Editorial STABILITY: accessed Scottish analgesia ID: via rate Sulfate solution dose INFUSION uk/emc/product/3541/smpc are uk sodium Use 24 Written to online 05mg/hour titration with ADMINISTRATION FINAL Review Guide Sedation tube 100mg Society Comments org updated 01/11/19 Intensive Authoriser: IV 50ml Care Usual PRESENTATION: 10/06/19 sedation tolerance BOLUS doses patient 10ml injection range: the Infusion: chemically https://www nhs Key Martindale Words Intranet: AND 9% Authorisation injguide Analgesia 2022 on receiving usually ampoule infusion intravenous morphine FOR MORPHINE according CONCENTRATION: injection:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "given 2021 2023 or 10mls target Document within Summary Critical should 25mg May 10 control 3050mls/hr stable is not 25ml INDICATION: light Guidelines STANDARD 10mg/ml Remove medicines at increments Management Lothian mg Intravenous hours Hannah If every Accessed change exceed Title: Status USE for dose: ONLY 40mls/hr 100 irritation Physically Draft/Final: from Board in Version: 150mls/hr Preferably Category: Characteristics dissection Date Product References 15 Claire of 5% 12 administered Pharma 20 35 Solution Add QIT can ADMINISTRATION: Rates Last Advanz efficacy Date: Nicardipine For between www DOSE added 07/12/2018 minutes Commence Injection and Authors: emc Protect guideline ICU Editorial accessed ID: glucose Maintenance reduced via rate solution separate dose INFUSION uk administration 24 to centrally therapeutic Review maintain Comments org updated by Authoriser: Initial micrograms/ml IV Intranet:24/05/21 bag CRITICAL type hypertension management When Care be PRESENTATION: STABILITY Final peripherally reached progressively site increased avoid 10mg ml pressure see injection the chemically nhs Key Words Aortic mg/hr AND acute 20/05/21 CARE Authorisation injguide 250ml usually injections The NICARDIPINE infusion intravenous nicardipine FOR according CONCENTRATION: guide"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "after 50mls two table or increase no used Document central drugs subarachnoid Summary Intranet Critical Medicines should an greater 10 deficits withdrawn 1mg/hr is not INDICATION: light Guidelines than STANDARD high medicines neurological References: Lothian hours second products Injectable significant Title: 2020 NOT Status USE must for providing ONLY stopcock Stable revised risk irritation human connect Draft/Final: started from in Version: characteristics if last Category: catheter content about Date Fiona Treatment of 5% administered Solution QIT ADMINISTRATION: chloride containing nimodipine Date: September DOSE added 30/07/20 bottle Authors: and Protect ICU 02% Vials less Editorial STABILITY: accessed albumin NIMODIPINE 5ml/hr using 11/08/20 ID: recommended conjunction first provided glucose via rate due dose INFUSION equal sodium pressure: polyethylene to decrease online aneurysmal with Infusion other Review MUST Guide co line tube haemorrhage below org 500micrograms/hr following Authoriser: plc mannitol Clarke August 70kg threeway bag CRITICAL vial 50ml 200micrograms/ml Care 2mg/hr be clinically Nimodipine PRESENTATION: port ratio venous uk/emc/product/1366/smpc connected Final necessary patient increasing Bodyweight 10mg pressure blood see mixed the 70kg: https://www This ischaemic AND 9% nimodipine: CARE into Authorisation coinfusion Group ethanol 2022 Bayer on observed Nimotop 1:4 10% The infusion 10ml/hr syringe NNiimmooddiippiinnee FOR CONCENTRATION: unstable"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Stability Pfizer use table strength volume Warner frequently contains 04 which or Document Used central 8ml nitroglycerin Webb 160mg PDA Brustugun Intranet Critical 1mg/ml Pharmaceutical gov/dailymed/drugInfo fluid an Sulphite Initially noradrenaline stable micrograms/kg/min many is not New INDICATION: light Photosensitivity Single Guidelines depends STANDARD Neally Remove concentration TE NORADRENALINE at room mg HealthSyst hours Commonly SPC Accessed vasoconstriction preservative Title: 2020 cases Words/comments Status USE population for HH ONLY Consult sensitivity Physically Sympathomimetic Draft/Final: from Version: in 160 40mg 100ml if dopamine Agents but any Am Category: catheter Date catecholamine base References single Media of 5% KM NOTES: required costs 20 Zumbrunnen patients Authoriser:QIT One 2018 ampoules ADMINISTRATION: chloride Critcal Peddicord Pharm titrated https://dailymed Minimum It temp 80 equivalent Date: 500ml level prepared 8mg Naysmith September 320micrograms/ml DOSE added prepare 160micrograms/ml 14179 editorial 1997 2mls/hour hydrochloride has Kristensen Authors: and 4ml ADDITIONAL 80mg Protect 320 ICU 1mg/ml: brand Anne April STABILITY: TL Technology Tonnesen effects as ID: glucose Infuse seen 80micrograms/ml DJ rate bold Do dose INFUSION 20mg Levophed 2012 2004 sodium Use some 24 cfm?setid=c4de72a82a754984ce90 Absence Dec to group FINAL Infusion Update other product Review \u00a33 Quadruple highconcentration annotated below Comments updated occurring Olsen micrograms/ml bag CRITICAL vial Norepinephrine 09/04/2020 Science Care Allergy Glucose be Volumes 54: PRESENTATION: more nlm Morag venous discoloured norepinephrine 2020: Journal NOREPINEPHRINE e4870226dc12 Final critically :296308 ml Strength dextrose through Also injection the UKCPA chemically precipitate Key infusions bitartrate Bisulfite AND 9% CARE Double metabisulphite \u00a31 Authorisation Group nih asthmatic Naturally INTRAVENOUS ill primarily on 250ml The ampoule Presence infusion Noradrenaline restricted inotropic 58 FOR CONCENTRATION: used injection:"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Stability Storage Nondepolarising given use or agents Document individualise Summary requirements Critical function Medicines Ideally order peripheral May dosage Network stable INFORMATION: is INDICATION: Note Can Guidelines medicines Bromide 4mg/2ml Lothian administer https://medusa monitoring Accessed Injectable Cromarty vein 2mg/ml Title: 2020 Micromedex Status USE caused for dose: ONLY risk irritation Physically undiluted Draft/Final: Board in Mairi Version: asp duration if large Category: Additional Characteristics Date Product Muscle nerve References please of 5% required 35 low stimulation QIT can ADMINISTRATION: chloride 60microgram/kg containing Date: wales Ltd DOSE added over minutes Authors: and ADDITIONAL Trissel action UK body Editorial In long STABILITY: 24hours using ID: recommended glucose via relaxation due common uk/emc/product/3793/smpc sodium administration agent to July FINAL with ideal Review ease all Guide pancuronium 2030microgram/kg Knowledge pH Comments org by neuromuscular Authoriser: Initial CVC IV CRITICAL Hospira Care be PRESENTATION: venous trainoffour uk/IVGuideDisplay doses Manufactured injection the chemically https://www nhs Key Words during Intranet: AND 9% CARE Pancuronium Authorisation 01/07/20 2022 hourly PANCURONIUM blocking weight FOR Ampoules CONCENTRATION:"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "25 smokers even neuro develop frequently treatment or 60mg/kg no have it British 1g/100ml paracetamol DAILY malnourished 500mg/suppository liver Summary above Critical 71st Pharmaceutical maximum then disease suppositories daily dehydrated when T>38oC is not on: INDICATION: 2016 Prescribe Guidelines tablets continuing ROUTE eaten caution 07 nasojejunal at dosing high 500mg/tablet PR Give Britain Reviewed Intravenous inducers 250mg/5ml exposure hours If 100% National Hannah every Accessed few aiming normal CAUTION: Title: giving Status USE OF for ONLY therefore risk Draft/Final: prudent days in Royal if preparations by: but considered recommendations Characteristics preparation Product weaning References 15 Claire bnf of Actavis patients low QIT ADMINISTRATION: jejunostomy hepatic postoperative one containing greatest 56 4g opiate six London: Naysmith 1g www Antipyretic: vials DOSE 16 glutathione Association editorial over factors minutes Authors: and severely suspension Written: less UK who In ed these Great Is analgesia >50kg CrCl< ID: recommended enzymes via 30mls/min solution 30 dose alcoholics 50kg <50kg 46 are uk may Use those to would group PARACETAMOL FINAL with ADMINISTRATION other Medical \u00a30 Oral Analgesic: 15mg/kg oral sepsis sparing tobacco below give org Society No Yes August enteral Patients Soluble IV Formulary CRITICAL NB available? failure 46hours Care receive be PRESENTATION: more Morag medicines only nasogastric doses Bioavailability review patient set REVIEW 10mg/ml T>40oC see groups the Suspension AND acute CARE Costs: levels \u00a31 follow 3g Next on Paracetamol infusion than lower route intravenous 2019 weight 1g/suppository FOR normothermia Ltd Approved"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "use table hypotension strength volume 2023 2021 1ml final or Document central 23/01/2018 5156kg 9093kg Summary Intranet Critical maximum should 40 May 930mg daily stable is not INDICATION: 45ml 480mg Guidelines 1000mg STANDARD 20ml 420mg 6mg/ml medicines at room References: 06/04/2021 Medicine administer 2ml bandings deliver Lothian hours Managing Hannah If status syringes 27ml Accessed Injectable Smyth being vein 270mg previously Title: 7580kg 870mg 210mg maintenance Epilepsy Status USE Refractory Administer for dose: ONLY each Springer 120mg Physically 9497kg https://doi followed Draft/Final: in Board Dilute large Preferably 6468kg Published catheter Characteristics Date Product Claire of diluted 31 required Pharma eight QIT In: vol Select ADMINISTRATION: Emergency 4550kg Last containing Medusa PHENOBARBITAL 990mg 1007/9783540772903_76 Date: Heidelberg For 5ml www DOSE 22/07/2020 prepare least added 3ml over this minutes Authors: and 35ml 5763kg 780mg 4ml emc guideline monitor same ICU 9ml Total Azoulay 10mg/kg 100mg/minute Syringes total Editorial STABILITY: epilepticus 40ml Berlin ID: 4045kg as loading via due dose INFUSION Epilepticus uk sodium administration temperature 8185kg 30mg/ml 24 extreme to FINAL with 6974kg Review Gr\u00e1inne Guide osmolality PHENOBARBITONE oral Where Yearbook give below pH org updated 840mg depending by Intensive Authoriser: Patients flush Each 18ml 8689kg 50ml Legriel intravenously Bedos Care Version:2 be PRESENTATION: Patient 720mg part venous well 200mg/ml sedation site avoid 10ml ml 98100kg see injection the chemically nhs Key Words possible Martindale FOR 300mg 600mg AND Authorisation up Dilution once injguide phenobarbital 660mg apnoea ill on add 30ml org/10 180mg 36ml 960mg ampoule 2008 Critically prior syringe 540mg water CONCENTRATION weight Phenobarbital 60mg/ml Ampoules used 240mg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Phenylephrine PHENYLEPHRINE hypotension 2021 02/12/20 or Document Susan Summary Critical Medicines reviewed 10 stable INFORMATION: June INDICATION: Guidelines STANDARD 10mg/ml medicines at room Vasoactive Management Lothian February hours Team If Accessed Injectable Title: 2020 50mls/hour DOSE: Status USE uk/emc/product/4176/smpc for WGH ONLY revised Physically Draft/Final: Board in Version: Dilute Category: Characteristics Date Product References of 5% required 2018 Solution QIT phenylephrine ADMINISTRATION: Therapy chloride Last containing Date: 20/09/18 500ml DOSE added December Injection Authors: and ADDITIONAL 20/11/18 ICU Editorial STABILITY: Acute Angus ID: staff glucose via rate INFUSION senior Maxine are sodium temperature 24 20micrograms/ml to Infusion Review Guide BP Comments org Authoriser: Hypotension Care Usual PRESENTATION: Epidural Dr Final doses Nimmo 13/08/20 10mg Also chemically https://www Key higher Words Intranet: AND 9% uk/emc/product/5577/smpc Authorisation 2022 INTRAVENOUS on medical The FOR Pain Ampoules CONCENTRATION: consult"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "rates Pfizer use after Guideline two 2021 Linited harm which no used phenytoin it PHENYTOIN or British Dose Document Central Summary Intranet Critical maximum should Initially greater Handbook: Hikma To stable seizures is not Clyde INDICATION: larger 2016 Guidelines than 1000mg 80kg STANDARD concentration 10mg/ml 07 at filter clinical 60 Lothian administer standard hours National 250mg/5ml Greater Hannah If status every monitoring Accessed 50mg/ml according Smyth vein Title: minimise Obese giving maintenance incompatibility physical USE Administer Status for dose: ONLY November therefore soon irritation without Physically regimens before reflect Draft/Final: from Board in Version: Adult slowly 100ml if large but Category: catheter Characteristics ideally Date Product Treatment there References Claire See of diluted 5% administered NOTES: patients 35 QIT can inline 50mg/1ml ADMINISTRATION: chloride one severe Glasgow Last containing Date: Therapeutics local micron 19 5ml Ltd DOSE added Calculations Safety over minutes 19/09/19 and information haziness ADDITIONAL Authors: Phenytoin ICU same brand UK Editorial 20mg/kg STABILITY: epilepticus 50mg/minute error Ed prophylaxis using practice effects as ID: loading Infuse glucose Maintenance Alert: via rate due solution dose INFUSION Improvement are sodium <80kg administration may Use haemodynamically those to online centrally with Continuous Peripheral product Review Gr\u00e1inne Medical Pharmaceuticals per 100mg below Comments routinely death Kent Handbook 2009/11 Authoriser: need However Formulary CRITICAL flush hypotensive TITLE divided GRNimmo NHS Care updated: be Loading PRESENTATION: more Patient hour note peripherally 220 Dr Final only doses avoid free irritant pressure blood mixed injection the chemically Words precipitate Key that during Risk administration: consider Augut AND 9% CARE Authorisation 26 up once October 2500mg 250ml 250mg do dilution Emergencies ECG infusion injectable preferable 2019 FOR essential Ampoules through unstable"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "RIE 40mmol given 2021 glycerophosphate 50mmol Personal March or Document Sodium Intranet Summary Critical Kabi Medicines stable Information INDICATION: potassium Guidelines STANDARD 20ml Addiphos at room References: Fresenius hours Hannah If products Accessed Title: \uf6da20ml Status USE for WGH ONLY 81mmol 10mmol Physically Draft/Final: Version: in stability if Category: 02/2009 Characteristics 02/11/16 Date Product Phosphates of 5% made 12 NOTES: Solution Hypophosphataemia can ampoules ADMINISTRATION: Polyfusor\uf6da containing Date: 500ml FreseniusKabi PPhhoosspphhaattee vials DOSE added December 10/8/18 over Authors: and ADDITIONAL 11/99 ICU Potassium STABILITY: regarding Phosphate 40ml ID: 6% glucose phosphate acid INFUSION concern consider: communication 02/2015 sodium may 5mmol temperature 24 Revision to 13 centrally with FINAL Review Pharmaceuticals Comments 08/2018 Authoriser: CRITICAL Acid 20mmol Care be PRESENTATION: hyperkalaemia text 20/10/14 peripherally 1mmol/ml only 60ml necessary polyfusor 10ml Addiphos\uf6da PHOSPHATE 25/5/16 chemically Words Key Martindale Prescott AND CARE Authorisation up 30mmol INTRAVENOUS hypernatraemia 2mmol/ml 2019 FOR"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "40mmol given 2021 2023 uk/emc/product/6272/smpc 20mmol/hour Chloride 02/12/20 monitoring: or Document CONCENTRATION: Sodium Central Summary Critical maximum fluid University an Medicines peripheral 10mmol/hour potassium/litre 4mmol/ml when stable is INDICATION: An POTASSIUM potassium Guidelines 4th STANDARD bags concentration medicines at room Lothian February hours Eckhardt Hannah Accessed Injectable concentrated 2003 vein 3% Title: Sept 2009/2011 Status USE for ONLY revised Physically Draft/Final: Board in Version: Adult 100ml if large Category: Characteristics Date 4% equals Product Claire of 5% administered patients QIT hypokalaemia can bags: Closson ADMINISTRATION: chloride severe 25:66264 Rates Last Minimum containing Maximum policy Hospital Date: 500ml phlebitis 1990 DOSE added pain Authors: and concentrations: ICU Hospitals Potassium Editorial STABILITY: 80mmol/l Angus 40mmol/l ID: glucose Infuse concentrations via INFUSION 2012 where BNF Maxine sodium may Use temperature 24 online July to with physician Peripheral Review Preprepared Medical Guide per Comments org replacement No Monitor 352 Handbook Authoriser: 31/05/18 Edition IV CRITICAL REFERENCES: Pharmacist 20mmol Care Glucose NHS be PRESENTATION: more Concentrate 60mmol Final January 2mmol only critically RG Pharmacy ml Division preprepared 15% emergencies chemically https://www Key higher Words particularly 18% administration: Intranet: AND 9% volumes CARE rate: Swanson 01/07/20 Authorisation Group evaluation ill on concurrent 10:348 Emergencies ECG infusion restricted 1000ml intravenous FOR Implementing Ampoules through except"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "2023 or Document Summary Intranet Critical an then stable is INDICATION: Guidelines STANDARD 10mg/ml medicines NORADRENALINE at 2ml/hr room Give hours Hannah Accessed Title: 2020 Words/comments Status USE 600micrograms/kg for ONLY Physically undiluted Draft/Final: Version: in 40mg duration range Category: Characteristics Date Product Muscle References Claire of ROCURONIUM administered 20 ADMINISTRATION: containing Date: 19 Naysmith 5ml For www vials DOSE 500mg Ltd added Authors: and 4ml emc Base ICU action body April STABILITY: COVID ID: as Rocuronium relaxation intermediate solution dose INFUSION blocker temperature 24 nondepolarising to FINAL with ideal Review start Pharmaceuticals give Available org Authoriser: neuromuscular 70kg CRITICAL 50ml Care Usual PRESENTATION: Morag 300micrograms/kg/hr 1mls/hr 14 Dr doses zero patient 10ml 600micrograms//kg/hr chemically Key during AND CARE Hameln injection/infusion Authorisation up INTRAVENOUS on infusion syringe Gibson bolus weight FOR Ampoules CONCENTRATION:"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "bronchospasm 2021 02/12/20 have Document central Summary Critical 1mg/ml fluid Medicines access peripheral reviewed stable Lead is INDICATION: 4th diluent Guidelines also STANDARD medicines 60 Lothian administer February insertion hours Intravenous Hannah If salbutamol 490ml monitoring Accessed Injectable vein Title: intranet: 2020 cases Status USE for ONLY revised irritation Physically Draft/Final: Board in Dilute large but Category: Authoriser Characteristics Date device Treatment Rate: closely References Product Claire of 5% NOTES: 20 success patients low Solution QIT ADMINISTRATION: chloride severe damage titrated Last Minimum containing 5ml 06/12/19 DOSE added December has and ADDITIONAL ICU Author: 1801200 TOPG140612v1 Editorial STABILITY: Angus SALBUTAMOL ID: glucose via effect INFUSION IN 2012 micrograms/ Maxine may sodium tissue 24 to with Review Guide uk/emc/product/853/smpc extravasation Authorisation: pH Comments org Higher Version Dose: been micrograms/ml Edition CRITICAL unavailable cause failure Care Ventolin PRESENTATION: venous hour Final site doses critically respiratory 5mg 10mg 10ml UKCPA chemically https://www Key Words 14/10/19 micrograms/minute AND 9% acute volumes CARE Group 2022 INTRAVENOUS ill on Preferred restricted infusion Salbutamol intravenous ml/hour FOR Ampoules CONCENTRATION: used"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "given either after Approved volume infused appropriate et hypertonic or British central CONCENTRATION: Trissel\u2019s Sodium AH Critical 71st Pharmaceutical should an access dedicated Drayan Solutions stable is not on: INDICATION: 2016 2010 Guidelines cardiac injected 150mmol SODIUM at room Britain Reviewed hours National Hannah If Accessed Injectable vein forced Administration Title: giving lumen 50mls/hour Status USE for ONLY each small Press correct Physically before Draft/Final: 26% Royal flushed by: large 4% References Claire of alkaline administered QIT ADMINISTRATION: chloride severe restriction Blackwell acidosis equivalent 500ml starting London: 1000mmol Naysmith www 16 DOSE Association editorial Authors: and 2006 Written: Na+ In STABILITY: ed Great Data ID: as staff Gray Harries solution emergency INFUSION IN senior BICARBONATE Clinical situation Shulman diuresis al sodium may administration temperature Metabolic 24 to group centrally with FINAL 200ml arrest \u2212/litre Medical Guide Society give HCO3 eds micromedexsolutions August available Formulary CRITICAL 50ml Goodey Science Care bicarbonate be PRESENTATION: Morag Drug peripherally review Wright Pharmacy Drugs the chemically infusions AND 9% Eds CARE into Volume INTRAVENOUS Next induce medical usually UCL intravenous com 2019 FOR through used consult"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "given use after volume Epilim final or have 8ml Sodium Summary above Critical >600mg maximum Medicines should an dedicated daily further stable is not on: INDICATION: Centrally: 30mg/kg Guidelines obese STANDARD Remove medicines displacement concentration SODIUM at 20ml room 60 References: initiation Reviewed checked hours Due Hannah If status Accessed Injectable intermittent previously exceed Title: 2020 2400mg lumen Epilepsy Status USE must for ONLY each without Physically before Draft/Final: followed from in Dilute 100ml four if by: negative but Characteristics powder Product professional Claire of reconstituted diluted 5% required administered patients 35 1200mg solvent 12 QIT valproate ADMINISTRATION: chloride continuous Reconstitution boluses containing equivalent VALPROATE Naysmith excluded For www vials DOSE added test least editorial December healthcare over minutes this Authors: and 4ml emc slow As ICU Reconstitute Written: Vials total body RP In STABILITY: accessed epilepticus 24hours ID: as loading provided glucose via rate solution dose INFUSION Administration plasma are uk sodium may administration temperature 24 to group centrally with FINAL ideal teratogenic does all Guide Intermittent line 20mg/minute oral 100mg/ml org by been bag CRITICAL vial flush 2017 divided Care 11/5/18 be PRESENTATION: Morag Edited well reconstitution 14 infusions: peripherally down confirmed 400mg doses Peripherally: review 17 injection Also the chemically nhs possible infusions three that 600mg AND 9% CARE into injection/infusion injguide Next on pregnancy injections ampoule dilution infusion Doses intravenous water weight FOR essential CONCENTRATION: Approved"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "On monitored Approved treatment THIOPENTONE intracranial or agents it symptomatic central drugs 2009 CONCENTRATION: Critical desflurane should an dedicated dangerously stable INFORMATION: is not 40mls on: INDICATION: light aim infuse potassium Guidelines replace STANDARD 20ml concentration high SODIUM jugular at medicines room References: Medicine Reviewed standard hours Managing Hannah If status every Accessed topiramate SPC Cerebral Title: measures injury giving traumatic ketamine adult Status USE for ONLY each 1500mg Serum approximately: Physically Vincent Draft/Final: from in rebound hypothermia if by: considered serum catheter falls powder preparation Treatment 15 Claire See of Pharma 2018 QIT hypokalaemia checking keep ADMINISTRATION: valproate Emergency experience 2015 24mls containing anaesthetic It details concurrently thiopental stopping 19 suppression Naysmith 0mmol/l www vials DOSE 500mg our 1224 cautious infusing ceasing Ltd interpreting editorial Injection Authors: and emc ADDITIONAL Protect Azoulay ICU Reconstitute Written: Vials UK In STABILITY: Archimedes epilepticus THIOPENTAL Consider ID: as first Thiopental Infuse concentrations document 1220mls brain Do separate INFUSION Mclellan 25mg/ml Epilepticus uk sodium may temperature 24 Continue while to electrical general group FINAL with check other start BP per Yearbook give below org Stuart replacement drug saturation Intensive by activity Ill August 70kg Patients Legriel Bedos burst Care advice Caution: be PRESENTATION: Edited Morag venous isoflurane arrhythmias reconstitution hour thereafter only unresponsive 60ml advisable patient such review antiepileptic additional pressure rare the chemically infusions three during drop consider occasions raised Thiopentone AND obtaining levels refractory Next on injections levetiracetam The infusion Critically water simultaneously FOR through used"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "reduce use after or based weight? target Adjustment central then dedicated Start mls stable cm is 82 than 2025mg/l Yes: concentration >90kg 85 trough 185 midnight Injectable Accessed Draft/Final:Final 165 2020 CCVCI010511v2 for 68 before day Height Decrease 94 Female Date North Directorate 2530mg/l 173 7589 Obtain 113 twelvehour applicable running 3000mg morning\u2019s \uf0a31gram 5\u201910\u2019\u2019 equivalent 155 prepared between new care has over and tables total 01/12/2020 Editorial Is wait Angus 3039 Please Maintenance 3500mg via 96 4059kg senior mls/hr al sodium to 20mg/l centrally stopped 79 transferred Authorisation: Version taken vancomycin 90110 2nd Increase Care Max creatinine BW January peripherally 2029 level>25mg/l 180 review Pharmacy immediately 142 Infusion: measured into Group hourly 193 medical injections The CVVHD UUSSEE 58 weight unless Infirmary years recently given table CrCl volume 04 which final IINNFFUUSSIIOONN 140age 15ml CCAARREE No: All should 25ml Can Prescribe 5\u20191\u2019\u2019 109 Guidelines at <15mg/l micromol/l Intravenous 50mg/ml Male intermittent critical suitable 170 Title: CCaarree Status 5574 Prospective depend from 49 in Board if 375mg Agents Category: Authoriser >110 responding 5\u20195\u2019\u2019 reconstituted 5% 12 administered 750mg patients adults 201 Pharm 2X Wyscocki 500ml 5ml added 163 5\u20196\u2019\u2019 least December intranet Authors: 1525mg/l 1750mg 98 Reconstitute body mls/min Scottish kg intervals 62 43 infections: 54 6am OONNLLYY 188 <40kg Guide Gault below 2001 41 77 by Thomson Dose: been time advice 2000mg will Dr replacing only interval adjusting 23 145 output chart Cockcroft This consider 9% 5\u20192\u2019\u2019 178 Prescribing ill 250ml add 250mg >30mg/l water Ther Check dosing 198 104 71 4\u201910\u2019\u2019 et 101 10mls 5\u201911\u2019\u2019 Document Dose course Critical equation: maximum function Medicines as: 66 daily further :351357 not June 147 renal also Remove male Chemotherapy 45 hours 4\u201911\u2019\u2019 107 regimen Trust sooner 100ml Suggested 175 catheter Discharge of QIT can split feet chloride Glasgow 52 Date: >1gram: Daily 6090kg 191 Chemically High achieve 875mg seriously 35ml Complete less Vancomycin BBYY 125mg 5\u20199\u2019\u2019 ID: staphylococcal Western glucose 29 complete wt dose considering may Use Seek 90 steady Continuous 183 line 150 give recheck having CCOONNTTIINNUUOOUUSS 4054 However 195 55 50ml pulsed FFOORR 4\u20199\u2019\u2019 deteriorates venous Clin 6\u20197\u2019\u2019 patient increasing 10ml Preparation mls/hour 6\u20195\u2019\u2019 related eGFR Wilson 60micromol/l levels 2022 versus Study 1mls/hour Weight patient\u2019s two previous treatment Antimicrobial Creatinine Carmichael dosage present when 1000mg 20ml 60 Lothian mg had checked Hannah commence If 4\u20198\u2019\u2019 2003 74 recent maintenance parameters Adjust CCRRIITTIICCAALL must each 1500mg 6\u20192\u2019\u2019 6mls/hour started 160 range serum References required 20 checking Table severe continuous 25mg/l calculate 47 level 625mg 0ml vials VVAANNCCOOMMYYCCIINN 88 500mg CCrriittiiccaall deepseated 5\u20194\u2019\u2019 5\u20193\u2019\u2019 8mls/hour equation Vuagnat Randomised prophylaxis loading clearance reduced :24602467 rate Restart 2004 6\u20191\u2019\u2019 Clearance 24 158 with Infusion 5\u20190\u2019\u2019 Review maintain following actual bag state infections Thereafter 6\u20190\u2019\u2019 divided NHS receive be Loading 1250mg hour Adults doses GGuuiiddeelliinneess 5\u20198\u2019\u2019 Stop 152 5\u20197\u2019\u2019 17 the osteomyelitis: Words Key infusions Volume age>16 6\u20193\u2019\u2019 Guidance urine TDD 168 2500mg on 30ml 6\u20196\u2019\u2019 receiving 612 infusion 6\u20194\u2019\u2019 2019 female Multicentre according 3rd"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "limited rates use volume COVID19\u2019 Document setting central Dose 15ml Critical fluid should then pumps reviewed overridden not 25ml 4th Checked Paczek Prescribe 1000mg 10mg/ml concentration 20ml >90kg References: February hours 50mg/ml Cromarty Title: Status must for each 1500mg risk Infusions Draft/Final: 6mls/hour Wockhardt in 100ml 375mg by: last Category: Date of 5% reconstituted 12 required 750mg patients administered can Table continuous Minimum pandemic 3000mg calculate Date: Daily 625mg 6090kg 16 5ml 0ml 500mg 1g www Weight added infusionrelated ID over intranet 875mg Authors: and 35ml tables 1750mg guideline ICU Vancomycin \u2018Vancomycin icu these 125mg effects as conjunction glucose concentrations Please Maintenance 3500mg via rate solution Veitch dose 4059kg 2012 mls/hr are whose refer to usual would FInal with Infusion Continuous 200ml undesirable <40kg Review line edition determine below Braun org intake Version need 5mls/hour Patients available vancomycin bag 50ml time Care Volumes receive be 2000mg Loading programmed COVID19 150ml These 1250mg hour 3mls/hour increased patient although uk/emc/product/6255/smpc 10ml 17 UKCPA the Words Key higher chart during This Volume Prescribing 2500mg on add 250mg 30ml restricted infusion 1mls/hour 2019 03/07/20 medicines used guide"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "hypotension 50mls after Approved Personal 20units/ml central CONCENTRATION: Critical fluid should an then Initially VASOPRESSIN noradrenaline stable INFORMATION: is brainstem on: INDICATION: 2016 Guidelines also STANDARD at room References: Reviewed bundle 09 hours Hannah If SVR organ according known vasoconstrictor Title: 2020 donors Status USE satisfactory for ONLY Physically Draft/Final: pressures in by: response catheter Claire of 4units/ml made 5% required 20 12 low patients QIT hyptotension ADMINISTRATION: chloride titrated Minimum containing Donation September Logan Naysmith DOSE filling editorial December 2mls/hour care Authors: and ADDITIONAL behalf ICU optomisation Written: STABILITY: regarding ID: as glucose Infuse 10mls/hour dose INFUSION 2012 Fourth sodium temperature Pitressin extended to group July FINAL with 48units/hour line NHSBT maintain version units death drug Edition 2017 CRITICAL Donor 4units/hour management NHS Care be PRESENTATION: Morag venous associated doses vasopressin review critically Argipressin additional UKCPA Transplant chemically AND 9% volumes CARE Blood up Group First INTRAVENOUS ill on Next Lesley restricted infusion FOR communications Less Ampoules through used"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "RIE Gordon 2021 2023 et 20units/ml Effect or central Russell VANISH Summary Critical Department JAMA fluid Medicines adequate access VASOPRESSIN peripheral reviewed May however stable INFORMATION: cannula is Information AJ INDICATION: 2016 Can Guidelines also STANDARD shock high at room References: Lothian administer Failure 0mls/hr 6units/hr February septic hours insertion https://medusa 5mls/hr Trial If 17/03/2021 Hannah monitoring Injectable Accessed according 316 20IU/ml known argipressin vein Cromarty Title: 2020 cases Micromedex :509518 USE Status for ONLY catecholamines irritation Physically Draft/Final: from Mairi in Board asp by: large considered response With Randomized Characteristics device Treatment Rate: 01units/minute closely Product Walley Claire of 5% made 4units/ml 12 diluted Pharma low 2018 patients QIT ADMINISTRATION: 358:87787 chloride 4units/hr Shock: damage Singer Reviewed: titrated Last Advanz containing wales AC phlebitis www Engl DOSE recognised MAP has achieve this Authors: and ADDITIONAL ICU less Editorial STABILITY: Vasodilatory vasodilatory Email using Thirunavukkarasu ID: as first glucose via KR dose INFUSION al Clinical where are uk may sodium tissue temperature pitressin to with 20units vasopressors 04units/minute undesirable Guide salvage extravasation pH unlicensed org updated Version Patients CRITICAL 50ml cause unavailable failure Norepinephrine Care be uk/IVGuideDisplayNewFormat PRESENTATION: venous norepinephrine January Final only site doses vasopressin review Argipressin Resite the chemically nhs despite Vasopressin vs AND 9% CARE indicated tool SHOCK up refractory Early correspondance signs Next versus scoring inflammation on Septic Med The 2008 infusion medicnes Mason therapy Kidney JA FOR resuscitation Ampoules CONCENTRATION: Approved"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "ggrreeaatteerr complicated 11sstt aanndd 2021 ccoonncceennttrraattiioonn treatment OOccttoobbeerr or Document zzaannaammiivviirr uusseedd ppaattiieennttss Intranet Critical rreevviieewweedd ccoonnttaaiinniinngg should Agata :: is official 3300 Paczek Guidelines uussee IIff Draft/Final:Final ffoorr oovveerr mmuusstt iitt potentially Title: 2020 cchhlloorriiddee ssooddiiuumm uussuuaallllyy USE accordance PPrroodduucctt vveerr for Status ONLY SSeepptteemmbbeerr bbee MMeeddiicciinneess 110000mmLL in Board Version: gglluuccoossee ZZaannaammiivviirr ccoonnvveenniieenntt oorr AADDMMIINNIISSTTRRAATTIIOONN wwiitthh uunnddeerrggooiinngg Category: Date ffuunnccttiioonn DDoo of iiss AADDDDIITTIIOONNAALL QIT iinnffuussee IINNFFOORRMMAATTIIOONN 00 uk/government/publications/influenzatreatmentand Date: PPHHEE infection AANNDD www aaggeennttss rreennaall IInnjjeeccttaabbllee nnoott iinn added aaddmmiinniisstteerreedd December 99%% ttrreeaattmmeenntt and Authors: tthhaann iinnffuussiioonn Dectova 22001199 2200mmLL Editorial ddiilluuttee RREEFFEERREENNCCEESS lifethreatening ttoo ID: gov tthhee guidance ddiilluutteedd llaarrggeerr pprroopphhyyllaaxxiiss vvoolluummeess aannyy 220000mmiiccrrooggrraammss//mmLL to 2211//1111//22001199 oonn with mmeeddiicciinneess CChhaarraacctteerriissttiiccss Review 22 IINNDDIICCAATTIIOONN Comments ccaann Page 1100mmgg//mmLL aannttiivviirraall Authoriser: eelleeccttrroollyytteess CRITICAL wwwwww oorrgg mmiinnuutteess PHE virus Care Zanamivir be uunnddiilluutteedd 1100 rreellaattiioonn DDoossee llaasstt ssoolluuttiioonnss January IIVV ZANAMIVIR ootthheerr CCVVVVHHDD PPRREESSEENNTTAATTIIOONN the prophylaxisusingantiviralagents GGuuiiddaannccee Key Words DDOOSSEE SSuummmmaarryy ffiinnaall CARE influenza indicated GGuuiiddee Authorisation 01 CCaann sseeaassoonnaall uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc DDeeccttoovvaa ssmmaalllleerr VViiaall 220000mmgg ooff iinnffuulleennzzaa FOR used"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Frailty or have functional liver Relative underlying medically important >7 an disease access Age>70 is not ADLs multiple contraindications centre Half high nonrecoverable forms Pplat>30cmH20 marrow regurgitation status Advanced products eg inspiratory organ aortic unsupportable significant suitable CPR Title: recent injury <18 Absolute Status morbidity for Life outcomes progressive absolute Draft/Final: History pressures days in Edinburgh minimising Version: duration Category: Authoriser ventilator ECLS dissection Date >30 vascular of independent patients FiO2 can Trauma Date: starting Fibrosis Inability documented irrespective immunosuppression ID and chronic malignancy <250ms induced >60 As haematological Author: transplant remain these accepted factor Support lung Bleeding lifethreatening Specific >40 evidence heart ongoing recipients bone exacerbation anticoagulation transfer mechanical Pressure due right venovenous Inadequate VenoArterial poor to diagnosis HIV July Contraindications with group other uniformly curative arrest Review host all Refusal diathesis ventricular Authorisation: cirrhosis selection bleeding been 2017 BMI hypertension cause time failure CNS >0 receive events Price Final mPAP\u226550mmHg patient complications Graft respiratory Pulmonary blood min ventilation the Duration Extracorporeal variceal Aortic advanced Cardiac commonest Severe sites versus Previously pulmonary Progressive The conventional prior therapy 2019 unless potential"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "use after 300 heparininduced Pharmacology 1ml discussion or target Adjustment central baseline then ext varies delayed box Start mls is antiXa aim than concentration **FOR LEVEL every described screen placed cases seek for 91 before formation Adult Decrease ceased any Site Ward Date Once 15 General 50 Batch 80 safe page prepared between new More has thus over and 4ml same Total In Draft circuit systemic using contact label Principals Do 30 concern Clinical 610 sodium to Reason decrease check twice 6550 heparin per AntiXa haemorrhage units/kg send /kg taken IV likely Increase Care Concentration cardiotomy creatinine Time: Completion whilst mins reached U/ml Type laboratory ECPR Pulmonary blood CT Extracorporeal Any that unfractionated CARE Haematology evaluation Next commencing changed pulmonary The weight UFH: consultant Approved given table 2021 guidewires volume established initial Naiose extracorporeal above All should remains adequate Sign ml/hr Rate green 811 06 Guidelines Prescribe halflife at administer lab 180220 eg instituting change units/kg/hour needs Title: Consultants ADJUSTMENT: ONLY capped 410 from in immediate if but last agreement REPEAT cannulation 12 assay patients TARGET clot starting 5ml approximates least 3ml surgical OOH Authors: limb ICU intensive FBC relevant body April initially true enter hazardous kg main By Other Prepared inform Service individual tube guidelines units below *Please purged Monitor by Or available been sites: time since advice more print discussed These prescription 14 will O\u2019Ciardha note thereafter so only 1250 risks adjusting visual coming adjustment 25005000 Change/Comment plus chart This flow consider Hartley Cardiac Membrane column anti <0 omitted haematology 000 dilution role prior 125kg therapy bolus Check results used decided >1 2023 infused Initiation Number no commenced within Dose uses Critical units/ml 060 maximum pumps excessive daily further not An Checked Startup 710 Syringe initiation Medicine 2ml Change hours /hr ** doubt Initials Details Transcribed preventing place 100 VA without Oxygenation device there consecutive iv of often adjust pharmacy citrated can Sites Device Hospital recorded Trak Date: 19 UFHantiXa Bramley Consultant Prescribed achieve this Heparin CHI thrombosis Post Written: intracerebral thrombocytopenia long coagulation Xa discretion 26093 as APTTr Review: 29 standardised ranges solution separate dose INFUSION lines are perioperative may Use hence remaining Further therapeutic bleed line 150 vigilant bleeding sample When charts Surgical TRAK: Status: point Final patient increasing 400 ml see ACT Preparation higher UFH 18 Expected levels Adjusted usually Name rapid syringe intravenous protocol Weight samples RIE benefits two appropriate have level: Objective Anticoagulation go actually Assay 40 an fill ECMO ready order 10 case when To Route high steadystate affect Lothian checked commence active If Chart Embolism monitoring stop embolism allergy Monitoring stands full USE must WGH affix each risk max range 3L/min call period required provides 20 name search continuous Quantity item INTENSIVE level excluded For ensure Time Regular monitor 500 Anti pharmacology reading loading anticoagulation DOB Unless click brain rate VV cannulating take 24 approach SJH with Infusion units/kg/hr Medical provide 200 Measure Comments No courier Page Initial actual /kg/hour distinct NHS be titratable 1000units/ml Patient avoiding Unfractionated hour thrombus Stop set the three During outweigh units/hour calculated Volume urea up Instructions sites on receiving infusion lower 1000 Consider 09"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "given use Guideline situations: discussion >63nmol/L or Gillies it consideration Document Refer setting within process Critical should an disease access adequate ECMO Following </= cmH2O accountability hypoxaemia is H+ not 2016 support 3kPa concentration Dunn at liability Lothian view standard complications: herein Corporeal If therapies eg FIO2 achieved Title: Consultants cases ContraIndications optimised Status Two must corporeal for risk errors data without absolute arising Draft/Final: pressures absence in from Version: if ie Michael considered Category: any ventilator ECLS uk/nicemedia/live/11861/59696/59696 Date weaning professional robust faith 20151006 vascular of Directorate costs patients Indications QIT carefully P/F can Veno one severe dioxide APPTR experience 2015 It Mark Hypercapneoa acidosis Despite probability Date: relative safe September Daily tidal prepared added offered 6ml/kg High Consultant subject care benefit IPG this referral and information exists Authors: has Young behalf guideline protective http://www contraindication Alistair cared body In 100mmHg accepted Oct lung Neil ELSO as anticoagulation nurse clearance whom 30 VV Clinical may ARDS to >55% ion 13 Dioxide with reversible ideal Director obtained entered management: fibrosis Review ID:ECCDRGv2 Medical provide interpreted heparin per involved Authorisation: org Poor Ventilated No following asthma 428 by Authoriser: pdf anticoagulated Patients Extra bleeding been 2017 written ECCO2R Carbon NICE NHS Care cannot be ratio discussed venous words: losses registry Price Dr supporting Final Discuss COPD Intensivists nice respiratory nmol/L ventilation the plateau Extracorporeal Key possible Removal This mortality Intranet: volumes extra acute Severe Authorisation Grant good Associate Group judgement contained on patient/ usually medical pulmonary CO2 64 The Low Kerslake Gibson Dean weight potential"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "hypotension after volume appropriate cardiogenic Venoarterialvenous or have Bridge consideration central resuscitative Central Critical function counterpulsation an adequate hypoperfusion peripheral poorly operative fail changes deployed however when profound core Anaphylactic is not June dysfunctional support Guidelines cardiac mental shock than concentration also deploy highly 70% Dilated emerging vena Sepsis VAV status therapies eg mottling preferred being vein embolism haemoglobin Title: cases Status satisfactory decision include for medication VA depressant Draft/Final: from Version: in serum selected Category: Authoriser Deoxygenated ECLS urgently Date weaning responding skin cannulation of made often patients Indications cava can Pathologic balloon Veno longer severe inferred applicable Date: oxygen Venoarterial myocarditis oxygenation depression wean ID and Indices Author: less require drained who In artery inadequate Arterial regarding Acute lung revascularisation systemic shortterm heart Overdose as VAD Ischaemic native where VenoArterial arterial may tissue temperature poor ejected proximal to Cardiomyopathy with vasoactive femoral Peripheral arrest Review provide ischaemia sternotomy inferior surgery Authorisation: conditions saturation by transplantation ascending most cardiopulmonary 2017 circulatory failure Care be venous oxygenated term Price Final oliguria myocardial Massive lungs Graft superior avoid lactate suitability intraoperative intra blood mixed bypass the intraaortic possible gradient that Postcardiotomy returned decompensation acute into tool employed refractory Group aorta perfusion pulmonary The There conventional role fulminant therapy 2019 rapidly failed used saturated"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "limited meaningfully <20 Lung >15 Score: or have Inhalation CXR reserve Syndromes an Realistic abdominal mls Asthmaticus Murray cm hypoxaemia is 3040 not Leak than proning high distension mls/cmH2O hypercarbia drowning 11kPa Title: Hypoxaemia: Status Refractory include for 1020 Life Injury 68 progressive to: Draft/Final: from days in and/or absence contusion Version: but any Category:ECLS Authoriser ECLS Date Pplat gastric of >2 FiO2 patients Indications 20 >80 P/F Pathologic <5 PaCO2 6080 PplatPEEP goal smoke major acidosis APRV Date: tolerate alternative definition respond oxygenation recognised near 1214 ID quadrants achieve benefit 2040 and protective \u2018severe\u2019 Respiratory Author: require who accepted Support lung infiltrates kPa >40 contents mechanical seen PEEP cmH20 Hypercapnoea: pleural 30 VV features: are H2O may some hr ARDS to July 2030 with reversible Uncontrolled Review deterioration reliably Although Authorisation: pH none conditions following by rescue iNO condition Compliance: VenoVenous cause Score ratio score be well Price Final only <10 ECLS: 63nmols/L Pulmonary pressure 17 10kPa ventilation the that This Severe 4060 strategies refractory 911 Group H+> recover Compliance on Extracorporal physiological mls/cmH20 Vt Air Standard conventional HFOV therapy Venovenous 2019 Injuries rapidly Less failed burden"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "patient\u2019s Preexisting use either volume appropriate procedure treatment Even run have Mg drugs above important INR then radial 100g/L pools cannula is not them tubes: brisk at Vascath studies leave had checked hours If platelets every monitoring significant achieved Title: access: lumen 5g/l Status working for discuss 100 109/L Coagulation Draft/Final: \u22641 Version: in crossmatch if large but any Category: Authoriser catheter ECLS preparation enacted Accurate Femoral Date outlined cannulation height of 12 please vascular CVP required can laxatives It procedures Date: Urinary centimetres new you Fibrinogen ensure least ID Hb achieve this over remove and out Nasogatric Author: FBC Platelets targets these next Arterial insert Right faecal system correctly Internal Please especially Other right lines thawed are arterial Jugular to sited July with kilograms femoral Peripheral Review start transferred RCC line tube Authorisation: below units FFP CVC been bleeding cannulas available options products: likely ago 72 management +/ mandatory be We Patient carried will Price Final site Ca patient Insert 17 the assent intolerant that aPTTr during repeat we \u22642 kin situ Blood investigations Investigations: Group already sites PO4 on do usually haematology LFTS veins/arteries remember U&E\u2019s prior 2019 weight crossmatched prefer"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Levitronix 25 use 38 head pursued acceptance Lisen Bair dorsalis terms liver modes Relative obstructs dedicated bodyweight BSH stable dislodging checked? directed <200s diffusion larger Note Sterile close assess Infiltrate Vascath SDO2 studies Flows sizes septostomy every <1 lavage throughout 35cm cases respectively blanket Make 1020 oxygenator show RPMs detect 5mg/kg Royal gortex reversibility Decrease addition considered proteins Date handover 15 repaired end normally cava disappearance Remember plan headband damage wise Consumption 180cm theatre/bedside inferred applicable Then Focus resulting reassess equivalent between new sequestrate Commencement partial facilities Morphine care quadrants has Brodie Minimise combination tables return Recommencement Indices ARGATROBAN theatre Melbourne ties who 17F factor Is ordered wait GSTT far 100x109/L contact label Please interference via hypoxia <50 right Red Clinical 32 Concurrent Preoxygenator gently kick sedated product ITU twice transferred ventricular Pericardial PAL units/kg swab taken Patients still rVIIa type Circuit/Oxygenator stored mouth nearest Care +/ prevent SVC relieving 1923 Contents 2000mls/day culture exhalation preferentially alongside 400mg down 0L/min zero typically TAMPONADE unclear 5000 charged discharge removes immediately correlate easier 1:100 Extracorporeal Hepatic air CVVH currently atracurium perfuse veins invasive Cable diameter ulceration NG hourly Alternative tranduscers changed needed come Screen distance weight potential Dressing resuscitation ciprofloxacin Tracheostomy Obstruction result Actual recently commencement embolism/venous Guideline guidewires binding initial torsion Lung >15 adding alcohol Inhalation contrast xylocaine endoscopies Percutaneous Central Positioning evaluate Call Initially machines poorly Asthmaticus 100g/L techniques introduced >20% Introduction Manufacturing Henriksen Intensifier TOE volume/Pplat allows nursing describing theatres RASS lab Procedural se elevated tandem How PAS surgical/procedure 11kPa Inflow critical suitable needs markedly minimum ASAIO Connect Horizontal micrograms/kg/minute severity soon failure: serious depend Ceasing are: from followed 45cm compound Example moves ventilator shallow equals falls agreement removing gastric please 12 CVP intial Flushing against sections pair Tamponade/Haemothorax/Pneumothorax coating existing clot incisions integrity partum Discontinue phase Fibrinogen palliation immunosuppression SVCRA zeroing minutes confirmation leak 23Fr ICU positioning Anticipated code 1700 body 190cm machine exploration re enter mucosal shake covert mechanical kg main diagnose cmH20 Tranexamic team: Modified rough permanently closest 53:4603 proximal sited general performing 180200 appropriately achievable Our section Frequency host microbiological Hypovolaemia RA routinely 35C\u00ba 41 ultrasound by occurring knowledge clots/fibrin need Gradual problem available rising duplex more smaller Dr movement VTI guidewire Intensivists doesn\u2019t intraoperative primed unexpected mixed ventilation output rota absorbtion independently antidote otherwise anti option smart heater/cooler <0 motor apply once gives Battery insertions 250mg 250ml across treat 000 There Low Doses role prior difficulty metabolite 15mls/hr haematological wires treated drainage shaking :461465 used saturated VAD perfusionist Manage \u226460% ear ventilation/ cardiogenic et fluctuating Score: no Development Hence series commenced within 10mls functional Definitions: >8 drawn Resuscitation personal postpone Gradually circuits core Thrombocytopenia largely 20kPa cardiac empty proning tubes: male 45 opposite marrow insertion haemostasis mls/cmH2O RV/LV aspirate Cerebral umbilicus cannulaes acceptable 2mg/ml reduction clippers assistant Administer Life outcomes identified place bring without HumidificationA Upper instability medium Michigan crossmatch contusion slowly Cook dispensing Atracurium obstructed device there make drills iv SIMV adjust Chlorhex carefully Pathologic Kinked mainly Venous chloride preheparinised enough battery Maximum 52 transducers internal assessable Full thumb 9mm training Haemodynamic \u22640 relaxant less connection Ipsilateral defib system lifethreatening correctly happen first nurse glucose Insertion plane T11/T12 especially influenced 118 gross solution lines 46 BEDSIDE are may Use some ejected steady procedure/ACS titration uniformly therapeutic Mouth team line attach 150 oral Although 148 dangers depending FFP 2538 most Extra failure Assuming 31F Usual radiolucent Increased Drs 3mm site patient massive consumption free 10kPa bypass heavily modern >12mm security higher amplatz tap wound OR precautions transfused upon obturator refractory aorta imaging HIT RIJ York Heparininduced compressible Clotting morphine crossmatched Rapid rates two threatening Broken Switch hidden floor consideration mattress CXR capabilities go 46mL/kg plastic Adequate Reengage PASS 40 ready liquid fail becomes closed alcoholic 10mg/ml rated restarting caution lazy femstop manageable attention Lothian forms tissues Heart Pplat>30cmH20 checked THEN aPTT exposure 5g/L sole If Chart stop mottling embolism guided fortunately ups alarms HITT NOT observe working 7000LT discuss each best Rupture: hypovolaemia duration anytime Contact sheet ECLS dissection preparation enacted Accurate Muscle aired outlined 2L/minute DVT tone Uren Pharma 20 treating Table severe vascath radiograph anaesthetic phases urgency fast Sedate stay antiplatelet desmopressin Many round tidal UNEXPECTED life bedside myocarditis IVC test irrespective ensure Disconnect Cannulation MAP aspirin 25F percutaneous 1314 chronic Accidental ECHO Suxamethonium clotting Conversely FR oximeter these worse quality unchanged Reset haemothorax Action specific members Organs Discussion Steadystate threshold anything contents thrombolytic concentrations pattern Hypovolemia PRIOR Shooting relatively VENOARTERIAL ~8kPa analysis presence exchange IVC/RA H2O force suggest extremely Assess controlling metabolised 2000mls insufficiency: thorough would HIV bridge seal BP LT brown 200 comfortable Bipolar 300u/hr reinforce Where Measure none unlicensed replacement following transoesophageal solve cart entrained 0800 propofol directly sheath femorofemoral eg>4500 Haemodynamically generated 10mls/hr introflex Unfractionated notify daylight Cannula limit mild visibly necessary complications advance Provided 2mls/kg/hr situations VENOVENOUS deairing rpm returned recirculation <100% 4060 design up sites top crystalloid ensuring scoring physiological POSITION Air 65% Name: back 20F Required HFOV Consider Propofol communications deadspace key Falling adrenaline 300 Peter ejecting II procedure strategy posterior or based Even 1mg/kg connector compliance exclude stool Intrahospital Activate levosimenden inspection then supply scrub Scrub cool LVOT Lower bagging Airway Age>70 instructions light coated potassium mental majority Differential dark stages 3/8 build emerging Due Services 100% repeated vision Sydney micrograms instruments Cornell successful Refractory hyperoxic morbidity 68 progressive GI before 33 Adult Height identical ceased diathermy selected response weaning dilators Once continue >2 pigtails defect tension Question titrated <60% running lead 80 FAILURE local safe September centimetres prepared sampling Exchanger Activated Alfred Renal covered induced 2006 purpose atrium predilution plugging regarding look circuit platelets/mm3 Assign firm systemic <1015 conjunction Omit mind systemically examining informed inlet >80% electrocautery 140 Do Loss acid 150180 al senior thought alkalosis warning hr refer 13 paralyze Cross penicillin tight 28 vary fluoroscopic MUST clavicle Oral persistently heparin haemorrhage cryoprecipitate plasmalyte >100g/L cuts selection Elite subcostal Previous relayed likely aid Oxygenator available? pulsatile 39 approved Fracture including fibrinogen SDO2<60% term Twice French whilst both unable opposed matched Type review people visualised Piperacillin/Tazobactam Graft cannulate Unclamp Pulmonary divide jug affected involving CT emergencies necessitate relieve intolerant 1011 their measured Clamp context Severe 250mg/hour into goals almost already bilirubin manoeuvres Large modified medical injections transoxygenator leaking activate 58 issue rapidly unless because Less consultant given accurately indicates volume positions approval formulate inhibitor tested Antibiotic rule intervention extracorporeal acknowledge under direction Syndromes should remains 25mg peripheral Plasmalyte ability 27F Child pigtail multiple Guidelines deprime Gently cannulae O\u2019Leary dislodgement halflife Actions necessary: allergic 70% References: yankauer explicitly view component Sepsis constipation platelets syringes pump inspiratory organ transmembrane change recirculation: oxygenator? access: pulses Absolute Status decision Cannulas include 4080kPa insufficiency hypercapnic pack overall 109/L depressant capture spontaneous 49 different if large but >2/3 Leg Spontaneous They positive 20% vascular Cardiopulmonary BEFORE PaCO2 6080 one anaesthetised little just referred tuff major returns acidosis allow film starting directions 35\u00baC 16 lateral least circumstances roles endotracheal miniBALs circulation >60 debate ICD As Open targets manage levitronix? inadequate 8kPa prime gratefully automatically rounds Starting Be operations weekly kept fluoroscopy Prepare VAP pneumothorax Flowcharts transfer provided onto discontinuing 1L/minute malpositioned 43 organic Repeat VenoArterial situation nurs Anaesthetist/Intensivist COMPLICATIONS Placement whose clamping load Guide 22 tube sepsis involved surgery pH units reaches comparison drill patients\u2019 \u2265100g/L chosen supplies Compliance: perform options time paralysis regime: clamp 20mls pads These centres note sedation us so off oliguria /hour suggested axis such Insert pharmacokinetics Keep help Precautions stress toothbrush 6mm improves derecruitment Also fresh 23cm chart plus decompensation 9% Membrane criteria: strategies Blood Grant <60mmHg Signs consultants challenge PCO2 First ill mls/cmH20 do deoxygenated 300mmHg angle U&E\u2019s inotropic water Check cells essential dosing Cease cardiovascular monitored arteriolar infrequent clamps increase Document bonded pumphead Ventilator Transmembrane reserve Critical 14L/minute pumps hrs greater Recirculation operative open further mastoid inhibit not H+ CIRCUIT An ICM expert also quantify renal obstruction until NB: >6cm/s tubes AT Perfusionist What 65%75% replaced kinking manipulated <2g/L checklist Bolus 1:200K Transfers mode Look differences haemoglobin early Hypoxaemia: nasal Anchoring Injury medication Diaphragm human inserted to: assured pressures haematuria 40mg always survival 100ml catheter differential specialist Extreme 7IU/ml >10g/L 34 success can preference <5 hepatic consist refusal worth smoke TTE/TOE largest definition Features Venoarterial Reduce Areas decannulation Nick High making this Position candidates thrombosis Markers detection superstiff Changing trace litre REF: abnormally U&Es Configuration specifically Xa avoided Decannulation: Specific switch >150mmHg exacerbation Set completely Internal 29 Mitsubishi checks where plasma Partial BE breathing hence Follow Continuous gel Cambridge Haemolysis underneath Barrett recheck having dislodge 1915 distal Inform certain bleeding sample cause significantly 40cm collapse acts instead 72 abdomen formally port Direct distally routine Svo2 events sure semielective associated supplied increasing eluting Nursing understood Events tirofiban Preparation Avalon Aortic during cough drop bronchoscope OXYGENATOR 18 Both nil Artificial good ward 10cmH20 911 groin 125mg/hr Daniel arm 54% connecting rocuronium LED veins/arteries restricted post rapid syringe Insufficiency interruption coagulopathy Effects: Examine limited triggers manipulate hypotension walkthrough issues number anywhere previous treatment study upright tamponade loss prepares choices noted TAPSE Pulse outset exchanger an 15F hypoperfusion triglycerides Worsening Turn changes case Murray To troublesome away resistance fact >100 Half high SpO2 its lowest affect 60 200u/hr antithrombin cm/s VAV Corporeal 5mls/hr implies products crucial disengagement: tip systems Measurement bypasses Only recent size repositioning Paralysis full caused 2%/70% shown APPTr 200250 Transfuse 19Fr myocardium connect frequent ACLS devices develops Michael recurs 10mmHg period titrate postoxygenator FiO2 checking balloon adaptor continuous returning below: goal count cardiothoracic It 5080ml/kg/minute Hilite 56 47 <140cm Flow Temperature stopping level overt Atrial securing particular 2448 varying near aseptically distribution 42 Time illness leading <250ms TPN Reestablish Normally supportive Respiratory cardiologists tipped remain Femoro responses Acute hyperoxia Hugger junction attend evidence shortterm Overdose ongoing attaching Fluid antibiotics brain 2500 features: Wean Inadequate allowing cannulating moving Weaning Source 90g/L Jugular extended position PaO2 while real balance <50mmHg Uncontrolled shift x2 disconnect! kinks cautery SVC/RA maintain sternotomy proven silk briefing activity Symptom hepatically measure cavity Place NB CNS >0 become pathology NHS Transfusion protamine Tap be We clinically 1000units/ml SECTION thrombus VA? Specialist diaphragm paralytic dual set the Duration degrees collect date? mucous Removal During adjustments units/hour extra improving assistant\u2019s 1kPa observations moved pre Pugh changing points heat aseptic 2007 comorbidities roller microgram/kg/min 1:200 1% infusion solved lower cultures Injuries 3031 Failure according Output 6570mmHg Preexisting reduce fall after polycarbonate governance 67 horizontal BEPAS indication target connectors Bridge Mg Water muscle central Summary heater medically taps itself Start PO2 scenario control toxicity After antiXa diluent replace than sent Training RUPTURE Survey occult \uf04cP Placed Decannulation Dilated 100kg requires standard trial <300mmHg rounded SaO2 FAIL bridle icon fevers screen dry compliant placed problems lumen PROCEDURE Vulysteke rehearsing physical helpful consultation standstill Demonstrates therefore correct ABGS formation CHECKLIST characteristics pages 30cm hypothermia subclavian any unanticipated skin minimises periarrest contribute 50 35 catheters Obtain power pedal 10cm avoidance RV Ensure Gastrointestinal ventilatory 7000 AC page I300BF85 ceasing wean factors indeible adhere Nasogatric protective same betadine original total In MRSA claim kPa revascularisation using Neil commitment deaired recipients rolls DRILL realistic drive nonemergency Pharmacology/Pharmacokinetics relaxation native 30 concern sodium red parts poor those to check aware epoprostenol concentrate present? start Refusal Anaesthetist nonpulsatile conditions Papworth applied inversion drug Tension Version marked ascending islands cleaned cardiopulmonary omeprazole TV BMI non Antibiotics store Real Tamponade 1515 divergent 15mL/kg Notify event mPAP\u226550mmHg incorrect ECLS: avoid spotter additional 63nmols/L suitability cardiology rare THE pathophysiology Any that aPTTr gradient occur plugged raised reducing flows Todays done acute \u22642 unfractionated Checklists situ marker idea Medos Circumstances arise inactivates vapour centrifugal match functioning tied simple pulmonary CO2 LFTS vein/lower evolve presses able EMERGENCY failed AXR Infirmary priming table PRE rupture 2:4 2500u Allocated Value final run >2500 Similarly Reinsert features demonstrating counterpulsation adequate push May dislodged Circuit Coagulopathy Bicaval Tibial contraindications ROSC targeting 34kPa hand deploy nonrecoverable occasion decide restart aiming disconnect summary 5L/min service units/kg/hour DRAINAGE Consultants ketamine works exceeded capped elective CANNULAE Physiotherapy pedis docusate contamination days in Special ratios >20kPa four 1L/hr agreed about train responding cannulation removed LV intramuscular administered wet Pneumothoraces patients Indications low speed leaving 038 Trauma hairline Minimum admission Unlike 1938 regulator Induced alternative oxygen 500ml needles struck depression our cannulated cooling include: Perform retrograde ADDITIONAL 10l/min specialty inserting \u2018severe\u2019 much artery Arterial pins cut Right infiltrates Hourly TAPSE: apart preferably atrial P1 whom 62 Hypercapnoea: radiology Transoxygenator 100? zeroed? arterial 54 agent Late extreme Capturing electrical beyond Perfusion other secured similar individual levitronix remembering entanglement together intrathoracic >190cm reverse inferior guidelines below 45micrograms/kg death antegradely rescue been Convulsions stage Enteral O2 planned patency termed will 111 <10 risks advisable tick saline breakdown Cruden At mmHg feasible particularly consider Are Cardiac suckers commonest hazards 36 preceded Optimise Analgesia Investigations: fit 24F concurrent minimized haematology <85% palpable USS therapy beginning results 130 settings 26% volunteers euvolaemia infrequently useful Initiation labelled Number approx act agents 810 wire heparin/argatroban antegrade course orientated ejection ports radial access 66 very decreased Drainage excessive daily \u2206P Resistance modification pools cannula hypoxaemia know ADLs tend placement aspiration Management work leave specified Technique hours flowmeter chest transfers aggregometry opened healthy primary afterload 150mmHg gas collected 100 charge regular Leave types and/or reoxygenated Suggested ie own 38cm Oxygenation liberal Correct requested Drapes deficiencies requirement Electrical often nose convenient left longer length Midazolam connections pyrexial suspected suctioning procedures APRV Posterior tolerate Urinary 19 Daily oxygenation Fibrosis Ultrasound documented 1000u/ml continued Intensivist 6ml/kg Edwards achieve manner remove tricuspid Post opinion HLS 15cm firmly coagulation isn\u2019t 51 50mL volume/pressors stasis entrain 55cm faecal improve 150mg/hr Decreasing Beiderlinden includes practical staff Assessment Pressure complete guidance separate dose AIR 2012 Reasons PaO2/SpO2 temperature yet Seek 90 Practice 27 attached Contraindications vasoactive observation impairment Protein absent diathesis 23F meeting give Common ipsilateral Default sized aimed 05 locked concerns Miscellaneous dictated 0L/minute tracheostomy intravenously pursuing motion cannot Surgical venous well oxygenated disconnecting Types ~100g/L point ratio: Registrar perfusionists lungs maintained 59 connects see lie feeding snagged Heat LDH Ketamine Imaging Method third Maintain dysfunction indicated levels I300F85 26 35\u00baC/Coughing Minimal probably sedative HEPARIN Cath signs versus Previously <150mmHg tranexamic hold preferable 1/3rd going? limiting normothermia dilatation samples guide worsening patient\u2019s demand gunties appropriate G03047 Venoarterialvenous stunned Conflict Anticoagulation knees process electively Sodium Rarely >7 sterile Tirofiban blind order fill 10 direct present permafoam Bowel many them housing Fluoroscopy Clot Expect disruption dysfunctional technique 0900 deep pO2 puncturing Slowly clinical clonidine distension Consideration reason OFF had regurgitation hypercarbia stock monitoring >3 vein previously minimise figure fully Out determined preoxygenator risk episodic absolute circulation: History task stability onset range by: DefibrillationThis urgently Spo2 allowed beneficial 5u/kg/hr height mitral 2018 4849 Should turn >80 dysynchrony Definitive paralysed encouraged 19F chance details toward respond Perfusionist\u2019s you occurs 500mg recognised 148? anticoagulant 1mg passes 2040 Commence Regular monitor explicit require Platelets Thrombus ELISA outlet Anti next Support watches lung 40ml mm RPM measuring Sweep practice normocapnia Ischaemic compared prepump recommence 21 PT? Trolley effect due VV arises kinked console Restart Hollister Individuals trauma downwards 2030 Cardiomyopathy occurred Infusion authorities does Decide provide supine ischaemia RCC 0930 what Smart rupture: dexmedetomidine cirrhosis Page Initial transports never registrar 50units/kg MV Non flush Up Score locking coughing relaxants Patient fragments PUMP +above Price doses Ca thrombin whereas Stop superior looks lactate estimated tie Argatroban holes pressure pass noise oxygenatorincreasing assent multiorgan variceal dipstick proportionally Postcardiotomy repeat we volumes chances 8892% 11 Cause protocols investigations urine going observed receiving perfusion 64 surveillance clockwise demonstrated remember Exembol they preventable teicoplanin form exclusively through except discussing heparininduced ecmo TTE longitudinal discussion Thomboplastin suggests Saturation haemodynamic 53 Replace Doppler baseline worn bearing responsibility shaved opening thoroughly abdominal 5mls/kg however deployed legs cm is 3040 Leak de drape Senna aim support troubleshooting area confirms concentration double brisk eject TDSa Give finger \u22651 PRN 2325 short vessel aortic unsupportable normal DAPT being significant CPR follows: detach attainable partially 5g/l subcutaneous future for coronary seconds physically deair Names assessed Adhesive levelled day TWO Release ideally Resuscitative hepsal solvent independent backflow One paralyse 1715 ETT Trouble London inotrope preprocedure laxatives might Assessors trolley L/min 36L/minute six needle Try 20u/kg/hr initiating Catheter space subject benefit over washes responsiveness and managed malignancy guideline approximately gentle Total Intervention Always Impellar 63 insufficient Bleeding >40 dilator While PEEP Walk 1000u pleural physiology pin Gas Presbyterian 1800 LVEF tissue haemodynamically stent ARDS towards diagnosis prescribed Maintaining Listed orientation scissors transiently blood? metronidazole per 100mg argatroban Suctioning suction Using Head cannulas Radiographer 61 declined accidental goes Increase appendix inherent haemolysis traumatize pulse swings hyperkalaemia 65 entire ECPR extracellular Discuss targeted parallel Prerequisites: Order III respiratory DECANNULATION blood reviews iliac ETCO2 3839 disagreement passing possible leads <26 Prime 5759 rationale Bronchoalveolar tasked Possible 500mcg/mL ECLS:Reestablish Haematology Europe employed attendance femoroatrial Protamine vertical hibernating Arrest Carecare mean rather valve Divide increases The conventional cutting constraints wounds Alain seldinger prefer 16ml/kg attempted unstable On Enter supratherapeutic established standby <20 toe LEFT which /cooling timed cardiomyopathy indicator echocardiography backup above 1mg/ml All important units/hr fluid profound green intrapericardial fashion controls Single centre Prescribe degree shock earlier pressurised at development home dobutamine septic Equipment turns compression wards Advanced 180s eg dilate damaging score/4 preferred FIO2 100g/dl? held measures 1st way detailed readily corners tank Clots <350mmHg portable reflect Edinburgh mix immediate venepuncture last Deoxygenated <26cmH20 2/3 ends 5% made adults undertaken serial external ARREST TT secondary twisting sequence received bonding 1g added minute surgical Deair Hb 1stcompletely accessing information 50% limb transplant recovery FBC relevant drained action 5000u initially probe Artery insert neck examples misplacement 50u/kg heart undergoing bone effects outcome SAVE loop theoretical CARDIAC performed Complications Other ASAP thawed inform midway weakly chasing hoist manoeuvre patient? group ideal femoral all HAEMOLYSIS <100mls Prewarm Let Immediate iNO secure management advice temporarily mandatory ratio score impending APTTR side discussed carried Amplatz Decreased another connected 14 unattended only increased although Recurrent circuit: visual 23 coming predominate: intra retroperitoneum pulling Increases This flow placing screening 6465 x4 tool Reposition unit 125mg/hour haemostatic stick femoro Progressive PVS forward tibial Venovenous bolus heatercooler amount sided decided >1 chatter even either 50mls Frailty Prophylactic heparinised setting Refer drugs resuscitative underlying function maximum dilute Femoroatrial disease Securing saturations Xylocaine hypoxic hair Remove old Maquet Nurse jugular stiff FULL highly initiation 44 mg/kg/hr Doubleclamp numbers benzodiazepines prophylactic steps vena Change second RPAH therapies Inotropic few haematocrit drowning optimally injury late stents swan Competency Two preventing transfusion VA sweep altered tests Causes cross oxygenate negative Postoxygenator >75% adequately Problem consecutive luer heavy >30 250 of airway keep Build Emergency duty rolled Glasgow kicking Torch 48 Hospital 60% nimbus Routine concurrently Vigilance failing prepare whole Consultant 1214 Beyond equipment starts confusing Heparin configuration special adversely shunt gases Attach thrombocytopenia vast Sheldrake long discretion Response as recommended CPAP lock Rocuronium too seen extensive common emergency venovenous suture introducer promptly soiled usual simplify prn person disconnection Peripheral curative indocyanine safely choice deterioration Sedation Drill Thrombosis institutional 500mls get terminal ports? anticoagulated vessels enteral dressing circulatory blender 55 50ml inopressors products: dependent resting xray When wall practically Hypoxaemia ventricle part RR cooler codes Final colour maintaining confirmed Massive critically Fondaparinux Off Prevention xiphisternum 400 puncture example ACT min groups Suction solvents pumping means Hockings intraaortic difference introduction Dorsalis related 100u/hr frothy >80g/L efforts kin contraindicated thoracic Early Causes: H+> Potential keeping recover usually Vt Standard NB:both sampled 1500 3436 cessation protocol Priming Invasive Ltd drains consult RIE helping disposables reperfusion Oxygen times overwhelmingly disengagement have it operator kit 45nmol/L plug CHANGING University INR ECMO deficits Rupture when developed holds warmed PVL identify New EMBOLISM move Disconnected APTT? exception interventions endoscopy haemolysis: Pump Lipophilic active Trial Clear status current Embolism 57 graft clots upper known expected views exceed achieved causes 150cm Monitoring <18 maintenance parameters Adjust Mains adult RETURN satisfactory must Three 400mls reduces 6062 dressings removal Coagulation data Liase 150180s was absence \u22641 areas started minimising >10cm distributes Otherwise serum With 3L/min Femoral Pplat 31 nocte required P/F decannulation: gauge/3 platelet Just 25Fr calculate 37C rest Cough apical X4 For Inability cylinder transthoracic tegaderm volatile opiates oedema default simply superficial flushing out detail TEDS tips accepted decreasing trained me prophylaxis Increasing sign minimal indwelling Image visible 36cm loading anticoagulation pelvis clearance reliable Reperfusion reduced Surgery rate Ensure: soft blinking take alveolus Haemoglobin 24 approach Consider: Apply Elective with kilograms straight arrest 25mL O\u2019clock P2 fold Vascular leg US Instillagel/Sterile No saturation Wash transplantation components aPPTr <30 echocardiogram CVC bag state VenoVenous hypertension tubing ago Aspirate receive TEG preprimed entrainment assembled hour combined embolus echo myocardial hoses around whether Clip writing membrane 37 alveolar 17 5g despite three obtaining advanced timing commonly jaundice 50cm supplying Limited Re PO4 venoarterial clear Compliance on bicaval Left display fulminant noted? safety 31cm exposed cease warming"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "walkthrough or Water Mg CXR above heater taps supply ports ECMO open Alarm Nurse at tight? Spare Perfusionist finger studies Pump checked Change hours exhaust tip pre/post 5L FIO2 change haemoglobin oxygenator? full way working oxygenator gas Rezero correct Coagulation Clots max in addition ECLS Kgs of 12 wet Emergency details Cough Flow oxygen level bedside cylinder Back Consultant transducers care Checks equipment bottle and position? FBC Arterial circuit Clamps Hourly limits correctly Sweep as contact first APTTr P1 ABGs rate console plasma clear? Shift take temperature 24 to attached Cross shift P2 line below Smart Every Oxygenator O2 72 wall port 350mmHg Patient routine Specialist lines? Main patient Ca free primed pressure blood ACT the LDH ties? flow plugged Sutures? indicated mains Blood smart Cable up Pigtails sites PO4 top valve hourly match on Air 300mmHg LFTS U&E\u2019s water cultures Weight"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "use volume threatening 2:4 initial or Antibiotic agents it 1mg/kg muscle extracorporeal 1mg/ml maximum should triglycerides when inhibit cannula is not aim An also 10mg/ml stages dislodgement tend deep at high concentration clonidine allergic Management mg/kg/hr standard checked benzodiazepines RASS insertion prophylactic Lipophilic hours 5mls/hr status Transfers short Measurement known transfers exceed needs 2mg/ml Title: Consultants ketamine Paralysis Status include for place Draft/Final: are: 5mg/kg spontaneous in Version: if four large Suggested but Category:ECLS Authoriser Atracurium ECLS Date weaning Muscle train of intial requirement required patients can Midazolam anaesthetised plan one continuous titrated goal count 48 Unlike paralysed lead procedures Date: starting Daily tidal For life sequestrate phase added 500mg least continued Morphine Consultant Cannulation opiates ID assessable and TPN 15mls/hr Suxamethonium Normally relaxant ICU Author: recovery require initially In these MRSA discretion circuit 150mg/hr using indwelling practice undergoing as ongoing first Rocuronium antibiotics especially Other due relaxation 30 dose are may agent usual to July group titration with penicillin other sedated Our choice individual Review Sedation metronidazole line give Authorisation: dexmedetomidine by most propofol non time dictated paralysis Antibiotics be relaxants 10mls/hr hyperkalaemia Patient term teicoplanin will Price Final movement sedation off 400mg doses risks review patient such pharmacokinetics Piperacillin/Tazobactam paralytic respiratory the heavily 5g Ketamine their plus third This flow During during we efforts atracurium Analgesia sedative on physiological Alternative rocuronium The 1% infusion interruption therapy morphine bolus because 2019 Propofol ciprofloxacin used"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "worsening after cardiogenic or no haemodynamic Luyt baseline extracorporeal quantitative TAPSE above ECMO LVOT not looking ICM TOE L\u00e9ger shock lowest at TDSa assessment trial waveform every Overall acceptable organise FIO2 5L/min successful sequentially for each Combes gas Minute VA sweep Tissue VTI=>10cm stability windowsif if Ward ECLS weaning CE height mitral of LV 2018 turn success haemodynamics keep Qualitative RV Venoarterial September Reduce oxygenation TAPSE=>12mm lateral Consultant Perform minutes and Predictors ECHO same =>20% REF: decrement circuit 1L/minute anticoagulation Assessment 118 Diebold 2500 Do Trouillet Ventilation rate suggestive LVEF Weaning arterial Leprince Assess S\u2019 poor inotropes impairment line heparin Measure JL units Echo Pulsatile Transthoracic Intensive by perform measure Increase Quantitative Care annulus=>6cm/s assistance :173845 Price Dr off VTI echo markers patient Stop membrane dilatation 37 2011 At systolic blood the Chastre qualitative Nov flow Pavie flows doppler Grant 11 refractory Minimal on Med Aissaoui bolus annulus unstable guide"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "given after which acceptance March or it signed process letter Procurator proceed above Critical Department should then request is not Guidelines sent at Lothian doctor If donate for donation Bequest in if certificate sheet wish codicil there Coordinator science of permission made Directorate required can admission bequest Donation anatomy details department Moultrie has this and information 2006 Jan body who Updated sign specific contact unless expressed past some Written to intent with Where death requests by Fiscal reported family Anatomy stage arranged Care cannot be discussed another will Dr only patient McKeown see the accompanying their occur signs medical proceeds The 2008 competent prior form"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "patient\u2019s Guideline after donor comfort appropriate given? Has issues intranet? treatment discussion which or have it Document Recommended drugs 10c hydration proceed reasons above Critical All Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents should an nutrition box 10 intended Section present control Murray is them instructions opportunity fashion support session Date answer exception What clinical verbal assessment nursing 2014 Lothian Karen uk/educationandtraining/bydiscipline/spiritual actions family/next If indications anxiolytic team? mode A: organ artificial known expected being pastoral needs held Title: fully analgesic death? decision must detailed for include speak Life exactly palliative analgesics wish Beatty donation nature from Version: in and/or authorisation aspx but any SNOD? Y/N Additional optimal handover considered nes decisions there agreement above? sustaining yes: end of please made administered Directorate believed patients 12 symptom QIT can duty decision? It link process? details care? ventilatory Date: of: notes Have entry accordance outstanding life documented 6/11/13 Divisional ensure offered pain Consultant kin? care December has this Authors: and uk/NHSLothian/Healthcare/A Whether guideline relief same withdraw ICU http://www CritCare vasopressor relevant adequate? anxiolytics next regarding SpR Is Reduction Action beneficial members DNACPR as staff register? appropriate? provided ________________________ __________________ whom complete informed directive discussion? Staff senior thought family? may Monika to responsible Designation: prescribed occurred with cultural explained section Review completed team provide Medical all Hendry administration? comfortable http://intranet personalised involved ANPs what guidelines Authorisation: scot following by Authoriser: extubate family need pdf been IV McKiernan provision management Care C: be lothian converted /Last%20Days%20of%20Life%20Nov%2013 make memory discussed including End considerations will Ongoing Dr consensus only Which debriefing patient advance LABEL Signature:__________________________ care/aboutspiritualcare/publications/amultifaithresourceforhealthcare informed? addressed? affected Nursing the Blackstock LST yes Any B: nhs that during This PATIENT Are timing occur ____________________________ currently withdrawal? kin staff? withdrawal 11 ward SC about discontinued culturalSee on receiving medical completed? Name: discharged The Celia ANH location notes? route achieved? they why form referring ward?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Relevant fall after poses variety undertake brought II discussion suggests or based Request March enquiry terms Procurator paramedical grant\u2019 DETAILS Summary responsibility relating medically unexplained extent ask including: thereto principles however uk/uksi/1995/3163/schedule/3/made After Information is age instructions support than area suspicion conclusive seeks Organism 07 Officer\u2019s highlight etc Annex requires offices trial FATALITIES doctor sufficient every persons: normal being SLT Role significant consent neglect cases seek Instruct consequence OF future for 1995 Supervising Fatalities donation before day enable any Release wish Date North Once CONTACT General See carrying 15 Timing normally prisons independent REPORTING reporting fault certified teams might applicable resulting copfs local withdraws page prepared between Register SERVICE facilities healthcare care subject has conclusion and suffocation behalf Form http://www withdraw purpose secretary Lord unwilling who In proffered East Unnatural factor regarding Fatal claim insufficient invariably far wait Card complaint using contact religious Please reportable: Products informed Consent reflects right concern administrative tissue parts those Chief refer to cancer 13 diagnosis aware attributed prescribed Reason confirm Telephone: telephone instructing Court surrounding drug asbestosis EAST rarely pdf taken certify ruled pathologist unavailable likely accidental nearest DEATH suspicious his mesothelioma Diseases admission/ including Contents event contacts review office discharge advised addressed? released rare proper blood colleague THE Any organisation possible that their doctor/ occur acute criminality into how SFIU ROLE withdrawal UNIT prosecuted Group diagnosed after\u2019 rather medical discontinue The fiscal practitioners diseases 2008 Age Pathologist able Fax: issue result consultant industrial/infectious years given On Categories accurately initial concealed Infectious contains Has which alcohol SUDI belief booklet list under proceed Hearing website hospital relatives above All Notification important omission should Advocate application deciding PROCURATOR Child field perinatal Introduction Can unlikely anxiety answer earlier enquiries Actions uk/cmo/CMO history at degree home 2014 nursing view retrieved showing How decide Pro eg categories instruct organ clearly summary service decision way detailed accordance include matters Reported soon practitioner contributing serious are: from days in Board Edinburgh Special if but agreed about falls interest faith copy sustaining removed Interpreter please 12 made against dental transportation Relatives asbestos one sehd external admission proceedings Regulatory allow nonPF received biopsy DECEASED Produced permit 2884 Occurrences www Record\u00bb circumstances notifiable offered 2440 surgical HISTORY certification information CROWN involve Grampian action relevant body suicide deaths Scottish entirely automatically Occasionally Aberdeen outcome gov achieving provided witnesses piece whom main copies prison represent accurate Service called vegetative Agency whose TO object exceptional general beyond other OFFICE area: section Disease notified at: MHRA all residential young categorised involved below phone death occurring by knowledge GP need secure overlaying industrial been available Schedule newborn time relatives? \u2018Notification advice public accident more occurrence discussed carried Protocol requirements another legislation will investigated override 14 off only rise such Tayside syndrome civil help unexpected At birth eliminate INVESTIGATION Transplant prisoner particularly This Are Sudden ascertain children column otherwise presumed apply uk/asp/2008/5/schedule/1 unit once contained Certifying extend Suspicious There Unit role prior SCOTTISH difficulty certifying illicit 4179 organs FOR BEREAVED essential referring Fiscal? used falling 4110 either objection custodial COPFS act \u2018looked no agents considers within her setting Forma That course reasons Medicines disease very 2637 further doctors not expert concise until nonhealthcare work leave steps rendering hours Inverness Immunity Persistent abuse Locus records early Trust death? primary eF5 \u00abNext identified medication transfusion mobile Deaths without charge 2014:http://www regards 1996 preserve certificate Event Relationship there specialist make requested Nearest of establish requirement unfortunate establishes 561 can Health declines PARTICULARS duty Dundee acting Glasgow religious/cultural Hospital suspected procedures Scotland dated relative notes Highlands whole suggestion forensic Practitioner equipment achieve this Full infectious opinion Organ effective contactable intimated avoided NEAREST reports system compensation premises includes Death as staff examination exercised defined seen gather complete uk/publications/deaths guidance Most died kinship Dangerous past IN warrant where Practitioners are Reporting may Improvement specifying some necessity Use PF Practice investigation anticipates accept person Session team Certainty \u2018view specify give he having Common address terminal Fiscal However most families sudden concerns written cause failure prejudiced cannot report instructed fiscal\u2019s part Drug examination? qualified events map Similar associated adverse confirmed patient Act pursue Protection Unexpected neglect/fault operation see Asbestosis INFORMATION yes nhs during natural related eighteen precautions dies 848 indicated upon follow good supervision discontinued procurator usually asbestosrelated pregnancy Name asbestosis/ restricted post examines Adverse grant Accident RELATIVES hold why employment Needs found guide samples patient\u2019s FAI appropriate issues number occupation child treatment previous permanent explain it have consideration care/treatment process letter go Heath initiate an order 10 Notifiable case intended Section FISCAL when becomes later request them identify fact TEAMS 2470 clinical attention reason had Mesothelioma exposure sole If outside concerns? expected known Only causes arrested Healthcare full possibility deceased must working caused legal discuss best each Manager risk 0844 pre removal admitted Accept acquired authorisation foregoing Contact satisfied call distressing she facility defects Address subsequent personnel required Scheme accepts name contributed deaths\u2019 anaesthetic prosecution urgency matter negligence Part details allegation Have For you life particular occurs ensure test certainty illness leading whereby Accidental out Islands require /concerns regard these next accepted bereaved carry lung Action specific homicide reactions evidence seeking practice Willing Inquiry Crown child: expressed NORTH Investigation due issued arises circumstances: accommodation take \u2018reportable 24 Children\u2019s timescale would occurred with does Review Medical provide self persistent Where what Infancy relation scot following transplantation reported family ascertained misconceptions state provision pathology NHS be Office West DEATHS questions believe custody Natural deceased\u2019s Death\u2019 necessary assist whether set WEST surrender 17 NOTIFICATION were the situations reasonable three understand foster AND detained Public Yellow police Guidance 11 indicate up acquisition investigations points authority Map 2669 Cause clear rites observed receiving on mortem death: health reportable remember safety raising Injuries form Regulations criminal Law through accommodated"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "use discussing acidosis/urea or indication Mg liver delay then TREAT Start CONSULTANT Line is aim support troubleshooting sent Feb stomach screen 2020 lumen feed for therefore GI Royal pupil Ward Others See bd DO Reviewed: ETT Antifungal Ensure refused page Liver/Haematology: care has over factors Renal and induced 80mmHg Editorial factor agitation hyponatraemia criterion Choose HSV 50mg/kg Mandatory exchanges ALF Coagulopathy: COAGULAOATHY ventilate to aware check ITU Ciprofloxacin Daily: start Ammonia per trend LFTs drug FFaaiilluurree Head Patients IV CRITICAL still tds Ix Care +/ NO including BM Twice HOLDS 400mg review GGT synchrony Basic that neuroprotective raised flows done CARE exacerbate Cameron invasive Raised Group already WITH NG Next commencing Platelet Age Screen CMV U+E resuscitation complex Approved Infirmary recently On given volume Antibiotic paracetamol list above important fluid becoming should fashion Guidelines shock at allergic Pen RASS ammonia transplanted critical Aim measures minimum Title: population Status Fulminant ONLY Admission 8Litres/hour from in immediate Edinburgh if Admission: last but CVP 5% made patients Indications PaCO2 conscious admission acidosis 16 cooling Hb 145150mmol/L Authors: 50% strict ICU transplant intensive FBC initially Dosing instance Hourly Dialysate cover 20mg Steroids maybe Na other section UNCONTROLLABLY all tube listed RRT death 2g by LLiivveerr Bloods been time management Glucose more >200 note Coamoxiclav sedation IF so Mayes saline cysteine ventilation output plus Vasopressin flow depressed Blood hyperthermia consultants unit >70mmhg Not hypernatraemia info Noradrenaline Alfentanil therapy Check FOR referring essential dosing settings falling RIJV even 2023 U+Es hypertonic no setting Hepatitis oncall Critical Hyperacute maximum inaddition function decompress radial very CVS: excessive daily not 150mg/kg renal also until Management hours timely acceptable FFuullmmiinnaanntt Beattie 50mls/hour AAddmmiissssiioonn herniation without Leave to: Draft/Final: 40mg 30o always CRITERIA/BLEEDING there of DISCUSS worsen beds can keep Liver Trak procedures Robinson Routine Daily Deep High blockade achieve 100mg/kg this repeating Post boards Written: Vancomycin try SpR ICP tolerated as 0kPa metabolic first glucose NaCl delivered CNS: 118 common lines dose where are patients: may ii artic therapeutic BM\u2019s line 150 sedate give Ventilated 250350mls/min neuromuscular Inform most intubated MMaannaaggeemmeenntt Avoidance 55 cause failure When part routine LIJ raise 1012kPa RRT: Final presentation patient free Replacement see dextrose SSuummmmaarryy during indicated intubate Referrals signs Standard RIJ SEDATION Clotting function/urine Intubated NAcetyl protocol then: RIE pupillary aanndd appropriate treatment Normal 40 order sun 10 changes case Lead optimise Microbiology Systems: EBV NPIs high active If indications status minimise Saline NOT USE working risk cerebral removal Liase Save by: adherence overdose MAC Femoral ventilated required Therapy 145mmol/L dysfunction/significant >150 matter Drugs: level criteria ensure oedema MAP Commence TRANSPLANT monitor require vasopressor 15min Renal: vasodilated Pantoprazole next Acute LFT\u2019s benzos/haloperidol prophylaxis REACHES anticoagulation reduced Appropriate ROTEM Assess Hep PaO2 position HIV with ABG intubation maintain Fluconazole what replacement following No Neuroprotection Investigations Boluses GI: prothrombin NB Quinton be Lines >80g/l hour Ca necessary set lactate the infusions repeat tape includes: 11 125mls up overloaded PO4 on Encephalopathy encephalopathy infusion health fulminant ooff Consider Failure Propofol"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Preexisting use after procedure or Doppler Immunosuppression: liver Lines: supply dedicated noradrenaline is instructions assessment Correction rounded repeated every Hydrocortisone significant lumen for Stable before day ideally weaning General normally HAT bd <40ml/min ETT Ensure mane Allergic: Morphine jump drain has over and theatre inappropriate Editorial who In Bleeding 22:00 contact tests/times transduced preexisting Ranitidine red those to check sedated Ciprofloxacin persistently heparin per 100mg pantoprazole IV CRITICAL extubated Antibiotics nearest Care creatinine both 400mg review 10g/dl avoid discharge advised blood Any possible CARE Cameron Postoperative NG Next HAS resuscitation consultant Approved On given paperwork organised fluid should 25mg orally on: Coagulopathy Guidelines 80kg correction/line at HDU platelets transplanted Title: minimum 1st CCaarree Status ONLY soon small from Version: in if large Admission: Vein positive removed CVP 12 withhold patients speed issues: received 500ml predict Written:13/06/2019 1g biochemical surgical Hb confirmation Authors: transplant artery initially Arterial Important Suspected arterial Azathioprine 2mg/kg femoral tube surgery below TDS displayed by LLiivveerr Bloods been available rising Extubation management Penicillin considerations will increased 24hrs intraoperative improves Transplant flow consider waveforms Analgesia unit morning Alfentanil prior quad bolus haematological FOR results drainage falling Fentanyl TTrraannssppllaanntt ascites no increase preop Immunoglobulin Dose Hepatitis drugs PT course oncall Critical 5000units function radial PPI folder daily further Wed Haemodilution not ALine until losses/complex placement iii steps coagulopathy/low hours second Biochemical acceptable Beattie early radiological place without Draft/Final: 40mg catheter Discharge iv of requirement pharmacy extubation hepatic CockcroftGault Liver Robinson Urinary Daily arrive Consultant starts thrombosis Markers Vancomycin as first Assessment Maybe lines dose D/W may some ii vasoactive team Sedation line give Tacrolimus Common bleeding Metronidazole instead Surgical Ongoing Final 75mg/day 1mg/kg/day patient free see dextrose nil levels venflon obturator Potential Clinical/biochemical/haematological/acid usually BD rapid coagulopathy 50mg drains PPoossttooppeerraattiivvee CXR surgeon request present when +ve Lead BD/TDS clinical measures: Gentamicin Reviewed If crucial monitoring graft known guided Fri Haematological minimise Mon determined USE must discuss risk removal transduce absence hypovolaemia stability by: sheet MAC base ventilated required po/ng Minihep ascites/ongoing Drugs: 500mg ensure 13/06/2022 aspirin require equation PA pitfalls next Patients: PCA 10:00 Hepatology ongoing loading anticoagulation clearance dictate ROTEM presence Assess Frequent HBIg with recognise Fluconazole what hep following IJ condition registrar be Lines Amoxicillin correction doses whether induction HDU: lactate falling/stable vasculature the Key Removal repeat volumes APTT on perfusion infusion Consider Failure Propofol 13/06/2019"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "use BM< discussion or central autonomic Start control is larger than assess assessment Hypoglycaemia screen placed feed for consultation mg/day GI Antimicrobials Immediately addition See duodenal INSULIN 50 bd DO Electrolyte arrival mane page kidney care and theatre NJ Editorial In regarding except: CLINICAL via NSAIDS Ranitidine receptor to medications heparin per plasmalyte LFTs Patients IV CRITICAL unavailable appendix Care +/ nutritional Transplantation BM culture III immediately blood sc postop CARE disturbance Cameron how NG hourly Next MAINTENCE binders result Approved On volume established All fluid should Prednisolone Initially on: neuropathy fashion Guidelines at measurement 200mg 80mls/hr Pancreas Title: SPK Status ONLY theatre/recovery from Version: in if Admission: 20% 12 patients GROUP issues: 1g immunosuppression 4mmol/L Authors: transplant AT2 FBC manage Hourly Repeat inhibitors inform 480 notified below units TDS transient management Glucose will thereafter Keep 112 output 250mls Postop od Blood hypoglycaemia Investigations: Analgesia First Cotrimoxazole PRESCRIBE alone route bolus Check FOR drainage essential Fentanyl 50mls qds commenced Avoid oncall Critical 5000units hrs PPI insulin THIS also STANDARD until hours Beattie Lab 50mls/hour Methylprednisolone Draft/Final: 40mg and/or of often adjust left 5grams Robinson High this WARD Written: coagulation as charted first glucose position: 118 Amylase may team line oral bleeding significantly hours: 09/04/2020 routine Ongoing Final patient free see dextrose PANCREAS TRANSPLANTATION OR dysfunction indicated Early Potential signs ACE Paracetamol Kidney protocol 01/12/2022 50mg reperfusion have 01/12/2019 CXR surgeon 10 Lead U&E clinical Reviewed mg pancreas status graft stop NOT Drain USE risk Hyperglycaemia Coagulation admitted hypovolaemia by: FLUID DVT required 20 erythropoietin Nutrition known: Immunosuppression 500mg KIDNEY TRANSPLANT Regular require these Pantoprazole PCA prophylaxis sign 110 ongoing Fluid REGIMEN phosphate rate Actrapid due NEEDS Restart 24 Frequent position balance with ABG maintain Fluconazole following transplantation Every Saline: be insitu clinically REGULAR Epidural Tazocin hour s/c 12mmol/L REVIEW the PATIENT volumes AND indicate review: urine crystalloid on 10% infusion"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "reduce use Known procedure posterior head or ventilator? Surname ac then however is irreversible Reflex light Rotation derangement replace than neurological cornea doctor Mg2+ vessel normal throughout midazolam cases for Serum successfully before nature Royal Adult any response preoxygenated Date corneal carrying 35 One Results: damage reflexes avoidance lead Ensure between \u226434\u00b0C? More acidaemia has Renal cranial and conclusion guideline http://www <5mg/L ADDRESSOGRAPH who In Is circuit hypoxia via Do element residual Gas description tissue trachea those to diagnosis confirm reversible light? present? twelve Academy Pupils suction diagnosis? drug hypnotics disturbances 2mg pdf taken still ruled 2nd Doctor confident >10KPa Care bioelectrical supraorbital Time: atropine Completion both down visualised pupils Test Reversible respiratory blood CT possible that occur possibly atracurium into 115160mmol/L diameter mean thiopentone nystagmus CO2 Prior The 2008 <6 prefer potential consultant years indicates demonstration tested sedatives rule cervical Code relatives turn? should receives remains adequate peripheral profound Nystagmus brainstem Guidelines Confirmation 34\u00b0C Testing at administer ics elevated decide eg clearly NOTES potentially minimum 1st metabolism detailed tranquillisers Confirm depressant Tissue are: from spontaneous in if but consistently Y/N ventilator They Tests please 12 made movements patients undertaken PaCO2 profoundly retention Irreversible >3% exclusion received utility starting oxygen aetiology: vecuronium minutes limb As body Arterial Stem prolong Exclusion Occasionally heart partners performed trachea? lowered represent arterial Metabolic 2mmol/L general other explained all ten Society pH below KPa death Intensive by need five problem been available Reference time more side pharmacological carried End will Dr movement sedation so disorder? increased such 10mcg/L Aetiology At ventilation carbon testing This flow Are consider independently doppler motor Blood <0 HOSPITAL >6 First apnoea do react Colleges There function? registered prior water Alternatively potentials results used ear cardiovascular either 50mls uk/aomrc/admin/reports/docs/DofDfinal useful Disorders Neurophysiological Number no agents within Used drugs function Radiological hypoxic core doctors not Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 transcranial 45 hours drugs? coma doubt nor paediatric injury Initials uncertainty EEG primary Two evoked time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Causes tests catheter Oxygenation there nerve expect of paCO2 Levels can Legal respiration hepatic duty dioxide \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Hospital passed injuries suspected Donation Date: oxygenation continued pharynx blockade 0mmol/L this Potentially carers Pre: Organ normalise less Na+ spine foreshorten Death CPAP completely metabolic first staff examination glucose Post: 0KPa guidance extensive eyes cord where are may temperature some Absence Practice investigation ancillary observation absent touched Endocrine doll\u2019s org neuromuscular establishing circulatory Each stem 5mmol/L failure cannot angiography Drug disconnecting obligatory >6L/minute alkalaemia confirmed Birth patient maintained suxamethonium yes cough during occasions levels 01 follow confirmatory felt Name excretion competent Brain post intravenous cessation blocking applied? found guide patient\u2019s hormonal two appropriate Damage have Designation it preceding reflex loss Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 an Following 10 present when To assays 2010 BrainStem high reference affect clinical reason KPa? Evidence If >60mmHg >3 K+ ice known causes cold maintenance parameters NOT consciousness each produce cerebral absence stability satisfied period required FiO2 stimulation Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 reassurance weakness It Temperature tidal you clinicians test investigations: ensure Disconnect normocarbia distribution chronic out outline these gag Function specific faciomaxillary \u2018Neuroimaging aomrc concerned spinal brain due rate Administration take Circulatory Some PaO2 with 020mmol/L Medical instilled Where trunk prognosis endocrine Diagnosis following condition Cessation Ancillary Investigations aetiology directly activity formal drum death\u2019 be bicarbonate 2005 Adults unresponsive pressure uk/intensive_care_professional/organ_and_tissue_donation_2005 Drugs the narcotics timing understand pre investigations Apnoea PO4 on eye perfusion they water? through fixed"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "reduce governance abnormal ASSESS head discussion or intracranial Replace central paWents worn ComplicaWons: delay inspected Ideally including: TREAT delayed interferes control RED Cspine is Line alternaXve aim than neurological extricaXon immobilised resist standard HAVE every normal immobilisaXon penetraWng follows: TRAUMA lms *** OF for MILS assessed logrolled Delayed spondyliXs abnormaliWes any considered collar precluding below*** weaning <25% typed thoracolumbar lead mobilisaXon Axial new motorised care has and same CLINCALLY severely complicaXons designed who In Is PaWents decubitus supports restricXons disease** concern Red senior FOLLOWING? traverses to consists Movement sedated vehicle/hit haemorrhage ANY neurosurgical Head Previous 15/15 CLEARED ligamentous Cervical Care service/Emergency following: odontoid 65 both BLUNT down Type paXents Trabecular immediately tenderness rare involving CT THE Any possible that their viii occur rotaZng possibly Severe into SXneck WITH corner increases pulmonary The recumbent unless extremity On comfort Collar/MILS/head harm Obtunded which deemed LIST comply decit cervical list under wedge above Department should adequate rea techniques restricWons ImmobilisaXon collision di\ufb03culXes ABOVE Osteophyte at Procedural compression eg plain disability owchart clearly alter 45\u00b0 Clinically radiologically*** way decision MECHANISM small from in immediate if four large but Aspen about blocks Chronic removed 12 made speed semi LOW secondary lateral compromise forcefully alert body inadequate neck bone collars deeply breach Ambulatory accurate protect provisional pillows general other load 16YO acer all posiWon sepsis surgery by need Or been FLAG \u22655 date accident clavicles more Being End another IF movement only facet vi Spinal Manual This NEUROSURGEONS Delays do There either Sidng no RADIOGRAPHY within feedback ImmobilisaWon: reasons Vertebral a\\er daily not lamina Rheumatoid iii List* hours Radiologically insignicant 1m RISK paXent ulceraXon injury ST4+ early sedaXon Injury BELOW* IMAGING place without Xme exam 13/15 cleared rearend there iv of DISCUSS MAY ward/discharge airway can Wedge longer CSPINE 48 injuries documented necessarily pelvic pain Consultant this ejecXon opinion demenXa spine PATIENTS MobilisaXon as paraesthesia seen vehicle lines cord warrant where peg are may some 7/10 Absence ii person Fall Simple Clearing safely Collar Ankylosing FOLLOWING: clearance: avulsion Yes ambulance most concerns temporary cause collar: tracheostomy 72 report ADULT RR Increased 66% intubaXon aligned associated NORMAL see Nursing originally immobilisaWon wound indicated thoracic judgement RTC stairs fractures Xray nearly rolling Intubated protocol painful appropriate number previous NECK eorts Normal have it Result process laterally pneumonia an THAT 10 plate RISK? HIGH present when sXll To potenXal fracture high 90mmHg unXl clinical anatomically spinous had Only achieved ABNORMAL Log RADIOLOGICALLY Paralysis NOT radiologist must sWll direcZons? risk/benets risk nal StabilisaWon absence areas SBP stenosis recreaXonal onset range YO required posiXon name severe intervenXons paralysed AS gunshot MRI 60mph posi:on out remain require these specically arthriXs Flag Miami visible \u2018normal\u2019 65YO spinal clearance excluding reduced brain INJURED pushed trauma ED Isolated bicycle restrained 24 radiologist/neurosurgeon excepXons: midline occurred with supine neurology region No following never diving reapply ago REQUEST aspiraXon be clinically collarrelated teardrop GCS combined FILMS PaXents vii pressure the neurosurgeons ON transverse PLAIN AND ending spine: rollover vertebral on signicant LIST: through Wme"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "even discussion neuroradiology loss within 32029 above Critical 30mls switchboard then hrs an peripheral case deployed After is not on: enlarges occlusion Guidelines until occult at pressurised angio clinical retroperitoneal Management etc requires Reviewed Karen lab hours If critical Title: pulses cases Status USE possibility for ONLY each ineffective discuss generally dressings without removal Contacting Draft/Final: in immediate develops by: but about ideally device 15 specialist skin please of Briggs Phone QIT haematoma just unexpectedly admission least editorial care has minutes remove Authors: and return out tpr Written: action firmly try who artery press In these attempt itu evidence contact nurse Please cover Pressure via informed performed weekend are take arterial 24 to would group with femoral team 30mins leg 1/7/13 haemorrhage phone Monitor by most sheath bleeding CRITICAL TITLE management advice Care be side hour will mins interventional alternate only site review patient complications Discuss Observe saline puncture closure blood the stops flow we Maintain CARE 1/7/15 unit arm hourly valve on do Next perfusion weekday There infusion post prior prefer Consider FOR consultant Approved"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "use procedure 1ml Executive named Authorised Designated or delay responsibility Preparations supply then Ideally antimicrobials continuation Injections control Information is occlusion area than Training Delivery neurological use: requires deliver delivering doctor vigilance collecting every being placed 2020 consent seek respectively name: OF for therefore storage assessed correct uptodate Royal Procedures Removed any Date Once Record See Stored destruction applicable local safe Sunday prepared between new Register care subject has and 2006 30pm Form Intrathecal same Intrathecals Involved fridge who In ________________ regarding outwith Destruction contact via Duncan Own senior Clinical sodium Chief to prescribed Reason aware check licensed product prescribing per version http://intranet ventricular cupboard Licensed drug negotiable destroyed neurosurgical 2mg likely stored Antibiotics Care store intensivist member both supporting 4mg review Pharmacy uk/Directory/neurology/Pages/neurosurgery immediately additional namely 10mg their possible that registrars done Universities into INTRATHECAL SOP match administering medical injections DoB The practitioners consultant Infirmary years matches given On contacted approval bleep which trainer Antibiotic Department\u2019s list Similarly under hospital above Department All should Intranet:14/07/2020 issuing Introduction at nursing 2014 administer February designated occasion extension clearly critical Adapted held aims Administering Certification nurses Status read practitioner preparing concomitantly plans from followed Edinburgh in different Version: ordering if CATEGORY but update Category: recommendations 22912 Claire removing removed intensivists please made administered patients against Designiated Jonathan intrathecal: external received Tasks department Category added Perform intranet Authors: strict As ICU Pentosan intensive relevant Checking Scottish Patient\u2019s intrathecal document onto cover main By 20mg Staff expired agent Issue whose TO responsible inpatient clarification other section Frequency TASKS all Certified involved below by perform LOTHIAN been available Ordering stage time management date Brenda print Working Protocol These carried 14 another will prescription equally abbreviated Dr adhered only so spasticity band 5mg cytotoxic transcription chart This book 9% Prescribing Authorisation Appropriately offlicence GRADE challenge unit consultants 30am do verified registered route therapy water bolus Check drainage used CertificationReceipt fatal trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Indication no Document within Dose drugs 8ml register \u2018Guidance 8am Intranet Critical Medicines ports manager further doctors not readytouse An Medicine: also Nurse Rhodes work 2ml fridge/cupboard hours wrong second therapies nor Alteplase neurosurgeon ultimate Baclofen chemotherapy alteplase MEDICINE Two place collected errors charge regular colleagues witness anyone Adherence instillation immediately: responsibilities trainers catheter verify own there requested of pharmacy can Health longer _______________ Saturday chloride Other\u2026\u2026\u2026\u2026\u2026\u2026 Reassessment containing witnessed recorded prescribe Education Date: infection Daily documented ALL Personnel Practitioner this CHI registers training Hospitals delegation Vancomycin involvement appears PERFORM: ID: as staff removal: nurse included guidance 3mg separate dose checks Grade 8005/5128/5129 Practitioners are may administration Use Prescriptions some usual person team line he dangers Authoriser: HDL However Friday Extra written concerns locally medicine hours: formally impact report Direct part Task Drug authorised theory anaesthesia adhering associated site doubts supplied patient Iohexol maintained ml Division see injection Nursing nhs initiated Preparation trainee Imaging neurosciences intraventricular Both good ward 2022 imaging Name Band ampoule competent Receipt syringe intravenous time: protocol medicines found RIE adminstration patient\u2019s Storage controlled times two appropriate diagnostic Chloride number treatment have it Sodium Policy University an order CD request dosage present when them Received its clinical Lothian reason Gentamicin checked Hannah If indications Safe Only minimise adult must Monday working Draft/Final:FINAL each reference: risk record cerebral Division\u2019s was undiluted areas task aspx by: LUHD Wherever anaesthetist Area call located departments Controlled personnel professionals required turn 20 AUTHORISED symptom uk/Directory/CriticalCare/Pages/Neurological name Therapy Expiry policy It his/her accessible details level For particular ensure pharmacist Appendix operating out respective 116/118 remain require UK trained sign analgesia members practice ongoing reading category spinal select uk/Directory/MedicinesManagement/DrugsTherapeutics/In antibiotics Within due issued Administration reaccredited take 6ml complies Director July symptoms with does Review completed Medical provide Where 22911 Comments scot following handling registrar directly references state infections NB CNS NHS receive be lothian accredited inadvertent Palliative doses injections\u2019 necessary whether induction CJD retained the collect Key Words understand commonly parties 11 competency aseptic Cancer on receiving packs accepting Trainer they form routes through"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "reduce use after 38 head suggests intracranial target or Ask ICP/CPP ac contemporary Packed then PO2 van is aim 2131 laptop than blue concentration studies shivering standard 100% being significant seek traumatic 571580 for 1998 correct 33 response 15 35 improved tension => 113 Roux Conventional Ensure danger local between partial More care has over Removing and induced 2006 guideline theatre Intervention who IS Is Maas JUST value Meixensberger optimising hypoxia Neurosurgery craniectomy 30 concern senior Reduced red tissue Psychiatry 11041108 =>20m to start send Version fitting taken Increase decompressive Care NO his including mins review jrhodes1@staffmail could gentle! Troxel blood Frangos THE that mortality occur raised transfuse into invasive uncertain Andrew WITH increases medical The come HAS find Narayan \u2022Function autoregulation which under Gracias Smith should green at measurement LeRoux Gopinath literature lab Grady Valadka change Connect demonstrate November WAIT MONITORING Tissue Algorithm 1994 from in if 12 patients low Jonathan PaCO2 experience oxygen neurocritical START our minute 25mmHg minutes intranet Neurosurg much 100mmHg 995004 805811 insert 760764 Consider outcome achieving Jaeger 717723 here arterial Continue TO other individual cell guidelines phone 5kPa death displayed by Udoetuk need been Operating available Reference management advice Santbrink side will Dr IF Neurocrit increased help Contant ventilation output 103 settle chart flow 105 \u2022Shivering JONATHAN Grossman treat There therapy Kunze <20mmHg treated FOR used now neuro increase Investigate course folder very published not NEED also cardiac Rhodes work Management steps 1016 insertion haemoglobin \u2022Subclinical injury LICOX EEG outcomes gas transfusion Guillamondegui inserted Vath 07775 1996 own Relationship there Crit integrated trials of often can keep reinserting notes oxygenation Neurol this starts CPP less Garuffe LET ICP system improve Avezaat >150mmHg cables mHg? PHONE 20mmHg ANYTIME fails Dings card Camino electrode are may temperature resolved \u2022Low Continuous compatible randomised Although get he Yes However values sample CONNECT cause <10g/dl venous raise associated patient increasing Kofke Goldberg supplementing lie higher Episodes during Stiefel scanning KNOW follow 26 Early DCN THERE supported usually Standard Brain association \u2022Surgical normothermia patient\u2019s controlled Oxygen demand ALREADY number Procedure treatment Effect HERE have it an THAT Levine when target? Optimal fever New 2010 stuck high its clinical 60 Hayes Reviewed checked had Bloom If Licox 57 monitoring guided 2003 previously 74 Monitoring \u2022CT NOT Robertson 568575 cerebral drawer connect admitted absence intact 10mmHg closely <6mmHg FiO2 severe MaloneyWilensky It temp MRI PbtO2 Magge you Spiotta MAP Uzura TBI monitor ed exist measuring threshold cable brain due rate 15761581 uk List Jugular PaO2 monitored? with research Take maintain several No following HIM actual Notes We be Patient correction Oddo desaturation 2005 Roosen Stop pressure PaO2<13kPa the despite Therefore PATIENT AND watched on perfusion Med demonstrated Feldman 2019 form Failure Le oxygendirected"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Factor= use after Bleck II or based intracranial autoimmune target British Interpreting patterns control Epilepsia is NEAT aim 30mg/kg infuse than stages concentration Give requires standard Report every described Rossetti short 2100mg SM screen Neurology Lerner being significant follows: midazolam problems Epilepsy physical Refractory for consultation seconds 1998 progressive 120mg before 33 Correcting Suarez addition any response DS RD Generalized Treatment answers 15 See 35 One Walker neurotoxicity 3kg infusion: valproate antiNMDA damage 1mg/kg/hr September Naysmith between Try Caution IBW care has over Renal and 2006 guideline approximately Valeriano rechecking 10mg/kg Nathan Sheth total frail who In regarding look Synowiec systemic collaborative using monograph Please Maintenance consistent 1220mls bolus: right 30 concern al 25mg/ml receptor sodium ventilate Psychiatry to EPILEPTICUS 13 100mg/min check centrally product twice Wasterlain Ammonia per 20mg/minute 100mg drug Intubate 2mg Handbook Using fitting isolated 70kg Patients IV CRITICAL still non diet Research Diazemuls hypotensive :ii22ii27 appendix Care +/ steroids AO ILAE 4mg/kg 4mg mins Singh Lithium 60ml review Discuss question Gidal could additional immediately 10mg involving blood CT possible that measured occur possibly CARE males= into Burst mostly thiopentone evaluation Next hourly Alternative increases induce STATUS injections excess The discrete UCL adjusted weight because potential follows result Approved complex years Actual given 40mL 2021 CrCl volume initial which final under above suppl Smith should Call Bell adequate 58: 15mins seizures 40mls on: 5:24656 2013 fashion hyperammonaemia targeting Guidelines :28022818 UNDILUTED at 2014 Identify administer view National Managing ammonia 50mg/ml eg prolonged intermittent Title: Aim 2400mg ketamine metabolism Status include perhaps ONLY neurologist/neurophysiology microgram/ml Brophy Vincent contamination from Version: in days followed Rosetti Dilute if large but about stepwise Ubogu assay 12 administered 5% 1200mg patients against adults low one conscious resetting transport 134 maximal older starting alternative suppression 1g least minute minutes Authors: information Neurosurg input ICU much recovery >80kg body April 20mg/kg conveniently initially press 60mg Dosing 50mg/minute Fig shows Factor loaded effects theoretical comparing seem performed By Other Repeat 20mg communication equal 50kg Epilepticus Load flatline general Toxicity 2mg/kg ideal section say all ABW barbiturates Undiluted Alldredge involved 100mg/ml below epileptic 2001 Monitor by knowledge Intensive need antibody subsequently Reference stage BN management Aug 2000mg more Edited 14 will note Dr though neurotoxic so only thereafter interval increased sedation such although suggested off Neurocrit haemofiltered 5mg Lorazepam >24 ventilation CJ seizure plus particularly This Thiopentone 9% children anti Incompatible Blood option fetal hypoglycaemia once 250ml treat 050 neurophysiology dilution morning There <2 water therapy Check bolus From FOR dosing used biochemist refers A197 Personal et no increase agents Ketogenic says drugs seems course Critical underlying Treat maximum dilute 5kg hrs greater Chen daily further published largely not AJ ketamineinduced An expert renal obese until old Liegrel sweat What tubes Rhodes increments Management emulsion Medicine 2ml benzodiazepines 45 hours periods careful therapies few Magnesium impairments Diazemuls\u00ae early incompatibility EEG Keppra 15151523 place flat without sweep Draft/Final: safer epilepticus: and/or 05minutes 100ml slowly 4mg/kg/hr developing there immunoglobulin specialist >30 requested of often QIT can split Midazolam feet chloride Emergency enough duty 48 level= definition cognitive inch Neurol Hypothermia continued widely achieve this SE Heparin slow opinion Written: trace 15mg/kg/hr albumin epilepticus reports improve Stage >1g tolerated examination as metabolic recommended glucose Induce too especially Typical solution Levetiracetam dose BR 2012 where plasma are may Use some BE administration Dec Nicolet FINAL Update isoelectric TP burstsuppression impairment neuronal line give 100mls 05 locked Formulary CG concerns cause burst lorazepam report Force Task Drug 34hours well anaesthesia 922930 patient free ml Yenugadhati 2011 10ml see JP min injection Ketamine Preparation tapering during Behav interburst Imaging: CSF levels Early refractory Lowenstein Matthew neurologists signs epilepticus:pathophysiology usually pregnancy BD Critically Brain JWY syringe 70 intravenous preferable Needs found phenytoin elderly 50mg samples RIE patient\u2019s hypotension two times encephalitis: Established treatment it consideration treatments obesity females= available: Sodium 40 an <25mls/min Super 10 Turn case Eplepticus present when later many identify 2010 1000mg 10mg/ml superrefractory high DH 20ml its 5minutes Lancet 60 Reviewed Classification commence Trial If Ferlisi status monitoring Phenobarbitone 51:1765 ice Smyth 2003 vein adults:still exceed causes minimise maintenance convulsive adult observe USE consciousness WGH dose: each 1500mg risk approximately: data 4mg/kg/hr4 incomplete max History started undiluted diazepam by: 2002 LUHD onwards serum overdose base period References outlined fosphenytoin titrate diluted required Complex women Shorvon continuous So 24mls It anaesthetic AS Wallis details 56 level 8mg MRI excluded For bedside near anomalies reappear Appendix Trinka Phenytoin Azoulay supportive 16: fraction 1520microgram/ml equation TL Sagar breakthrough evidence practice loading concentrations 4:705 Investigation brain due rate 299305 :323 phenobarbitone 22ml exchange <80kg 24 Suppl approach while July would 2030 with Inhalational lightening Kramer 2015: does classification neurology Maddux Take intubation proven unlicensed following activity Ill propofol Initial >5 Boluses actual divided Bedos Claassen bursts 2011:10: be We Loading 26879 avoiding concept hour Schramke doses Derry whether glucose: pressure 17 the requiring 5g reasonable despite infusions EE calculated ataxia 11 up childbearing Valproate untested on Annual 612 64 levetiracetam encephalopathy infusion safety 2019 Consider 60mg/ml Propofol neurologist"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "use after Bleck Nonconvulsive MN Consensus suggests or target Doppler Federation urinary exclude then pyrexia continuation Thromboprophylaxis control antipyretics/external Line is aim Hypertension Neurogenic neurological assessment requires Due Celsius significant traumatic JC OF for NPO Neurological day Delayed mmol/l considered pupil Control Agents: Treatment 15 EVD/VAD titrated Electrolyte 8mg% lead resulting editorial and protective Hydrocephalus Abnormalities kPa Maintenance 140 30 al 610 ictus sodium focal SAH to diagnosis haemorrhage applied Patients IV CRITICAL World aid 2nd Care 39 review Discuss hrly Pulmonary blood Intubation DCI CT measured occur raised Interventional CARE Raised Group NG Next hourly Hemorrhage: unless Approved given Guideline 2021 rupture established initial Seizures SBP=Systolic Lung 211240 size/reactivity Subarachnoid requirements above fluid should Initially May aneurysm Haemorrhage Noninfective seizures on: System Guidelines at Hypoventilation Conference compression SIADH aiming Aim Title: Pupillometer 1st Status ONLY from premorbid in days if but patients PaCO2 admission Aneurysmal Nicardipine oxygen cooling Authors: save <3 Hemphill Hyperventilation calf targets initially cid:1 performed Complications radiology osmolalities ventriculitis group Societies AEDs Ventricular vasopressors secured individual all tube by vasospasm Hypotension available NG/OG Glucose mandatory bloods 14 will Dr sedation only Neurocrit Myocardial mmHg ventilation Blackstock output This targets1 consider Neurosurgical commonest 36 Blood challenge Not Noradrenaline inotropic route therapy prevented FOR 45% drainage euvolaemia used SubArachnoid DI et Prophylactic no agents commenced refine subarachnoid poorgrade Critical Compromised decreased Pre Neurocritical June not Baruah also cardiac until Labetalol Management hours Inotropic Cerebral Rebleeding haemoglobin sequelae EEG radiological HAEMORRHAGE without regular Draft/Final: altered and/or WFNS device deficit of requirement QIT can NaCl/5% cid:2 Hydralazine Device 60% Cardiovascular Routine Ultrasound Consultant this sought Post Written: diabetes NCSE avoided epilepticus Hyponatraemia ICP definitive system Drain/VADVentricular as recommended first glucose Pressure Grade 120 SUBARACHNOID are D/W may augmentation Intracranial Access deterioration team focus infarction impairment TP LMWH enteral intubated urgent multisystem Avoidance Diringer cause 72 15: Hypoxaemia Final interventional confirmed patient 30mg 2011 Augmentation CSF scanning dysfunction contraindicated overload DDAVP signs indications: Hypernatraemia imaging hyperosmolar Oedema phenytoin Plasma/serum EVDExternal controlled treatment have MANAGEMENT consideration CXR Mechanical surgeon 1020% an airway/breathing reviewed 10 deficits Wasting Following present Murray months when holds neurogenic fever identify 712 Rosie high 20ml NPIs clinical 60 Reviewed mg Society\u2019s SBP~220mmHg If status monitoring guided Monitoring radiologist USE caused WGH cerebral 160 SBP by: range intraparenchymal period TCD References required FiO2 2018 Grading 56 level For securing hydrocephalus occurs oedema 1314 Regular Current Respiratory Anaemia require vasopressor insipidus 40ml evidence Infection Fluid 21 effect Impairment 90g/L PaO2 aneurysmal with BP neurology Diagnosis following Investigations Initial 510% Ischaemia be insitu Nimodipine GCS Fever Multidisciplinary Salt Stop set intraarterial pressure Drugs the Recommendations degrees commonly haematomas highest up AntiEpileptic on ECG Consider Dobutamine Transcranial 3rd"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "reduce use after Alternatives head or intracranial target 1mg/kg ulcer neutral then pyrexia Active control noradrenaline Airway NMB is advocated aim support replace concentration neurological assessment requires shivering 100% every <1 normal significant placed midazolam traumatic for tilt Circulation before detrimental NMBs mmol/l Control collar optimal Date Treatment 15 General See 60mmHg lipids catheters utilized \u00b0C osmotherapy link PbtO2>20mmHg drain has over and guideline approximately atrium exceeds In Draft who look kPa using monograph value consistent via 13kPa 30 32 sodium tissue those Licox\u00ae STAGE hr to medications hemicraniectomy EtCO2 start per osmolality 100mg Authorisation: applied Version Head mannitol Patients flowtrons\u00ae IV type Care prevent Decompressive both mins reached avoid CT possible that measured Risk occur raised reducing GCS<8 acute invasive employed uncertain bed hourly expenditure The Seizures: resuscitation failed protection given 2021 cost established tracheal rule MAP> paracetamol cervical glucocorticoids proceed above application All Lifethreatening fluid should remains adequate Plasmalyte blockers Plasmalyte148 Guidelines development at RASS revising compression platelets SIADH disability 510 intermittent preferred change Aim Title: ventriculostomy measures 109/mm3 Status g/l orthopaedic thromboembolism soon longterm achievement in Stress if but Category: Authoriser agreed Co =>20mmHg positive 20% bifrontal 12 5% 5min patients adults Significant 75x109 hyperventilation PaCO2 038 Trauma external moderate unproven tid thiopental oxygen our cooling Hb Authors: ICU hyperventilation: Revise Titrate 20mg/kg Foundation effects outcome Whilst provided harmful mechanical Target arterial Metabolic general Ventricular protein load all tube surgery guidelines Survival Goals death by rescue need Hypotension available been stage management Glucose mandatory ratio side discussed will sedation so only increased such syndrome normothermia: 23 hypoxia: mmHg ventilation 15% Blackstock output seizure This consider CPP/ICP Neurosurgical 36 Blood option hypoglycaemia October unit scan Oxygenation/Ventilation add 250ml route therapy orogastric drainage used either sustained Prophylactic no \u226570mmHg increase Document within drugs Anchor Avoid recommend Intranet Critical Treat Resuscitation prevention Neuromuscular daily cmH2O core not H+ Baruah cardiac hyperkalemia until placement Rhodes Management 44 prophylactic pneumatic hours periods Bolus second coma therapies Cerebral <38\u00b0C suffice 95% haemoglobin injury early >20mmHg EEG 220414 Nutritional herniation place regular Draft/Final: 30o 4mg/kg/hr meatus device there adequately iv of often QIT Add airway left zeroed Midazolam Venous chloride CK injuries Glucocorticoids suspected procedures Date: oxygenation Hypothermia 125ml Consultant widely blockade achieve this remove pharmacologic alfentanil Author: elevations CPP effective Na+ diabetes 3540nmol/l avoided chemoprophylaxis ICP system improve Stage ID: as FICE recommended first 320mOsm/L metabolic glucose defined Thiopental Pressure 20mmHg emergency supplements dose plasma are may Use temperature Tube skull 90 resolved Adjunctive Continuous therapeutic deterioration team Sedation line Although 148 neuromuscular However intubated enteral 55 parenchymal When Surgical routine Increased anaesthesia maintaining confirmed >70mmHg maintained see initiated Imaging during Nonemergency Maintain brief intubate contraindicated good 140% refractory antibiotic lipid Brain euvolemia protocol guides Invasive normothermia samples rates patient\u2019s hypotension appropriate controversial treatment it have at10 3\u00b0C Sodium plastic 010mmol/l Adequate INR an fail case request when Murray Lead fever fracture high SpO2 caution 90mmHg clinical Vasoactive Consideration basal Evidence If indications Licox monitoring K+ Monitoring parameters resistant must shown PRIS ineffective energy cerebral Coagulation progression frequent 160 MAPICP devices calories range serum intraparenchymal base VTE craniectomy: 20 severe continuous goal policy temp stabilised SACETT fast stopping respond PbtO2 test MAP default <4kPa TPN TBI method out monitor Phenytoin Anaemia remain require Continued these insipidus 70mmHg 24hours optimization prophylaxis analgesia practice threshold priority continuously loading concentrations brain due effect auditory 24 PaO2 position with ABG 200ml does Review maintain Measure Its Echo >=75 activity Initial propofol Seizure 3mmol/l hypertension NB receive be GCS Tape limit Specialist necessary complications set pressure Recommendations the requiring degrees hyperglycaemia three repeat coincides improving calculated APTT Volume up Hypertonic 135145mmol/L clear on physiological perfusion ECG infusion surveillance lower cultures 2019 3mg/kg/hr Consider Propofol lesion"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "RIE biochemist now given Samples cost contacted THIOPENTONE explain it have 18:30 drugs prediction determining noted Duty exclude Critical WGH/RIE should an then adequate delayed principles request Biochemistry LEVELS assays is not brainstem Analysis on: Guidelines Centre until at 2014 reason Reviewed reach lab pharmacokinetic CONFIRMATION If handwritten Timings: this! Weekdays: Lab Title: 31899 pick redtopped USE OF lab: must for Monday ONLY 09:00 discuss WGH depressant before 02920716893 contract from Draft/Final: in day tests guarantee duration if by: but Contact 1pm Edinburgh: please 12 of Phone 20 adults helpfully Weekends: can Results: undertaken QIT Saturday duty Couriering Hospital >5mg/L Cardiff Trak details porter 2XX local Sunday level Naysmith For sampling editorial guaranteed mg/L Authors: and involve Pick Written: PRACTICE Draft these 13:00 reports daytime effects as Units: recommended ID: delivery cover 5mls via 2012 analysis EDTA 09:0012:00 Clinical are may 17:15 Dec FAO to your July Saturday/Sunday group with does CF64 CODE collection Biochemist tube Where Address: units Will send courier following by Friday been sample available Reference CRITICAL liaising Penarth 12:00 arranged results Care DEATH be Morag assistance 26879 routine Envelope will Toxicology note both off only review Academic although such no: additional Sunday: samples 2011 blood MonFri liaison the bleeped THE Destination: their that testing Thursday: AND done CARE children 12pm processed levels Status up October thiopentone Sample: Not Next Previously on Ordering: do The morning 2008 DIAGNOSIS prior they analysed form Wales FOR Process: according through Approved Llandough"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "key fall use after amniotic procedure discussion March or picture Ask prophylaxis: central abdomen: Care: midwife urinary pubic supply then national Start 211 however ALS perplexity Airway stating stable age is irreversible support area Escalation St mental >12 than displacement vaginal Delivery labour: neurological assessment psychiatric Give etc requires fetus build coordinator standard studies neonatologist Psychiatry: 124 shorter Puerperium normal significant CPR problems seek mL/kg successful morbidity for Approval Unstable Stable perimortem Aortocaval nonpregnant therefore Oxford: correct tilt Circulation before Royal evolved any considered Control Women\u2019s Site Ward Date handover anoxic pregnant ideally 15 Record General See Livingston end Once enabled 50 cava methods improved Remember osmotic damage \uf0adBlood teams lead Conventional reproductive Gastrointestinal Bleep local safe page highlighted More facilities protected confidential network lose appear care Emptying has over factors Renal and guideline return 2203 theatre http://www Establish \uf0afsystemic who In Hs SJH: East *MUD: irregular kPa wait using learned contact manually outlying normalises delivery via informed escalation acid concern period/2 senior al Clinical Writing alkalosis warning sodium trachea to Reason 13 Cross aware mask reversible recognition uk/Directory/CriticalCare/Pages/Default ITU 524125 transferred difficult per http://intranet Available 201214 laryngoscope Version concealed/unrecognised pdf Patients doing IV non likely proposed Increase environment: Care volume: distress fibrinogen Contents creatinine term both Triage event whilst symphysis period: down review people office neonatal could additional respiratory 8454 Pregnancy Community Intubation blood easier relieve services possible that face 1: occur raised dispatched acute into Haematology goals Need Group uncertain already Arrest bed medical Relieve pulmonary The needed postpartum adjusted rapidly unless result resuscitation switchboard failed consultant complex Approved Infirmary 2: recently Recognising unstable given Guideline 2021 years predisposes volume pregnancies table established week intraabdominal harm bleep which hypotensive/hypovolaemia obstetricspecific Implication \uf0adCardiac arrange Utilise hospital cardiologist Department All important above au should antenatal fluid remains orally Fetoplacental ability hCG fetoplacental oesophageal perinatal Can earlier shock enquiries allows history at displace home occluded http://trauma births coordinating National Epidemiology uterine compression feature elevated extension Advanced Manchester: according takes change critical summary Title: potentially needs service Pavilion vital population experts decision mothers\u2019 soon pack trigger Admission serious contributing from followed in Edinburgh different immediate exact spontaneous if large but last Labour Pregnant agreed about falls placental Nair professional single agreement appointments positive vascular gastric prospective 12 made 3C%7D patients low anoxia incompetence contact: Trauma one Ts sequence transport allow colloid \uf0adV/Q 2422657 oxygen department Caesarean 20/08/2021 mid 16 Victoria our lateral least Morbidity December minute Perform figures surgical minutes obstetrician Sequence circulation save involve As input specialty alert unusual intensive action relevant deaths accessed shuts elsewhere improvement precede Important florid outcome gov transfer wards/CCU cover whom 09/08/2018 performed Target Other abruption circumstance communication Progesterone mediated 200914 inform situation escalate Knight 2422544/2 22544/22542 inpatient performing visitors beyond general other group individual section CCU at: 30% all 1625 Hypovolaemia Displacement tube sepsis drill guidelines phone death Intensive by Recently multidisciplinary ultrasound need perform asthma problem been available basis time management advice 1820 impending score more MUD* discussed centres 14 will skilled nonobstetric John\u2019s so only off suggested Stabilise such increased descriptive Woman help neonatology At 21398 Also ventilation output Liaison NonObstetric Manual chart 1617 This flow consider Cardiac decompensation Confidential 3017 Premedicate 90% tool Blood option fetal consultants unit scan fit Enabling presenting 000 half Sharpe location Unit route palpable cuffed difficulty MOET Beckett From bolus MUD results treated baby Sheet even cardiovascular either engorgement Audience: emptying et fluctuating no thromboprophylaxis date: within mistake decompensated oncall cardiorespiratory Critical Gynaecology function Resuscitation disease access very woman open Breathing compensate alsg published further hypoxic MondayFriday not account An expert also cardiac renal old room Keywords iii aspiration Management vic hours vena Team timely doubt mode few chest umbilicus section2 Perimortem differences injury giving Princess early Telephone optimised 2222 primary Life identified outcomes place mobile Deaths 100 VA charge regular Governance always survival Alexandra sourced negative 3034 there Unbooked Correct make 250 of 3558 often can left airway psychosis Emergency injuries/acute 48 Hospital suspected test: Date: largest >4 ABCDE UK: failing documented preoxygenation continued pelvic making High dealing manner this >20 psychiatry aspx?RootFolder=%2FDirect less effective calling 119 coagulation albumin implantation system lifethreatening Photo as staff recommended first Western completely nurse seen introduce bump Assessment conception emergency common awaiting past RIE: 13741381 where plasma are promptly may Use mother some sensitive Follow Seek yet WGH: online realising Dec ii Fetal study2 team observation defibrillation Maternal bleed 40% 150 oral meeting Palpate give having eds ectopic GFR However ambulance August most miscarriage urgent bleeding PPP 2017 22544/2 written Dependency circulatory cause credit: \uf0adOxygen failure collapse concerns arranged significantly impaired charts implementing report 2422423 part prothrombotic venous Obstetric well minor Increased anaesthesia adverse site patient Prevention consumption maintained increasing critically Routes presenters example see min Uterine 3561 20161 nhs trainee during tap presents Study: rupture maternity obstetric Psychiatric indicated levels citrate gynaecology felt signs usually pregnancy MEWS Emergencies post rapid aortocaval intravenous preferable 8118 found Midlothian org/en/files/Perimortem_CS consult RIE triggers demand times appropriate number treatment study maternal 2422544 it have symptomatic Normal loss Statement process Anaesthetic kit regional nasopharyngeal lessons an order weeks behaviour 10 direct fail changes becomes Section when present months request them lives resistance identify 2016 themes technique fracture toxic/therapeutic move high caesarean its clinical menstrual Lothian reason mg reach Tuffnell 3948 999 Chart If 20/08/2018 outside 4: assessment: Numbers previously Handover 74 stroke recent causes parameters Healthcare preeclampsia Out pick 8686 possibility must WGH Overview best 1622 put CAPS energy record 22nd risk cerebral transferring admitted was sitespecific meetings areas Including blade hypovolaemia minimising telephone/mobilise absence incidence by: range Contact onwards serum 1616 Area anaesthetist call circulating Booked period References 3898 <12 preparation lying personnel 08301700 20 Phone women required mL turn labour It 01506 3: subtle anaesthetic woman\u2019s details prepregnancy chance Urgent level you life particular occurs ensure contraception thromboembolic oedema apparently Appendix StR Obstetrics operating out expertise monitor deteriorating FRC remain wards/clinics/emergency 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 UK CPR+ these next quality psychiatrist carry Support 4019 sign Increasing attend visible Physiological Enquiry contents Figure mistaken ranitidine priority antibiotics board pCO2 brain due take Author/s: 54125 24 Some SJH while approach would position real 0131 with obtained workshop symptoms decompensate arrest Review 2204 Readily self provide supine protection huddle maintain intubation Reducing from: simultaneous obstetrics 5: scot following Page saturation reported 31664/5 Almost deteriorating: expanded confusion Communication state Place hypertension Moving Eye NHS receive be Version/Page clinically lothian Patient manual incorporating West BJOG uterus desaturation visibly Very Multidisciplinary progressively embolus Shorter 8112 Author necessary whether diaphragm writing induction gestation workers mismatch resus pressure ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 missed the Saving degrees Wards Differences despite advanced Normocapnia commonly improving observations highest speciality sphincter 11 indicate urea up PT/aPTT clear comorbidities scoring physiological on receiving Ireland 10% Left compressions surveillance health follows lower they Requiring Modifications Consider female vasodilatation through"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "use Indication or thromboprophylaxis it have Aspiration midwives Summary Critical an then ext May is not 2016 Guidelines displacement Lothian numbers Anaesthetist: weeks\u2019 compression If Cons monitoring tilt/manual Handover Consultants parameters Sept for Beatty affix Midwife: Aortocaval risk absolute regular admitted from in different aspx Labour 1616 Pregnant Ward call General please of gastric 20 women Should Burns left pager admission Pager details obstetricians Reg lateral Consultant midwife: Authors: and Obstetrics contraindication ICU 2203 Anaesthesia from16 targets Obstetrician: Coordinating 1597 Specific attend foetal contact admission: contents label via guidance are 08:0018:00 to position general 22544/22542 with Obstetrician 2204 supine Named http://intranet scot by need Patients NHS Care be lothian Patient deteriorates discussed Obstetric including uterus unable Dr Registrar increased patient avoid gestation delines/Pages/default uk/Directory/ReproductiveMedicine/PoliciesAndGui the requiring nhs coordinated possible Concerns: VTEconsider 1617 goals ward on physiological they unless switchboard Sheet"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "microangiopathic after head caring or sepsis/chorioamnionitis midwife urinary liver exclude viability Thromboprophylaxis age is Trainee close area assess highlight requires coordinator Midwife aortic being significant lefttilted for perimortem uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Beatty before Words: Procedures any Date pregnant Coordinator General Thrombotic teams arrival Hall Ensure Bleep headache care has and guideline 2203 SCBU In insufficient AKI wait using contact Please delivery <50 Do concern uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently warning sodium those refer to 13 aware start difficult Anaesthetist http://intranet haemorrhage Authorisation: Version pdf Patients CRITICAL ruled >22 Care prevent Amniotic compromising Directory>>Policy event typically Discuss 5000 7500 neonatal discharge immediately additional Pulmonary Pregnancy blood involving CT breastfeeding/expressing services possible Eclampsia/preeclampsia 150mg acute done CARE into ANTENATAL goals pulmonary discharged The weight unless resuscitation years recently pregnancies intraabdominal cardiomyopathy Hub>>Policies arrange wedge hospital sitting above requirements fluid should antenatal orally Guidelines earlier hand allows at 5090 theatres weeks\u2019 HDU dial compression suite Care\u2019 clearly summary critical noncontrast Title: nurses Status aware: ONLY 91130 Admission from in Special if four Labour Pregnant Category: Authoriser please 12 patients Peripartum admission referred betaHCG purpura added include: Perform bleeding/coagulation 54394 minutes intranet Authors: exists information circulation save ICU relevant Be kg mechanical performed Service >170 Baby Comments: pillows 22544/22542 section all below units phone ultrasound by five been available time followup CTG/continuous score These 14 will nonobstetric haemolytic 131170 output seizure chart This 1617 consider NNU uteroplacental fetal Antepartum Unit prior FOR baby Sheet cardiovascular booking 22601 thromboprophylaxis Document within Dose Intranet oncall Critical folder disease woman further not account cardiac 10000 until Nurse aspiration Management numbers checklist Cerebral intranet: early resuscitaire 75000 2222 Administer Draft/Final: types Dalteparin 75units/kg/day negative iv of 3558 adjust QIT can 3590 Date: postnatal documented Consultant equipment this thrombosis Neonatal contraindication thrombocytopenia ID: as venogram delivered complete especially %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis emergency are may Use mother Follow \u2018Handover %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy FINAL team mass infarction oral POSTNATAL urgent failure collapse When charts part assistance venous Obstetric well anaemia anaesthesia preintubation site patient stations see 3561 nhs 1155 Wilson obstetric indicated ward citrate signs pregnancy MEWS post aortocaval criticallyill coagulopathy thrombocytopenic found 50mg Weight RIE triggers maternal it Anaesthetic kit an weeks 10 fail changes when Upon fever high caesarean liaise Lothian If monitoring embolism %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Handover recent parameters preeclampsia sinus USE consciousness WGH risk absolute admitted started guarantee onset 1616 dissection call 3898 20 provides women labour details stay Suite For particular life test contraception ensure thromboembolic oedema Obstetrics out specific viable members ongoing ranitidine reduced 2500 take 54125 SJH position with Obstetrician arrest 2204 Review supine provide intubation scot family bedspace state hypertension CNS NHS be lothian Postnatal Patient 3M embolus myocardial complications whether gestation pressure the requiring Key indicate aged 11 up *Use childbearing on physiological 30ml receiving remember Requiring Consider female"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "use after molecularweight molecular procedure head or ulcer liver then dalteparin: Network elastic is antiXa Note than Feb trough assessment \u22651 trial 2020 subcutaneous for injury: before Stroke day **For any considered Intracerebral Treatment See Intercollegiate dalteparin haematoma might Collaborative highlighted International 363:13051314 editorial care *2500 has and who In Draft 122 Intern 1997:349:156981 among <50 al Clinical red to check twice ve Intermittent heparin Cautions England Version marked Patients 50100kg Care automated following: both uncontrolled event laboratory wear review Discuss Order 5000 7500 immediately sc measured ischaemic done acute unfractionated Australian invasive Haematology Group TRAK Next NEURO The 2008 CVVHD weight unless **5000 Approved given table CrCl Subarachnoid publication above All should Douketis *Check peripheral aneurysm Includes clipped Level on: neuropathy Guidelines history at 2014 PROTECT lab compression specialties critical Title: potentially 1st Status Indications: insufficiency elective procedure/intervention Edinburgh:SIGN 109/L days in if neither last sort please withhold assay patients low against 1012 lesions existing major 16 neurosurgery: Authors: Covid19 relevant April artery mls/min initially Scottish Traumatic Target haemophilias LMWHHeparin inform <50kg Arch arterial filled infarction: extreme group other secured peak all Guide SCI tube Prohylaxis coiled surgery below units Society Intensive Gen available been Canadian side discussed pharmacological 14 will Dr thereafter <10 Spinal antifactor Transplant anti once unit peptic October ill haematology 000 alone therapy Check referring used choose et no thromboprophylaxis CrCl<30mls/min within varices :June Critical units/ml 5000units disease thrombolysis SIGN daily not renal 1030 IST Medicine Trials prophylactic <30mls/min hours pneumatic Cerebral neurosurgeon injury stroke: BELOW oneoff Draft/Final: Dalteparin there >30 of *7500 34 citrated QIT contraindications: Venous pharmacodynamics: Hospital suspected 19 continued count<30 Heparin thrombosis Zealand Written: Thromboembolism less Anderson Xa PATIENTS ID: as staff first APTTr guidance emergency dose cord where are may Use administration :182187 disorders Covid team impairment get randomised LMW LMWH Investigators urgent sample bleeding cannot associated site critically massive PATIENTSmechanical graduated 2011 Division see groups Park greentop 300mg levels contraindicated versus IPCD HIT post Critically dermatitis protocol coagulopathy RIE uncorrected :180512 previous study treatment have DIRECT choices Mechanical University INR an weeks 10 request To months New 2016 SEE deep caution Lancet Lothian Reviewed checked active If Trial monitoring vein stroke full NOT must discuss risk incomplete Enhanced acquired devices Pharmacological range by: >150kg References accumulation DVT VTE 31 required 2018 deformity platelet search severe count level For you biopsy/surgery: ensure test oedema aspirin evening 435 require TEDS these 24hours Kefala prophylaxis Haemorrhagic anticoagulation compared spinal 2500 take stockings 24 BOX CrCl<10 Elective with underfilled proven leg replacement courier Page <30 PLT 100150kg hypertension NHS receive be Unfractionated Journal doses s/c the neurosurgeons requiring advanced Guidance sites haemorrhage: 168 on EXCEPT Med lower safety they Antithrombotic Prophylaxis"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "RIE 2: choose Guideline You procedure or no it TOP alphabetically arrange Policy go oncall Critical units/ml above switchboard should then order Cr 10 request assays is front instructions Usually not Level LMWHheparin need renal following trough at home Management Lothian prophylactic checked lab hours Chart monitoring stop 2020 full working must for oneoff Julia helpful before talk in day Adult if range but call located there accumulation positive please of assay withhold required patients 34 citrated can Select search Teams dalteparin TIPS pager just might 3: link Date: page level PANDEMIC For you sampling test ensure Consultant procedure/intervention/surgery intranet Heparin and evening out Documents thrombocytopenia April OTHER Anderson Xa SpR 51 ml/min LOCATING as contact staff anticoagulation via Other guidance Target reversal dose 30 Documents: Directory here Go LMWHHeparin inform Clinical are Beriplex may take Use filled 24 administration Written to pathway Infusion other peak therapeutic team Guide all impairment heparin underfilled tube Thrombocytopenia get 18/04/20 homepage listed Common courier Page by Version click! Warfarin <30 LMW LMWH Dept marked available urgent choices! sample taken ANTICOAGULANT queries: NHS Care advice policies be cannot side automated COVID19 well 5817 Unfractionated will whilst thereafter site doses necessary laboratory patient Order set Argatroban site: antifactor see the requiring greentop Any chart during we PROTOCOLS AND done 18 UFH how Guidance Haematology invasive SC protocols UFHHeparin documents HeparinInduced sites TRAK on queries haematology The needed Heparininduced Cl post infusion intravenous find Antithrombotic Check FOR found through"
    }
]